data_2m20_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2m20 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.362 0.125 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.27 139.02 40.84 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.626 2.217 . . . . 0.0 112.729 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.8 m -80.58 -7.14 59.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.503 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mp -82.94 -32.6 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.131 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.91 -28.33 27.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.587 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.15 -31.9 73.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.545 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.96 -41.94 9.21 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.229 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 13' ' ' LEU . 23.9 mt -61.98 -43.21 99.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.749 -0.225 . . . . 0.0 111.194 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.695 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 25.2 m -61.0 -39.05 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.832 0.349 . . . . 0.0 111.656 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.21 -48.4 52.99 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.742 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -74.28 -43.16 58.02 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.33 -40.0 93.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.455 0.169 . . . . 0.0 110.954 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.695 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.1 mp -72.41 -39.77 67.66 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.082 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.2 OUTLIER -70.16 -39.25 75.43 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.567 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -70.08 -34.7 73.49 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.591 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.44 -42.29 75.14 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.59 HG21 ' O ' ' A' ' 14' ' ' LEU . 99.3 t -69.1 -42.85 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.128 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 15' ' ' LEU . 94.8 t -68.89 -39.69 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.024 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.59 -36.46 73.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.352 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 1.7 tp -70.27 -44.97 67.34 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.71 -56.22 8.66 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.529 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.1 mm -64.25 -37.64 80.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.745 0.307 . . . . 0.0 110.621 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.16 -46.58 87.45 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.329 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.7 mt -73.05 -24.0 60.65 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.677 0.275 . . . . 0.0 110.986 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.51 -39.91 64.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.194 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.404 ' O ' ' HD2' ' A' ' 31' ' ' HIS . 18.9 mt -83.34 -33.68 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.248 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.76 -26.0 66.76 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.645 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -81.88 -18.16 44.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.401 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.51 -21.61 38.52 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.617 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.404 ' HD2' ' O ' ' A' ' 27' ' ' ILE . 58.0 m-70 -70.74 -28.63 64.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.692 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt . . . . . 0 N--CA 1.466 0.347 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.106 179.938 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 1.005 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 6.1 tp . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 121.058 0.456 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -97.87 -33.87 11.07 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 114.706 -1.133 . . . . 0.0 107.966 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -75.68 -21.84 57.24 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.157 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.7 mt -104.84 -19.72 13.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.405 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 1.005 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 4.1 tt . . . . . 0 N--CA 1.469 0.522 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.676 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 111.184 0.068 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.14 138.95 41.1 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.726 2.284 . . . . 0.0 112.719 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 52.8 m -80.52 -7.24 59.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.49 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . 0.404 ' H ' HD13 ' B' ' 65' ' ' ILE . 2.4 mp -82.9 -32.76 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.072 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.417 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -28.22 28.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.605 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.13 -31.97 73.37 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.538 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.99 -41.86 9.25 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.228 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.521 ' O ' HD13 ' B' ' 73' ' ' LEU . 23.8 mt -62.02 -43.2 99.34 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.625 0.25 . . . . 0.0 111.215 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.686 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 25.5 m -61.02 -39.09 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 111.619 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.18 -48.47 52.66 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.714 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' B' ' 76' ' ' LEU . . . -74.2 -43.17 58.27 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.521 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.31 -40.0 93.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.029 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.1 mp -72.3 -39.85 67.97 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.095 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.2 OUTLIER -70.21 -39.22 75.28 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.553 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 0.7 OUTLIER -70.04 -34.65 73.51 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.67 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.45 -42.43 74.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.976 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.593 HG21 ' O ' ' B' ' 74' ' ' LEU . 99.9 t -68.99 -42.88 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.128 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.494 HG23 ' O ' ' B' ' 75' ' ' LEU . 95.5 t -68.91 -39.73 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.031 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.46 -36.53 73.97 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.371 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 1.7 tp -70.37 -44.89 67.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.035 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.76 -56.22 8.6 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.489 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 47.2 mm -64.22 -37.71 80.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.683 0.277 . . . . 0.0 110.554 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.05 -46.64 88.17 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.406 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 25.8 mt -73.1 -23.94 60.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.577 0.227 . . . . 0.0 110.962 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -39.83 64.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.25 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 18.8 mt -83.34 -33.76 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.2 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.76 -25.97 66.75 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.682 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -81.96 -18.03 44.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.416 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.55 -21.58 38.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.575 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -70.77 -28.6 64.8 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.683 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mt . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.065 179.949 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 1.026 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 6.1 tp . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 121.105 0.479 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -97.81 -33.88 11.09 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.025 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -75.61 -21.83 57.41 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.224 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 22.8 mt -104.78 -19.72 13.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.42 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . 1.026 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 4.2 tt . . . . . 0 N--CA 1.47 0.564 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.331 0.11 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.38 143.72 59.07 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.629 2.219 . . . . 0.0 112.803 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 t -80.58 -8.35 59.57 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.465 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 mp -83.01 -32.0 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.089 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.433 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.93 -26.62 29.17 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.585 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.0 -32.87 74.56 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.524 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.94 -41.36 9.64 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.245 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 22.3 mt -62.14 -42.99 99.79 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.736 -0.232 . . . . 0.0 111.36 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.679 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 23.9 m -60.93 -39.47 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.777 0.322 . . . . 0.0 111.688 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.68 -48.98 46.31 Favored Glycine 0 C--O 1.236 0.222 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.703 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.75 -41.3 62.68 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -67.09 -39.69 86.81 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.679 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.6 mp -71.25 -39.38 71.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.625 0.25 . . . . 0.0 110.771 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.508 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.33 -40.48 77.57 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.303 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 tp -69.64 -32.25 70.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 3.5 tp -69.96 -42.55 73.04 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.91 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 14' ' ' LEU . 59.1 t -69.18 -43.42 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.015 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 15' ' ' LEU . 91.0 t -66.46 -43.46 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.852 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.79 83.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.101 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.2 tp -69.44 -36.35 76.54 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.522 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.414 ' O ' ' HD1' ' A' ' 26' ' ' PHE . . . -67.42 -53.38 25.35 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.222 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.561 ' O ' HG12 ' A' ' 27' ' ' ILE . 11.0 mt -64.47 -37.34 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.649 0.261 . . . . 0.0 110.536 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.66 -44.32 95.13 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.414 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 mt -73.45 -27.01 61.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.445 0.164 . . . . 0.0 111.141 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.414 ' HD1' ' O ' ' A' ' 22' ' ' GLY . 2.8 m-85 -76.43 -36.59 57.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.432 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 23' ' ' ILE . 47.5 mm -83.52 -32.84 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.237 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -67.73 -25.77 65.82 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.554 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.79 -33.79 30.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.164 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -86.32 -21.33 27.34 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.411 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 27' ' ' ILE . 3.2 t60 -70.03 -15.94 63.08 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.806 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt . . . . . 0 CA--C 1.533 0.298 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.133 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.95 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.3 mm? . . . . . 0 C--O 1.221 -0.405 0 CA-C-O 120.531 0.205 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -63.28 -28.57 70.11 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.313 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -67.52 -21.84 65.46 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.4 mt -111.78 -26.31 9.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 113.537 -1.665 . . . . 0.0 109.941 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.95 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.353 0.721 0 CA-C-O 120.577 0.227 . . . . 0.0 111.448 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.248 0.07 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.49 143.71 58.38 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.606 2.204 . . . . 0.0 112.797 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.1 t -80.53 -8.39 59.56 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.517 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . 0.4 ' H ' HD12 ' B' ' 65' ' ' ILE . 2.7 mp -82.9 -32.1 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.128 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.425 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.95 -26.5 29.22 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.659 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.03 -32.77 74.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.542 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.08 -41.24 9.6 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.243 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.2 mt -62.17 -43.08 99.64 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 122.331 0.253 . . . . 0.0 111.365 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.672 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 23.4 m -61.0 -39.31 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.878 0.371 . . . . 0.0 111.782 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.78 -48.79 46.91 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.809 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.22 62.52 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -67.19 -39.54 86.4 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.434 0.159 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.672 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.5 mp -71.35 -39.37 71.35 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.641 0.258 . . . . 0.0 110.712 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.527 ' O ' HG22 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.33 -40.48 77.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.266 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 2.4 tp -69.74 -32.29 70.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.42 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' B' ' 73' ' ' LEU . 3.5 tp -69.88 -42.6 73.24 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.016 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.607 HG23 ' O ' ' B' ' 74' ' ' LEU . 59.1 t -69.13 -43.44 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.983 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.527 HG22 ' O ' ' B' ' 75' ' ' LEU . 91.0 t -66.44 -43.42 91.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.899 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.86 83.62 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.08 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 3.1 tp -69.31 -36.41 76.96 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.53 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.417 ' O ' ' HD1' ' B' ' 86' ' ' PHE . . . -67.51 -53.23 25.81 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.196 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.57 ' O ' HG12 ' B' ' 87' ' ' ILE . 11.0 mt -64.59 -37.33 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.704 0.287 . . . . 0.0 110.495 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.3 95.04 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.396 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 19.0 mt -73.43 -27.05 61.22 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.557 0.218 . . . . 0.0 111.287 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' B' ' 82' ' ' GLY . 2.7 m-85 -76.51 -36.42 57.77 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.458 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.57 HG12 ' O ' ' B' ' 83' ' ' ILE . 47.6 mm -83.58 -32.77 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.212 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -67.77 -25.82 65.8 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.459 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.81 -33.74 30.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.201 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -86.21 -21.43 27.46 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.501 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 91' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' B' ' 87' ' ' ILE . 3.2 t60 -69.98 -15.89 63.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.726 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mt . . . . . 0 N--CA 1.465 0.318 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.044 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.947 ' O ' ' N ' ' B' ' 102' ' ' LEU . 1.3 mm? . . . . . 0 C--O 1.222 -0.37 0 CA-C-O 120.607 0.241 . . . . 0.0 110.588 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -63.29 -28.74 70.22 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.577 0.751 . . . . 0.0 109.272 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -67.42 -21.85 65.55 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 mt -111.8 -26.2 9.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.979 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . 0.947 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.352 0.691 0 CA-C-O 120.61 0.243 . . . . 0.0 111.464 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 111.178 0.066 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.57 147.06 81.43 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.556 2.171 . . . . 0.0 112.6 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.1 m -80.66 -21.74 41.12 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.494 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.41 ' H ' HD13 ' A' ' 5' ' ' ILE . 2.3 mp -83.0 -22.12 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.92 -33.89 24.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.601 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -27.81 69.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.465 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.87 -44.67 7.59 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.238 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 18.6 mt -62.36 -42.47 99.43 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.586 0.231 . . . . 0.0 111.227 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.706 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 22.4 m -61.37 -41.85 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.761 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -67.1 -48.23 60.74 Favored Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.974 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -74.11 -44.14 55.01 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.73 -38.84 90.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.432 0.158 . . . . 0.0 111.092 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.706 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.1 mp -72.76 -39.44 66.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.586 0.232 . . . . 0.0 110.958 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -70.29 -38.22 74.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.363 179.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.9 tp -71.02 -35.19 71.91 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.688 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tt -68.99 -44.38 72.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.257 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 14' ' ' LEU . 58.6 t -69.45 -44.48 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.365 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 15' ' ' LEU . 74.4 t -66.77 -42.33 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.171 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.37 83.63 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.977 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.68 -35.64 77.47 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.614 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.97 -52.69 26.95 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.36 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.525 ' O ' HG12 ' A' ' 27' ' ' ILE . 13.7 mt -65.96 -35.23 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.558 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -65.75 -45.78 86.91 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.117 -0.564 . . . . 0.0 112.402 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.0 mt -75.24 -24.82 57.72 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.55 0.214 . . . . 0.0 111.309 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.8 t80 -77.56 -37.86 49.79 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.253 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 23' ' ' ILE . 50.6 mm -83.65 -33.44 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.194 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.519 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 15.0 ttm180 -66.22 -26.96 67.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.654 0.264 . . . . 0.0 111.312 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -82.23 -18.21 43.34 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.347 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -83.9 -21.77 31.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.521 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.09 -20.43 34.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.473 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 28' ' ' ARG . 11.0 mm . . . . . 0 N--CA 1.464 0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.995 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 1.052 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 3.3 mm? . . . . . 0 C--O 1.226 -0.181 0 CA-C-O 120.948 0.404 . . . . 0.0 110.614 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -98.03 -35.44 10.44 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.367 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -73.85 -19.07 60.84 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.441 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.57 -20.7 13.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.508 177.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 1.052 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 3.9 tt . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 120.824 0.345 . . . . 0.0 110.754 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 111.128 0.047 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.79 147.05 80.4 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.628 2.219 . . . . 0.0 112.487 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -80.47 -21.94 41.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.505 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . 0.41 ' H ' HD13 ' B' ' 65' ' ' ILE . 2.3 mp -82.81 -22.14 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.247 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.91 -33.95 24.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.56 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.61 -27.84 69.51 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.539 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.82 -44.7 7.6 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.266 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 18.4 mt -62.19 -42.71 99.54 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-O 120.627 0.251 . . . . 0.0 111.25 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 22.5 m -61.31 -41.79 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.766 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.08 -48.33 60.34 Favored Glycine 0 CA--C 1.517 0.177 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.008 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' B' ' 76' ' ' LEU . . . -74.12 -44.17 54.84 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.71 -38.71 89.96 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.403 0.144 . . . . 0.0 111.126 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.1 mp -72.79 -39.56 66.6 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.92 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -70.17 -38.27 75.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.442 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.9 tp -71.02 -35.18 71.93 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.697 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' B' ' 73' ' ' LEU . 2.1 tt -68.88 -44.44 73.26 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.296 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.554 HG23 ' O ' ' B' ' 74' ' ' LEU . 58.4 t -69.47 -44.46 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.312 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.466 HG22 ' O ' ' B' ' 75' ' ' LEU . 75.0 t -66.81 -42.39 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.154 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.27 83.76 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.098 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.2 tp -68.74 -35.58 77.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.94 -52.7 27.01 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.404 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.52 ' O ' HG12 ' B' ' 87' ' ' ILE . 13.7 mt -65.94 -35.38 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.616 0.246 . . . . 0.0 110.514 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -65.58 -45.9 87.29 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.451 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 16.0 mt -75.1 -24.87 58.15 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.558 0.218 . . . . 0.0 111.281 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.8 t80 -77.58 -37.89 49.5 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.225 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.52 HG12 ' O ' ' B' ' 83' ' ' ILE . 50.7 mm -83.55 -33.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.202 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.517 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 15.1 ttm180 -66.05 -27.08 67.83 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.657 0.265 . . . . 0.0 111.327 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -82.16 -18.25 43.45 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.412 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -83.72 -21.84 32.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.621 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.09 -20.47 34.84 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.426 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . 0.433 HG12 ' O ' ' B' ' 88' ' ' ARG . 11.1 mm . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.983 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 1.067 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.463 0.176 0 CA-C-O 121.1 0.476 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -98.15 -35.41 10.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.38 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -73.85 -19.05 60.84 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.48 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -108.52 -20.81 12.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.536 177.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . 1.067 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 3.8 tt . . . . . 0 N--CA 1.472 0.625 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.772 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 111.205 0.076 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.99 141.77 49.34 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.711 2.274 . . . . 0.0 112.765 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 m -80.57 -7.67 59.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.534 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.401 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.7 mp -82.93 -32.38 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.075 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -84.01 -27.64 28.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.552 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.42 -31.98 73.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.456 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.04 -41.69 9.32 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.217 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 13' ' ' LEU . 23.2 mt -62.01 -43.65 98.39 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 122.309 0.244 . . . . 0.0 111.187 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.684 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 25.2 m -60.48 -38.18 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 111.663 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -69.0 -49.32 42.03 Favored Glycine 0 CA--C 1.518 0.24 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.756 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.58 -41.48 62.84 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.9 mp -66.21 -41.79 89.65 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.79 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.684 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.8 mp -70.5 -38.83 74.38 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.916 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -69.7 -37.16 76.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.442 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tp -69.81 -36.93 76.06 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.6 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.58 -40.85 76.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.288 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 14' ' ' LEU . 93.1 t -69.57 -42.37 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.2 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 15' ' ' LEU . 97.7 t -70.62 -38.38 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.176 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.67 -39.17 73.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.295 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.7 tp -70.86 -43.4 68.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.945 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.82 -57.84 7.5 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.5 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.544 ' O ' HG12 ' A' ' 27' ' ' ILE . 41.4 mm -65.86 -33.64 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.643 0.259 . . . . 0.0 110.589 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -65.6 -47.65 75.32 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.322 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt -74.8 -24.1 58.59 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.55 0.214 . . . . 0.0 111.147 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.2 t80 -75.43 -39.69 58.56 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.242 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 23' ' ' ILE . 45.5 mm -83.59 -32.33 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.192 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.2 ttt180 -65.4 -26.1 67.84 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.351 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -81.74 -18.04 45.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.406 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -81.53 -21.48 38.52 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.616 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' A' ' 27' ' ' ILE . 54.8 m-70 -70.57 -27.86 64.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.642 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 mt . . . . . 0 N--CA 1.466 0.342 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.136 179.888 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 1.002 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 23.3 mt . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 121.239 0.542 . . . . 0.0 110.138 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.85 -33.29 11.3 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -77.24 -24.24 51.2 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.013 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.5 mt -100.37 -20.29 15.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.238 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 1.002 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 2.6 tp . . . . . 0 N--CA 1.469 0.511 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.585 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 111.221 0.082 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.14 141.9 49.09 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.635 2.223 . . . . 0.0 112.698 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.6 m -80.67 -7.66 59.38 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.497 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . 0.4 ' H ' HD12 ' B' ' 65' ' ' ILE . 2.6 mp -82.81 -32.38 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.116 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.416 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.96 -27.7 28.31 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.552 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.44 -31.99 73.44 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.521 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.01 -41.67 9.36 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.207 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.543 ' O ' HD13 ' B' ' 73' ' ' LEU . 23.1 mt -61.95 -43.59 98.53 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.598 0.237 . . . . 0.0 111.32 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.671 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 25.4 m -60.44 -38.23 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 111.605 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -69.13 -49.29 41.28 Favored Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.671 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.51 -41.5 62.99 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.543 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.9 mp -66.2 -41.76 89.72 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.806 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.671 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -70.62 -38.7 73.97 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.875 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.0 OUTLIER -69.62 -37.3 76.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.481 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tp -69.73 -36.89 76.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.61 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.62 -40.74 76.39 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.32 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.587 HG22 ' O ' ' B' ' 74' ' ' LEU . 93.1 t -69.63 -42.46 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.188 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.479 HG23 ' O ' ' B' ' 75' ' ' LEU . 98.1 t -70.51 -38.45 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.089 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.68 -39.24 73.66 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.22 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.7 tp -70.9 -43.31 68.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.937 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.84 -57.87 7.44 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.49 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.536 ' O ' HG12 ' B' ' 87' ' ' ILE . 41.2 mm -65.78 -33.64 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.581 0.229 . . . . 0.0 110.625 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -65.64 -47.61 75.4 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.361 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 20.7 mt -74.84 -24.03 58.54 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.563 0.22 . . . . 0.0 111.179 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.3 t80 -75.51 -39.73 58.04 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.159 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.536 HG12 ' O ' ' B' ' 83' ' ' ILE . 45.6 mm -83.59 -32.38 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.135 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.1 ttt180 -65.36 -26.01 67.83 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.438 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -81.72 -18.01 45.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.46 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -81.61 -21.38 38.35 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.59 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 91' ' ' HIS . . . . . 0.417 ' HD2' ' O ' ' B' ' 87' ' ' ILE . 54.9 m-70 -70.65 -27.8 64.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.644 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 1.8 mt . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.102 179.899 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 1.006 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 23.8 mt . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 121.204 0.526 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.83 -33.17 11.35 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -77.45 -24.17 50.33 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 114.281 -1.327 . . . . 0.0 107.896 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 14.6 mt -100.39 -20.35 15.85 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.29 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . 1.006 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 2.6 tp . . . . . 0 N--CA 1.468 0.471 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.686 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.234 0.255 0 N-CA-C 111.234 0.087 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.9 141.21 48.12 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.78 2.32 . . . . 0.0 112.696 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 t -80.69 -7.6 59.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.44 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.6 mp -82.99 -32.66 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.09 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.95 -25.86 29.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.656 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -63.78 -33.49 75.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.59 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.0 -40.91 9.95 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.289 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 22.0 mt -62.24 -43.38 98.96 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 122.283 0.233 . . . . 0.0 111.393 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.678 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.1 m -60.91 -41.09 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 111.779 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -67.51 -48.34 57.64 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.877 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -73.99 -43.5 57.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.4 -39.47 92.25 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 122.911 0.132 . . . . 0.0 110.971 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.678 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.0 mp -72.22 -39.83 68.23 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.605 0.241 . . . . 0.0 110.924 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -70.2 -38.43 75.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.583 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.3 tp -70.69 -34.52 72.05 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.657 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.34 -44.14 72.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.162 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 14' ' ' LEU . 59.8 t -69.25 -44.04 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.226 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 15' ' ' LEU . 71.8 t -66.55 -43.27 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.151 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.26 86.49 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.124 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.36 -36.32 79.04 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.635 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.93 -50.14 43.14 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.299 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 mt -64.39 -41.22 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.669 0.271 . . . . 0.0 110.603 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.42 -44.65 96.45 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.404 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.491 ' HG ' ' NH2' ' A' ' 28' ' ' ARG . 20.1 mt -73.95 -23.83 59.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.595 0.236 . . . . 0.0 110.931 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 6.6 t80 -74.43 -39.13 62.79 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.35 -35.0 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.255 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.491 ' NH2' ' HG ' ' A' ' 25' ' ' LEU . 74.0 mtm180 -64.14 -26.29 68.47 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.656 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -82.14 -18.13 43.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.358 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.46 ' NH2' ' HE2' ' A' ' 26' ' ' PHE . 97.6 mtt180 -86.12 -21.58 27.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.622 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -70.39 -29.32 65.93 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.713 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt . . . . . 0 N--CA 1.466 0.327 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.097 179.923 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 1.041 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 121.132 0.491 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -97.66 -34.46 10.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -74.73 -20.24 59.91 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.097 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.8 mt -104.82 -22.47 13.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.315 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 1.041 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 2.9 tt . . . . . 0 N--CA 1.469 0.482 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.555 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.259 0 CA-C-O 120.312 0.101 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.04 141.3 47.74 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.6 2.2 . . . . 0.0 112.708 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.4 t -80.61 -7.7 59.36 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.413 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . 0.401 ' H ' HD11 ' B' ' 65' ' ' ILE . 2.6 mp -82.88 -32.65 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.133 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.443 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.99 -25.9 29.62 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.639 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -63.76 -33.62 76.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.465 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.86 -40.96 10.02 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.289 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 21.9 mt -62.26 -43.37 98.98 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.346 0.258 . . . . 0.0 111.381 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.667 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 23.7 m -60.99 -40.96 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.765 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.58 -48.43 56.7 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.806 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' B' ' 76' ' ' LEU . . . -73.86 -43.63 58.03 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.27 -39.42 92.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.45 0.167 . . . . 0.0 111.056 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.667 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.0 mp -72.39 -39.68 67.8 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.646 0.26 . . . . 0.0 110.947 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -70.13 -38.52 75.57 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.584 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.3 tp -70.76 -34.53 71.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.566 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.21 -44.23 72.5 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.168 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.57 HG21 ' O ' ' B' ' 74' ' ' LEU . 59.9 t -69.31 -43.88 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.286 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.451 HG22 ' O ' ' B' ' 75' ' ' LEU . 71.7 t -66.51 -43.5 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.029 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.15 86.52 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.159 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.3 tp -68.39 -36.33 78.99 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.683 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.88 -50.1 43.73 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.427 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 19.1 mt -64.44 -41.23 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.652 0.263 . . . . 0.0 110.562 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.55 -44.63 96.29 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.317 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.489 ' HG ' ' NH2' ' B' ' 88' ' ' ARG . 20.0 mt -73.86 -23.85 59.67 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.704 0.288 . . . . 0.0 111.015 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 6.5 t80 -74.37 -39.22 62.88 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.127 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.29 -35.08 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.258 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.489 ' NH2' ' HG ' ' B' ' 85' ' ' LEU . 74.2 mtm180 -64.11 -26.3 68.48 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.632 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -82.11 -18.3 43.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . 0.464 ' NH2' ' HE2' ' B' ' 86' ' ' PHE . 97.6 mtt180 -86.01 -21.71 27.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.607 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -70.31 -29.44 66.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.69 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.465 0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 179.917 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 1.015 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 121.042 0.449 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -97.59 -34.46 10.95 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -74.63 -20.26 59.97 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.127 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 6.8 mt -104.78 -22.56 13.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.239 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . 1.015 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 2.8 tt . . . . . 0 N--CA 1.469 0.489 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.637 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.25 0 CA-C-O 120.286 0.089 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.93 150.59 73.34 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.597 2.198 . . . . 0.0 112.691 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.7 m -80.59 -10.12 59.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.595 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.1 mp -82.88 -30.89 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.076 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.92 -27.1 28.82 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.637 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -63.86 -32.68 74.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.543 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.52 9.55 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.346 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.515 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 21.8 mt -62.15 -43.02 99.76 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 115.725 -0.237 . . . . 0.0 111.431 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.675 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.5 m -60.83 -39.61 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.726 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.69 -48.81 47.39 Favored Glycine 0 C--O 1.235 0.217 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.836 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.82 -41.41 62.37 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -67.03 -39.65 87.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.438 0.161 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.675 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.5 mp -71.37 -39.35 71.28 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.766 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.511 ' O ' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.37 -40.44 77.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.323 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tp -69.55 -32.68 71.63 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.528 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 3.5 tp -69.68 -43.0 73.38 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.99 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.604 HG21 ' O ' ' A' ' 14' ' ' LEU . 60.0 t -68.99 -43.65 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.061 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 15' ' ' LEU . 93.3 t -66.34 -43.31 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.69 -37.5 82.39 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.094 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -69.78 -35.85 75.22 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.592 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.14 -52.75 25.88 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.279 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.584 ' O ' HG12 ' A' ' 27' ' ' ILE . 11.2 mt -65.13 -37.76 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.633 0.254 . . . . 0.0 110.577 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.94 -46.53 91.28 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.31 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.56 -24.47 60.11 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.587 0.232 . . . . 0.0 111.126 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 8.1 t80 -75.81 -38.74 57.89 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.274 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 23' ' ' ILE . 39.3 mm -83.7 -31.91 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.196 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -66.62 -25.8 66.77 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.691 0.281 . . . . 0.0 111.578 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.7 -18.09 45.64 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.304 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -82.68 -21.29 34.96 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.529 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -69.57 -15.8 63.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.883 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.9 mt . . . . . 0 N--CA 1.466 0.354 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.01 179.922 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.906 ' O ' ' N ' ' A' ' 42' ' ' LEU . 15.1 tp . . . . . 0 C--O 1.223 -0.331 0 CA-C-O 120.683 0.278 . . . . 0.0 110.378 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -67.71 -29.09 68.25 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -69.28 -17.99 63.8 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.0 -27.11 8.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.633 177.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.906 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.351 0.672 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.296 0.093 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.68 150.49 74.46 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.668 2.246 . . . . 0.0 112.755 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.4 m -80.63 -10.14 59.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.473 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 3.1 mp -82.95 -30.83 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.082 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.426 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -26.97 28.94 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.628 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -63.89 -32.68 74.28 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.528 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.89 -41.6 9.51 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.289 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.1 mt -62.21 -43.11 99.57 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.657 -0.272 . . . . 0.0 111.31 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.67 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.2 m -60.81 -39.5 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.744 0.306 . . . . 0.0 111.767 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.73 -48.87 46.73 Favored Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.775 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.76 -41.33 62.6 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -67.11 -39.73 86.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.876 -0.147 . . . . 0.0 110.85 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -71.27 -39.36 71.62 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.67 0.271 . . . . 0.0 110.824 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.523 ' O ' HG21 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.31 -40.48 77.64 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.389 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 tp -69.6 -32.54 71.34 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.556 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.83 -42.87 73.05 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.997 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.608 HG21 ' O ' ' B' ' 74' ' ' LEU . 59.7 t -69.06 -43.67 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.066 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.523 HG21 ' O ' ' B' ' 75' ' ' LEU . 94.3 t -66.3 -43.41 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.61 -37.44 82.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.146 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.2 tp -69.82 -35.73 75.04 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.63 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.2 -52.71 25.85 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.215 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.59 ' O ' HG12 ' B' ' 87' ' ' ILE . 11.2 mt -65.23 -37.77 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 110.471 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.98 -46.44 91.42 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.377 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.53 -24.54 60.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.595 0.236 . . . . 0.0 111.179 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 8.3 t80 -75.85 -38.64 57.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.269 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.59 HG12 ' O ' ' B' ' 83' ' ' ILE . 39.1 mm -83.72 -31.91 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.178 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -66.65 -25.95 66.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.506 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.55 -18.09 46.17 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.332 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -82.63 -21.32 35.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.522 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -69.52 -15.96 63.34 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.825 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.9 mt . . . . . 0 CA--C 1.533 0.325 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.989 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.896 ' O ' ' N ' ' B' ' 102' ' ' LEU . 15.0 tp . . . . . 0 C--O 1.222 -0.366 0 CA-C-O 120.655 0.264 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -67.59 -29.18 68.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -69.21 -18.05 63.85 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 11.7 mt -112.02 -27.06 8.56 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.671 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . 0.896 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.351 0.638 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.233 0.236 0 CA-C-O 120.374 0.13 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.93 143.79 56.17 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.687 2.258 . . . . 0.0 112.809 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.0 m -80.57 -8.1 59.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.498 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.87 -32.26 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.128 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.96 -27.02 28.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.557 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.0 -32.56 74.15 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.574 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.06 -41.36 9.53 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.208 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 22.1 mt -62.26 -43.16 99.47 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 122.339 0.256 . . . . 0.0 111.27 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.67 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.1 m -60.79 -39.86 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 111.713 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.5 -48.74 49.06 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.754 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.8 -41.73 61.97 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -66.75 -39.63 87.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.421 0.153 . . . . 0.0 110.982 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.7 mp -71.38 -39.57 71.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.647 0.26 . . . . 0.0 110.83 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.51 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.37 -40.11 77.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.244 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 tp -69.85 -32.83 71.43 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.54 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.58 -43.26 73.18 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.059 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 14' ' ' LEU . 61.7 t -69.0 -43.9 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.087 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 15' ' ' LEU . 98.7 t -66.22 -43.04 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.014 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.58 82.04 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.4 tp -69.45 -36.04 76.24 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.534 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.19 -52.85 25.08 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.219 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.559 ' O ' HG12 ' A' ' 27' ' ' ILE . 12.1 mt -65.53 -36.33 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.689 0.28 . . . . 0.0 110.456 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.96 -46.24 89.92 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.37 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.489 ' HG ' ' NH2' ' A' ' 28' ' ' ARG . 17.5 mt -74.12 -24.38 59.43 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.663 0.268 . . . . 0.0 111.221 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.8 t80 -76.89 -38.07 54.28 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.303 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 23' ' ' ILE . 46.7 mm -83.68 -33.43 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.236 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.489 ' NH2' ' HG ' ' A' ' 25' ' ' LEU . 68.6 mtm180 -64.19 -25.81 68.24 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.67 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -79.47 -18.2 52.55 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.2 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.07 -21.43 27.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.51 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . 0.427 ' HD2' ' O ' ' A' ' 27' ' ' ILE . 42.8 m-70 -69.65 -15.73 63.24 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.9 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 CA--C 1.533 0.305 0 CA-C-O 120.676 0.274 . . . . 0.0 111.042 179.902 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.931 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.5 mm? . . . . . 0 C--O 1.223 -0.336 0 CA-C-O 120.548 0.214 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.4 -28.91 70.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.083 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -68.1 -20.21 64.91 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.9 mt -112.31 -25.76 9.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.828 177.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.931 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.352 0.696 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.279 0 CA-C-O 120.28 0.086 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.93 143.8 56.17 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.624 2.216 . . . . 0.0 112.797 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.0 m -80.59 -8.03 59.46 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.536 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.91 -32.32 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.063 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.426 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.91 -26.91 28.97 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.612 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -32.62 74.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.484 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.86 -41.5 9.61 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.297 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.515 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.1 mt -62.25 -43.07 99.67 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.684 -0.258 . . . . 0.0 111.344 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.667 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.1 m -60.88 -39.79 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.733 0.302 . . . . 0.0 111.735 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.56 -48.6 49.55 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.862 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.85 -41.7 61.87 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -66.8 -39.67 87.84 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.438 0.161 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.667 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -71.3 -39.66 71.32 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.77 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.512 ' O ' HG22 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.32 -40.03 77.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.415 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tp -69.92 -32.81 71.29 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.6 -43.21 73.24 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.033 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.607 HG22 ' O ' ' B' ' 74' ' ' LEU . 61.6 t -69.04 -43.91 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.036 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.512 HG22 ' O ' ' B' ' 75' ' ' LEU . 99.0 t -66.24 -43.09 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.957 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.83 -37.57 82.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.4 tp -69.46 -36.05 76.21 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.599 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.2 -52.8 25.31 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.249 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.561 ' O ' HG12 ' B' ' 87' ' ' ILE . 12.0 mt -65.48 -36.28 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.665 0.269 . . . . 0.0 110.537 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.92 -46.25 89.95 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.339 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . 0.491 ' HG ' ' NH2' ' B' ' 88' ' ' ARG . 17.8 mt -74.14 -24.47 59.43 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.525 0.202 . . . . 0.0 111.071 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.8 t80 -76.89 -38.08 54.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.306 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.561 HG12 ' O ' ' B' ' 83' ' ' ILE . 46.6 mm -83.59 -33.46 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.258 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.491 ' NH2' ' HG ' ' B' ' 85' ' ' LEU . 69.0 mtm180 -64.16 -25.88 68.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.638 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -79.37 -18.32 52.62 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.244 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.02 -21.44 27.78 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.527 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 91' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' B' ' 87' ' ' ILE . 43.0 m-70 -69.63 -15.73 63.25 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.926 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.466 0.338 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.067 179.83 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.911 ' O ' ' N ' ' B' ' 102' ' ' LEU . 1.5 mm? . . . . . 0 C--O 1.221 -0.41 0 CA-C-O 120.544 0.211 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.35 -29.05 70.13 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 123.565 0.746 . . . . 0.0 109.126 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -67.97 -20.21 65.02 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 6.8 mt -112.23 -25.83 9.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.868 177.641 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . 0.911 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.352 0.713 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.53 0.186 0 CA-C-O 120.323 0.106 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.19 139.52 42.42 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.642 2.228 . . . . 0.0 112.834 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.4 m -80.53 -7.19 59.11 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.544 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.401 HD12 ' H ' ' A' ' 5' ' ' ILE . 2.5 mp -82.97 -32.87 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.083 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.433 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.95 -27.12 28.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.553 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.09 -32.54 74.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.593 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.98 -41.41 9.57 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.233 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 23.4 mt -62.31 -43.32 99.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.694 -0.253 . . . . 0.0 111.285 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.657 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.0 m -60.66 -39.56 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.737 0.303 . . . . 0.0 111.717 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.5 -49.19 46.11 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.82 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.5 -41.77 62.65 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.91 -41.39 91.5 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.818 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.657 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.6 mp -70.35 -39.53 74.6 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.902 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.497 ' O ' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.31 -37.88 77.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.414 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.03 -35.01 73.99 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.646 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 14.8 mt -69.48 -42.15 75.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.591 HG21 ' O ' ' A' ' 14' ' ' LEU . 58.0 t -68.71 -44.97 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.058 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 15' ' ' LEU . 93.0 t -65.91 -43.19 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.82 84.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.078 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.93 -36.31 77.82 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.614 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.36 -49.98 41.58 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.286 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 mt -64.17 -41.23 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 110.495 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -64.44 -44.39 95.35 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.366 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.6 mt -72.78 -24.66 60.97 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.724 0.297 . . . . 0.0 111.038 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.91 -40.67 62.98 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.11 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.4 mt -83.65 -27.27 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.999 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.3 ttt180 -63.58 -25.79 68.4 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.488 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -81.66 -35.0 30.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.329 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.25 -21.27 27.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.47 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -69.89 -15.81 63.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.804 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.102 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.916 ' O ' ' N ' ' A' ' 42' ' ' LEU . 15.8 tp . . . . . 0 C--O 1.222 -0.361 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -67.52 -28.92 68.23 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -69.96 -18.79 63.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.33 -27.37 8.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.718 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.916 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.351 0.659 0 CA-C-O 120.746 0.308 . . . . 0.0 111.05 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.234 0.248 0 N-CA-C 111.235 0.087 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.13 139.46 42.47 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.723 2.282 . . . . 0.0 112.78 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.0 m -80.53 -7.13 59.1 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.543 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . 0.401 ' H ' HD12 ' B' ' 65' ' ' ILE . 2.5 mp -83.04 -32.86 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.055 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.426 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -27.21 28.77 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.629 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -32.68 74.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.498 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.89 -41.33 9.71 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.264 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.515 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.9 mt -62.18 -43.57 98.53 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 122.377 0.271 . . . . 0.0 111.308 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.651 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.0 m -60.46 -39.61 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.746 0.308 . . . . 0.0 111.723 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.48 -49.27 45.71 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.718 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.59 -41.73 62.49 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.92 -41.28 91.61 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.005 0.191 . . . . 0.0 110.823 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -70.42 -39.56 74.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.833 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.28 -37.83 78.05 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.413 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.1 -35.06 73.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.6 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 14.8 mt -69.49 -42.07 75.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.158 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.601 HG21 ' O ' ' B' ' 74' ' ' LEU . 57.9 t -68.85 -44.84 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.085 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.489 HG21 ' O ' ' B' ' 75' ' ' LEU . 93.6 t -65.84 -43.28 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.964 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.25 -37.64 83.85 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.1 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.3 tp -68.95 -36.38 77.85 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.608 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.33 -50.04 41.41 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.311 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 mt -64.2 -41.1 91.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.634 0.254 . . . . 0.0 110.546 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -64.39 -44.52 95.22 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.395 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 20.7 mt -72.69 -24.77 61.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.643 0.259 . . . . 0.0 110.971 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.84 -40.71 63.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' B' ' 91' ' ' HIS . 12.3 mt -83.53 -27.41 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.996 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.3 ttt180 -63.56 -25.63 68.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.476 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -81.8 -34.91 30.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.364 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.26 -21.38 27.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.481 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 91' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' B' ' 87' ' ' ILE . 4.2 t60 -69.81 -15.73 63.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.883 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.466 0.326 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.101 179.909 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.917 ' O ' ' N ' ' B' ' 102' ' ' LEU . 15.8 tp . . . . . 0 C--O 1.222 -0.343 0 CA-C-O 120.64 0.257 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -67.46 -28.92 68.27 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.474 -0.785 . . . . 0.0 108.922 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -69.99 -18.83 63.35 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 13.3 mt -111.31 -27.3 8.72 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.777 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . 0.917 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.351 0.654 0 CA-C-O 120.601 0.238 . . . . 0.0 110.991 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 111.222 0.082 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.83 140.53 46.58 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.713 2.275 . . . . 0.0 112.78 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 t -80.57 -7.74 59.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.496 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.4 HD11 ' H ' ' A' ' 5' ' ' ILE . 2.5 mp -82.89 -32.57 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.143 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 10' ' ' VAL . . . -83.96 -26.2 29.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.572 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -63.84 -33.21 75.17 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.562 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.13 9.82 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.268 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 22.0 mt -62.22 -43.36 99.0 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 122.286 0.235 . . . . 0.0 111.291 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.678 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.0 m -60.9 -39.99 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.769 0.319 . . . . 0.0 111.73 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.26 -48.5 52.01 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.828 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -73.93 -42.43 60.6 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -66.25 -39.54 89.57 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.846 -0.161 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.678 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.8 mp -71.86 -39.59 69.58 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.68 0.276 . . . . 0.0 110.846 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.75 -39.4 76.75 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.394 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.2 tp -70.22 -33.71 72.0 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.49 -43.29 73.44 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.12 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 14' ' ' LEU . 58.2 t -69.43 -43.58 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.129 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 15' ' ' LEU . 89.3 t -66.7 -43.27 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.114 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.38 -39.27 85.61 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.158 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.1 tp -69.37 -35.2 75.6 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.598 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.02 -52.4 28.41 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.305 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.577 ' O ' HG12 ' A' ' 27' ' ' ILE . 12.1 mt -65.58 -37.18 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.648 0.261 . . . . 0.0 110.566 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -64.48 -46.16 91.14 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.382 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.9 mt -74.21 -24.98 59.41 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.497 0.189 . . . . 0.0 111.208 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.1 t80 -75.82 -39.26 57.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.278 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 23' ' ' ILE . 41.6 mm -83.66 -30.51 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.116 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.6 ttt180 -64.91 -26.1 68.17 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.693 0.283 . . . . 0.0 111.337 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.9 -18.19 44.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.414 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.54 -21.5 35.35 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.597 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -68.48 -21.56 64.61 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.687 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mt . . . . . 0 N--CA 1.465 0.295 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.102 179.879 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.968 ' O ' ' N ' ' A' ' 42' ' ' LEU . 13.4 tp . . . . . 0 C--O 1.222 -0.353 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.409 ' HA ' ' CB ' ' A' ' 42' ' ' LEU . 74.6 mtp180 -66.45 -31.66 72.54 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.674 0.79 . . . . 0.0 108.959 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -69.48 -19.42 63.75 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.6 mt -111.53 -25.67 9.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.008 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.968 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.351 0.65 0 CA-C-O 120.623 0.249 . . . . 0.0 110.996 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 120.322 0.106 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.1 140.61 45.6 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.628 2.219 . . . . 0.0 112.743 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.1 t -80.6 -7.7 59.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.472 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . 0.401 ' H ' HD11 ' B' ' 65' ' ' ILE . 2.5 mp -83.01 -32.6 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.051 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.435 ' O ' HG23 ' B' ' 70' ' ' VAL . . . -83.85 -26.22 29.65 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.688 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -63.95 -33.13 75.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.551 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.15 9.82 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.333 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 21.9 mt -62.24 -43.14 99.5 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.648 -0.276 . . . . 0.0 111.393 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.669 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.2 m -60.97 -40.13 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.699 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.22 -48.48 52.42 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.9 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' B' ' 76' ' ' LEU . . . -73.95 -42.5 60.43 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -66.2 -39.65 89.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.867 -0.151 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.669 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -71.85 -39.42 69.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.591 0.234 . . . . 0.0 110.861 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.95 -39.38 76.1 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.385 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.2 tp -70.09 -33.84 72.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.593 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.37 -43.36 73.71 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.074 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.597 HG23 ' O ' ' B' ' 74' ' ' LEU . 58.2 t -69.41 -43.48 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.165 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' ' 75' ' ' LEU . 88.8 t -66.71 -43.38 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.029 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.25 85.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.151 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.1 tp -69.21 -35.28 76.05 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.669 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.98 -52.43 28.44 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.241 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.573 ' O ' HG12 ' B' ' 87' ' ' ILE . 12.0 mt -65.6 -37.21 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.667 0.27 . . . . 0.0 110.564 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -64.41 -46.18 91.22 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.485 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 18.0 mt -74.18 -24.86 59.43 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.547 0.213 . . . . 0.0 111.252 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.2 t80 -76.02 -39.25 56.1 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.573 HG12 ' O ' ' B' ' 83' ' ' ILE . 41.5 mm -83.56 -30.53 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.186 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.7 ttt180 -64.97 -26.07 68.14 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.254 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.99 -18.22 44.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.272 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.52 -21.53 35.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.54 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -68.5 -21.55 64.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.741 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.097 179.828 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.944 ' O ' ' N ' ' B' ' 102' ' ' LEU . 13.3 tp . . . . . 0 C--O 1.222 -0.387 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . 0.409 ' HA ' ' CB ' ' B' ' 102' ' ' LEU . 74.8 mtp180 -66.5 -31.59 72.41 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.646 0.778 . . . . 0.0 109.015 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -69.42 -19.46 63.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 27.8 mt -111.47 -25.68 9.48 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.048 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . 0.944 ' N ' ' O ' ' B' ' 98' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.352 0.679 0 CA-C-O 120.666 0.269 . . . . 0.0 110.984 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.273 0 CA-C-O 120.333 0.111 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.05 141.43 48.09 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.636 2.224 . . . . 0.0 112.666 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.8 m -80.72 -7.43 59.35 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.513 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.6 mp -82.96 -32.73 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.134 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ALA . . . . . 0.437 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.99 -26.23 29.36 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.62 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.04 -33.08 74.94 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.539 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.79 -41.13 9.95 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.382 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.508 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 21.9 mt -62.3 -43.55 98.56 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.7 -0.25 . . . . 0.0 111.37 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 23.5 m -60.71 -40.48 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 111.761 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.0 -48.88 51.45 Favored Glycine 0 C--O 1.235 0.201 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.808 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.57 -42.82 61.11 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.25 -41.16 94.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.442 0.163 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.9 mp -70.54 -40.01 73.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.626 0.251 . . . . 0.0 110.953 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -69.46 -36.84 76.97 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.603 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 tp -69.93 -36.8 75.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.573 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.7 mt -68.48 -44.22 75.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.274 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 14' ' ' LEU . 61.9 t -67.35 -44.88 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.229 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 15' ' ' LEU . 83.8 t -67.03 -39.11 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.2 83.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.054 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.6 mt -69.36 -34.33 74.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.657 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.35 -54.3 20.78 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.277 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.518 ' O ' HG12 ' A' ' 27' ' ' ILE . 15.1 mt -66.3 -35.72 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.592 0.234 . . . . 0.0 110.634 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.06 -45.98 90.24 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.473 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.56 -24.69 56.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.53 0.205 . . . . 0.0 111.299 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.9 t80 -77.78 -36.87 50.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.333 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 23' ' ' ILE . 52.1 mm -83.69 -36.62 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.309 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -67.65 -29.2 68.45 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.619 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -82.1 -18.24 43.69 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.469 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -85.32 -21.77 28.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.529 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -81.97 -15.93 52.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.489 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.8 mm . . . . . 0 CA--C 1.533 0.304 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.965 179.902 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' LEU . . . . . 0.956 ' O ' ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.403 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -66.98 -29.4 69.24 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.025 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -70.06 -18.41 63.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 38.7 mt -112.09 -26.69 8.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.115 177.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.956 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.2 tt . . . . . 0 C--N 1.351 0.647 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 111.224 0.083 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.06 141.41 48.02 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.623 2.215 . . . . 0.0 112.771 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.6 m -80.6 -7.55 59.3 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.493 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 mp -82.88 -32.9 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.094 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 66' ' ' ALA . . . . . 0.443 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.98 -26.14 29.44 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.544 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.03 -33.16 75.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.47 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.88 -41.05 9.92 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.329 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 69' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.1 mt -62.42 -43.6 98.43 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 115.691 -0.254 . . . . 0.0 111.324 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 70' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.4 m -60.45 -40.64 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.873 0.368 . . . . 0.0 111.825 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 71' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.97 -48.91 51.43 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.819 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.62 -42.74 61.09 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 73' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.27 -41.24 94.43 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.882 -0.144 . . . . 0.0 110.862 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 74' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -70.61 -39.94 73.48 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.895 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 75' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.52 -36.85 76.82 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.485 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tp -69.96 -36.61 75.39 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.64 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.67 -44.01 74.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.274 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 78' ' ' VAL . . . . . 0.588 HG21 ' O ' ' B' ' 74' ' ' LEU . 61.6 t -67.48 -44.98 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.134 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 79' ' ' VAL . . . . . 0.453 HG21 ' O ' ' B' ' 75' ' ' LEU . 84.7 t -66.78 -39.23 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.096 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.19 83.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.042 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 20.7 mt -69.36 -34.39 74.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.636 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 82' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.27 -54.19 21.68 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.398 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 83' ' ' ILE . . . . . 0.515 ' O ' HG12 ' B' ' 87' ' ' ILE . 14.9 mt -66.4 -35.73 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.553 0.216 . . . . 0.0 110.599 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.06 -46.12 89.8 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.435 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.34 -24.77 57.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.569 0.223 . . . . 0.0 111.351 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 86' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.9 t80 -77.88 -36.82 49.28 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.282 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 87' ' ' ILE . . . . . 0.515 HG12 ' O ' ' B' ' 83' ' ' ILE . 52.2 mm -83.63 -36.61 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.344 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -67.7 -29.17 68.36 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.571 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -82.21 -18.18 43.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.416 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -85.3 -21.83 28.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.521 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -81.96 -16.07 51.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.483 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 6.7 mm . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.046 179.847 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 98' ' ' LEU . . . . . 0.931 ' O ' ' N ' ' B' ' 102' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.462 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.08 -29.35 69.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -70.17 -18.31 63.2 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 38.3 mt -112.12 -26.65 8.73 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.074 177.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 102' ' ' LEU . . . . . 0.931 ' N ' ' O ' ' B' ' 98' ' ' LEU . 1.2 tt . . . . . 0 C--N 1.351 0.636 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.8 mttp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.582 0.229 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.97 146.7 55.95 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.27 139.02 40.84 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.626 2.217 . . . . 0.0 112.729 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.8 m -80.58 -7.14 59.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.503 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mp -82.94 -32.6 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.131 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.42 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.91 -28.33 27.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.587 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.15 -31.9 73.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.545 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.96 -41.94 9.21 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.229 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 13' ' ' LEU . 23.9 mt -61.98 -43.21 99.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.749 -0.225 . . . . 0.0 111.194 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.695 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 25.2 m -61.0 -39.05 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.832 0.349 . . . . 0.0 111.656 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.21 -48.4 52.99 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.742 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.478 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -74.28 -43.16 58.02 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.33 -40.0 93.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.455 0.169 . . . . 0.0 110.954 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.695 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.1 mp -72.41 -39.77 67.66 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.082 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.2 OUTLIER -70.16 -39.25 75.43 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.567 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -70.08 -34.7 73.49 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.591 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.419 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.44 -42.29 75.14 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.59 HG21 ' O ' ' A' ' 14' ' ' LEU . 99.3 t -69.1 -42.85 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.128 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 15' ' ' LEU . 94.8 t -68.89 -39.69 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.024 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.59 -36.46 73.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.352 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 1.7 tp -70.27 -44.97 67.34 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.71 -56.22 8.66 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.529 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.1 mm -64.25 -37.64 80.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.745 0.307 . . . . 0.0 110.621 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.16 -46.58 87.45 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.329 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.7 mt -73.05 -24.0 60.65 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.677 0.275 . . . . 0.0 110.986 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.51 -39.91 64.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.194 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.404 ' O ' ' HD2' ' A' ' 31' ' ' HIS . 18.9 mt -83.34 -33.68 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.248 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.76 -26.0 66.76 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.645 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.478 ' O ' HG21 ' A' ' 33' ' ' VAL . 96.5 mtt180 -81.88 -18.16 44.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.401 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.496 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 99.2 mtt180 -81.51 -21.61 38.52 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.617 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.404 ' HD2' ' O ' ' A' ' 27' ' ' ILE . 58.0 m-70 -70.74 -28.63 64.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.692 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt -83.17 -24.39 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.106 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.478 HG21 ' O ' ' A' ' 29' ' ' ARG . 2.6 t -95.55 -7.39 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.496 ' HB2' ' O ' ' A' ' 30' ' ' ARG . 28.4 ttt180 -92.49 159.95 15.29 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.73 153.09 20.97 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.037 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.51 17.76 6.02 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.365 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.441 ' O ' HD12 ' A' ' 41' ' ' LEU . 18.2 p -83.0 -16.73 46.02 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.715 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 1.005 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 6.1 tp -89.71 -13.91 35.86 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.058 0.456 . . . . 0.0 110.312 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -97.87 -33.87 11.07 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 114.706 -1.133 . . . . 0.0 107.966 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.662 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 70.1 mtp180 -75.68 -21.84 57.24 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.157 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.441 HD12 ' O ' ' A' ' 37' ' ' THR . 22.7 mt -104.84 -19.72 13.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.405 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 1.005 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 4.1 tt -62.54 -45.36 93.31 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.676 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -92.04 -12.76 32.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.62 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.662 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 1.9 tp10 -83.79 -43.68 15.16 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.56 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -88.24 -10.98 47.94 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.686 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.53 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 5.2 tt0 -63.33 -59.7 4.36 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.621 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 mp -146.5 27.38 1.12 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.966 0.412 . . . . 0.0 111.26 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.459 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 3.1 t -127.28 58.12 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.429 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -95.44 141.43 23.19 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.884 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.54 132.98 23.13 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.575 2.184 . . . . 0.0 112.832 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mt -142.83 87.23 1.97 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.308 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 p -138.33 146.72 52.59 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.158 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.5 119.16 6.16 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.614 2.209 . . . . 0.0 112.731 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.2 t -100.56 -10.51 20.94 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.857 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.79 75.58 0.06 OUTLIER Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.449 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -127.62 -42.18 1.64 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.671 0.272 . . . . 0.0 111.063 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -85.16 -42.89 14.32 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.28 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 mt -90.09 -8.29 51.74 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.446 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -129.31 143.61 50.91 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.786 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 mttp . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.596 0.236 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.88 146.6 55.68 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.184 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.14 138.95 41.1 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.726 2.284 . . . . 0.0 112.719 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 52.8 m -80.52 -7.24 59.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.49 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.404 ' H ' HD13 ' B' ' 65' ' ' ILE . 2.4 mp -82.9 -32.76 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.072 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.417 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -28.22 28.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.605 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.13 -31.97 73.37 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.538 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.99 -41.86 9.25 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.228 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.521 ' O ' HD13 ' B' ' 73' ' ' LEU . 23.8 mt -62.02 -43.2 99.34 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.625 0.25 . . . . 0.0 111.215 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.686 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 25.5 m -61.02 -39.09 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 111.619 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.18 -48.47 52.66 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.714 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.481 ' O ' ' HB2' ' B' ' 76' ' ' LEU . . . -74.2 -43.17 58.27 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.521 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.31 -40.0 93.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.029 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.1 mp -72.3 -39.85 67.97 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.095 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.2 OUTLIER -70.21 -39.22 75.28 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.553 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 0.7 OUTLIER -70.04 -34.65 73.51 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.67 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.429 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.45 -42.43 74.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.976 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.593 HG21 ' O ' ' B' ' 74' ' ' LEU . 99.9 t -68.99 -42.88 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.128 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.494 HG23 ' O ' ' B' ' 75' ' ' LEU . 95.5 t -68.91 -39.73 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.031 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.46 -36.53 73.97 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.371 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 1.7 tp -70.37 -44.89 67.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.035 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.76 -56.22 8.6 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.489 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 47.2 mm -64.22 -37.71 80.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.683 0.277 . . . . 0.0 110.554 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.05 -46.64 88.17 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.406 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 25.8 mt -73.1 -23.94 60.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.577 0.227 . . . . 0.0 110.962 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -39.83 64.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.25 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 18.8 mt -83.34 -33.76 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.2 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.76 -25.97 66.75 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.682 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.482 ' O ' HG21 ' B' ' 93' ' ' VAL . 96.5 mtt180 -81.96 -18.03 44.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.416 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . 0.495 ' O ' ' HB2' ' B' ' 94' ' ' ARG . 99.2 mtt180 -81.55 -21.58 38.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.575 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -70.77 -28.6 64.8 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.683 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mt -83.25 -24.38 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.065 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.482 HG21 ' O ' ' B' ' 89' ' ' ARG . 2.6 t -95.54 -7.34 9.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.99 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . 0.495 ' HB2' ' O ' ' B' ' 90' ' ' ARG . 28.3 ttt180 -92.4 159.91 15.34 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.94 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.76 153.11 20.94 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.065 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.5 17.75 6.01 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.377 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.447 ' O ' HD12 ' B' ' 101' ' ' LEU . 18.5 p -82.99 -16.71 46.13 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.791 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 1.026 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 6.1 tp -89.72 -13.94 35.74 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.105 0.479 . . . . 0.0 110.342 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -97.81 -33.88 11.09 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.025 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.675 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 70.1 mtp180 -75.61 -21.83 57.41 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.224 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.447 HD12 ' O ' ' B' ' 97' ' ' THR . 22.8 mt -104.78 -19.72 13.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.42 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 1.026 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 4.2 tt -62.6 -45.26 93.68 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -92.01 -12.82 32.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.647 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.675 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 1.9 tp10 -83.8 -43.73 15.1 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.521 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -88.17 -11.07 47.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.651 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.535 ' HB2' ' O ' ' B' ' 102' ' ' LEU . 5.2 tt0 -63.4 -59.74 4.29 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.498 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mp -146.43 27.34 1.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.929 0.395 . . . . 0.0 111.225 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.444 ' HB ' ' O ' ' B' ' 104' ' ' GLU . 3.1 t -127.19 58.13 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.463 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -95.57 141.43 23.18 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.53 132.96 23.1 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.646 2.231 . . . . 0.0 112.831 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 9.9 mt -142.84 87.25 1.98 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.282 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 17.9 p -138.36 146.76 52.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.121 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.47 119.07 6.09 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.662 2.241 . . . . 0.0 112.806 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 14.9 t -100.5 -10.6 20.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.84 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.78 75.63 0.06 OUTLIER Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.509 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -127.68 -42.14 1.63 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.542 0.211 . . . . 0.0 110.994 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -85.12 -42.94 14.31 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.282 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 9.6 mt -90.04 -8.3 51.85 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.465 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -129.28 143.63 50.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.829 179.949 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.613 0.244 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.5 146.77 57.11 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.183 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.38 143.72 59.07 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.629 2.219 . . . . 0.0 112.803 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 t -80.58 -8.35 59.57 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.465 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.7 mp -83.01 -32.0 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.089 -179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.433 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.93 -26.62 29.17 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.585 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.0 -32.87 74.56 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.524 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.94 -41.36 9.64 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.245 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 22.3 mt -62.14 -42.99 99.79 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.736 -0.232 . . . . 0.0 111.36 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.679 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 23.9 m -60.93 -39.47 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.777 0.322 . . . . 0.0 111.688 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.68 -48.98 46.31 Favored Glycine 0 C--O 1.236 0.222 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.703 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.75 -41.3 62.68 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.045 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.516 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -67.09 -39.69 86.81 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.679 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.6 mp -71.25 -39.38 71.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.625 0.25 . . . . 0.0 110.771 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.508 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.33 -40.48 77.57 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.303 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 tp -69.64 -32.25 70.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 3.5 tp -69.96 -42.55 73.04 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.91 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 14' ' ' LEU . 59.1 t -69.18 -43.42 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.015 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.508 HG22 ' O ' ' A' ' 15' ' ' LEU . 91.0 t -66.46 -43.46 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.852 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.79 83.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.101 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 3.2 tp -69.44 -36.35 76.54 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.522 179.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.414 ' O ' ' HD1' ' A' ' 26' ' ' PHE . . . -67.42 -53.38 25.35 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.222 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.561 ' O ' HG12 ' A' ' 27' ' ' ILE . 11.0 mt -64.47 -37.34 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.649 0.261 . . . . 0.0 110.536 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.66 -44.32 95.13 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.414 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 mt -73.45 -27.01 61.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.445 0.164 . . . . 0.0 111.141 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.414 ' HD1' ' O ' ' A' ' 22' ' ' GLY . 2.8 m-85 -76.43 -36.59 57.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.432 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.561 HG12 ' O ' ' A' ' 23' ' ' ILE . 47.5 mm -83.52 -32.84 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.237 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -67.73 -25.77 65.82 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.554 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.79 -33.79 30.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.164 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -86.32 -21.33 27.34 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.411 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 27' ' ' ILE . 3.2 t60 -70.03 -15.94 63.08 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.806 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt -81.96 -10.88 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.23 -45.22 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.745 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -120.6 128.6 53.19 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.748 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -132.05 -43.85 0.96 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.205 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.93 25.4 4.29 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.283 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.1 p -83.29 -37.39 23.52 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.621 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.95 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.3 mm? -89.71 -38.32 13.94 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.489 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.424 ' HD3' ' OE1' ' A' ' 43' ' ' GLN . 99.3 mtt180 -63.28 -28.57 70.11 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.313 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.484 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 30.7 mtt180 -67.52 -21.84 65.46 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.671 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 5.4 mt -111.78 -26.31 9.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 113.537 -1.665 . . . . 0.0 109.941 177.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.95 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -83.67 -51.08 7.57 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 120.577 0.227 . . . . 0.0 111.448 -179.278 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.424 ' OE1' ' HD3' ' A' ' 39' ' ' ARG . 54.3 mt-30 -77.44 -9.97 59.19 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.03 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 9.7 tt0 -83.27 -45.52 13.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.255 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -88.37 -11.71 45.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.336 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.541 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 10.9 tt0 -62.76 -29.72 70.9 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.265 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -106.31 9.27 32.0 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.087 0.47 . . . . 0.0 111.06 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.3 t -127.73 53.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.4 179.585 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -111.03 135.75 20.84 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.54 131.99 18.28 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.594 2.196 . . . . 0.0 112.65 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mt -142.95 87.31 1.97 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.314 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.8 p -140.21 132.74 14.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.03 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.61 154.07 49.49 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.547 2.165 . . . . 0.0 112.735 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.4 m 60.43 20.77 10.42 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.795 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.49 -157.98 18.78 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.528 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.516 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 41.8 mt-10 -107.56 152.91 23.63 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.819 0.342 . . . . 0.0 110.95 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -85.06 -20.07 30.97 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.671 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.66 -10.59 19.79 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . 0.516 ' NE1' ' HB2' ' A' ' 56' ' ' GLU . 68.9 p-90 -134.67 -16.95 1.99 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.355 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.906 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.739 0.304 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.59 146.76 56.9 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.181 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.49 143.71 58.38 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.606 2.204 . . . . 0.0 112.797 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.1 t -80.53 -8.39 59.56 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.517 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.4 ' H ' HD12 ' B' ' 65' ' ' ILE . 2.7 mp -82.9 -32.1 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.128 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.425 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.95 -26.5 29.22 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.659 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.03 -32.77 74.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.542 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.08 -41.24 9.6 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.243 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.519 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.2 mt -62.17 -43.08 99.64 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 122.331 0.253 . . . . 0.0 111.365 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.672 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 23.4 m -61.0 -39.31 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.878 0.371 . . . . 0.0 111.782 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.481 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.78 -48.79 46.91 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.809 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.86 -41.22 62.52 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.091 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.519 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -67.19 -39.54 86.4 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.434 0.159 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.672 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.5 mp -71.35 -39.37 71.35 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.641 0.258 . . . . 0.0 110.712 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.527 ' O ' HG22 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.33 -40.48 77.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.266 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 2.4 tp -69.74 -32.29 70.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.42 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.436 ' HB2' ' O ' ' B' ' 73' ' ' LEU . 3.5 tp -69.88 -42.6 73.24 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.016 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.607 HG23 ' O ' ' B' ' 74' ' ' LEU . 59.1 t -69.13 -43.44 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.983 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.527 HG22 ' O ' ' B' ' 75' ' ' LEU . 91.0 t -66.44 -43.42 91.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.899 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.86 83.62 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.08 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.412 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 3.1 tp -69.31 -36.41 76.96 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.53 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.417 ' O ' ' HD1' ' B' ' 86' ' ' PHE . . . -67.51 -53.23 25.81 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.196 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.57 ' O ' HG12 ' B' ' 87' ' ' ILE . 11.0 mt -64.59 -37.33 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.704 0.287 . . . . 0.0 110.495 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.3 95.04 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.396 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 19.0 mt -73.43 -27.05 61.22 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.557 0.218 . . . . 0.0 111.287 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.417 ' HD1' ' O ' ' B' ' 82' ' ' GLY . 2.7 m-85 -76.51 -36.42 57.77 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.458 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.57 HG12 ' O ' ' B' ' 83' ' ' ILE . 47.6 mm -83.58 -32.77 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.212 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -67.77 -25.82 65.8 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.459 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.81 -33.74 30.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.201 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -86.21 -21.43 27.46 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.501 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 91' ' ' HIS . . . . . 0.439 ' HB2' ' O ' ' B' ' 87' ' ' ILE . 3.2 t60 -69.98 -15.89 63.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.726 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mt -81.98 -10.96 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.044 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.29 -45.14 14.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.704 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -120.6 128.58 53.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.688 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -132.01 -43.9 0.96 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.87 25.44 4.31 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.318 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 18.9 p -83.31 -37.42 23.44 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.618 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.947 ' O ' ' N ' ' B' ' 102' ' ' LEU . 1.3 mm? -89.62 -38.18 14.11 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.588 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . 0.424 ' HD3' ' OE1' ' B' ' 103' ' ' GLN . 99.3 mtt180 -63.29 -28.74 70.22 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.577 0.751 . . . . 0.0 109.272 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 31.1 mtt180 -67.42 -21.85 65.55 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 5.4 mt -111.8 -26.2 9.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.979 177.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.947 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.3 OUTLIER -83.77 -51.12 7.49 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 120.61 0.243 . . . . 0.0 111.464 -179.262 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . 0.424 ' OE1' ' HD3' ' B' ' 99' ' ' ARG . 54.3 mt-30 -77.36 -10.0 59.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.043 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.491 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 9.7 tt0 -83.44 -45.32 13.79 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.228 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -88.42 -11.75 45.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.289 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.537 ' HB2' ' O ' ' B' ' 102' ' ' LEU . 10.9 tt0 -62.76 -29.75 70.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.303 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -106.25 9.16 32.14 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 111.063 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 t -127.68 53.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.447 179.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -111.17 135.86 20.9 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.75 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.51 131.95 18.26 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.571 2.181 . . . . 0.0 112.732 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 mt -142.92 87.24 1.97 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.239 0.542 . . . . 0.0 110.303 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 16.8 p -140.13 132.77 14.84 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.989 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.63 154.17 49.42 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.524 2.149 . . . . 0.0 112.77 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 52.5 m 60.36 20.75 10.31 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.835 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.56 -157.99 18.73 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.573 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . 0.515 ' HB2' ' NE1' ' B' ' 119' ' ' TRP . 41.8 mt-10 -107.62 152.93 23.63 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.806 0.336 . . . . 0.0 110.972 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -85.15 -20.0 30.93 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.657 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.7 -10.53 19.8 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 119' ' ' TRP . . . . . 0.515 ' NE1' ' HB2' ' B' ' 116' ' ' GLU . 68.8 p-90 -134.7 -17.03 1.98 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.374 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.963 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.67 0.271 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.8 155.01 76.76 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.178 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.57 147.06 81.43 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.556 2.171 . . . . 0.0 112.6 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.1 m -80.66 -21.74 41.12 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.494 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.41 ' H ' HD13 ' A' ' 5' ' ' ILE . 2.3 mp -83.0 -22.12 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . . . . . . . . . . . -83.92 -33.89 24.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.601 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -27.81 69.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.465 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.87 -44.67 7.59 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.238 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 18.6 mt -62.36 -42.47 99.43 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.586 0.231 . . . . 0.0 111.227 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.706 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 22.4 m -61.37 -41.85 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.761 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -67.1 -48.23 60.74 Favored Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.974 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.416 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -74.11 -44.14 55.01 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.73 -38.84 90.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.432 0.158 . . . . 0.0 111.092 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.706 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.1 mp -72.76 -39.44 66.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.586 0.232 . . . . 0.0 110.958 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -70.29 -38.22 74.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.363 179.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.416 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.9 tp -71.02 -35.19 71.91 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.688 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tt -68.99 -44.38 72.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.257 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.556 HG23 ' O ' ' A' ' 14' ' ' LEU . 58.6 t -69.45 -44.48 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.365 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 15' ' ' LEU . 74.4 t -66.77 -42.33 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.171 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.37 83.63 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.977 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.68 -35.64 77.47 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.614 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.408 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.97 -52.69 26.95 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.36 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.525 ' O ' HG12 ' A' ' 27' ' ' ILE . 13.7 mt -65.96 -35.23 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.558 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.519 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -65.75 -45.78 86.91 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.117 -0.564 . . . . 0.0 112.402 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.0 mt -75.24 -24.82 57.72 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.55 0.214 . . . . 0.0 111.309 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.408 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.8 t80 -77.56 -37.86 49.79 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.253 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.525 HG12 ' O ' ' A' ' 23' ' ' ILE . 50.6 mm -83.65 -33.44 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.194 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.519 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 15.0 ttm180 -66.22 -26.96 67.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.654 0.264 . . . . 0.0 111.312 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.484 ' O ' HG23 ' A' ' 33' ' ' VAL . 99.1 mtt180 -82.23 -18.21 43.34 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.347 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 74.6 mtp180 -83.9 -21.77 31.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.521 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.09 -20.43 34.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.473 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . 0.421 HG12 ' O ' ' A' ' 28' ' ' ARG . 11.0 mm -83.23 -29.56 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.995 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 29' ' ' ARG . 2.3 t -95.94 -3.6 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.015 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.536 ' HB2' ' O ' ' A' ' 30' ' ' ARG . 28.8 ttt180 -90.8 157.11 17.57 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.931 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -93.0 157.36 16.35 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.987 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -88.9 28.04 1.24 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.284 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.663 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 18.1 p -82.98 -13.97 54.95 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.729 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 1.052 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 3.3 mm? -90.43 -18.2 25.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.948 0.404 . . . . 0.0 110.614 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -98.03 -35.44 10.44 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.367 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.649 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 94.9 mtt180 -73.85 -19.07 60.84 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.441 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.663 ' HB2' ' O ' ' A' ' 37' ' ' THR . 3.0 mm? -108.57 -20.7 13.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.508 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 1.052 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 3.9 tt -62.81 -44.61 95.7 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.824 0.345 . . . . 0.0 110.754 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -92.85 -11.39 33.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.681 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.649 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 6.6 tt0 -83.79 -45.14 13.64 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.563 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -88.08 -11.03 48.27 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.748 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.578 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 9.6 tt0 -62.44 -57.13 12.35 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.611 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tp -150.13 27.17 0.78 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.017 0.437 . . . . 0.0 111.242 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.448 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 3.4 t -126.69 60.02 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.46 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -94.91 148.07 34.13 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.974 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.85 133.13 26.46 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.625 2.217 . . . . 0.0 112.801 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 tp -142.99 87.3 1.97 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.233 0.539 . . . . 0.0 110.194 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.2 p -99.34 155.05 36.95 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.112 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.81 119.54 6.58 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.67 2.246 . . . . 0.0 112.539 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.6 p -100.27 -10.3 21.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.938 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 -98.62 2.46 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.476 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -102.35 149.33 24.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.734 0.302 . . . . 0.0 110.865 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.23 -42.15 14.94 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.367 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.23 -9.1 49.28 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.409 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -131.27 144.7 51.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.4 p . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.92 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.713 0.292 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.86 155.02 76.67 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.128 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.79 147.05 80.4 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.628 2.219 . . . . 0.0 112.487 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -80.47 -21.94 41.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.505 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.41 ' H ' HD13 ' B' ' 65' ' ' ILE . 2.3 mp -82.81 -22.14 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.247 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . . . . . . . . . . . -83.91 -33.95 24.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.56 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.61 -27.84 69.51 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.539 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.82 -44.7 7.6 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.266 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 18.4 mt -62.19 -42.71 99.54 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-O 120.627 0.251 . . . . 0.0 111.25 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 22.5 m -61.31 -41.79 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.766 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.08 -48.33 60.34 Favored Glycine 0 CA--C 1.517 0.177 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.008 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' B' ' 76' ' ' LEU . . . -74.12 -44.17 54.84 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.71 -38.71 89.96 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.403 0.144 . . . . 0.0 111.126 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.1 mp -72.79 -39.56 66.6 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.92 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -70.17 -38.27 75.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.442 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.419 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.9 tp -71.02 -35.18 71.93 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.697 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' B' ' 73' ' ' LEU . 2.1 tt -68.88 -44.44 73.26 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.296 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.554 HG23 ' O ' ' B' ' 74' ' ' LEU . 58.4 t -69.47 -44.46 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.312 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.466 HG22 ' O ' ' B' ' 75' ' ' LEU . 75.0 t -66.81 -42.39 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.154 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.27 83.76 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.098 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.2 tp -68.74 -35.58 77.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.94 -52.7 27.01 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.404 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.52 ' O ' HG12 ' B' ' 87' ' ' ILE . 13.7 mt -65.94 -35.38 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.616 0.246 . . . . 0.0 110.514 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . 0.517 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -65.58 -45.9 87.29 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.451 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 16.0 mt -75.1 -24.87 58.15 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.558 0.218 . . . . 0.0 111.281 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.403 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.8 t80 -77.58 -37.89 49.5 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.225 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.52 HG12 ' O ' ' B' ' 83' ' ' ILE . 50.7 mm -83.55 -33.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.202 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.517 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 15.1 ttm180 -66.05 -27.08 67.83 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.657 0.265 . . . . 0.0 111.327 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.49 ' O ' HG23 ' B' ' 93' ' ' VAL . 99.1 mtt180 -82.16 -18.25 43.45 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.412 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . 0.535 ' O ' ' HB2' ' B' ' 94' ' ' ARG . 74.7 mtp180 -83.72 -21.84 32.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.621 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.09 -20.47 34.84 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.426 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . 0.433 HG12 ' O ' ' B' ' 88' ' ' ARG . 11.1 mm -83.33 -29.49 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.983 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.49 HG23 ' O ' ' B' ' 89' ' ' ARG . 2.4 t -95.96 -3.51 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . 0.535 ' HB2' ' O ' ' B' ' 90' ' ' ARG . 28.8 ttt180 -90.78 157.15 17.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -93.07 157.34 16.34 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.005 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.86 28.1 1.22 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.268 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.663 ' O ' ' HB2' ' B' ' 101' ' ' LEU . 17.8 p -83.09 -13.81 54.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.701 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 1.067 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 3.3 mm? -90.51 -18.14 25.83 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.1 0.476 . . . . 0.0 110.58 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -98.15 -35.41 10.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.38 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.643 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 94.9 mtt180 -73.85 -19.05 60.84 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.48 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.663 ' HB2' ' O ' ' B' ' 97' ' ' THR . 3.0 mm? -108.52 -20.81 12.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.536 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 1.067 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 3.8 tt -62.75 -44.56 95.89 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.772 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -92.87 -11.42 33.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.643 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.643 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 6.6 tt0 -83.7 -45.16 13.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.581 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -88.08 -11.08 48.16 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.671 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.568 ' HB2' ' O ' ' B' ' 102' ' ' LEU . 9.6 tt0 -62.43 -57.12 12.38 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.645 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 tp -150.06 27.22 0.78 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.007 0.432 . . . . 0.0 111.173 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . 0.456 ' HB ' ' O ' ' B' ' 104' ' ' GLU . 3.4 t -126.78 60.08 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.469 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -95.03 148.06 34.06 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.004 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.85 133.0 26.09 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.7 2.267 . . . . 0.0 112.803 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 tp -142.85 87.3 1.98 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.146 0.498 . . . . 0.0 110.137 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 18.2 p -99.4 155.03 36.97 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.148 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.82 119.58 6.61 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.572 2.181 . . . . 0.0 112.62 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 39.9 p -100.23 -10.39 21.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.934 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.3 -98.53 2.45 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.466 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -102.31 149.31 24.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.694 0.283 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.28 -42.18 14.87 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.307 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.16 -9.23 49.02 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.416 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -131.21 144.77 51.59 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 40.5 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.901 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.698 0.285 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.01 146.3 54.17 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.205 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.99 141.77 49.34 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.711 2.274 . . . . 0.0 112.765 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 m -80.57 -7.67 59.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.534 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.401 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.7 mp -82.93 -32.38 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.075 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -84.01 -27.64 28.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.552 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.42 -31.98 73.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.456 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.04 -41.69 9.32 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.217 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 13' ' ' LEU . 23.2 mt -62.01 -43.65 98.39 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 122.309 0.244 . . . . 0.0 111.187 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.684 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 25.2 m -60.48 -38.18 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 111.663 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.526 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -69.0 -49.32 42.03 Favored Glycine 0 CA--C 1.518 0.24 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.756 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.58 -41.48 62.84 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.9 mp -66.21 -41.79 89.65 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.79 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.684 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.8 mp -70.5 -38.83 74.38 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.916 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.526 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -69.7 -37.16 76.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.442 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tp -69.81 -36.93 76.06 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.6 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.58 -40.85 76.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.288 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 14' ' ' LEU . 93.1 t -69.57 -42.37 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.2 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 15' ' ' LEU . 97.7 t -70.62 -38.38 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.176 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.67 -39.17 73.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.295 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.7 tp -70.86 -43.4 68.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.945 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.82 -57.84 7.5 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.5 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.544 ' O ' HG12 ' A' ' 27' ' ' ILE . 41.4 mm -65.86 -33.64 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.643 0.259 . . . . 0.0 110.589 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.543 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -65.6 -47.65 75.32 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.322 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt -74.8 -24.1 58.59 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.55 0.214 . . . . 0.0 111.147 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.2 t80 -75.43 -39.69 58.56 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.242 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.544 HG12 ' O ' ' A' ' 23' ' ' ILE . 45.5 mm -83.59 -32.33 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.192 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.2 ttt180 -65.4 -26.1 67.84 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.351 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -81.74 -18.04 45.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.406 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -81.53 -21.48 38.52 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.616 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' A' ' 27' ' ' ILE . 54.8 m-70 -70.57 -27.86 64.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.642 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 mt -83.19 -13.23 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.136 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 t -95.8 -9.2 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.414 ' NH2' HD11 ' A' ' 38' ' ' LEU . 31.0 ttt180 -92.38 157.83 16.4 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -91.51 154.32 19.19 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.003 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.44 20.34 3.94 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.36 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.416 ' O ' HD12 ' A' ' 41' ' ' LEU . 18.5 p -83.19 -16.62 45.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.657 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 1.002 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 23.3 mt -89.41 -10.67 45.64 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.239 0.542 . . . . 0.0 110.138 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.85 -33.29 11.3 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.67 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 75.5 mtp180 -77.24 -24.24 51.2 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.013 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.416 HD12 ' O ' ' A' ' 37' ' ' THR . 14.5 mt -100.37 -20.29 15.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.238 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 1.002 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 2.6 tp -62.83 -48.49 78.86 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.585 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -88.06 -10.24 50.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.747 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.67 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 2.2 tp10 -83.68 -40.98 18.24 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.536 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -88.66 -12.05 43.54 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.458 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.464 ' OE2' ' HG ' ' A' ' 42' ' ' LEU . 32.3 mt-10 -96.37 -24.3 16.22 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.606 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tp -94.97 0.33 54.56 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.113 0.482 . . . . 0.0 111.384 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.94 55.85 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.53 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -111.05 145.27 32.11 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.56 132.04 22.81 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.616 2.211 . . . . 0.0 112.767 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 tt -142.82 87.3 1.98 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.135 0.493 . . . . 0.0 110.204 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.1 p -137.18 131.61 17.75 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.067 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.0 155.89 47.73 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.519 2.146 . . . . 0.0 112.742 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.6 m 60.42 20.97 10.61 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.892 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.16 -147.23 18.38 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.489 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.5 148.5 25.13 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.626 0.25 . . . . 0.0 110.889 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -85.15 -41.73 15.41 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.404 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.16 -8.97 49.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.467 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -131.33 142.55 50.11 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.8 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.883 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.646 0.26 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.9 146.33 54.52 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.221 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.14 141.9 49.09 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.635 2.223 . . . . 0.0 112.698 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.6 m -80.67 -7.66 59.38 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.497 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.4 ' H ' HD12 ' B' ' 65' ' ' ILE . 2.6 mp -82.81 -32.38 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.116 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.416 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.96 -27.7 28.31 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.552 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.44 -31.99 73.44 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.521 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.01 -41.67 9.36 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.207 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.543 ' O ' HD13 ' B' ' 73' ' ' LEU . 23.1 mt -61.95 -43.59 98.53 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.598 0.237 . . . . 0.0 111.32 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.671 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 25.4 m -60.44 -38.23 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 111.605 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.531 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -69.13 -49.29 41.28 Favored Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.671 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.51 -41.5 62.99 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.543 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.9 mp -66.2 -41.76 89.72 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.806 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.671 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -70.62 -38.7 73.97 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.875 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.531 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.0 OUTLIER -69.62 -37.3 76.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.481 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tp -69.73 -36.89 76.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.61 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.62 -40.74 76.39 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.32 179.522 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.587 HG22 ' O ' ' B' ' 74' ' ' LEU . 93.1 t -69.63 -42.46 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.188 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.479 HG23 ' O ' ' B' ' 75' ' ' LEU . 98.1 t -70.51 -38.45 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.089 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.68 -39.24 73.66 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.22 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 1.7 tp -70.9 -43.31 68.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.937 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.432 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.84 -57.87 7.44 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.49 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.536 ' O ' HG12 ' B' ' 87' ' ' ILE . 41.2 mm -65.78 -33.64 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.581 0.229 . . . . 0.0 110.625 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . 0.55 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -65.64 -47.61 75.4 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.361 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 20.7 mt -74.84 -24.03 58.54 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.563 0.22 . . . . 0.0 111.179 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.432 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.3 t80 -75.51 -39.73 58.04 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.159 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.536 HG12 ' O ' ' B' ' 83' ' ' ILE . 45.6 mm -83.59 -32.38 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.135 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.1 ttt180 -65.36 -26.01 67.83 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.438 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -81.72 -18.01 45.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.46 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -81.61 -21.38 38.35 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.59 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 91' ' ' HIS . . . . . 0.417 ' HD2' ' O ' ' B' ' 87' ' ' ILE . 54.9 m-70 -70.65 -27.8 64.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.644 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 1.8 mt -83.22 -13.27 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.102 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 2.7 t -95.69 -9.31 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.997 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . 0.423 ' NH2' HD11 ' B' ' 98' ' ' LEU . 31.1 ttt180 -92.32 157.89 16.39 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -91.57 154.36 19.12 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.5 20.44 3.92 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.343 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.427 ' O ' ' HB2' ' B' ' 101' ' ' LEU . 18.6 p -83.18 -16.68 45.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.627 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 1.006 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 23.8 mt -89.46 -10.67 45.54 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.204 0.526 . . . . 0.0 110.121 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.83 -33.17 11.35 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.662 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 75.5 mtp180 -77.45 -24.17 50.33 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 114.281 -1.327 . . . . 0.0 107.896 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' B' ' 97' ' ' THR . 14.6 mt -100.39 -20.35 15.85 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.29 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 1.006 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 2.6 tp -62.75 -48.51 78.89 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.686 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -87.99 -10.26 50.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.776 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.662 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 2.2 tp10 -83.7 -41.03 18.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.494 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -88.65 -11.98 43.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.53 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.458 ' OE2' ' HG ' ' B' ' 102' ' ' LEU . 32.3 mt-10 -96.33 -24.31 16.24 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.594 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tp -95.0 0.29 54.49 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.166 0.508 . . . . 0.0 111.332 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 t -129.96 55.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.437 179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -111.11 145.26 32.1 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.64 132.1 22.8 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.64 2.227 . . . . 0.0 112.683 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 tt -142.93 87.34 1.98 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.208 0.528 . . . . 0.0 110.166 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 17.3 p -137.23 131.41 17.63 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.083 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.8 155.81 48.71 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.543 2.162 . . . . 0.0 112.832 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 53.1 m 60.51 20.93 10.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.827 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.12 -147.12 18.35 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.509 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.59 148.48 25.18 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.648 0.261 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -85.23 -41.58 15.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.396 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.05 -9.24 49.27 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.455 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -131.23 142.51 50.17 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 41.1 p . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.967 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 50.6 tttt . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.607 0.241 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.77 146.3 56.69 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.234 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.9 141.21 48.12 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.78 2.32 . . . . 0.0 112.696 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 t -80.69 -7.6 59.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.44 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.6 mp -82.99 -32.66 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.09 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.446 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.95 -25.86 29.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.656 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -63.78 -33.49 75.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.59 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.0 -40.91 9.95 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.289 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.493 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 22.0 mt -62.24 -43.38 98.96 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 122.283 0.233 . . . . 0.0 111.393 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.678 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.1 m -60.91 -41.09 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 111.779 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -67.51 -48.34 57.64 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.877 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.429 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -73.99 -43.5 57.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.493 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.4 -39.47 92.25 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 122.911 0.132 . . . . 0.0 110.971 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.678 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.0 mp -72.22 -39.83 68.23 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.605 0.241 . . . . 0.0 110.924 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -70.2 -38.43 75.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.583 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.429 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.3 tp -70.69 -34.52 72.05 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.657 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.426 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.34 -44.14 72.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.162 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.564 HG21 ' O ' ' A' ' 14' ' ' LEU . 59.8 t -69.25 -44.04 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.226 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.467 HG22 ' O ' ' A' ' 15' ' ' LEU . 71.8 t -66.55 -43.27 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.151 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.26 86.49 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.124 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.36 -36.32 79.04 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.635 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.93 -50.14 43.14 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.299 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 mt -64.39 -41.22 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.669 0.271 . . . . 0.0 110.603 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.42 -44.65 96.45 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.404 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.491 ' HG ' ' NH2' ' A' ' 28' ' ' ARG . 20.1 mt -73.95 -23.83 59.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.595 0.236 . . . . 0.0 110.931 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.465 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 6.6 t80 -74.43 -39.13 62.79 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.35 -35.0 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.255 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.491 ' NH2' ' HG ' ' A' ' 25' ' ' LEU . 74.0 mtm180 -64.14 -26.29 68.47 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.656 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.441 ' O ' HG21 ' A' ' 33' ' ' VAL . 98.6 mtt180 -82.14 -18.13 43.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.358 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.46 ' NH2' ' HE2' ' A' ' 26' ' ' PHE . 97.6 mtt180 -86.12 -21.58 27.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.622 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -70.39 -29.32 65.93 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.713 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -83.32 -19.01 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.097 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.441 HG21 ' O ' ' A' ' 29' ' ' ARG . 4.1 t -97.94 -28.29 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.986 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -92.36 156.24 17.36 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.007 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . 0.455 ' HZ1' ' CG ' ' B' ' 109' ' ' GLU . 96.5 mttt -94.0 158.34 15.67 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.923 179.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -88.55 34.89 0.76 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.351 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.534 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.2 p -82.99 -16.43 47.26 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.716 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 1.041 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 4.2 mm? -89.81 -14.8 33.67 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.132 0.491 . . . . 0.0 110.475 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -97.66 -34.46 10.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.649 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 68.8 mtp180 -74.73 -20.24 59.91 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.097 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' A' ' 37' ' ' THR . 6.8 mt -104.82 -22.47 13.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.315 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 1.041 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 2.9 tt -66.98 -48.81 67.37 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.555 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -84.51 -8.94 58.76 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.51 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.649 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -83.44 -35.85 24.66 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.4 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -88.12 -11.68 46.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.248 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.445 ' OE1' HD21 ' A' ' 42' ' ' LEU . 32.4 mt-10 -75.26 -13.64 60.45 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.48 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 tp -117.18 4.83 12.66 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.085 0.469 . . . . 0.0 110.991 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 4.5 t -126.34 62.34 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.506 179.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.461 ' CG ' ' HZ1' ' B' ' 95' ' ' LYS . 12.1 tt0 -99.13 130.59 26.98 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.759 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.7 133.51 20.43 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.474 2.116 . . . . 0.0 112.717 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.9 87.4 1.98 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.117 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -123.48 145.92 48.29 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.102 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.42 120.62 7.43 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.533 2.155 . . . . 0.0 112.743 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.0 p -120.67 -10.09 9.25 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.908 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.39 57.13 0.01 OUTLIER Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.531 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.76 148.29 25.46 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.74 0.305 . . . . 0.0 111.004 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -85.19 -41.32 15.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.347 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.11 -8.99 49.99 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.543 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -131.37 135.06 46.9 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.4 p . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.903 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 50.5 tttt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.623 0.249 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.83 146.35 56.99 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.19 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.04 141.3 47.74 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.6 2.2 . . . . 0.0 112.708 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.4 t -80.61 -7.7 59.36 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.413 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.401 ' H ' HD11 ' B' ' 65' ' ' ILE . 2.6 mp -82.88 -32.65 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.133 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.443 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.99 -25.9 29.62 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.639 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -63.76 -33.62 76.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.465 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.86 -40.96 10.02 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.289 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 21.9 mt -62.26 -43.37 98.98 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.346 0.258 . . . . 0.0 111.381 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.667 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 23.7 m -60.99 -40.96 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.765 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.529 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.58 -48.43 56.7 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.806 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' B' ' 76' ' ' LEU . . . -73.86 -43.63 58.03 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.27 -39.42 92.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.45 0.167 . . . . 0.0 111.056 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.667 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.0 mp -72.39 -39.68 67.8 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.646 0.26 . . . . 0.0 110.947 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.529 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -70.13 -38.52 75.57 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.584 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.3 tp -70.76 -34.53 71.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.566 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.422 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.21 -44.23 72.5 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.168 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.57 HG21 ' O ' ' B' ' 74' ' ' LEU . 59.9 t -69.31 -43.88 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.286 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.451 HG22 ' O ' ' B' ' 75' ' ' LEU . 71.7 t -66.51 -43.5 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.029 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.15 86.52 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.159 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.422 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.3 tp -68.39 -36.33 78.99 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.683 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.88 -50.1 43.73 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.427 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 19.1 mt -64.44 -41.23 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.652 0.263 . . . . 0.0 110.562 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.55 -44.63 96.29 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.317 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.489 ' HG ' ' NH2' ' B' ' 88' ' ' ARG . 20.0 mt -73.86 -23.85 59.67 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.704 0.288 . . . . 0.0 111.015 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.467 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 6.5 t80 -74.37 -39.22 62.88 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.127 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.29 -35.08 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.258 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.489 ' NH2' ' HG ' ' B' ' 85' ' ' LEU . 74.2 mtm180 -64.11 -26.3 68.48 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.632 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . 0.44 ' O ' HG21 ' B' ' 93' ' ' VAL . 98.5 mtt180 -82.11 -18.3 43.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . 0.464 ' NH2' ' HE2' ' B' ' 86' ' ' PHE . 97.6 mtt180 -86.01 -21.71 27.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.607 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -70.31 -29.44 66.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.69 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.7 mt -83.21 -18.94 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . 0.44 HG21 ' O ' ' B' ' 89' ' ' ARG . 4.2 t -98.04 -28.21 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.935 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -92.34 156.33 17.32 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.016 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . 0.461 ' HZ1' ' CG ' ' A' ' 49' ' ' GLU . 96.5 mttt -94.19 158.36 15.63 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.913 179.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -88.58 35.05 0.76 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.368 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.533 ' O ' ' HB2' ' B' ' 101' ' ' LEU . 18.9 p -83.15 -16.54 46.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.511 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 1.015 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 4.2 mm? -89.74 -14.83 33.8 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.042 0.449 . . . . 0.0 110.414 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -97.59 -34.46 10.95 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.664 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 68.8 mtp180 -74.63 -20.26 59.97 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.127 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.533 ' HB2' ' O ' ' B' ' 97' ' ' THR . 6.8 mt -104.78 -22.56 13.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.239 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 1.015 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 2.8 tt -66.77 -48.93 67.53 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.637 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -84.47 -8.95 58.78 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.513 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.664 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 0.8 OUTLIER -83.38 -35.85 24.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.494 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -88.14 -11.72 46.09 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.257 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.444 ' HG3' ' O ' ' B' ' 102' ' ' LEU . 32.3 mt-10 -75.36 -13.5 60.41 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.432 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 tp -117.26 4.78 12.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.171 0.51 . . . . 0.0 111.027 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 4.5 t -126.37 62.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.417 179.585 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . 0.455 ' CG ' ' HZ1' ' A' ' 35' ' ' LYS . 12.1 tt0 -99.17 130.51 27.11 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.709 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.78 133.45 20.2 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.541 2.161 . . . . 0.0 112.724 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.88 87.36 1.98 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.197 0.523 . . . . 0.0 110.173 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 17.9 p -123.44 145.93 48.22 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.095 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.43 120.57 7.39 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.705 2.27 . . . . 0.0 112.692 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 39.4 p -120.66 -10.04 9.26 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.913 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 160.33 57.16 0.01 OUTLIER Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.498 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -101.77 148.29 25.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.681 0.277 . . . . 0.0 110.972 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -85.31 -41.2 15.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.325 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.11 -9.07 49.75 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.574 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -131.37 134.95 46.8 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 39.4 p . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.873 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 65.9 mttm . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.721 0.296 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.08 146.87 56.38 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.186 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.93 150.59 73.34 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.597 2.198 . . . . 0.0 112.691 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.7 m -80.59 -10.12 59.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.595 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.1 mp -82.88 -30.89 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.076 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.92 -27.1 28.82 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.637 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -63.86 -32.68 74.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.543 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.52 9.55 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.346 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.515 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 21.8 mt -62.15 -43.02 99.76 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 115.725 -0.237 . . . . 0.0 111.431 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.675 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.5 m -60.83 -39.61 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.726 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.467 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.69 -48.81 47.39 Favored Glycine 0 C--O 1.235 0.217 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.836 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.82 -41.41 62.37 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -67.03 -39.65 87.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.438 0.161 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.675 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.5 mp -71.37 -39.35 71.28 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.766 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.511 ' O ' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.37 -40.44 77.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.323 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tp -69.55 -32.68 71.63 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.528 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 3.5 tp -69.68 -43.0 73.38 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.99 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.604 HG21 ' O ' ' A' ' 14' ' ' LEU . 60.0 t -68.99 -43.65 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.061 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.511 HG21 ' O ' ' A' ' 15' ' ' LEU . 93.3 t -66.34 -43.31 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.69 -37.5 82.39 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.094 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -69.78 -35.85 75.22 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.592 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.14 -52.75 25.88 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.279 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.584 ' O ' HG12 ' A' ' 27' ' ' ILE . 11.2 mt -65.13 -37.76 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.633 0.254 . . . . 0.0 110.577 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.94 -46.53 91.28 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.31 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.56 -24.47 60.11 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.587 0.232 . . . . 0.0 111.126 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.411 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 8.1 t80 -75.81 -38.74 57.89 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.274 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.584 HG12 ' O ' ' A' ' 23' ' ' ILE . 39.3 mm -83.7 -31.91 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.196 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -66.62 -25.8 66.77 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.691 0.281 . . . . 0.0 111.578 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.7 -18.09 45.64 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.304 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -82.68 -21.29 34.96 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.529 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -69.57 -15.8 63.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.883 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.05 -19.19 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.01 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.78 -46.09 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.706 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -113.04 125.31 54.25 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.736 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -132.05 110.5 10.76 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.046 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 55.99 27.32 11.05 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.1 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.416 ' O ' HD12 ' A' ' 41' ' ' LEU . 18.2 p -83.5 -34.78 25.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.555 179.943 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.906 ' O ' ' N ' ' A' ' 42' ' ' LEU . 15.1 tp -89.54 -34.71 16.27 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.378 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.451 ' HD3' ' NE2' ' A' ' 43' ' ' GLN . 98.9 mtt180 -67.71 -29.09 68.25 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.458 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 42.8 mtt180 -69.28 -17.99 63.8 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.492 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 11.7 mt -112.0 -27.11 8.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.633 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.906 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.8 OUTLIER -88.69 -60.54 1.93 Allowed 'General case' 0 C--N 1.351 0.672 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.485 ' O ' ' HB2' ' A' ' 47' ' ' LEU . 37.7 mt-30 -69.66 -22.08 63.47 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.697 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.458 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 8.8 mm-40 -83.8 -19.69 34.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.569 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.514 ' HB3' ' OE2' ' A' ' 46' ' ' GLU . 2.9 tmt_? -88.71 -11.85 43.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.432 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.514 ' OE2' ' HB3' ' A' ' 45' ' ' ARG . 2.1 mp0 -116.12 -39.25 3.45 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.485 ' HB2' ' O ' ' A' ' 43' ' ' GLN . 4.2 mm? -88.83 10.33 21.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 112.031 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.4 39.73 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.643 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -100.25 143.83 27.26 Favored Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.882 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.64 160.61 48.88 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.639 2.226 . . . . 0.0 112.745 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mp -142.59 87.41 2.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.253 0.549 . . . . 0.0 110.229 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 p -112.45 146.76 35.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.122 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.37 121.43 8.2 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.647 2.232 . . . . 0.0 112.739 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.4 m -126.04 -10.12 6.54 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.905 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -139.86 55.91 0.63 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.391 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -102.31 134.32 45.8 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.721 0.296 . . . . 0.0 110.832 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.22 -41.99 15.1 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.237 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.21 -7.67 52.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.342 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 92.8 m95 62.23 121.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.975 0.51 . . . . 0.0 111.537 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.897 179.947 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 65.9 mttm . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.715 0.293 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.1 146.71 55.68 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.189 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.68 150.49 74.46 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.668 2.246 . . . . 0.0 112.755 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.4 m -80.63 -10.14 59.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.473 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 3.1 mp -82.95 -30.83 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.082 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.426 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -26.97 28.94 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.628 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -63.89 -32.68 74.28 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.528 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.89 -41.6 9.51 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.289 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.52 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.1 mt -62.21 -43.11 99.57 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.657 -0.272 . . . . 0.0 111.31 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.67 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.2 m -60.81 -39.5 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.744 0.306 . . . . 0.0 111.767 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.484 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.73 -48.87 46.73 Favored Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.775 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.76 -41.33 62.6 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -67.11 -39.73 86.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.876 -0.147 . . . . 0.0 110.85 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -71.27 -39.36 71.62 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.67 0.271 . . . . 0.0 110.824 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.523 ' O ' HG21 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.31 -40.48 77.64 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.389 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 2.3 tp -69.6 -32.54 71.34 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.556 179.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.438 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.83 -42.87 73.05 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.997 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.608 HG21 ' O ' ' B' ' 74' ' ' LEU . 59.7 t -69.06 -43.67 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.066 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.523 HG21 ' O ' ' B' ' 75' ' ' LEU . 94.3 t -66.3 -43.41 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.61 -37.44 82.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.146 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.2 tp -69.82 -35.73 75.04 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.63 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.418 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.2 -52.71 25.85 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.215 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.59 ' O ' HG12 ' B' ' 87' ' ' ILE . 11.2 mt -65.23 -37.77 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 110.471 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.98 -46.44 91.42 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.377 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.53 -24.54 60.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.595 0.236 . . . . 0.0 111.179 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.418 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 8.3 t80 -75.85 -38.64 57.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.269 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.59 HG12 ' O ' ' B' ' 83' ' ' ILE . 39.1 mm -83.72 -31.91 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.178 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -66.65 -25.95 66.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.506 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.55 -18.09 46.17 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.332 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -82.63 -21.32 35.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.522 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -69.52 -15.96 63.34 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.825 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.03 -19.24 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.989 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.69 -46.17 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -113.0 125.3 54.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.739 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -132.01 110.45 10.75 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 55.98 27.29 11.01 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.029 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.411 ' O ' HD12 ' B' ' 101' ' ' LEU . 18.4 p -83.49 -34.72 25.28 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.597 179.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.896 ' O ' ' N ' ' B' ' 102' ' ' LEU . 15.0 tp -89.61 -34.76 16.2 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.36 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . 0.441 ' HD3' ' NE2' ' B' ' 103' ' ' GLN . 98.9 mtt180 -67.59 -29.18 68.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 43.0 mtt180 -69.21 -18.05 63.85 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.488 ' O ' ' HB2' ' B' ' 105' ' ' ARG . 11.7 mt -112.02 -27.06 8.56 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.671 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.896 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.8 OUTLIER -88.56 -60.68 1.89 Allowed 'General case' 0 C--N 1.351 0.638 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . 0.481 ' O ' ' HB2' ' B' ' 107' ' ' LEU . 37.5 mt-30 -69.57 -22.18 63.56 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.641 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 8.8 mm-40 -83.72 -19.79 34.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.512 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.518 ' HB3' ' OE2' ' B' ' 106' ' ' GLU . 2.9 tmt_? -88.67 -11.9 43.97 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.517 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . 0.518 ' OE2' ' HB3' ' B' ' 105' ' ' ARG . 2.1 mp0 -115.97 -39.34 3.48 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.481 ' HB2' ' O ' ' B' ' 103' ' ' GLN . 4.2 mm? -88.79 10.27 21.6 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 111.95 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.38 39.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.591 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -100.24 143.77 27.14 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.934 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.52 160.68 48.68 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.686 2.257 . . . . 0.0 112.738 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 mp -142.64 87.46 2.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.184 0.516 . . . . 0.0 110.252 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 18.0 p -112.53 146.65 35.42 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.071 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.29 121.5 8.29 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.638 2.225 . . . . 0.0 112.703 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 53.0 m -126.13 -10.15 6.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.86 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -139.73 55.89 0.64 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.435 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -102.43 134.22 46.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.786 0.327 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -85.18 -41.89 15.23 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.331 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.17 -7.71 52.98 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.418 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 92.8 m95 62.35 121.79 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.559 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.822 179.999 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.8 mttp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.595 0.236 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.83 146.74 56.37 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.247 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.93 143.79 56.17 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.687 2.258 . . . . 0.0 112.809 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.0 m -80.57 -8.1 59.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.498 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.87 -32.26 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.128 -179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.432 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.96 -27.02 28.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.557 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.0 -32.56 74.15 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.574 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.06 -41.36 9.53 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.208 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.511 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 22.1 mt -62.26 -43.16 99.47 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 122.339 0.256 . . . . 0.0 111.27 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.67 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.1 m -60.79 -39.86 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 111.713 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.471 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.5 -48.74 49.06 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.754 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.8 -41.73 61.97 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.023 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -66.75 -39.63 87.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.421 0.153 . . . . 0.0 110.982 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.7 mp -71.38 -39.57 71.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.647 0.26 . . . . 0.0 110.83 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.51 ' O ' HG22 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.37 -40.11 77.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.244 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.5 tp -69.85 -32.83 71.43 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.54 179.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.424 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.58 -43.26 73.18 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.059 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.6 HG22 ' O ' ' A' ' 14' ' ' LEU . 61.7 t -69.0 -43.9 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.087 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.51 HG22 ' O ' ' A' ' 15' ' ' LEU . 98.7 t -66.22 -43.04 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.014 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.58 82.04 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.4 tp -69.45 -36.04 76.24 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.534 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.405 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.19 -52.85 25.08 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.219 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.559 ' O ' HG12 ' A' ' 27' ' ' ILE . 12.1 mt -65.53 -36.33 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.689 0.28 . . . . 0.0 110.456 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.96 -46.24 89.92 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.37 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.489 ' HG ' ' NH2' ' A' ' 28' ' ' ARG . 17.5 mt -74.12 -24.38 59.43 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.663 0.268 . . . . 0.0 111.221 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.405 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.8 t80 -76.89 -38.07 54.28 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.303 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.559 HG12 ' O ' ' A' ' 23' ' ' ILE . 46.7 mm -83.68 -33.43 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.236 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.489 ' NH2' ' HG ' ' A' ' 25' ' ' LEU . 68.6 mtm180 -64.19 -25.81 68.24 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.67 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -79.47 -18.2 52.55 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.2 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.07 -21.43 27.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.51 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . 0.427 ' HD2' ' O ' ' A' ' 27' ' ' ILE . 42.8 m-70 -69.65 -15.73 63.24 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.9 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.7 mt -82.58 -16.47 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.676 0.274 . . . . 0.0 111.042 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.45 -46.34 12.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.719 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -119.3 130.31 55.33 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.72 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -130.78 -45.27 1.06 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -138.47 31.55 2.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.185 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.4 ' O ' HD11 ' A' ' 41' ' ' LEU . 18.3 p -83.32 -38.66 21.79 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.675 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.931 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.5 mm? -89.86 -36.61 14.97 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.515 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.448 ' HD3' ' NE2' ' A' ' 43' ' ' GLN . 98.8 mtt180 -64.4 -28.91 70.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.083 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.44 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 31.3 mtt180 -68.1 -20.21 64.91 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.487 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 6.9 mt -112.31 -25.76 9.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.828 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.931 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -87.84 -57.68 2.85 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.448 ' NE2' ' HD3' ' A' ' 39' ' ' ARG . 36.5 mt-30 -72.6 -21.84 61.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.583 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.44 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 8.4 mm-40 -83.82 -19.63 34.63 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.449 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.487 ' HB2' ' O ' ' A' ' 41' ' ' LEU . 3.0 tmt_? -88.59 -11.87 44.29 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.436 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.08 -38.34 3.64 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.07 10.01 25.93 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.968 0.413 . . . . 0.0 111.857 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.51 48.0 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.537 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -97.21 146.18 30.9 Favored Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.34 145.23 58.91 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.651 2.234 . . . . 0.0 112.8 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mt -142.79 87.37 1.99 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.251 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.9 p -100.49 147.61 33.83 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.174 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.92 1.41 7.13 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.695 2.263 . . . . 0.0 113.225 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.2 p -86.33 3.18 44.57 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.186 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -129.93 54.93 0.78 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.54 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -107.77 149.72 27.85 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.708 0.289 . . . . 0.0 110.871 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.29 -42.61 14.47 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.207 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.6 mt -90.08 -9.21 49.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.469 -179.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 30.9 m-90 -131.38 145.35 51.79 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -179.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.8 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.872 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 mttp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.633 0.254 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.82 146.77 56.51 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.225 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.93 143.8 56.17 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.624 2.216 . . . . 0.0 112.797 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.0 m -80.59 -8.03 59.46 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.536 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 2.8 mp -82.91 -32.32 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.063 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.426 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.91 -26.91 28.97 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.612 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -32.62 74.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.484 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.86 -41.5 9.61 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.297 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.515 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.1 mt -62.25 -43.07 99.67 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.684 -0.258 . . . . 0.0 111.344 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.667 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.1 m -60.88 -39.79 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.733 0.302 . . . . 0.0 111.735 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.49 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.56 -48.6 49.55 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.862 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.85 -41.7 61.87 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.105 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -66.8 -39.67 87.84 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.438 0.161 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.667 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -71.3 -39.66 71.32 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.77 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.512 ' O ' HG22 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.32 -40.03 77.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.415 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 2.5 tp -69.92 -32.81 71.29 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 179.317 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.6 -43.21 73.24 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.033 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.607 HG22 ' O ' ' B' ' 74' ' ' LEU . 61.6 t -69.04 -43.91 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.036 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.512 HG22 ' O ' ' B' ' 75' ' ' LEU . 99.0 t -66.24 -43.09 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.957 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.83 -37.57 82.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.4 tp -69.46 -36.05 76.21 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.599 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.2 -52.8 25.31 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.249 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.561 ' O ' HG12 ' B' ' 87' ' ' ILE . 12.0 mt -65.48 -36.28 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.665 0.269 . . . . 0.0 110.537 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.92 -46.25 89.95 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.339 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . 0.491 ' HG ' ' NH2' ' B' ' 88' ' ' ARG . 17.8 mt -74.14 -24.47 59.43 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.525 0.202 . . . . 0.0 111.071 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.413 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.8 t80 -76.89 -38.08 54.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.306 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.561 HG12 ' O ' ' B' ' 83' ' ' ILE . 46.6 mm -83.59 -33.46 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.258 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.491 ' NH2' ' HG ' ' B' ' 85' ' ' LEU . 69.0 mtm180 -64.16 -25.88 68.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.638 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -79.37 -18.32 52.62 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.244 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.02 -21.44 27.78 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.527 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 91' ' ' HIS . . . . . 0.418 ' HD2' ' O ' ' B' ' 87' ' ' ILE . 43.0 m-70 -69.63 -15.73 63.25 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.926 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.7 mt -82.61 -16.34 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.067 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.55 -46.31 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.715 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -119.35 130.18 55.22 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.811 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -130.73 -45.1 1.06 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -138.44 31.54 2.34 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.159 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.403 ' O ' HD11 ' B' ' 101' ' ' LEU . 18.2 p -83.37 -38.69 21.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.599 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.911 ' O ' ' N ' ' B' ' 102' ' ' LEU . 1.5 mm? -89.83 -36.52 15.04 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.567 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . 0.45 ' HD3' ' NE2' ' B' ' 103' ' ' GLN . 98.8 mtt180 -64.35 -29.05 70.13 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 123.565 0.746 . . . . 0.0 109.126 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.447 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 31.6 mtt180 -67.97 -20.21 65.02 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' B' ' 105' ' ' ARG . 6.8 mt -112.23 -25.83 9.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.868 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.911 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.3 OUTLIER -87.89 -57.72 2.83 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . 0.45 ' NE2' ' HD3' ' B' ' 99' ' ' ARG . 36.6 mt-30 -72.47 -21.95 61.14 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.685 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.447 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 8.5 mm-40 -83.68 -19.71 34.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.449 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.5 ' HB2' ' O ' ' B' ' 101' ' ' LEU . 2.9 tmt_? -88.68 -11.74 44.39 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.381 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.14 -38.36 3.62 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.13 10.1 25.74 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.025 0.44 . . . . 0.0 111.882 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.59 48.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.501 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -97.18 146.23 30.99 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.908 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.39 145.2 58.5 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.738 2.292 . . . . 0.0 112.711 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 9.9 mt -142.82 87.43 1.99 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.233 0.539 . . . . 0.0 110.303 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 17.7 p -100.47 147.62 33.84 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.1 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.95 1.39 7.17 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.634 2.223 . . . . 0.0 113.186 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 44.4 p -86.29 3.08 44.85 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.208 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -129.8 54.99 0.77 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.531 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -107.83 149.6 28.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.692 0.282 . . . . 0.0 110.934 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.09 -42.66 14.6 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.336 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 9.6 mt -90.08 -9.17 49.45 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.418 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -131.45 145.27 51.71 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.952 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 53.0 m . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.867 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 30.7 tttm . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.613 0.244 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.81 146.78 56.57 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.19 139.52 42.42 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.642 2.228 . . . . 0.0 112.834 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.4 m -80.53 -7.19 59.11 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.544 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.401 HD12 ' H ' ' A' ' 5' ' ' ILE . 2.5 mp -82.97 -32.87 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.083 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.433 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.95 -27.12 28.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.553 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.09 -32.54 74.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.593 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.98 -41.41 9.57 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.233 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.51 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 23.4 mt -62.31 -43.32 99.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.694 -0.253 . . . . 0.0 111.285 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.657 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.0 m -60.66 -39.56 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.737 0.303 . . . . 0.0 111.717 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.482 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.5 -49.19 46.11 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.82 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.5 -41.77 62.65 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.51 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.91 -41.39 91.5 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.818 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.657 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.6 mp -70.35 -39.53 74.6 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.902 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.497 ' O ' HG21 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.31 -37.88 77.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.414 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.03 -35.01 73.99 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.646 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 14.8 mt -69.48 -42.15 75.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.591 HG21 ' O ' ' A' ' 14' ' ' LEU . 58.0 t -68.71 -44.97 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.058 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.497 HG21 ' O ' ' A' ' 15' ' ' LEU . 93.0 t -65.91 -43.19 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.82 84.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.078 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.93 -36.31 77.82 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.614 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.36 -49.98 41.58 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.286 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 mt -64.17 -41.23 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 110.495 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.554 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -64.44 -44.39 95.35 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.366 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.6 mt -72.78 -24.66 60.97 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.724 0.297 . . . . 0.0 111.038 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.91 -40.67 62.98 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.11 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 12.4 mt -83.65 -27.27 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.999 179.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.554 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.3 ttt180 -63.58 -25.79 68.4 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.488 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -81.66 -35.0 30.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.329 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.25 -21.27 27.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.47 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 4.3 t60 -69.89 -15.81 63.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.804 -179.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt -81.51 -10.89 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.102 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.18 -45.94 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.72 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -127.4 128.14 45.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.725 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -129.73 -43.29 1.24 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.159 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.39 17.61 5.94 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.271 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.19 -32.03 26.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.308 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.916 ' O ' ' N ' ' A' ' 42' ' ' LEU . 15.8 tp -89.42 -35.73 15.86 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.3 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 43' ' ' GLN . 27.4 mmt180 -67.52 -28.92 68.23 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.554 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 27.6 mtp180 -69.96 -18.79 63.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 13.5 mt -111.33 -27.37 8.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.718 177.899 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.916 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -79.19 -46.48 17.83 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-O 120.746 0.308 . . . . 0.0 111.05 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . 0.47 ' O ' HD11 ' A' ' 47' ' ' LEU . 13.2 mm-40 -83.32 -3.19 57.24 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.616 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.554 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 10.3 tt0 -83.01 -40.28 20.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.497 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -88.41 -11.74 45.21 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.532 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -82.18 -22.99 35.74 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.341 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . 0.47 HD11 ' O ' ' A' ' 43' ' ' GLN . 9.6 mt -100.97 2.03 40.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.196 0.522 . . . . 0.0 111.193 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.5 t -128.08 57.24 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.459 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -101.01 148.29 34.88 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.801 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.1 134.77 30.25 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.638 2.226 . . . . 0.0 112.782 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 tp -142.83 87.41 1.99 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.233 0.54 . . . . 0.0 110.171 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -99.69 146.03 31.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.108 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.22 118.38 5.64 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.639 2.226 . . . . 0.0 112.743 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.1 m -103.05 -11.28 18.24 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.965 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.27 -55.67 0.25 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.458 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -126.71 139.18 53.34 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.622 0.248 . . . . 0.0 110.976 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.24 -40.36 16.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.306 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.4 tp -89.98 -8.21 52.2 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.295 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -130.47 144.17 51.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.858 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.805 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 30.9 tttm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.61 0.243 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.93 146.65 55.82 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.235 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.13 139.46 42.47 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.723 2.282 . . . . 0.0 112.78 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.0 m -80.53 -7.13 59.1 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.543 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.401 ' H ' HD12 ' B' ' 65' ' ' ILE . 2.5 mp -83.04 -32.86 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.055 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.426 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -27.21 28.77 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.629 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -32.68 74.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.498 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.89 -41.33 9.71 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.264 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.515 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.9 mt -62.18 -43.57 98.53 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 122.377 0.271 . . . . 0.0 111.308 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.651 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.0 m -60.46 -39.61 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.746 0.308 . . . . 0.0 111.723 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.48 -49.27 45.71 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.718 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.59 -41.73 62.49 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.92 -41.28 91.61 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.005 0.191 . . . . 0.0 110.823 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.651 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -70.42 -39.56 74.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.833 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.28 -37.83 78.05 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.413 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.1 -35.06 73.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.6 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 14.8 mt -69.49 -42.07 75.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.158 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.601 HG21 ' O ' ' B' ' 74' ' ' LEU . 57.9 t -68.85 -44.84 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.085 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.489 HG21 ' O ' ' B' ' 75' ' ' LEU . 93.6 t -65.84 -43.28 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.964 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.25 -37.64 83.85 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.1 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.3 tp -68.95 -36.38 77.85 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.608 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.33 -50.04 41.41 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.311 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 mt -64.2 -41.1 91.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.634 0.254 . . . . 0.0 110.546 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . 0.551 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -64.39 -44.52 95.22 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.395 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 20.7 mt -72.69 -24.77 61.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.643 0.259 . . . . 0.0 110.971 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.84 -40.71 63.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.41 ' O ' ' HB2' ' B' ' 91' ' ' HIS . 12.3 mt -83.53 -27.41 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.996 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.551 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.3 ttt180 -63.56 -25.63 68.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.476 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -81.8 -34.91 30.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.364 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.26 -21.38 27.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.481 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 91' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' B' ' 87' ' ' ILE . 4.2 t60 -69.81 -15.73 63.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.883 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 mt -81.55 -11.0 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.101 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.6 t -94.04 -45.94 13.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.778 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -127.34 128.14 45.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.775 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -129.83 -43.17 1.24 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.162 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.32 17.56 5.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.309 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.15 -32.04 26.86 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.381 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.917 ' O ' ' N ' ' B' ' 102' ' ' LEU . 15.8 tp -89.37 -35.75 15.89 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.353 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' B' ' 103' ' ' GLN . 27.4 mmt180 -67.46 -28.92 68.27 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.474 -0.785 . . . . 0.0 108.922 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.559 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 27.5 mtp180 -69.99 -18.83 63.35 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 176.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 13.3 mt -111.31 -27.3 8.72 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.777 177.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.917 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.7 OUTLIER -79.38 -46.38 17.7 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-O 120.601 0.238 . . . . 0.0 110.991 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . 0.46 ' O ' HD11 ' B' ' 107' ' ' LEU . 13.2 mm-40 -83.27 -3.25 57.26 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.62 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.559 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 10.3 tt0 -83.06 -40.17 20.23 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.545 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -88.46 -11.78 44.93 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.558 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -82.06 -23.13 36.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.353 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . 0.46 HD11 ' O ' ' B' ' 103' ' ' GLN . 9.6 mt -100.97 2.09 40.34 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.13 0.49 . . . . 0.0 111.136 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 3.5 t -128.1 57.28 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.453 179.511 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -101.03 148.21 34.78 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.863 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.19 134.8 30.14 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.641 2.227 . . . . 0.0 112.756 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 tp -142.78 87.36 1.99 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.204 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 18.0 p -99.62 146.08 31.21 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.107 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.25 118.34 5.61 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.721 2.281 . . . . 0.0 112.8 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 52.6 m -103.13 -11.23 18.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.897 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.35 -55.73 0.24 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.546 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -126.79 139.22 53.27 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.683 0.277 . . . . 0.0 110.837 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.14 -40.48 16.68 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.351 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 tp -90.01 -8.09 52.41 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.356 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -130.5 144.27 51.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.765 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.823 -179.993 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.63 0.252 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.0 146.63 55.6 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.222 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.83 140.53 46.58 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.713 2.275 . . . . 0.0 112.78 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 t -80.57 -7.74 59.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.496 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.4 HD11 ' H ' ' A' ' 5' ' ' ILE . 2.5 mp -82.89 -32.57 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.143 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.44 ' O ' HG23 ' A' ' 10' ' ' VAL . . . -83.96 -26.2 29.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.572 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -63.84 -33.21 75.17 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.562 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.13 9.82 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.268 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.5 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 22.0 mt -62.22 -43.36 99.0 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 122.286 0.235 . . . . 0.0 111.291 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.678 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.0 m -60.9 -39.99 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.769 0.319 . . . . 0.0 111.73 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.5 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.26 -48.5 52.01 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.828 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -73.93 -42.43 60.6 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.5 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -66.25 -39.54 89.57 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.846 -0.161 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.678 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.8 mp -71.86 -39.59 69.58 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.68 0.276 . . . . 0.0 110.846 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.75 -39.4 76.75 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.394 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.2 tp -70.22 -33.71 72.0 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.42 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.49 -43.29 73.44 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.12 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.584 HG23 ' O ' ' A' ' 14' ' ' LEU . 58.2 t -69.43 -43.58 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.129 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 15' ' ' LEU . 89.3 t -66.7 -43.27 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.114 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.38 -39.27 85.61 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.158 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.1 tp -69.37 -35.2 75.6 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.598 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.426 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.02 -52.4 28.41 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.305 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.577 ' O ' HG12 ' A' ' 27' ' ' ILE . 12.1 mt -65.58 -37.18 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.648 0.261 . . . . 0.0 110.566 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . 0.556 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -64.48 -46.16 91.14 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.382 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.9 mt -74.21 -24.98 59.41 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.497 0.189 . . . . 0.0 111.208 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.426 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.1 t80 -75.82 -39.26 57.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.278 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 23' ' ' ILE . 41.6 mm -83.66 -30.51 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.116 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.556 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.6 ttt180 -64.91 -26.1 68.17 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.693 0.283 . . . . 0.0 111.337 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.9 -18.19 44.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.414 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.54 -21.5 35.35 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.597 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -68.48 -21.56 64.61 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.687 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mt -83.25 -10.96 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 t -96.03 -22.05 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . 0.529 ' NH2' ' HB3' ' A' ' 38' ' ' LEU . 45.1 mtp180 -92.15 145.17 24.72 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.062 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -108.73 26.4 10.6 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.943 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 58.62 30.79 20.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.713 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.412 ' O ' HD12 ' A' ' 41' ' ' LEU . 18.4 p -83.25 -13.87 54.38 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.622 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.968 ' O ' ' N ' ' A' ' 42' ' ' LEU . 13.4 tp -89.02 -40.41 13.0 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.265 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.409 ' HA ' ' CB ' ' A' ' 42' ' ' LEU . 74.6 mtp180 -66.45 -31.66 72.54 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.674 0.79 . . . . 0.0 108.959 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.62 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 26.0 mmt180 -69.48 -19.42 63.75 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.412 HD12 ' O ' ' A' ' 37' ' ' THR . 27.6 mt -111.53 -25.67 9.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.008 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.968 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.3 tt -70.93 -43.91 67.22 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-O 120.623 0.249 . . . . 0.0 110.996 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -87.52 -13.62 42.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.475 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.62 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 9.1 tt0 -84.16 -39.69 19.1 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.669 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 21.3 mmt180 -88.19 -12.24 44.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.843 -179.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -100.09 12.87 35.89 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.782 0.325 . . . . 0.0 111.094 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.7 tp 58.87 34.37 23.62 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.416 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t 54.12 52.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.347 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -101.1 141.08 21.91 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.89 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.68 135.19 27.69 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.671 2.247 . . . . 0.0 112.787 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 tt -142.84 87.28 1.98 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.14 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.9 t -139.41 139.78 23.69 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.07 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.86 0.63 8.03 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.564 2.176 . . . . 0.0 113.133 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.8 m -87.15 3.85 44.69 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.242 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.26 -108.8 3.5 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.539 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -126.73 141.95 51.69 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.733 0.302 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -85.23 -41.37 15.66 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.394 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.02 -8.76 50.79 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.475 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -130.45 141.27 50.53 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.829 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 53.4 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.886 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.683 0.278 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.97 146.85 56.6 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.095 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.1 140.61 45.6 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.628 2.219 . . . . 0.0 112.743 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.1 t -80.6 -7.7 59.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.472 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . 0.401 ' H ' HD11 ' B' ' 65' ' ' ILE . 2.5 mp -83.01 -32.6 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.051 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.435 ' O ' HG23 ' B' ' 70' ' ' VAL . . . -83.85 -26.22 29.65 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.688 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -63.95 -33.13 75.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.551 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.15 9.82 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.333 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.506 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 21.9 mt -62.24 -43.14 99.5 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.648 -0.276 . . . . 0.0 111.393 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.669 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.2 m -60.97 -40.13 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.699 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.22 -48.48 52.42 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.9 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . 0.415 ' O ' ' HB2' ' B' ' 76' ' ' LEU . . . -73.95 -42.5 60.43 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.506 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -66.2 -39.65 89.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.867 -0.151 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.669 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -71.85 -39.42 69.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.591 0.234 . . . . 0.0 110.861 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.95 -39.38 76.1 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.385 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . 0.415 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.2 tp -70.09 -33.84 72.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.593 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . 0.414 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.37 -43.36 73.71 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.074 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.597 HG23 ' O ' ' B' ' 74' ' ' LEU . 58.2 t -69.41 -43.48 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.165 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.482 HG23 ' O ' ' B' ' 75' ' ' LEU . 88.8 t -66.71 -43.38 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.029 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.25 85.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.151 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . 0.414 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.1 tp -69.21 -35.28 76.05 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.669 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.43 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.98 -52.43 28.44 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.241 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.573 ' O ' HG12 ' B' ' 87' ' ' ILE . 12.0 mt -65.6 -37.21 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.667 0.27 . . . . 0.0 110.564 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -64.41 -46.18 91.22 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.485 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 18.0 mt -74.18 -24.86 59.43 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.547 0.213 . . . . 0.0 111.252 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.43 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.2 t80 -76.02 -39.25 56.1 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.573 HG12 ' O ' ' B' ' 83' ' ' ILE . 41.5 mm -83.56 -30.53 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.186 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . 0.553 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.7 ttt180 -64.97 -26.07 68.14 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.254 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.99 -18.22 44.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.272 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.52 -21.53 35.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.54 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -68.5 -21.55 64.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.741 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt -83.16 -11.03 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.097 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.97 -22.06 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.944 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . 0.532 ' NH2' ' HB3' ' B' ' 98' ' ' LEU . 45.5 mtp180 -92.15 145.12 24.76 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.053 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -108.8 26.68 10.28 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.971 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 58.61 30.67 20.17 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.681 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.413 ' O ' HD12 ' B' ' 101' ' ' LEU . 18.5 p -83.25 -13.87 54.38 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.659 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.944 ' O ' ' N ' ' B' ' 102' ' ' LEU . 13.3 tp -88.96 -40.41 13.06 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.317 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . 0.409 ' HA ' ' CB ' ' B' ' 102' ' ' LEU . 74.8 mtp180 -66.5 -31.59 72.41 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.646 0.778 . . . . 0.0 109.015 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.618 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 26.1 mmt180 -69.42 -19.46 63.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.413 HD12 ' O ' ' B' ' 97' ' ' THR . 27.8 mt -111.47 -25.68 9.48 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.048 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.944 ' N ' ' O ' ' B' ' 98' ' ' LEU . 1.3 tt -70.94 -43.85 67.32 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-O 120.666 0.269 . . . . 0.0 110.984 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -87.46 -13.71 42.46 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.508 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.618 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 9.1 tt0 -84.05 -39.84 19.1 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.628 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.402 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 21.3 mmt180 -88.14 -12.18 44.78 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.765 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -100.17 12.81 36.13 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.816 0.341 . . . . 0.0 111.038 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 tp 59.01 34.26 23.47 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.392 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 t 54.13 52.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.301 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -101.02 141.13 22.02 Favored Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.905 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.8 135.23 27.51 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.592 2.195 . . . . 0.0 112.778 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 tt -142.92 87.33 1.98 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.224 0.535 . . . . 0.0 110.07 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.9 t -139.53 139.69 23.14 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.016 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.62 0.55 8.0 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.653 2.236 . . . . 0.0 113.269 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 53.0 m -87.25 3.9 44.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.173 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.18 -108.74 3.49 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.481 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -126.73 141.98 51.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.693 0.282 . . . . 0.0 110.841 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.35 -41.33 15.59 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.3 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.06 -8.62 51.02 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.504 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -130.51 141.3 50.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.735 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 53.1 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.951 179.94 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.669 0.271 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.13 146.48 54.65 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.166 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.05 141.43 48.09 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.636 2.224 . . . . 0.0 112.666 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.8 m -80.72 -7.43 59.35 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.513 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.6 mp -82.96 -32.73 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.134 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ALA . . . . . 0.437 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.99 -26.23 29.36 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.62 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.04 -33.08 74.94 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.539 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.79 -41.13 9.95 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.382 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.508 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 21.9 mt -62.3 -43.55 98.56 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.7 -0.25 . . . . 0.0 111.37 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 23.5 m -60.71 -40.48 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 111.761 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLY . . . . . 0.513 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.0 -48.88 51.45 Favored Glycine 0 C--O 1.235 0.201 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.808 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ALA . . . . . . . . . . . . . . . -73.57 -42.82 61.11 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.039 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.25 -41.16 94.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.442 0.163 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.9 mp -70.54 -40.01 73.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.626 0.251 . . . . 0.0 110.953 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -69.46 -36.84 76.97 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.603 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 tp -69.93 -36.8 75.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.573 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.7 mt -68.48 -44.22 75.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.274 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . 0.578 HG21 ' O ' ' A' ' 14' ' ' LEU . 61.9 t -67.35 -44.88 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.229 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' VAL . . . . . 0.467 HG21 ' O ' ' A' ' 15' ' ' LEU . 83.8 t -67.03 -39.11 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.2 83.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.054 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.6 mt -69.36 -34.33 74.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.657 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.424 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.35 -54.3 20.78 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.277 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.518 ' O ' HG12 ' A' ' 27' ' ' ILE . 15.1 mt -66.3 -35.72 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.592 0.234 . . . . 0.0 110.634 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.06 -45.98 90.24 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.473 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.56 -24.69 56.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.53 0.205 . . . . 0.0 111.299 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' PHE . . . . . 0.424 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.9 t80 -77.78 -36.87 50.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.333 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.518 HG12 ' O ' ' A' ' 23' ' ' ILE . 52.1 mm -83.69 -36.62 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.309 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -67.65 -29.2 68.45 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.619 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -82.1 -18.24 43.69 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.469 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -85.32 -21.77 28.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.529 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -81.97 -15.93 52.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.489 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.8 mm -83.32 -11.76 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.965 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.71 -18.74 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.02 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -92.65 151.72 19.95 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.161 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -99.04 173.63 6.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.614 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . 0.407 ' O ' ' HG3' ' A' ' 40' ' ' ARG . 99.2 mtt180 -84.85 28.5 0.68 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.461 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.403 HG21 ' CZ ' ' B' ' 105' ' ' ARG . 9.1 t -83.23 -15.32 50.81 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.673 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LEU . . . . . 0.956 ' O ' ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -89.31 -38.83 13.89 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.415 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -66.98 -29.4 69.24 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.025 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.532 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 98.8 mtt180 -70.06 -18.41 63.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' LEU . . . . . 0.525 ' O ' ' HB2' ' A' ' 45' ' ' ARG . 38.7 mt -112.09 -26.69 8.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.115 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.956 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.2 tt -90.12 -53.09 4.63 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.89 -24.25 55.64 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.492 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.532 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 28.8 mt-10 -83.92 -19.84 34.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.748 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ARG . . . . . 0.525 ' HB2' ' O ' ' A' ' 41' ' ' LEU . 2.4 tmt_? -88.06 -31.71 19.13 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.959 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -92.32 0.73 57.47 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.5 mp 56.81 35.36 26.17 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.637 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 t 54.49 51.59 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.232 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -111.0 143.21 27.85 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.951 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.68 163.89 37.39 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.623 2.215 . . . . 0.0 112.66 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.78 87.39 1.99 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.244 0.545 . . . . 0.0 110.221 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 p -139.27 146.77 50.28 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.067 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.92 118.53 5.73 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.763 2.309 . . . . 0.0 112.789 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.6 p -109.41 -10.44 14.9 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.957 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.61 101.23 2.27 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.477 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 63.37 127.66 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.008 0.523 . . . . 0.0 111.608 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -85.13 -38.23 19.29 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.407 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.6 mp -90.13 -9.03 49.83 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.445 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -131.66 145.49 51.69 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.754 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.2 m . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.915 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.718 0.294 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.04 146.5 54.96 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.224 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.06 141.41 48.02 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.623 2.215 . . . . 0.0 112.771 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.6 m -80.6 -7.55 59.3 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.493 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 65' ' ' ILE . . . . . . . . . . . . . 2.6 mp -82.88 -32.9 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.094 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 66' ' ' ALA . . . . . 0.443 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.98 -26.14 29.44 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.544 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.03 -33.16 75.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.47 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.88 -41.05 9.92 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.329 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 69' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.1 mt -62.42 -43.6 98.43 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 115.691 -0.254 . . . . 0.0 111.324 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 70' ' ' VAL . . . . . 0.659 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.4 m -60.45 -40.64 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.873 0.368 . . . . 0.0 111.825 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 71' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.97 -48.91 51.43 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.819 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 72' ' ' ALA . . . . . . . . . . . . . . . -73.62 -42.74 61.09 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 73' ' ' LEU . . . . . 0.505 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.27 -41.24 94.43 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.882 -0.144 . . . . 0.0 110.862 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 74' ' ' LEU . . . . . 0.659 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -70.61 -39.94 73.48 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.895 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 75' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.52 -36.85 76.82 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.485 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tp -69.96 -36.61 75.39 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.64 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.67 -44.01 74.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.274 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 78' ' ' VAL . . . . . 0.588 HG21 ' O ' ' B' ' 74' ' ' LEU . 61.6 t -67.48 -44.98 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.134 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 79' ' ' VAL . . . . . 0.453 HG21 ' O ' ' B' ' 75' ' ' LEU . 84.7 t -66.78 -39.23 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.096 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.19 83.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.042 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 20.7 mt -69.36 -34.39 74.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.636 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 82' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.27 -54.19 21.68 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.398 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 83' ' ' ILE . . . . . 0.515 ' O ' HG12 ' B' ' 87' ' ' ILE . 14.9 mt -66.4 -35.73 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.553 0.216 . . . . 0.0 110.599 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.06 -46.12 89.8 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.435 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.34 -24.77 57.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.569 0.223 . . . . 0.0 111.351 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 86' ' ' PHE . . . . . 0.412 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.9 t80 -77.88 -36.82 49.28 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.282 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 87' ' ' ILE . . . . . 0.515 HG12 ' O ' ' B' ' 83' ' ' ILE . 52.2 mm -83.63 -36.61 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.344 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -67.7 -29.17 68.36 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.571 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -82.21 -18.18 43.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.416 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -85.3 -21.83 28.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.521 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -81.96 -16.07 51.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.483 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 6.7 mm -83.18 -11.7 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.046 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.75 -18.66 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.102 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -92.77 151.71 19.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.048 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -98.92 173.68 6.73 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.687 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 96' ' ' ARG . . . . . 0.404 ' O ' ' HG3' ' B' ' 100' ' ' ARG . 99.2 mtt180 -84.9 28.51 0.69 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.391 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 97' ' ' THR . . . . . 0.405 HG21 ' CZ ' ' A' ' 45' ' ' ARG . 8.9 t -83.32 -15.32 50.5 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.623 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 98' ' ' LEU . . . . . 0.931 ' O ' ' N ' ' B' ' 102' ' ' LEU . 0.2 OUTLIER -89.28 -38.75 13.97 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.427 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.08 -29.35 69.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 100' ' ' ARG . . . . . 0.531 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 98.8 mtt180 -70.17 -18.31 63.2 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' LEU . . . . . 0.523 ' O ' ' HB2' ' B' ' 105' ' ' ARG . 38.3 mt -112.12 -26.65 8.73 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.074 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' LEU . . . . . 0.931 ' N ' ' O ' ' B' ' 98' ' ' LEU . 1.2 tt -90.17 -53.11 4.61 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.73 -24.51 56.16 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.528 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' GLU . . . . . 0.531 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 29.0 mt-10 -83.72 -19.9 34.39 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.806 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' ARG . . . . . 0.523 ' HB2' ' O ' ' B' ' 101' ' ' LEU . 2.4 tmt_? -88.09 -31.61 19.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.003 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -92.31 0.72 57.47 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 5.5 mp 56.84 35.34 26.16 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.679 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t 54.56 51.55 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.205 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -111.07 143.18 27.81 Favored Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.71 163.87 37.5 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.591 2.194 . . . . 0.0 112.67 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.69 87.19 1.98 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.131 0.491 . . . . 0.0 110.259 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 17.6 p -139.22 146.81 50.61 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.048 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.02 118.52 5.73 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.639 2.226 . . . . 0.0 112.786 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 39.8 p -109.34 -10.48 14.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.025 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.59 101.18 2.26 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.473 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 63.51 127.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.965 0.506 . . . . 0.0 111.588 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -85.14 -38.22 19.29 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.346 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.02 -9.19 49.52 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.427 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -131.57 145.58 51.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.805 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 52.5 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.923 179.969 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.362 0.125 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.27 139.02 40.84 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.626 2.217 . . . . 0.0 112.729 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.8 m -80.58 -7.14 59.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.503 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.4 mp -82.94 -32.6 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.131 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.91 -28.33 27.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.587 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.15 -31.9 73.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.545 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.96 -41.94 9.21 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.229 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 13' ' ' LEU . 23.9 mt -61.98 -43.21 99.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.749 -0.225 . . . . 0.0 111.194 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.697 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 25.2 m -61.0 -39.05 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.832 0.349 . . . . 0.0 111.656 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.21 -48.4 52.99 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.742 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -74.28 -43.16 58.02 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.33 -40.0 93.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.455 0.169 . . . . 0.0 110.954 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.697 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.1 mp -72.41 -39.77 67.66 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.082 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.2 OUTLIER -70.16 -39.25 75.43 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.567 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -70.08 -34.7 73.49 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.591 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.44 -42.29 75.14 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 14' ' ' LEU . 99.3 t -69.1 -42.85 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.128 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 15' ' ' LEU . 94.8 t -68.89 -39.69 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.024 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.59 -36.46 73.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.352 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 1.7 tp -70.27 -44.97 67.34 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.71 -56.22 8.66 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.529 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.1 mm -64.25 -37.64 80.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.745 0.307 . . . . 0.0 110.621 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.16 -46.58 87.45 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.329 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.7 mt -73.05 -24.0 60.65 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.677 0.275 . . . . 0.0 110.986 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.51 -39.91 64.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.194 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 mt -83.34 -33.68 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.248 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.76 -26.0 66.76 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.645 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -81.88 -18.16 44.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.401 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.51 -21.61 38.52 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.617 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -70.74 -28.63 64.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.692 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt . . . . . 0 N--CA 1.466 0.347 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.106 179.938 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.013 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 6.1 tp . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 121.058 0.456 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -97.87 -33.87 11.07 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 114.706 -1.133 . . . . 0.0 107.966 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -75.68 -21.84 57.24 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.157 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.7 mt -104.84 -19.72 13.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.405 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.013 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 4.1 tt . . . . . 0 N--CA 1.469 0.522 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.676 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 111.184 0.068 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.14 138.95 41.1 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.726 2.284 . . . . 0.0 112.719 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 52.8 m -80.52 -7.24 59.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.49 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.468 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.4 mp -82.9 -32.76 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.072 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.444 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -28.22 28.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.605 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.13 -31.97 73.37 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.538 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.99 -41.86 9.25 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.228 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.531 ' O ' HD13 ' B' ' 73' ' ' LEU . 23.8 mt -62.02 -43.2 99.34 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.625 0.25 . . . . 0.0 111.215 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.69 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 25.5 m -61.02 -39.09 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 111.619 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.18 -48.47 52.66 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.714 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' B' ' 76' ' ' LEU . . . -74.2 -43.17 58.27 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.531 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.31 -40.0 93.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.029 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.69 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.1 mp -72.3 -39.85 67.97 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.095 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.2 OUTLIER -70.21 -39.22 75.28 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.553 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 0.7 OUTLIER -70.04 -34.65 73.51 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.67 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.45 -42.43 74.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.976 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.601 HG23 ' O ' ' B' ' 74' ' ' LEU . 99.9 t -68.99 -42.88 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.128 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.5 HG23 ' O ' ' B' ' 75' ' ' LEU . 95.5 t -68.91 -39.73 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.031 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.46 -36.53 73.97 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.371 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 1.7 tp -70.37 -44.89 67.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.035 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.76 -56.22 8.6 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.489 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 47.2 mm -64.22 -37.71 80.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.683 0.277 . . . . 0.0 110.554 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.05 -46.64 88.17 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.406 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 25.8 mt -73.1 -23.94 60.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.577 0.227 . . . . 0.0 110.962 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -39.83 64.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.25 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 18.8 mt -83.34 -33.76 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.2 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.76 -25.97 66.75 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.682 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -81.96 -18.03 44.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.416 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.55 -21.58 38.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.575 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -70.77 -28.6 64.8 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.683 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mt . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.065 179.949 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 1.028 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 6.1 tp . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 121.105 0.479 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -97.81 -33.88 11.09 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.025 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -75.61 -21.83 57.41 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.224 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 22.8 mt -104.78 -19.72 13.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.42 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 1.028 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 4.2 tt . . . . . 0 N--CA 1.47 0.564 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.331 0.11 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.38 143.72 59.07 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.629 2.219 . . . . 0.0 112.803 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 t -80.58 -8.35 59.57 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.465 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.7 mp -83.01 -32.0 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.089 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.93 -26.62 29.17 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.585 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.0 -32.87 74.56 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.524 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.94 -41.36 9.64 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.245 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 13' ' ' LEU . 22.3 mt -62.14 -42.99 99.79 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.736 -0.232 . . . . 0.0 111.36 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.683 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 23.9 m -60.93 -39.47 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.777 0.322 . . . . 0.0 111.688 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.68 -48.98 46.31 Favored Glycine 0 C--O 1.236 0.222 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.703 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.46 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.75 -41.3 62.68 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -67.09 -39.69 86.81 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.683 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.6 mp -71.25 -39.38 71.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.625 0.25 . . . . 0.0 110.771 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.33 -40.48 77.57 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.303 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 tp -69.64 -32.25 70.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 3.5 tp -69.96 -42.55 73.04 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.91 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 14' ' ' LEU . 59.1 t -69.18 -43.42 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.015 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 15' ' ' LEU . 91.0 t -66.46 -43.46 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.852 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.79 83.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.101 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 3.2 tp -69.44 -36.35 76.54 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.522 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.41 ' O ' ' HD1' ' A' ' 26' ' ' PHE . . . -67.42 -53.38 25.35 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.222 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.578 ' O ' HG12 ' A' ' 27' ' ' ILE . 11.0 mt -64.47 -37.34 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.649 0.261 . . . . 0.0 110.536 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.66 -44.32 95.13 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.414 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 mt -73.45 -27.01 61.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.445 0.164 . . . . 0.0 111.141 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.41 ' HD1' ' O ' ' A' ' 22' ' ' GLY . 2.8 m-85 -76.43 -36.59 57.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.432 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 23' ' ' ILE . 47.5 mm -83.52 -32.84 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.237 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -67.73 -25.77 65.82 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.554 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.79 -33.79 30.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.164 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -86.32 -21.33 27.34 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.411 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 27' ' ' ILE . 3.2 t60 -70.03 -15.94 63.08 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.806 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt . . . . . 0 CA--C 1.533 0.298 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.133 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.95 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.3 mm? . . . . . 0 C--O 1.221 -0.405 0 CA-C-O 120.531 0.205 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -63.28 -28.57 70.11 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.313 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -67.52 -21.84 65.46 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.537 HD22 HD22 ' B' ' 101' ' ' LEU . 5.4 mt -111.78 -26.31 9.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 113.537 -1.665 . . . . 0.0 109.941 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.95 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.353 0.721 0 CA-C-O 120.577 0.227 . . . . 0.0 111.448 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.248 0.07 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.49 143.71 58.38 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.606 2.204 . . . . 0.0 112.797 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.1 t -80.53 -8.39 59.56 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.517 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.466 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.7 mp -82.9 -32.1 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.128 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.437 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.95 -26.5 29.22 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.659 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.03 -32.77 74.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.542 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.08 -41.24 9.6 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.243 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.2 mt -62.17 -43.08 99.64 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 122.331 0.253 . . . . 0.0 111.365 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.673 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 23.4 m -61.0 -39.31 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.878 0.371 . . . . 0.0 111.782 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.78 -48.79 46.91 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.809 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.459 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.86 -41.22 62.52 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -67.19 -39.54 86.4 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.434 0.159 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.673 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.5 mp -71.35 -39.37 71.35 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.641 0.258 . . . . 0.0 110.712 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.535 ' O ' HG23 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.33 -40.48 77.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.266 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 2.4 tp -69.74 -32.29 70.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.42 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' B' ' 73' ' ' LEU . 3.5 tp -69.88 -42.6 73.24 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.016 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.616 HG23 ' O ' ' B' ' 74' ' ' LEU . 59.1 t -69.13 -43.44 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.983 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.535 HG23 ' O ' ' B' ' 75' ' ' LEU . 91.0 t -66.44 -43.42 91.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.899 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.86 83.62 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.08 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 3.1 tp -69.31 -36.41 76.96 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.53 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.414 ' O ' ' HD1' ' B' ' 86' ' ' PHE . . . -67.51 -53.23 25.81 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.196 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.59 ' O ' HG12 ' B' ' 87' ' ' ILE . 11.0 mt -64.59 -37.33 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.704 0.287 . . . . 0.0 110.495 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.3 95.04 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.396 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 19.0 mt -73.43 -27.05 61.22 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.557 0.218 . . . . 0.0 111.287 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.414 ' HD1' ' O ' ' B' ' 82' ' ' GLY . 2.7 m-85 -76.51 -36.42 57.77 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.458 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.59 HG12 ' O ' ' B' ' 83' ' ' ILE . 47.6 mm -83.58 -32.77 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.212 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -67.77 -25.82 65.8 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.459 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.81 -33.74 30.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.201 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -86.21 -21.43 27.46 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.501 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 91' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' B' ' 87' ' ' ILE . 3.2 t60 -69.98 -15.89 63.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.726 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mt . . . . . 0 N--CA 1.465 0.318 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.044 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.947 ' O ' ' N ' ' B' ' 102' ' ' LEU . 1.3 mm? . . . . . 0 C--O 1.222 -0.37 0 CA-C-O 120.607 0.241 . . . . 0.0 110.588 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -63.29 -28.74 70.22 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.577 0.751 . . . . 0.0 109.272 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -67.42 -21.85 65.55 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.537 HD22 HD22 ' A' ' 41' ' ' LEU . 5.4 mt -111.8 -26.2 9.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.979 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.947 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.352 0.691 0 CA-C-O 120.61 0.243 . . . . 0.0 111.464 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 111.178 0.066 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.57 147.06 81.43 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.556 2.171 . . . . 0.0 112.6 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.1 m -80.66 -21.74 41.12 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.494 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.475 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.3 mp -83.0 -22.12 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.481 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.92 -33.89 24.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.601 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -27.81 69.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.465 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.87 -44.67 7.59 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.238 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.508 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 18.6 mt -62.36 -42.47 99.43 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.586 0.231 . . . . 0.0 111.227 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.71 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 22.4 m -61.37 -41.85 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.761 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -67.1 -48.23 60.74 Favored Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.974 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.443 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -74.11 -44.14 55.01 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.73 -38.84 90.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.432 0.158 . . . . 0.0 111.092 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.1 mp -72.76 -39.44 66.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.586 0.232 . . . . 0.0 110.958 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -70.29 -38.22 74.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.363 179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.9 tp -71.02 -35.19 71.91 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.688 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tt -68.99 -44.38 72.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.257 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 14' ' ' LEU . 58.6 t -69.45 -44.48 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.365 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 15' ' ' LEU . 74.4 t -66.77 -42.33 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.171 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.37 83.63 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.977 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.68 -35.64 77.47 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.614 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.97 -52.69 26.95 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.36 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.545 ' O ' HG12 ' A' ' 27' ' ' ILE . 13.7 mt -65.96 -35.23 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.558 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -65.75 -45.78 86.91 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.117 -0.564 . . . . 0.0 112.402 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.0 mt -75.24 -24.82 57.72 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.55 0.214 . . . . 0.0 111.309 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.8 t80 -77.56 -37.86 49.79 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.253 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 23' ' ' ILE . 50.6 mm -83.65 -33.44 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.194 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 15.0 ttm180 -66.22 -26.96 67.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.654 0.264 . . . . 0.0 111.312 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -82.23 -18.21 43.34 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.347 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -83.9 -21.77 31.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.521 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.09 -20.43 34.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.473 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 28' ' ' ARG . 11.0 mm . . . . . 0 N--CA 1.464 0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.995 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.061 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 3.3 mm? . . . . . 0 C--O 1.226 -0.181 0 CA-C-O 120.948 0.404 . . . . 0.0 110.614 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -98.03 -35.44 10.44 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.367 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -73.85 -19.07 60.84 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.441 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.0 mm? -108.57 -20.7 13.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.508 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.061 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 3.9 tt . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 120.824 0.345 . . . . 0.0 110.754 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 111.128 0.047 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.79 147.05 80.4 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.628 2.219 . . . . 0.0 112.487 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -80.47 -21.94 41.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.505 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.478 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.3 mp -82.81 -22.14 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.247 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.478 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.91 -33.95 24.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.56 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.61 -27.84 69.51 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.539 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.82 -44.7 7.6 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.266 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 18.4 mt -62.19 -42.71 99.54 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-O 120.627 0.251 . . . . 0.0 111.25 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 22.5 m -61.31 -41.79 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.766 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.08 -48.33 60.34 Favored Glycine 0 CA--C 1.517 0.177 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.008 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.436 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -74.12 -44.17 54.84 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.71 -38.71 89.96 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.403 0.144 . . . . 0.0 111.126 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.1 mp -72.79 -39.56 66.6 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.92 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -70.17 -38.27 75.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.442 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.9 tp -71.02 -35.18 71.93 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.697 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 2.1 tt -68.88 -44.44 73.26 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.296 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 74' ' ' LEU . 58.4 t -69.47 -44.46 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.312 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.436 HG23 ' O ' ' B' ' 75' ' ' LEU . 75.0 t -66.81 -42.39 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.154 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.27 83.76 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.098 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.2 tp -68.74 -35.58 77.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.94 -52.7 27.01 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.404 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.54 ' O ' HG12 ' B' ' 87' ' ' ILE . 13.7 mt -65.94 -35.38 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.616 0.246 . . . . 0.0 110.514 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 84' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -65.58 -45.9 87.29 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.451 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 16.0 mt -75.1 -24.87 58.15 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.558 0.218 . . . . 0.0 111.281 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.8 t80 -77.58 -37.89 49.5 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.225 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.54 HG12 ' O ' ' B' ' 83' ' ' ILE . 50.7 mm -83.55 -33.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.202 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 15.1 ttm180 -66.05 -27.08 67.83 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.657 0.265 . . . . 0.0 111.327 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -82.16 -18.25 43.45 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.412 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -83.72 -21.84 32.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.621 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.09 -20.47 34.84 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.426 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 92' ' ' ILE . . . . . 0.437 HG12 ' O ' ' B' ' 88' ' ' ARG . 11.1 mm . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.983 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 1.073 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.463 0.176 0 CA-C-O 121.1 0.476 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -98.15 -35.41 10.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.38 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -73.85 -19.05 60.84 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.48 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' B' ' 101' ' ' LEU . 3.0 mm? -108.52 -20.81 12.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.536 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 1.073 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 3.8 tt . . . . . 0 N--CA 1.472 0.625 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.772 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 111.205 0.076 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.99 141.77 49.34 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.711 2.274 . . . . 0.0 112.765 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 m -80.57 -7.67 59.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.534 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.7 mp -82.93 -32.38 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.075 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.436 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -84.01 -27.64 28.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.552 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.42 -31.98 73.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.456 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.04 -41.69 9.32 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.217 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.546 ' O ' HD13 ' A' ' 13' ' ' LEU . 23.2 mt -62.01 -43.65 98.39 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 122.309 0.244 . . . . 0.0 111.187 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.686 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 25.2 m -60.48 -38.18 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 111.663 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -69.0 -49.32 42.03 Favored Glycine 0 CA--C 1.518 0.24 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.756 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.449 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.58 -41.48 62.84 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.9 mp -66.21 -41.79 89.65 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.79 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.8 mp -70.5 -38.83 74.38 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.916 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -69.7 -37.16 76.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.442 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tp -69.81 -36.93 76.06 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.6 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.58 -40.85 76.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.288 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 14' ' ' LEU . 93.1 t -69.57 -42.37 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.2 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 15' ' ' LEU . 97.7 t -70.62 -38.38 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.176 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.67 -39.17 73.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.295 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.7 tp -70.86 -43.4 68.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.945 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.82 -57.84 7.5 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.5 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.564 ' O ' HG12 ' A' ' 27' ' ' ILE . 41.4 mm -65.86 -33.64 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.643 0.259 . . . . 0.0 110.589 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -65.6 -47.65 75.32 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.322 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt -74.8 -24.1 58.59 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.55 0.214 . . . . 0.0 111.147 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.2 t80 -75.43 -39.69 58.56 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.242 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 23' ' ' ILE . 45.5 mm -83.59 -32.33 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.192 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.558 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.2 ttt180 -65.4 -26.1 67.84 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.351 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -81.74 -18.04 45.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.406 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -81.53 -21.48 38.52 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.616 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -70.57 -27.86 64.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.642 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 mt . . . . . 0 N--CA 1.466 0.342 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.136 179.888 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.008 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 23.3 mt . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 121.239 0.542 . . . . 0.0 110.138 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.85 -33.29 11.3 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -77.24 -24.24 51.2 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.013 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.5 mt -100.37 -20.29 15.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.238 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.008 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 2.6 tp . . . . . 0 N--CA 1.469 0.511 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.585 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 111.221 0.082 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.14 141.9 49.09 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.635 2.223 . . . . 0.0 112.698 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.6 m -80.67 -7.66 59.38 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.497 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.471 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.6 mp -82.81 -32.38 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.116 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.435 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.96 -27.7 28.31 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.552 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.44 -31.99 73.44 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.521 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.01 -41.67 9.36 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.207 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.549 ' O ' HD13 ' B' ' 73' ' ' LEU . 23.1 mt -61.95 -43.59 98.53 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.598 0.237 . . . . 0.0 111.32 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.672 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 25.4 m -60.44 -38.23 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 111.605 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -69.13 -49.29 41.28 Favored Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.671 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.455 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.51 -41.5 62.99 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.549 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.9 mp -66.2 -41.76 89.72 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.806 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.672 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -70.62 -38.7 73.97 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.875 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.0 OUTLIER -69.62 -37.3 76.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.481 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tp -69.73 -36.89 76.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.61 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 18.1 mt -69.62 -40.74 76.39 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.32 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 74' ' ' LEU . 93.1 t -69.63 -42.46 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.188 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.485 HG23 ' O ' ' B' ' 75' ' ' LEU . 98.1 t -70.51 -38.45 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.089 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.68 -39.24 73.66 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.22 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 1.7 tp -70.9 -43.31 68.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.937 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.84 -57.87 7.44 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.49 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.556 ' O ' HG12 ' B' ' 87' ' ' ILE . 41.2 mm -65.78 -33.64 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.581 0.229 . . . . 0.0 110.625 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 84' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -65.64 -47.61 75.4 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.361 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 20.7 mt -74.84 -24.03 58.54 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.563 0.22 . . . . 0.0 111.179 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.3 t80 -75.51 -39.73 58.04 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.159 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.556 HG12 ' O ' ' B' ' 83' ' ' ILE . 45.6 mm -83.59 -32.38 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.135 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.1 ttt180 -65.36 -26.01 67.83 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.438 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -81.72 -18.01 45.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.46 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -81.61 -21.38 38.35 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.59 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -70.65 -27.8 64.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.644 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 1.8 mt . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.102 179.899 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 1.01 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 23.8 mt . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 121.204 0.526 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.83 -33.17 11.35 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -77.45 -24.17 50.33 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 114.281 -1.327 . . . . 0.0 107.896 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 14.6 mt -100.39 -20.35 15.85 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.29 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 1.01 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 2.6 tp . . . . . 0 N--CA 1.468 0.471 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.686 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.234 0.255 0 N-CA-C 111.234 0.087 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.9 141.21 48.12 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.78 2.32 . . . . 0.0 112.696 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 t -80.69 -7.6 59.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.44 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.6 mp -82.99 -32.66 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.09 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.455 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.95 -25.86 29.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.656 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -63.78 -33.49 75.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.59 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.0 -40.91 9.95 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.289 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.514 ' O ' HD13 ' A' ' 13' ' ' LEU . 22.0 mt -62.24 -43.38 98.96 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 122.283 0.233 . . . . 0.0 111.393 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.1 m -60.91 -41.09 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 111.779 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -67.51 -48.34 57.64 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.877 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.447 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.99 -43.5 57.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.4 -39.47 92.25 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 122.911 0.132 . . . . 0.0 110.971 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.68 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.0 mp -72.22 -39.83 68.23 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.605 0.241 . . . . 0.0 110.924 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -70.2 -38.43 75.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.583 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.3 tp -70.69 -34.52 72.05 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.657 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.34 -44.14 72.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.162 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 14' ' ' LEU . 59.8 t -69.25 -44.04 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.226 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 15' ' ' LEU . 71.8 t -66.55 -43.27 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.151 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.26 86.49 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.124 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.36 -36.32 79.04 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.635 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.93 -50.14 43.14 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.299 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 mt -64.39 -41.22 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.669 0.271 . . . . 0.0 110.603 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.42 -44.65 96.45 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.404 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.501 ' HG ' ' NH2' ' A' ' 28' ' ' ARG . 20.1 mt -73.95 -23.83 59.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.595 0.236 . . . . 0.0 110.931 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 6.6 t80 -74.43 -39.13 62.79 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.35 -35.0 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.255 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.501 ' NH2' ' HG ' ' A' ' 25' ' ' LEU . 74.0 mtm180 -64.14 -26.29 68.47 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.656 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -82.14 -18.13 43.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.358 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.46 ' NH2' ' HE2' ' A' ' 26' ' ' PHE . 97.6 mtt180 -86.12 -21.58 27.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.622 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -70.39 -29.32 65.93 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.713 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt . . . . . 0 N--CA 1.466 0.327 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.097 179.923 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 1.044 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 121.132 0.491 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -97.66 -34.46 10.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -74.73 -20.24 59.91 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.097 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.8 mt -104.82 -22.47 13.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.315 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 1.044 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 2.9 tt . . . . . 0 N--CA 1.469 0.482 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.555 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.259 0 CA-C-O 120.312 0.101 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.04 141.3 47.74 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.6 2.2 . . . . 0.0 112.708 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.4 t -80.61 -7.7 59.36 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.413 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.468 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.6 mp -82.88 -32.65 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.133 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.451 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.99 -25.9 29.62 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.639 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -63.76 -33.62 76.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.465 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.86 -40.96 10.02 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.289 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.515 ' O ' HD13 ' B' ' 73' ' ' LEU . 21.9 mt -62.26 -43.37 98.98 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.346 0.258 . . . . 0.0 111.381 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 23.7 m -60.99 -40.96 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.765 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.58 -48.43 56.7 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.806 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.453 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.86 -43.63 58.03 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.515 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.27 -39.42 92.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.45 0.167 . . . . 0.0 111.056 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.0 mp -72.39 -39.68 67.8 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.646 0.26 . . . . 0.0 110.947 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -70.13 -38.52 75.57 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.584 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.3 tp -70.76 -34.53 71.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.566 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.21 -44.23 72.5 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.168 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 74' ' ' LEU . 59.9 t -69.31 -43.88 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.286 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 75' ' ' LEU . 71.7 t -66.51 -43.5 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.029 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.15 86.52 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.159 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.3 tp -68.39 -36.33 78.99 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.683 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.88 -50.1 43.73 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.427 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 19.1 mt -64.44 -41.23 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.652 0.263 . . . . 0.0 110.562 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.55 -44.63 96.29 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.317 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.497 ' HG ' ' NH2' ' B' ' 88' ' ' ARG . 20.0 mt -73.86 -23.85 59.67 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.704 0.288 . . . . 0.0 111.015 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 6.5 t80 -74.37 -39.22 62.88 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.127 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.29 -35.08 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.258 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.497 ' NH2' ' HG ' ' B' ' 85' ' ' LEU . 74.2 mtm180 -64.11 -26.3 68.48 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.632 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -82.11 -18.3 43.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 90' ' ' ARG . . . . . 0.464 ' NH2' ' HE2' ' B' ' 86' ' ' PHE . 97.6 mtt180 -86.01 -21.71 27.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.607 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -70.31 -29.44 66.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.69 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.465 0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 179.917 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 1.029 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 121.042 0.449 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -97.59 -34.46 10.95 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -74.63 -20.26 59.97 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.127 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 6.8 mt -104.78 -22.56 13.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.239 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 1.029 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 2.8 tt . . . . . 0 N--CA 1.469 0.489 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.637 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.25 0 CA-C-O 120.286 0.089 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.93 150.59 73.34 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.597 2.198 . . . . 0.0 112.691 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.7 m -80.59 -10.12 59.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.595 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 5' ' ' ILE . 3.1 mp -82.88 -30.89 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.076 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.444 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.92 -27.1 28.82 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.637 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -63.86 -32.68 74.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.543 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.52 9.55 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.346 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.52 ' O ' HD13 ' A' ' 13' ' ' LEU . 21.8 mt -62.15 -43.02 99.76 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 115.725 -0.237 . . . . 0.0 111.431 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.5 m -60.83 -39.61 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.726 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.69 -48.81 47.39 Favored Glycine 0 C--O 1.235 0.217 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.836 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.82 -41.41 62.37 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -67.03 -39.65 87.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.438 0.161 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.68 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.5 mp -71.37 -39.35 71.28 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.766 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.37 -40.44 77.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.323 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tp -69.55 -32.68 71.63 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.528 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 3.5 tp -69.68 -43.0 73.38 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.99 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 14' ' ' LEU . 60.0 t -68.99 -43.65 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.061 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 15' ' ' LEU . 93.3 t -66.34 -43.31 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.69 -37.5 82.39 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.094 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -69.78 -35.85 75.22 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.592 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.14 -52.75 25.88 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.279 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.599 ' O ' HG12 ' A' ' 27' ' ' ILE . 11.2 mt -65.13 -37.76 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.633 0.254 . . . . 0.0 110.577 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.94 -46.53 91.28 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.31 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.56 -24.47 60.11 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.587 0.232 . . . . 0.0 111.126 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 8.1 t80 -75.81 -38.74 57.89 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.274 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 23' ' ' ILE . 39.3 mm -83.7 -31.91 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.196 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -66.62 -25.8 66.77 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.691 0.281 . . . . 0.0 111.578 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.7 -18.09 45.64 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.304 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -82.68 -21.29 34.96 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.529 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -69.57 -15.8 63.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.883 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.9 mt . . . . . 0 N--CA 1.466 0.354 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.01 179.922 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.906 ' O ' ' N ' ' A' ' 42' ' ' LEU . 15.1 tp . . . . . 0 C--O 1.223 -0.331 0 CA-C-O 120.683 0.278 . . . . 0.0 110.378 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -67.71 -29.09 68.25 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -69.28 -17.99 63.8 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.677 HD22 HD22 ' B' ' 101' ' ' LEU . 11.7 mt -112.0 -27.11 8.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.633 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.906 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.351 0.672 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.296 0.093 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.68 150.49 74.46 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.668 2.246 . . . . 0.0 112.755 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.4 m -80.63 -10.14 59.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.473 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.465 HD12 ' H ' ' B' ' 65' ' ' ILE . 3.1 mp -82.95 -30.83 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.082 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.438 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -26.97 28.94 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.628 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -63.89 -32.68 74.28 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.528 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.89 -41.6 9.51 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.289 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.1 mt -62.21 -43.11 99.57 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.657 -0.272 . . . . 0.0 111.31 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.67 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.2 m -60.81 -39.5 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.744 0.306 . . . . 0.0 111.767 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.73 -48.87 46.73 Favored Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.775 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.462 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.76 -41.33 62.6 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -67.11 -39.73 86.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.876 -0.147 . . . . 0.0 110.85 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -71.27 -39.36 71.62 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.67 0.271 . . . . 0.0 110.824 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.529 ' O ' HG23 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.31 -40.48 77.64 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.389 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.3 tp -69.6 -32.54 71.34 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.556 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.83 -42.87 73.05 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.997 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.618 HG23 ' O ' ' B' ' 74' ' ' LEU . 59.7 t -69.06 -43.67 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.066 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.529 HG23 ' O ' ' B' ' 75' ' ' LEU . 94.3 t -66.3 -43.41 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.61 -37.44 82.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.146 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.2 tp -69.82 -35.73 75.04 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.63 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.2 -52.71 25.85 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.215 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.607 ' O ' HG12 ' B' ' 87' ' ' ILE . 11.2 mt -65.23 -37.77 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 110.471 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.98 -46.44 91.42 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.377 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.53 -24.54 60.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.595 0.236 . . . . 0.0 111.179 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 8.3 t80 -75.85 -38.64 57.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.269 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.607 HG12 ' O ' ' B' ' 83' ' ' ILE . 39.1 mm -83.72 -31.91 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.178 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -66.65 -25.95 66.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.506 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.55 -18.09 46.17 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.332 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -82.63 -21.32 35.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.522 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -69.52 -15.96 63.34 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.825 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.9 mt . . . . . 0 CA--C 1.533 0.325 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.989 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.896 ' O ' ' N ' ' B' ' 102' ' ' LEU . 15.0 tp . . . . . 0 C--O 1.222 -0.366 0 CA-C-O 120.655 0.264 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -67.59 -29.18 68.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -69.21 -18.05 63.85 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.677 HD22 HD22 ' A' ' 41' ' ' LEU . 11.7 mt -112.02 -27.06 8.56 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.671 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.896 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.351 0.638 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.233 0.236 0 CA-C-O 120.374 0.13 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.93 143.79 56.17 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.687 2.258 . . . . 0.0 112.809 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.0 m -80.57 -8.1 59.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.498 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp -82.87 -32.26 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.128 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.96 -27.02 28.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.557 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.0 -32.56 74.15 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.574 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.06 -41.36 9.53 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.208 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.522 ' O ' HD13 ' A' ' 13' ' ' LEU . 22.1 mt -62.26 -43.16 99.47 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 122.339 0.256 . . . . 0.0 111.27 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.675 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.1 m -60.79 -39.86 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 111.713 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.5 -48.74 49.06 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.754 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.8 -41.73 61.97 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -66.75 -39.63 87.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.421 0.153 . . . . 0.0 110.982 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.675 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.7 mp -71.38 -39.57 71.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.647 0.26 . . . . 0.0 110.83 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.515 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.37 -40.11 77.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.244 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.5 tp -69.85 -32.83 71.43 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.54 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.58 -43.26 73.18 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.059 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 14' ' ' LEU . 61.7 t -69.0 -43.9 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.087 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 15' ' ' LEU . 98.7 t -66.22 -43.04 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.014 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.58 82.04 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.4 tp -69.45 -36.04 76.24 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.534 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.19 -52.85 25.08 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.219 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.577 ' O ' HG12 ' A' ' 27' ' ' ILE . 12.1 mt -65.53 -36.33 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.689 0.28 . . . . 0.0 110.456 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.96 -46.24 89.92 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.37 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HG ' ' NH2' ' A' ' 28' ' ' ARG . 17.5 mt -74.12 -24.38 59.43 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.663 0.268 . . . . 0.0 111.221 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.8 t80 -76.89 -38.07 54.28 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.303 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 23' ' ' ILE . 46.7 mm -83.68 -33.43 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.236 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.494 ' NH2' ' HG ' ' A' ' 25' ' ' LEU . 68.6 mtm180 -64.19 -25.81 68.24 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.67 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -79.47 -18.2 52.55 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.2 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.07 -21.43 27.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.51 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -69.65 -15.73 63.24 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.9 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 CA--C 1.533 0.305 0 CA-C-O 120.676 0.274 . . . . 0.0 111.042 179.902 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.931 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.5 mm? . . . . . 0 C--O 1.223 -0.336 0 CA-C-O 120.548 0.214 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.4 -28.91 70.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.083 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -68.1 -20.21 64.91 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.515 HD22 HD22 ' B' ' 101' ' ' LEU . 6.9 mt -112.31 -25.76 9.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.828 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.931 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.352 0.696 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.279 0 CA-C-O 120.28 0.086 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.93 143.8 56.17 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.624 2.216 . . . . 0.0 112.797 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.0 m -80.59 -8.03 59.46 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.536 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.471 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.8 mp -82.91 -32.32 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.44 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.91 -26.91 28.97 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.612 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -32.62 74.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.484 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.86 -41.5 9.61 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.297 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.515 ' O ' HD13 ' B' ' 73' ' ' LEU . 22.1 mt -62.25 -43.07 99.67 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.684 -0.258 . . . . 0.0 111.344 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.668 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.1 m -60.88 -39.79 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.733 0.302 . . . . 0.0 111.735 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.56 -48.6 49.55 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.862 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.85 -41.7 61.87 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.515 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -66.8 -39.67 87.84 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.438 0.161 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.668 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -71.3 -39.66 71.32 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.77 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.516 ' O ' HG23 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.32 -40.03 77.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.415 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.5 tp -69.92 -32.81 71.29 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.6 -43.21 73.24 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.033 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.616 HG23 ' O ' ' B' ' 74' ' ' LEU . 61.6 t -69.04 -43.91 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.036 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.516 HG23 ' O ' ' B' ' 75' ' ' LEU . 99.0 t -66.24 -43.09 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.957 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.83 -37.57 82.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.4 tp -69.46 -36.05 76.21 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.599 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.2 -52.8 25.31 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.249 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.582 ' O ' HG12 ' B' ' 87' ' ' ILE . 12.0 mt -65.48 -36.28 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.665 0.269 . . . . 0.0 110.537 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.92 -46.25 89.95 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.339 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 85' ' ' LEU . . . . . 0.5 ' HG ' ' NH2' ' B' ' 88' ' ' ARG . 17.8 mt -74.14 -24.47 59.43 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.525 0.202 . . . . 0.0 111.071 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.8 t80 -76.89 -38.08 54.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.306 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.582 HG12 ' O ' ' B' ' 83' ' ' ILE . 46.6 mm -83.59 -33.46 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.258 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.5 ' NH2' ' HG ' ' B' ' 85' ' ' LEU . 69.0 mtm180 -64.16 -25.88 68.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.638 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -79.37 -18.32 52.62 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.244 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.02 -21.44 27.78 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.527 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -69.63 -15.73 63.25 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.926 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.466 0.338 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.067 179.83 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.911 ' O ' ' N ' ' B' ' 102' ' ' LEU . 1.5 mm? . . . . . 0 C--O 1.221 -0.41 0 CA-C-O 120.544 0.211 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.35 -29.05 70.13 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 123.565 0.746 . . . . 0.0 109.126 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -67.97 -20.21 65.02 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.515 HD22 HD22 ' A' ' 41' ' ' LEU . 6.8 mt -112.23 -25.83 9.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.868 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.911 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.352 0.713 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.53 0.186 0 CA-C-O 120.323 0.106 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.19 139.52 42.42 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.642 2.228 . . . . 0.0 112.834 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.4 m -80.53 -7.19 59.11 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.544 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.5 mp -82.97 -32.87 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.083 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.95 -27.12 28.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.553 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.09 -32.54 74.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.593 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.98 -41.41 9.57 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.233 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 13' ' ' LEU . 23.4 mt -62.31 -43.32 99.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.694 -0.253 . . . . 0.0 111.285 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.66 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.0 m -60.66 -39.56 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.737 0.303 . . . . 0.0 111.717 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.5 -49.19 46.11 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.82 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.5 -41.77 62.65 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.91 -41.39 91.5 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.818 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.66 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.6 mp -70.35 -39.53 74.6 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.902 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.31 -37.88 77.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.414 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.03 -35.01 73.99 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.646 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 14.8 mt -69.48 -42.15 75.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 14' ' ' LEU . 58.0 t -68.71 -44.97 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.058 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 15' ' ' LEU . 93.0 t -65.91 -43.19 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.82 84.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.078 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.93 -36.31 77.82 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.614 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.36 -49.98 41.58 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.286 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 mt -64.17 -41.23 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 110.495 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -64.44 -44.39 95.35 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.366 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.6 mt -72.78 -24.66 60.97 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.724 0.297 . . . . 0.0 111.038 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.91 -40.67 62.98 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.11 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 12.4 mt -83.65 -27.27 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.999 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.3 ttt180 -63.58 -25.79 68.4 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.488 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -81.66 -35.0 30.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.329 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.25 -21.27 27.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.47 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 27' ' ' ILE . 4.3 t60 -69.89 -15.81 63.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.804 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.102 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.916 ' O ' ' N ' ' A' ' 42' ' ' LEU . 15.8 tp . . . . . 0 C--O 1.222 -0.361 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -67.52 -28.92 68.23 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -69.96 -18.79 63.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.709 HD22 HD22 ' B' ' 101' ' ' LEU . 13.5 mt -111.33 -27.37 8.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.718 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.916 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.351 0.659 0 CA-C-O 120.746 0.308 . . . . 0.0 111.05 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.234 0.248 0 N-CA-C 111.235 0.087 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.13 139.46 42.47 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.723 2.282 . . . . 0.0 112.78 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.0 m -80.53 -7.13 59.1 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.543 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.467 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.5 mp -83.04 -32.86 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.055 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.437 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -27.21 28.77 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.629 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -32.68 74.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.498 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.89 -41.33 9.71 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.264 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.524 ' O ' HD13 ' B' ' 73' ' ' LEU . 22.9 mt -62.18 -43.57 98.53 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 122.377 0.271 . . . . 0.0 111.308 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.653 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.0 m -60.46 -39.61 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.746 0.308 . . . . 0.0 111.723 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.48 -49.27 45.71 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.718 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.462 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.59 -41.73 62.49 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.524 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.92 -41.28 91.61 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.005 0.191 . . . . 0.0 110.823 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.653 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -70.42 -39.56 74.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.833 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.28 -37.83 78.05 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.413 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.1 -35.06 73.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.6 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 14.8 mt -69.49 -42.07 75.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.158 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.613 HG23 ' O ' ' B' ' 74' ' ' LEU . 57.9 t -68.85 -44.84 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.085 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.497 HG23 ' O ' ' B' ' 75' ' ' LEU . 93.6 t -65.84 -43.28 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.964 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.25 -37.64 83.85 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.1 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.3 tp -68.95 -36.38 77.85 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.608 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.33 -50.04 41.41 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.311 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 mt -64.2 -41.1 91.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.634 0.254 . . . . 0.0 110.546 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 84' ' ' GLY . . . . . 0.563 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -64.39 -44.52 95.22 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.395 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 20.7 mt -72.69 -24.77 61.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.643 0.259 . . . . 0.0 110.971 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.84 -40.71 63.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' B' ' 91' ' ' HIS . 12.3 mt -83.53 -27.41 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.996 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.563 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.3 ttt180 -63.56 -25.63 68.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.476 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -81.8 -34.91 30.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.364 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.26 -21.38 27.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.481 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 91' ' ' HIS . . . . . 0.427 ' HB2' ' O ' ' B' ' 87' ' ' ILE . 4.2 t60 -69.81 -15.73 63.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.883 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.466 0.326 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.101 179.909 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.917 ' O ' ' N ' ' B' ' 102' ' ' LEU . 15.8 tp . . . . . 0 C--O 1.222 -0.343 0 CA-C-O 120.64 0.257 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -67.46 -28.92 68.27 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.474 -0.785 . . . . 0.0 108.922 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -69.99 -18.83 63.35 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.709 HD22 HD22 ' A' ' 41' ' ' LEU . 13.3 mt -111.31 -27.3 8.72 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.777 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.917 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.351 0.654 0 CA-C-O 120.601 0.238 . . . . 0.0 110.991 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 111.222 0.082 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.83 140.53 46.58 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.713 2.275 . . . . 0.0 112.78 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 t -80.57 -7.74 59.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.496 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.472 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.5 mp -82.89 -32.57 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.143 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.447 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.96 -26.2 29.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.572 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -63.84 -33.21 75.17 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.562 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.13 9.82 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.268 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.521 ' O ' HD13 ' A' ' 13' ' ' LEU . 22.0 mt -62.22 -43.36 99.0 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 122.286 0.235 . . . . 0.0 111.291 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.679 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.0 m -60.9 -39.99 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.769 0.319 . . . . 0.0 111.73 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.26 -48.5 52.01 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.828 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.454 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.93 -42.43 60.6 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -66.25 -39.54 89.57 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.846 -0.161 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.679 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.8 mp -71.86 -39.59 69.58 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.68 0.276 . . . . 0.0 110.846 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.75 -39.4 76.75 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.394 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.2 tp -70.22 -33.71 72.0 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.49 -43.29 73.44 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.12 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 14' ' ' LEU . 58.2 t -69.43 -43.58 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.129 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 15' ' ' LEU . 89.3 t -66.7 -43.27 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.114 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.38 -39.27 85.61 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.158 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.1 tp -69.37 -35.2 75.6 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.598 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.02 -52.4 28.41 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.305 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.597 ' O ' HG12 ' A' ' 27' ' ' ILE . 12.1 mt -65.58 -37.18 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.648 0.261 . . . . 0.0 110.566 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -64.48 -46.16 91.14 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.382 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.9 mt -74.21 -24.98 59.41 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.497 0.189 . . . . 0.0 111.208 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.1 t80 -75.82 -39.26 57.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.278 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 23' ' ' ILE . 41.6 mm -83.66 -30.51 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.116 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.569 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.6 ttt180 -64.91 -26.1 68.17 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.693 0.283 . . . . 0.0 111.337 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.9 -18.19 44.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.414 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.54 -21.5 35.35 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.597 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -68.48 -21.56 64.61 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.687 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mt . . . . . 0 N--CA 1.465 0.295 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.102 179.879 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.968 ' O ' ' N ' ' A' ' 42' ' ' LEU . 13.4 tp . . . . . 0 C--O 1.222 -0.353 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.405 ' HA ' ' CB ' ' A' ' 42' ' ' LEU . 74.6 mtp180 -66.45 -31.66 72.54 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.674 0.79 . . . . 0.0 108.959 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -69.48 -19.42 63.75 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.6 mt -111.53 -25.67 9.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.008 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.968 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.351 0.65 0 CA-C-O 120.623 0.249 . . . . 0.0 110.996 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 120.322 0.106 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.1 140.61 45.6 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.628 2.219 . . . . 0.0 112.743 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.1 t -80.6 -7.7 59.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.472 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.465 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.5 mp -83.01 -32.6 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.051 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.444 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.85 -26.22 29.65 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.688 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -63.95 -33.13 75.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.551 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.15 9.82 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.333 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.518 ' O ' HD13 ' B' ' 73' ' ' LEU . 21.9 mt -62.24 -43.14 99.5 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.648 -0.276 . . . . 0.0 111.393 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.674 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.2 m -60.97 -40.13 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.699 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.22 -48.48 52.42 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.9 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.95 -42.5 60.43 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.518 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -66.2 -39.65 89.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.867 -0.151 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.674 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -71.85 -39.42 69.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.591 0.234 . . . . 0.0 110.861 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.95 -39.38 76.1 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.385 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 76' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.2 tp -70.09 -33.84 72.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.593 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 77' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.37 -43.36 73.71 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.074 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 74' ' ' LEU . 58.2 t -69.41 -43.48 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.165 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.486 HG23 ' O ' ' B' ' 75' ' ' LEU . 88.8 t -66.71 -43.38 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.029 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.25 85.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.151 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 81' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.1 tp -69.21 -35.28 76.05 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.669 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.98 -52.43 28.44 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.241 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.592 ' O ' HG12 ' B' ' 87' ' ' ILE . 12.0 mt -65.6 -37.21 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.667 0.27 . . . . 0.0 110.564 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 84' ' ' GLY . . . . . 0.568 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -64.41 -46.18 91.22 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.485 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 18.0 mt -74.18 -24.86 59.43 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.547 0.213 . . . . 0.0 111.252 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.2 t80 -76.02 -39.25 56.1 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.592 HG12 ' O ' ' B' ' 83' ' ' ILE . 41.5 mm -83.56 -30.53 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.186 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 88' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.7 ttt180 -64.97 -26.07 68.14 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.254 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.99 -18.22 44.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.272 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.52 -21.53 35.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.54 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -68.5 -21.55 64.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.741 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.097 179.828 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.944 ' O ' ' N ' ' B' ' 102' ' ' LEU . 13.3 tp . . . . . 0 C--O 1.222 -0.387 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 99' ' ' ARG . . . . . 0.407 ' HA ' ' CB ' ' B' ' 102' ' ' LEU . 74.8 mtp180 -66.5 -31.59 72.41 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.646 0.778 . . . . 0.0 109.015 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -69.42 -19.46 63.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 27.8 mt -111.47 -25.68 9.48 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.048 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.944 ' N ' ' O ' ' B' ' 98' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.352 0.679 0 CA-C-O 120.666 0.269 . . . . 0.0 110.984 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.273 0 CA-C-O 120.333 0.111 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.05 141.43 48.09 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.636 2.224 . . . . 0.0 112.666 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.8 m -80.72 -7.43 59.35 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.513 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.6 mp -82.96 -32.73 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.134 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ALA . . . . . 0.444 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.99 -26.23 29.36 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.62 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.04 -33.08 74.94 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.539 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.79 -41.13 9.95 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.382 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.524 ' O ' HD13 ' A' ' 13' ' ' LEU . 21.9 mt -62.3 -43.55 98.56 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.7 -0.25 . . . . 0.0 111.37 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.662 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 23.5 m -60.71 -40.48 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 111.761 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.0 -48.88 51.45 Favored Glycine 0 C--O 1.235 0.201 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.808 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ALA . . . . . 0.452 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.57 -42.82 61.11 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.25 -41.16 94.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.442 0.163 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.9 mp -70.54 -40.01 73.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.626 0.251 . . . . 0.0 110.953 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -69.46 -36.84 76.97 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.603 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 tp -69.93 -36.8 75.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.573 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.7 mt -68.48 -44.22 75.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.274 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 14' ' ' LEU . 61.9 t -67.35 -44.88 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.229 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 15' ' ' LEU . 83.8 t -67.03 -39.11 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.2 83.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.054 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.6 mt -69.36 -34.33 74.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.657 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.35 -54.3 20.78 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.277 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.538 ' O ' HG12 ' A' ' 27' ' ' ILE . 15.1 mt -66.3 -35.72 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.592 0.234 . . . . 0.0 110.634 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.06 -45.98 90.24 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.473 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.56 -24.69 56.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.53 0.205 . . . . 0.0 111.299 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.9 t80 -77.78 -36.87 50.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.333 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 23' ' ' ILE . 52.1 mm -83.69 -36.62 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.309 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -67.65 -29.2 68.45 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.619 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -82.1 -18.24 43.69 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.469 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -85.32 -21.77 28.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.529 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -81.97 -15.93 52.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.489 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.8 mm . . . . . 0 CA--C 1.533 0.304 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.965 179.902 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 38' ' ' LEU . . . . . 0.956 ' O ' ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.403 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -66.98 -29.4 69.24 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.025 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -70.06 -18.41 63.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' LEU . . . . . 0.973 HD22 HD22 ' B' ' 101' ' ' LEU . 38.7 mt -112.09 -26.69 8.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.115 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.956 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.2 tt . . . . . 0 C--N 1.351 0.647 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 111.224 0.083 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.06 141.41 48.02 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.623 2.215 . . . . 0.0 112.771 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.6 m -80.6 -7.55 59.3 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.493 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 65' ' ' ILE . . . . . 0.474 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.6 mp -82.88 -32.9 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.094 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 66' ' ' ALA . . . . . 0.45 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.98 -26.14 29.44 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.544 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.03 -33.16 75.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.47 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.88 -41.05 9.92 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.329 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 69' ' ' LEU . . . . . 0.533 ' O ' HD13 ' B' ' 73' ' ' LEU . 22.1 mt -62.42 -43.6 98.43 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 115.691 -0.254 . . . . 0.0 111.324 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 70' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.4 m -60.45 -40.64 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.873 0.368 . . . . 0.0 111.825 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 71' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.97 -48.91 51.43 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.819 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 72' ' ' ALA . . . . . 0.46 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.62 -42.74 61.09 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 73' ' ' LEU . . . . . 0.533 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.27 -41.24 94.43 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.882 -0.144 . . . . 0.0 110.862 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 74' ' ' LEU . . . . . 0.658 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -70.61 -39.94 73.48 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.895 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 75' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.52 -36.85 76.82 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.485 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tp -69.96 -36.61 75.39 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.64 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.67 -44.01 74.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.274 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 78' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 74' ' ' LEU . 61.6 t -67.48 -44.98 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.134 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 79' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 75' ' ' LEU . 84.7 t -66.78 -39.23 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.096 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.19 83.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.042 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 20.7 mt -69.36 -34.39 74.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.636 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 82' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.27 -54.19 21.68 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.398 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 83' ' ' ILE . . . . . 0.533 ' O ' HG12 ' B' ' 87' ' ' ILE . 14.9 mt -66.4 -35.73 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.553 0.216 . . . . 0.0 110.599 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.06 -46.12 89.8 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.435 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.34 -24.77 57.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.569 0.223 . . . . 0.0 111.351 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 86' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.9 t80 -77.88 -36.82 49.28 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.282 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 87' ' ' ILE . . . . . 0.533 HG12 ' O ' ' B' ' 83' ' ' ILE . 52.2 mm -83.63 -36.61 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.344 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -67.7 -29.17 68.36 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.571 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -82.21 -18.18 43.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.416 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -85.3 -21.83 28.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.521 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -81.96 -16.07 51.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.483 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 6.7 mm . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.046 179.847 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 98' ' ' LEU . . . . . 0.931 ' O ' ' N ' ' B' ' 102' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.462 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.08 -29.35 69.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -70.17 -18.31 63.2 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 101' ' ' LEU . . . . . 0.973 HD22 HD22 ' A' ' 41' ' ' LEU . 38.3 mt -112.12 -26.65 8.73 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.074 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 102' ' ' LEU . . . . . 0.931 ' N ' ' O ' ' B' ' 98' ' ' LEU . 1.2 tt . . . . . 0 C--N 1.351 0.636 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.8 mttp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.582 0.229 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.97 146.7 55.95 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.27 139.02 40.84 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.626 2.217 . . . . 0.0 112.729 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.8 m -80.58 -7.14 59.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.503 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.4 mp -82.94 -32.6 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.131 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.91 -28.33 27.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.587 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.15 -31.9 73.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.545 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.96 -41.94 9.21 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.229 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 13' ' ' LEU . 23.9 mt -61.98 -43.21 99.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.749 -0.225 . . . . 0.0 111.194 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.697 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 25.2 m -61.0 -39.05 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.832 0.349 . . . . 0.0 111.656 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.21 -48.4 52.99 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.742 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -74.28 -43.16 58.02 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.33 -40.0 93.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.455 0.169 . . . . 0.0 110.954 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.697 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.1 mp -72.41 -39.77 67.66 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.082 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.2 OUTLIER -70.16 -39.25 75.43 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.567 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -70.08 -34.7 73.49 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.591 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.44 -42.29 75.14 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 14' ' ' LEU . 99.3 t -69.1 -42.85 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.128 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 15' ' ' LEU . 94.8 t -68.89 -39.69 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.024 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.59 -36.46 73.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.352 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 1.7 tp -70.27 -44.97 67.34 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.71 -56.22 8.66 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.529 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.1 mm -64.25 -37.64 80.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.745 0.307 . . . . 0.0 110.621 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.16 -46.58 87.45 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.329 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.7 mt -73.05 -24.0 60.65 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.677 0.275 . . . . 0.0 110.986 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.51 -39.91 64.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.194 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 18.9 mt -83.34 -33.68 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.248 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.76 -26.0 66.76 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.645 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' O ' HG23 ' A' ' 33' ' ' VAL . 96.5 mtt180 -81.88 -18.16 44.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.401 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 99.2 mtt180 -81.51 -21.61 38.52 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.617 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -70.74 -28.63 64.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.692 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt -83.17 -24.39 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.106 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 29' ' ' ARG . 2.6 t -95.55 -7.39 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 30' ' ' ARG . 28.4 ttt180 -92.49 159.95 15.29 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.73 153.09 20.97 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.037 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.51 17.76 6.02 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.365 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.451 ' O ' HD12 ' A' ' 41' ' ' LEU . 18.2 p -83.0 -16.73 46.02 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.715 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.013 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 6.1 tp -89.71 -13.91 35.86 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.058 0.456 . . . . 0.0 110.312 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -97.87 -33.87 11.07 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 114.706 -1.133 . . . . 0.0 107.966 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.672 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 70.1 mtp180 -75.68 -21.84 57.24 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.157 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 37' ' ' THR . 22.7 mt -104.84 -19.72 13.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.405 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.013 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 4.1 tt -62.54 -45.36 93.31 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.676 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -92.04 -12.76 32.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.62 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.672 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 1.9 tp10 -83.79 -43.68 15.16 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.56 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -88.24 -10.98 47.94 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.686 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 5.2 tt0 -63.33 -59.7 4.36 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.621 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 mp -146.5 27.38 1.12 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.966 0.412 . . . . 0.0 111.26 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 3.1 t -127.28 58.12 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.429 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -95.44 141.43 23.19 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.884 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.54 132.98 23.13 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.575 2.184 . . . . 0.0 112.832 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mt -142.83 87.23 1.97 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.308 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 p -138.33 146.72 52.59 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.158 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.5 119.16 6.16 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.614 2.209 . . . . 0.0 112.731 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.2 t -100.56 -10.51 20.94 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.857 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.79 75.58 0.06 OUTLIER Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.449 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -127.62 -42.18 1.64 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.671 0.272 . . . . 0.0 111.063 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -85.16 -42.89 14.32 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.28 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 mt -90.09 -8.29 51.74 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.446 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -129.31 143.61 50.91 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.786 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 mttp . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.596 0.236 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.88 146.6 55.68 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.184 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.14 138.95 41.1 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.726 2.284 . . . . 0.0 112.719 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 52.8 m -80.52 -7.24 59.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.49 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.468 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.4 mp -82.9 -32.76 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.072 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.444 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -28.22 28.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.605 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.13 -31.97 73.37 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.538 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.99 -41.86 9.25 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.228 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.531 ' O ' HD13 ' B' ' 73' ' ' LEU . 23.8 mt -62.02 -43.2 99.34 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.625 0.25 . . . . 0.0 111.215 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.69 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 25.5 m -61.02 -39.09 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 111.619 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.18 -48.47 52.66 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.714 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' B' ' 76' ' ' LEU . . . -74.2 -43.17 58.27 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.531 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.31 -40.0 93.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.029 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.69 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.1 mp -72.3 -39.85 67.97 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.095 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.2 OUTLIER -70.21 -39.22 75.28 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.553 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 0.7 OUTLIER -70.04 -34.65 73.51 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.67 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.45 -42.43 74.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.976 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.601 HG23 ' O ' ' B' ' 74' ' ' LEU . 99.9 t -68.99 -42.88 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.128 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.5 HG23 ' O ' ' B' ' 75' ' ' LEU . 95.5 t -68.91 -39.73 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.031 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.46 -36.53 73.97 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.371 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 1.7 tp -70.37 -44.89 67.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.035 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.76 -56.22 8.6 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.489 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 47.2 mm -64.22 -37.71 80.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.683 0.277 . . . . 0.0 110.554 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.05 -46.64 88.17 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.406 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 25.8 mt -73.1 -23.94 60.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.577 0.227 . . . . 0.0 110.962 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -39.83 64.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.25 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 18.8 mt -83.34 -33.76 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.2 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.76 -25.97 66.75 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.682 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.491 ' O ' HG23 ' B' ' 93' ' ' VAL . 96.5 mtt180 -81.96 -18.03 44.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.416 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 90' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' B' ' 94' ' ' ARG . 99.2 mtt180 -81.55 -21.58 38.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.575 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 57.5 m80 -70.77 -28.6 64.8 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.683 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mt -83.25 -24.38 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.065 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 89' ' ' ARG . 2.6 t -95.54 -7.34 9.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.99 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' B' ' 90' ' ' ARG . 28.3 ttt180 -92.4 159.91 15.34 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.94 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.76 153.11 20.94 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.065 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.5 17.75 6.01 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.377 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.455 ' O ' HD12 ' B' ' 101' ' ' LEU . 18.5 p -82.99 -16.71 46.13 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.791 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 1.028 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 6.1 tp -89.72 -13.94 35.74 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.105 0.479 . . . . 0.0 110.342 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -97.81 -33.88 11.09 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.025 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.688 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 70.1 mtp180 -75.61 -21.83 57.41 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.224 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.455 HD12 ' O ' ' B' ' 97' ' ' THR . 22.8 mt -104.78 -19.72 13.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.42 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 1.028 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 4.2 tt -62.6 -45.26 93.68 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -92.01 -12.82 32.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.647 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.688 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 1.9 tp10 -83.8 -43.73 15.1 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.521 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -88.17 -11.07 47.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.651 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' B' ' 102' ' ' LEU . 5.2 tt0 -63.4 -59.74 4.29 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.498 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mp -146.43 27.34 1.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.929 0.395 . . . . 0.0 111.225 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' B' ' 104' ' ' GLU . 3.1 t -127.19 58.13 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.463 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -95.57 141.43 23.18 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.53 132.96 23.1 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.646 2.231 . . . . 0.0 112.831 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 9.9 mt -142.84 87.25 1.98 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.282 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 17.9 p -138.36 146.76 52.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.121 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.47 119.07 6.09 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.662 2.241 . . . . 0.0 112.806 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 14.9 t -100.5 -10.6 20.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.84 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.78 75.63 0.06 OUTLIER Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.509 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -127.68 -42.14 1.63 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.542 0.211 . . . . 0.0 110.994 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -85.12 -42.94 14.31 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.282 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 9.6 mt -90.04 -8.3 51.85 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.465 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -129.28 143.63 50.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.829 179.949 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.613 0.244 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.5 146.77 57.11 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.183 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.38 143.72 59.07 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.629 2.219 . . . . 0.0 112.803 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 t -80.58 -8.35 59.57 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.465 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.7 mp -83.01 -32.0 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.089 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.93 -26.62 29.17 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.585 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.0 -32.87 74.56 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.524 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.94 -41.36 9.64 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.245 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 13' ' ' LEU . 22.3 mt -62.14 -42.99 99.79 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.736 -0.232 . . . . 0.0 111.36 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.683 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 23.9 m -60.93 -39.47 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.777 0.322 . . . . 0.0 111.688 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.68 -48.98 46.31 Favored Glycine 0 C--O 1.236 0.222 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.703 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.46 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.75 -41.3 62.68 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -67.09 -39.69 86.81 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.683 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.6 mp -71.25 -39.38 71.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.625 0.25 . . . . 0.0 110.771 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.33 -40.48 77.57 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.303 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 tp -69.64 -32.25 70.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 3.5 tp -69.96 -42.55 73.04 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.91 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 14' ' ' LEU . 59.1 t -69.18 -43.42 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.015 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 15' ' ' LEU . 91.0 t -66.46 -43.46 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.852 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.79 83.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.101 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 3.2 tp -69.44 -36.35 76.54 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.522 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.41 ' O ' ' HD1' ' A' ' 26' ' ' PHE . . . -67.42 -53.38 25.35 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.222 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.578 ' O ' HG12 ' A' ' 27' ' ' ILE . 11.0 mt -64.47 -37.34 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.649 0.261 . . . . 0.0 110.536 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.66 -44.32 95.13 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.414 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 mt -73.45 -27.01 61.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.445 0.164 . . . . 0.0 111.141 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.41 ' HD1' ' O ' ' A' ' 22' ' ' GLY . 2.8 m-85 -76.43 -36.59 57.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.432 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 23' ' ' ILE . 47.5 mm -83.52 -32.84 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.237 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -67.73 -25.77 65.82 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.554 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.79 -33.79 30.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.164 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -86.32 -21.33 27.34 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.411 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 27' ' ' ILE . 3.2 t60 -70.03 -15.94 63.08 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.806 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt -81.96 -10.88 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.23 -45.22 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.745 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -120.6 128.6 53.19 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.748 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -132.05 -43.85 0.96 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.205 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.93 25.4 4.29 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.283 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.1 p -83.29 -37.39 23.52 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.621 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.95 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.3 mm? -89.71 -38.32 13.94 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.489 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.43 ' HD3' ' OE1' ' A' ' 43' ' ' GLN . 99.3 mtt180 -63.28 -28.57 70.11 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.313 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 30.7 mtt180 -67.52 -21.84 65.46 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.671 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.537 HD22 HD22 ' B' ' 101' ' ' LEU . 5.4 mt -111.78 -26.31 9.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 113.537 -1.665 . . . . 0.0 109.941 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.95 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -83.67 -51.08 7.57 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 120.577 0.227 . . . . 0.0 111.448 -179.278 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.43 ' OE1' ' HD3' ' A' ' 39' ' ' ARG . 54.3 mt-30 -77.44 -9.97 59.19 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.03 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 9.7 tt0 -83.27 -45.52 13.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.255 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -88.37 -11.71 45.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.336 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 10.9 tt0 -62.76 -29.72 70.9 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.265 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -106.31 9.27 32.0 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.087 0.47 . . . . 0.0 111.06 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 44' ' ' GLU . 3.3 t -127.73 53.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.4 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -111.03 135.75 20.84 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.54 131.99 18.28 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.594 2.196 . . . . 0.0 112.65 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mt -142.95 87.31 1.97 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.314 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.8 p -140.21 132.74 14.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.03 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.61 154.07 49.49 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.547 2.165 . . . . 0.0 112.735 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.4 m 60.43 20.77 10.42 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.795 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.49 -157.98 18.78 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.528 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.523 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 41.8 mt-10 -107.56 152.91 23.63 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.819 0.342 . . . . 0.0 110.95 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -85.06 -20.07 30.97 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.671 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.66 -10.59 19.79 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.523 ' NE1' ' HB2' ' A' ' 56' ' ' GLU . 68.9 p-90 -134.67 -16.95 1.99 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.355 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.906 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.739 0.304 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.59 146.76 56.9 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.181 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.49 143.71 58.38 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.606 2.204 . . . . 0.0 112.797 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.1 t -80.53 -8.39 59.56 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.517 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.466 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.7 mp -82.9 -32.1 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.128 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.437 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.95 -26.5 29.22 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.659 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.03 -32.77 74.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.542 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.08 -41.24 9.6 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.243 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.2 mt -62.17 -43.08 99.64 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 122.331 0.253 . . . . 0.0 111.365 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.673 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 23.4 m -61.0 -39.31 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.878 0.371 . . . . 0.0 111.782 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.78 -48.79 46.91 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.809 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.459 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.86 -41.22 62.52 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -67.19 -39.54 86.4 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.434 0.159 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.673 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.5 mp -71.35 -39.37 71.35 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.641 0.258 . . . . 0.0 110.712 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.535 ' O ' HG23 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.33 -40.48 77.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.266 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 2.4 tp -69.74 -32.29 70.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.42 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' B' ' 73' ' ' LEU . 3.5 tp -69.88 -42.6 73.24 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.016 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.616 HG23 ' O ' ' B' ' 74' ' ' LEU . 59.1 t -69.13 -43.44 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.983 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.535 HG23 ' O ' ' B' ' 75' ' ' LEU . 91.0 t -66.44 -43.42 91.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.899 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.86 83.62 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.08 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 3.1 tp -69.31 -36.41 76.96 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.53 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.414 ' O ' ' HD1' ' B' ' 86' ' ' PHE . . . -67.51 -53.23 25.81 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.196 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.59 ' O ' HG12 ' B' ' 87' ' ' ILE . 11.0 mt -64.59 -37.33 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.704 0.287 . . . . 0.0 110.495 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.3 95.04 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.396 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 19.0 mt -73.43 -27.05 61.22 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.557 0.218 . . . . 0.0 111.287 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.414 ' HD1' ' O ' ' B' ' 82' ' ' GLY . 2.7 m-85 -76.51 -36.42 57.77 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.458 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.59 HG12 ' O ' ' B' ' 83' ' ' ILE . 47.6 mm -83.58 -32.77 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.212 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -67.77 -25.82 65.8 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.459 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.81 -33.74 30.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.201 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -86.21 -21.43 27.46 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.501 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 91' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' B' ' 87' ' ' ILE . 3.2 t60 -69.98 -15.89 63.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.726 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mt -81.98 -10.96 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.044 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.29 -45.14 14.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.704 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -120.6 128.58 53.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.688 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -132.01 -43.9 0.96 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.87 25.44 4.31 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.318 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 18.9 p -83.31 -37.42 23.44 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.618 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.947 ' O ' ' N ' ' B' ' 102' ' ' LEU . 1.3 mm? -89.62 -38.18 14.11 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.588 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 99' ' ' ARG . . . . . 0.428 ' HD3' ' OE1' ' B' ' 103' ' ' GLN . 99.3 mtt180 -63.29 -28.74 70.22 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.577 0.751 . . . . 0.0 109.272 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 31.1 mtt180 -67.42 -21.85 65.55 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.537 HD22 HD22 ' A' ' 41' ' ' LEU . 5.4 mt -111.8 -26.2 9.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.979 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.947 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.3 OUTLIER -83.77 -51.12 7.49 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 120.61 0.243 . . . . 0.0 111.464 -179.262 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 103' ' ' GLN . . . . . 0.428 ' OE1' ' HD3' ' B' ' 99' ' ' ARG . 54.3 mt-30 -77.36 -10.0 59.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.043 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 9.7 tt0 -83.44 -45.32 13.79 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.228 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -88.42 -11.75 45.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.289 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' B' ' 102' ' ' LEU . 10.9 tt0 -62.76 -29.75 70.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.303 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -106.25 9.16 32.14 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 111.063 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 104' ' ' GLU . 3.3 t -127.68 53.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.447 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -111.17 135.86 20.9 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.75 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.51 131.95 18.26 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.571 2.181 . . . . 0.0 112.732 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 mt -142.92 87.24 1.97 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.239 0.542 . . . . 0.0 110.303 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 16.8 p -140.13 132.77 14.84 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.989 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.63 154.17 49.42 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.524 2.149 . . . . 0.0 112.77 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 52.5 m 60.36 20.75 10.31 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.835 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.56 -157.99 18.73 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.573 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' GLU . . . . . 0.523 ' HB2' ' NE1' ' B' ' 119' ' ' TRP . 41.8 mt-10 -107.62 152.93 23.63 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.806 0.336 . . . . 0.0 110.972 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -85.15 -20.0 30.93 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.657 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.7 -10.53 19.8 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 119' ' ' TRP . . . . . 0.523 ' NE1' ' HB2' ' B' ' 116' ' ' GLU . 68.8 p-90 -134.7 -17.03 1.98 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.374 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.963 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.67 0.271 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.8 155.01 76.76 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.178 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.57 147.06 81.43 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.556 2.171 . . . . 0.0 112.6 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.1 m -80.66 -21.74 41.12 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.494 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.475 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.3 mp -83.0 -22.12 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.481 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.92 -33.89 24.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.601 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -27.81 69.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.465 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.87 -44.67 7.59 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.238 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.508 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 18.6 mt -62.36 -42.47 99.43 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.586 0.231 . . . . 0.0 111.227 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.71 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 22.4 m -61.37 -41.85 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.761 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -67.1 -48.23 60.74 Favored Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.974 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.443 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -74.11 -44.14 55.01 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.73 -38.84 90.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.432 0.158 . . . . 0.0 111.092 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.1 mp -72.76 -39.44 66.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.586 0.232 . . . . 0.0 110.958 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -70.29 -38.22 74.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.363 179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.9 tp -71.02 -35.19 71.91 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.688 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tt -68.99 -44.38 72.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.257 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 14' ' ' LEU . 58.6 t -69.45 -44.48 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.365 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 15' ' ' LEU . 74.4 t -66.77 -42.33 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.171 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.37 83.63 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.977 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.68 -35.64 77.47 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.614 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.97 -52.69 26.95 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.36 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.545 ' O ' HG12 ' A' ' 27' ' ' ILE . 13.7 mt -65.96 -35.23 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.558 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -65.75 -45.78 86.91 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.117 -0.564 . . . . 0.0 112.402 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.0 mt -75.24 -24.82 57.72 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.55 0.214 . . . . 0.0 111.309 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.8 t80 -77.56 -37.86 49.79 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.253 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 23' ' ' ILE . 50.6 mm -83.65 -33.44 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.194 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 15.0 ttm180 -66.22 -26.96 67.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.654 0.264 . . . . 0.0 111.312 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.493 ' O ' HG23 ' A' ' 33' ' ' VAL . 99.1 mtt180 -82.23 -18.21 43.34 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.347 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 74.6 mtp180 -83.9 -21.77 31.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.521 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.09 -20.43 34.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.473 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 28' ' ' ARG . 11.0 mm -83.23 -29.56 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.995 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 29' ' ' ARG . 2.3 t -95.94 -3.6 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.015 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 30' ' ' ARG . 28.8 ttt180 -90.8 157.11 17.57 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.931 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -93.0 157.36 16.35 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.987 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -88.9 28.04 1.24 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.284 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.665 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 18.1 p -82.98 -13.97 54.95 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.729 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.061 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 3.3 mm? -90.43 -18.2 25.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.948 0.404 . . . . 0.0 110.614 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -98.03 -35.44 10.44 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.367 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.66 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 94.9 mtt180 -73.85 -19.07 60.84 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.441 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' A' ' 37' ' ' THR . 3.0 mm? -108.57 -20.7 13.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.508 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.061 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 3.9 tt -62.81 -44.61 95.7 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.824 0.345 . . . . 0.0 110.754 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -92.85 -11.39 33.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.681 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.66 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 6.6 tt0 -83.79 -45.14 13.64 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.563 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -88.08 -11.03 48.27 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.748 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 9.6 tt0 -62.44 -57.13 12.35 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.611 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tp -150.13 27.17 0.78 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.017 0.437 . . . . 0.0 111.242 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 3.4 t -126.69 60.02 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.46 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -94.91 148.07 34.13 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.974 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.85 133.13 26.46 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.625 2.217 . . . . 0.0 112.801 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 tp -142.99 87.3 1.97 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.233 0.539 . . . . 0.0 110.194 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.2 p -99.34 155.05 36.95 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.112 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.81 119.54 6.58 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.67 2.246 . . . . 0.0 112.539 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.6 p -100.27 -10.3 21.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.938 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 -98.62 2.46 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.476 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -102.35 149.33 24.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.734 0.302 . . . . 0.0 110.865 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.23 -42.15 14.94 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.367 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.23 -9.1 49.28 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.409 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -131.27 144.7 51.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.4 p . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.92 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.713 0.292 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.86 155.02 76.67 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.128 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.79 147.05 80.4 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.628 2.219 . . . . 0.0 112.487 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -80.47 -21.94 41.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.505 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.478 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.3 mp -82.81 -22.14 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.247 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.478 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.91 -33.95 24.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.56 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.61 -27.84 69.51 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.539 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.82 -44.7 7.6 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.266 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 18.4 mt -62.19 -42.71 99.54 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-O 120.627 0.251 . . . . 0.0 111.25 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 22.5 m -61.31 -41.79 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.766 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.08 -48.33 60.34 Favored Glycine 0 CA--C 1.517 0.177 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.008 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.436 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -74.12 -44.17 54.84 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.71 -38.71 89.96 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.403 0.144 . . . . 0.0 111.126 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.1 mp -72.79 -39.56 66.6 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.92 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -70.17 -38.27 75.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.442 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.9 tp -71.02 -35.18 71.93 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.697 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 2.1 tt -68.88 -44.44 73.26 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.296 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 74' ' ' LEU . 58.4 t -69.47 -44.46 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.312 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.436 HG23 ' O ' ' B' ' 75' ' ' LEU . 75.0 t -66.81 -42.39 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.154 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.27 83.76 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.098 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.2 tp -68.74 -35.58 77.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.94 -52.7 27.01 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.404 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.54 ' O ' HG12 ' B' ' 87' ' ' ILE . 13.7 mt -65.94 -35.38 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.616 0.246 . . . . 0.0 110.514 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 84' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -65.58 -45.9 87.29 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.451 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 16.0 mt -75.1 -24.87 58.15 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.558 0.218 . . . . 0.0 111.281 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.8 t80 -77.58 -37.89 49.5 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.225 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.54 HG12 ' O ' ' B' ' 83' ' ' ILE . 50.7 mm -83.55 -33.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.202 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 15.1 ttm180 -66.05 -27.08 67.83 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.657 0.265 . . . . 0.0 111.327 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.498 ' O ' HG23 ' B' ' 93' ' ' VAL . 99.1 mtt180 -82.16 -18.25 43.45 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.412 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 90' ' ' ARG . . . . . 0.548 ' O ' ' HB2' ' B' ' 94' ' ' ARG . 74.7 mtp180 -83.72 -21.84 32.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.621 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.09 -20.47 34.84 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.426 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 92' ' ' ILE . . . . . 0.437 HG12 ' O ' ' B' ' 88' ' ' ARG . 11.1 mm -83.33 -29.49 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.983 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 89' ' ' ARG . 2.4 t -95.96 -3.51 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' B' ' 90' ' ' ARG . 28.8 ttt180 -90.78 157.15 17.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -93.07 157.34 16.34 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.005 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.86 28.1 1.22 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.268 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.662 ' O ' ' HB2' ' B' ' 101' ' ' LEU . 17.8 p -83.09 -13.81 54.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.701 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 1.073 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 3.3 mm? -90.51 -18.14 25.83 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.1 0.476 . . . . 0.0 110.58 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -98.15 -35.41 10.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.38 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.654 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 94.9 mtt180 -73.85 -19.05 60.84 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.48 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' B' ' 97' ' ' THR . 3.0 mm? -108.52 -20.81 12.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.536 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 1.073 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 3.8 tt -62.75 -44.56 95.89 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.772 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -92.87 -11.42 33.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.643 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.654 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 6.6 tt0 -83.7 -45.16 13.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.581 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -88.08 -11.08 48.16 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.671 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.572 ' HB2' ' O ' ' B' ' 102' ' ' LEU . 9.6 tt0 -62.43 -57.12 12.38 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.645 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 tp -150.06 27.22 0.78 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.007 0.432 . . . . 0.0 111.173 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' B' ' 104' ' ' GLU . 3.4 t -126.78 60.08 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.469 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -95.03 148.06 34.06 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.004 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.85 133.0 26.09 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.7 2.267 . . . . 0.0 112.803 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 tp -142.85 87.3 1.98 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.146 0.498 . . . . 0.0 110.137 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 18.2 p -99.4 155.03 36.97 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.148 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.82 119.58 6.61 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.572 2.181 . . . . 0.0 112.62 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 39.9 p -100.23 -10.39 21.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.934 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.3 -98.53 2.45 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.466 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -102.31 149.31 24.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.694 0.283 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.28 -42.18 14.87 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.307 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.16 -9.23 49.02 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.416 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -131.21 144.77 51.59 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 40.5 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.901 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.698 0.285 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.01 146.3 54.17 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.205 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.99 141.77 49.34 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.711 2.274 . . . . 0.0 112.765 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 m -80.57 -7.67 59.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.534 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.7 mp -82.93 -32.38 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.075 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.436 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -84.01 -27.64 28.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.552 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.42 -31.98 73.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.456 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.04 -41.69 9.32 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.217 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.546 ' O ' HD13 ' A' ' 13' ' ' LEU . 23.2 mt -62.01 -43.65 98.39 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 122.309 0.244 . . . . 0.0 111.187 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.686 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 25.2 m -60.48 -38.18 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 111.663 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -69.0 -49.32 42.03 Favored Glycine 0 CA--C 1.518 0.24 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.756 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.449 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.58 -41.48 62.84 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.9 mp -66.21 -41.79 89.65 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.79 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.8 mp -70.5 -38.83 74.38 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.916 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -69.7 -37.16 76.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.442 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tp -69.81 -36.93 76.06 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.6 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.58 -40.85 76.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.288 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 14' ' ' LEU . 93.1 t -69.57 -42.37 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.2 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 15' ' ' LEU . 97.7 t -70.62 -38.38 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.176 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.67 -39.17 73.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.295 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.7 tp -70.86 -43.4 68.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.945 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.82 -57.84 7.5 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.5 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.564 ' O ' HG12 ' A' ' 27' ' ' ILE . 41.4 mm -65.86 -33.64 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.643 0.259 . . . . 0.0 110.589 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -65.6 -47.65 75.32 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.322 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt -74.8 -24.1 58.59 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.55 0.214 . . . . 0.0 111.147 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.2 t80 -75.43 -39.69 58.56 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.242 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 23' ' ' ILE . 45.5 mm -83.59 -32.33 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.192 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.558 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.2 ttt180 -65.4 -26.1 67.84 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.351 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -81.74 -18.04 45.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.406 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -81.53 -21.48 38.52 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.616 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 61.4 m80 -70.57 -27.86 64.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.642 -179.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 mt -83.19 -13.23 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.136 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 t -95.8 -9.2 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.424 ' NH2' HD13 ' A' ' 38' ' ' LEU . 31.0 ttt180 -92.38 157.83 16.4 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -91.51 154.32 19.19 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.003 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.44 20.34 3.94 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.36 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.427 ' O ' HD12 ' A' ' 41' ' ' LEU . 18.5 p -83.19 -16.62 45.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.657 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.008 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 23.3 mt -89.41 -10.67 45.64 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.239 0.542 . . . . 0.0 110.138 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.85 -33.29 11.3 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.682 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 75.5 mtp180 -77.24 -24.24 51.2 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.013 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 37' ' ' THR . 14.5 mt -100.37 -20.29 15.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.238 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.008 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 2.6 tp -62.83 -48.49 78.86 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.585 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -88.06 -10.24 50.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.747 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.682 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 2.2 tp10 -83.68 -40.98 18.24 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.536 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -88.66 -12.05 43.54 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.458 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' OE2' ' HG ' ' A' ' 42' ' ' LEU . 32.3 mt-10 -96.37 -24.3 16.22 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.606 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tp -94.97 0.33 54.56 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.113 0.482 . . . . 0.0 111.384 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 44' ' ' GLU . 3.3 t -129.94 55.85 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.53 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -111.05 145.27 32.11 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.56 132.04 22.81 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.616 2.211 . . . . 0.0 112.767 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 tt -142.82 87.3 1.98 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.135 0.493 . . . . 0.0 110.204 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.1 p -137.18 131.61 17.75 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.067 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.0 155.89 47.73 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.519 2.146 . . . . 0.0 112.742 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.6 m 60.42 20.97 10.61 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.892 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.16 -147.23 18.38 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.489 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.5 148.5 25.13 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.626 0.25 . . . . 0.0 110.889 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -85.15 -41.73 15.41 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.404 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.16 -8.97 49.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.467 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -131.33 142.55 50.11 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.8 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.883 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.646 0.26 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.9 146.33 54.52 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.221 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.14 141.9 49.09 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.635 2.223 . . . . 0.0 112.698 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.6 m -80.67 -7.66 59.38 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.497 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.471 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.6 mp -82.81 -32.38 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.116 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.435 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.96 -27.7 28.31 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.552 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.44 -31.99 73.44 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.521 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.01 -41.67 9.36 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.207 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.549 ' O ' HD13 ' B' ' 73' ' ' LEU . 23.1 mt -61.95 -43.59 98.53 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.598 0.237 . . . . 0.0 111.32 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.672 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 25.4 m -60.44 -38.23 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 111.605 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -69.13 -49.29 41.28 Favored Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.671 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.455 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.51 -41.5 62.99 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.549 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.9 mp -66.2 -41.76 89.72 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.806 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.672 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -70.62 -38.7 73.97 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.875 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.0 OUTLIER -69.62 -37.3 76.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.481 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tp -69.73 -36.89 76.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.61 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 18.1 mt -69.62 -40.74 76.39 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.32 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 74' ' ' LEU . 93.1 t -69.63 -42.46 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.188 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.485 HG23 ' O ' ' B' ' 75' ' ' LEU . 98.1 t -70.51 -38.45 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.089 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.68 -39.24 73.66 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.22 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 1.7 tp -70.9 -43.31 68.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.937 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.84 -57.87 7.44 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.49 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.556 ' O ' HG12 ' B' ' 87' ' ' ILE . 41.2 mm -65.78 -33.64 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.581 0.229 . . . . 0.0 110.625 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 84' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -65.64 -47.61 75.4 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.361 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 20.7 mt -74.84 -24.03 58.54 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.563 0.22 . . . . 0.0 111.179 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.3 t80 -75.51 -39.73 58.04 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.159 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.556 HG12 ' O ' ' B' ' 83' ' ' ILE . 45.6 mm -83.59 -32.38 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.135 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.1 ttt180 -65.36 -26.01 67.83 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.438 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -81.72 -18.01 45.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.46 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -81.61 -21.38 38.35 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.59 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 61.5 m80 -70.65 -27.8 64.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.644 -179.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 1.8 mt -83.22 -13.27 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.102 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 2.7 t -95.69 -9.31 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.997 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.432 ' NH2' HD13 ' B' ' 98' ' ' LEU . 31.1 ttt180 -92.32 157.89 16.39 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -91.57 154.36 19.12 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.5 20.44 3.92 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.343 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.428 ' O ' HD12 ' B' ' 101' ' ' LEU . 18.6 p -83.18 -16.68 45.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.627 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 1.01 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 23.8 mt -89.46 -10.67 45.54 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.204 0.526 . . . . 0.0 110.121 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.83 -33.17 11.35 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.676 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 75.5 mtp180 -77.45 -24.17 50.33 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 114.281 -1.327 . . . . 0.0 107.896 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.428 HD12 ' O ' ' B' ' 97' ' ' THR . 14.6 mt -100.39 -20.35 15.85 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.29 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 1.01 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 2.6 tp -62.75 -48.51 78.89 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.686 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -87.99 -10.26 50.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.776 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.676 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 2.2 tp10 -83.7 -41.03 18.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.494 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -88.65 -11.98 43.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.53 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.465 ' OE2' ' HG ' ' B' ' 102' ' ' LEU . 32.3 mt-10 -96.33 -24.31 16.24 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.594 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tp -95.0 0.29 54.49 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.166 0.508 . . . . 0.0 111.332 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.429 HG23 ' O ' ' B' ' 104' ' ' GLU . 3.3 t -129.96 55.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.437 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -111.11 145.26 32.1 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.64 132.1 22.8 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.64 2.227 . . . . 0.0 112.683 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 tt -142.93 87.34 1.98 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.208 0.528 . . . . 0.0 110.166 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 17.3 p -137.23 131.41 17.63 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.083 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.8 155.81 48.71 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.543 2.162 . . . . 0.0 112.832 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 53.1 m 60.51 20.93 10.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.827 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.12 -147.12 18.35 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.509 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.59 148.48 25.18 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.648 0.261 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -85.23 -41.58 15.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.396 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.05 -9.24 49.27 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.455 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -131.23 142.51 50.17 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 41.1 p . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.967 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 50.6 tttt . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.607 0.241 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.77 146.3 56.69 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.234 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.9 141.21 48.12 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.78 2.32 . . . . 0.0 112.696 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 t -80.69 -7.6 59.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.44 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.6 mp -82.99 -32.66 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.09 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.455 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.95 -25.86 29.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.656 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -63.78 -33.49 75.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.59 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.0 -40.91 9.95 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.289 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.514 ' O ' HD13 ' A' ' 13' ' ' LEU . 22.0 mt -62.24 -43.38 98.96 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 122.283 0.233 . . . . 0.0 111.393 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.1 m -60.91 -41.09 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 111.779 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -67.51 -48.34 57.64 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.877 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.447 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.99 -43.5 57.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.4 -39.47 92.25 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 122.911 0.132 . . . . 0.0 110.971 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.68 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.0 mp -72.22 -39.83 68.23 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.605 0.241 . . . . 0.0 110.924 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -70.2 -38.43 75.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.583 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.3 tp -70.69 -34.52 72.05 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.657 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.34 -44.14 72.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.162 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 14' ' ' LEU . 59.8 t -69.25 -44.04 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.226 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 15' ' ' LEU . 71.8 t -66.55 -43.27 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.151 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.26 86.49 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.124 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.36 -36.32 79.04 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.635 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.93 -50.14 43.14 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.299 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 mt -64.39 -41.22 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.669 0.271 . . . . 0.0 110.603 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.42 -44.65 96.45 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.404 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.501 ' HG ' ' NH2' ' A' ' 28' ' ' ARG . 20.1 mt -73.95 -23.83 59.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.595 0.236 . . . . 0.0 110.931 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 6.6 t80 -74.43 -39.13 62.79 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.35 -35.0 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.255 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.501 ' NH2' ' HG ' ' A' ' 25' ' ' LEU . 74.0 mtm180 -64.14 -26.29 68.47 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.656 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 33' ' ' VAL . 98.6 mtt180 -82.14 -18.13 43.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.358 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.46 ' NH2' ' HE2' ' A' ' 26' ' ' PHE . 97.6 mtt180 -86.12 -21.58 27.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.622 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 38.5 m80 -70.39 -29.32 65.93 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.713 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -83.32 -19.01 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.097 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.1 t -97.94 -28.29 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.986 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -92.36 156.24 17.36 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.007 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -94.0 158.34 15.67 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.923 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -88.55 34.89 0.76 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.351 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.2 p -82.99 -16.43 47.26 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.716 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 1.044 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 4.2 mm? -89.81 -14.8 33.67 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.132 0.491 . . . . 0.0 110.475 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -97.66 -34.46 10.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.657 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 68.8 mtp180 -74.73 -20.24 59.91 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.097 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 37' ' ' THR . 6.8 mt -104.82 -22.47 13.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.315 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 1.044 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 2.9 tt -66.98 -48.81 67.37 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.555 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -84.51 -8.94 58.76 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.51 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.657 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -83.44 -35.85 24.66 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.4 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -88.12 -11.68 46.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.248 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' OE1' HD23 ' A' ' 42' ' ' LEU . 32.4 mt-10 -75.26 -13.64 60.45 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.48 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 tp -117.18 4.83 12.66 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.085 0.469 . . . . 0.0 110.991 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 44' ' ' GLU . 4.5 t -126.34 62.34 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.506 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -99.13 130.59 26.98 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.759 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.7 133.51 20.43 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.474 2.116 . . . . 0.0 112.717 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.9 87.4 1.98 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.117 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -123.48 145.92 48.29 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.102 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.42 120.62 7.43 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.533 2.155 . . . . 0.0 112.743 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.0 p -120.67 -10.09 9.25 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.908 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.39 57.13 0.01 OUTLIER Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.531 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.76 148.29 25.46 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.74 0.305 . . . . 0.0 111.004 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -85.19 -41.32 15.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.347 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.11 -8.99 49.99 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.543 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -131.37 135.06 46.9 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.4 p . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.903 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 50.5 tttt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.623 0.249 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.83 146.35 56.99 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.19 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.04 141.3 47.74 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.6 2.2 . . . . 0.0 112.708 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.4 t -80.61 -7.7 59.36 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.413 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.468 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.6 mp -82.88 -32.65 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.133 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.451 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.99 -25.9 29.62 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.639 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -63.76 -33.62 76.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.465 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.86 -40.96 10.02 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.289 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.515 ' O ' HD13 ' B' ' 73' ' ' LEU . 21.9 mt -62.26 -43.37 98.98 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.346 0.258 . . . . 0.0 111.381 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 23.7 m -60.99 -40.96 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.765 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.58 -48.43 56.7 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.806 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.453 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.86 -43.63 58.03 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.515 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.27 -39.42 92.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.45 0.167 . . . . 0.0 111.056 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.0 mp -72.39 -39.68 67.8 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.646 0.26 . . . . 0.0 110.947 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -70.13 -38.52 75.57 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.584 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.3 tp -70.76 -34.53 71.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.566 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.21 -44.23 72.5 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.168 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 74' ' ' LEU . 59.9 t -69.31 -43.88 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.286 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 75' ' ' LEU . 71.7 t -66.51 -43.5 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.029 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.15 86.52 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.159 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.3 tp -68.39 -36.33 78.99 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.683 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.88 -50.1 43.73 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.427 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 19.1 mt -64.44 -41.23 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.652 0.263 . . . . 0.0 110.562 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.55 -44.63 96.29 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.317 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.497 ' HG ' ' NH2' ' B' ' 88' ' ' ARG . 20.0 mt -73.86 -23.85 59.67 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.704 0.288 . . . . 0.0 111.015 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 6.5 t80 -74.37 -39.22 62.88 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.127 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.29 -35.08 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.258 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.497 ' NH2' ' HG ' ' B' ' 85' ' ' LEU . 74.2 mtm180 -64.11 -26.3 68.48 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.632 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 89' ' ' ARG . . . . . 0.449 ' O ' HG23 ' B' ' 93' ' ' VAL . 98.5 mtt180 -82.11 -18.3 43.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 90' ' ' ARG . . . . . 0.464 ' NH2' ' HE2' ' B' ' 86' ' ' PHE . 97.6 mtt180 -86.01 -21.71 27.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.607 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -70.31 -29.44 66.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.69 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.7 mt -83.21 -18.94 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 93' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 89' ' ' ARG . 4.2 t -98.04 -28.21 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.935 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -92.34 156.33 17.32 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.016 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -94.19 158.36 15.63 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.913 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -88.58 35.05 0.76 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.368 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' B' ' 101' ' ' LEU . 18.9 p -83.15 -16.54 46.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.511 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 1.029 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 4.2 mm? -89.74 -14.83 33.8 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.042 0.449 . . . . 0.0 110.414 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -97.59 -34.46 10.95 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.675 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 68.8 mtp180 -74.63 -20.26 59.97 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.127 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' B' ' 97' ' ' THR . 6.8 mt -104.78 -22.56 13.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.239 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 1.029 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 2.8 tt -66.77 -48.93 67.53 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.637 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -84.47 -8.95 58.78 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.513 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.675 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 0.8 OUTLIER -83.38 -35.85 24.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.494 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -88.14 -11.72 46.09 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.257 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.452 ' OE1' HD23 ' B' ' 102' ' ' LEU . 32.3 mt-10 -75.36 -13.5 60.41 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.432 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 tp -117.26 4.78 12.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.171 0.51 . . . . 0.0 111.027 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 104' ' ' GLU . 4.5 t -126.37 62.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.417 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -99.17 130.51 27.11 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.709 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.78 133.45 20.2 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.541 2.161 . . . . 0.0 112.724 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.88 87.36 1.98 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.197 0.523 . . . . 0.0 110.173 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 17.9 p -123.44 145.93 48.22 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.095 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.43 120.57 7.39 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.705 2.27 . . . . 0.0 112.692 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 39.4 p -120.66 -10.04 9.26 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.913 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 160.33 57.16 0.01 OUTLIER Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.498 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -101.77 148.29 25.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.681 0.277 . . . . 0.0 110.972 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -85.31 -41.2 15.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.325 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.11 -9.07 49.75 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.574 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -131.37 134.95 46.8 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 39.4 p . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.873 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 65.9 mttm . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.721 0.296 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.08 146.87 56.38 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.186 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.93 150.59 73.34 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.597 2.198 . . . . 0.0 112.691 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.7 m -80.59 -10.12 59.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.595 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 5' ' ' ILE . 3.1 mp -82.88 -30.89 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.076 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.444 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.92 -27.1 28.82 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.637 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -63.86 -32.68 74.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.543 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.52 9.55 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.346 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.52 ' O ' HD13 ' A' ' 13' ' ' LEU . 21.8 mt -62.15 -43.02 99.76 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 115.725 -0.237 . . . . 0.0 111.431 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.5 m -60.83 -39.61 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.726 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.69 -48.81 47.39 Favored Glycine 0 C--O 1.235 0.217 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.836 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.82 -41.41 62.37 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -67.03 -39.65 87.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.438 0.161 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.68 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.5 mp -71.37 -39.35 71.28 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.766 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.37 -40.44 77.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.323 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tp -69.55 -32.68 71.63 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.528 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 3.5 tp -69.68 -43.0 73.38 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.99 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 14' ' ' LEU . 60.0 t -68.99 -43.65 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.061 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 15' ' ' LEU . 93.3 t -66.34 -43.31 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.69 -37.5 82.39 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.094 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -69.78 -35.85 75.22 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.592 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.14 -52.75 25.88 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.279 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.599 ' O ' HG12 ' A' ' 27' ' ' ILE . 11.2 mt -65.13 -37.76 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.633 0.254 . . . . 0.0 110.577 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.94 -46.53 91.28 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.31 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.56 -24.47 60.11 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.587 0.232 . . . . 0.0 111.126 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 8.1 t80 -75.81 -38.74 57.89 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.274 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 23' ' ' ILE . 39.3 mm -83.7 -31.91 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.196 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -66.62 -25.8 66.77 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.691 0.281 . . . . 0.0 111.578 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.7 -18.09 45.64 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.304 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -82.68 -21.29 34.96 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.529 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -69.57 -15.8 63.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.883 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.05 -19.19 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.01 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.78 -46.09 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.706 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -113.04 125.31 54.25 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.736 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -132.05 110.5 10.76 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.046 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 55.99 27.32 11.05 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.1 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.2 p -83.5 -34.78 25.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.555 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.906 ' O ' ' N ' ' A' ' 42' ' ' LEU . 15.1 tp -89.54 -34.71 16.27 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.378 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -67.71 -29.09 68.25 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 42.8 mtt180 -69.28 -17.99 63.8 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.677 HD22 HD22 ' B' ' 101' ' ' LEU . 11.7 mt -112.0 -27.11 8.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.633 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.906 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.8 OUTLIER -88.69 -60.54 1.93 Allowed 'General case' 0 C--N 1.351 0.672 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 47' ' ' LEU . 41.8 mt-30 -69.66 -22.08 63.47 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.697 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 8.8 mm-40 -83.8 -19.69 34.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.569 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.516 ' HB3' ' OE2' ' A' ' 46' ' ' GLU . 2.9 tmt_? -88.71 -11.85 43.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.432 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' OE2' ' HB3' ' A' ' 45' ' ' ARG . 2.1 mp0 -116.12 -39.25 3.45 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 43' ' ' GLN . 4.2 mm? -88.83 10.33 21.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 112.031 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.4 39.73 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.643 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.406 ' OE2' ' HA ' ' A' ' 46' ' ' GLU . 42.5 mt-10 -100.25 143.83 27.26 Favored Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.64 160.61 48.88 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.639 2.226 . . . . 0.0 112.745 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mp -142.59 87.41 2.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.253 0.549 . . . . 0.0 110.229 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 p -112.45 146.76 35.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.122 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.37 121.43 8.2 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.647 2.232 . . . . 0.0 112.739 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.4 m -126.04 -10.12 6.54 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.905 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -139.86 55.91 0.63 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.391 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -102.31 134.32 45.8 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.721 0.296 . . . . 0.0 110.832 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.22 -41.99 15.1 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.237 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.21 -7.67 52.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.342 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 92.8 m95 62.23 121.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.975 0.51 . . . . 0.0 111.537 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.897 179.947 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 65.9 mttm . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.715 0.293 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.1 146.71 55.68 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.189 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.68 150.49 74.46 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.668 2.246 . . . . 0.0 112.755 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.4 m -80.63 -10.14 59.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.473 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.465 HD12 ' H ' ' B' ' 65' ' ' ILE . 3.1 mp -82.95 -30.83 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.082 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.438 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -26.97 28.94 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.628 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -63.89 -32.68 74.28 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.528 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.89 -41.6 9.51 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.289 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.1 mt -62.21 -43.11 99.57 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.657 -0.272 . . . . 0.0 111.31 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.67 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.2 m -60.81 -39.5 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.744 0.306 . . . . 0.0 111.767 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.73 -48.87 46.73 Favored Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.775 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.462 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.76 -41.33 62.6 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -67.11 -39.73 86.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.876 -0.147 . . . . 0.0 110.85 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -71.27 -39.36 71.62 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.67 0.271 . . . . 0.0 110.824 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.529 ' O ' HG23 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.31 -40.48 77.64 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.389 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.3 tp -69.6 -32.54 71.34 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.556 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.83 -42.87 73.05 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.997 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.618 HG23 ' O ' ' B' ' 74' ' ' LEU . 59.7 t -69.06 -43.67 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.066 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.529 HG23 ' O ' ' B' ' 75' ' ' LEU . 94.3 t -66.3 -43.41 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.61 -37.44 82.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.146 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.2 tp -69.82 -35.73 75.04 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.63 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.2 -52.71 25.85 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.215 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.607 ' O ' HG12 ' B' ' 87' ' ' ILE . 11.2 mt -65.23 -37.77 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 110.471 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.98 -46.44 91.42 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.377 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.53 -24.54 60.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.595 0.236 . . . . 0.0 111.179 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 8.3 t80 -75.85 -38.64 57.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.269 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.607 HG12 ' O ' ' B' ' 83' ' ' ILE . 39.1 mm -83.72 -31.91 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.178 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -66.65 -25.95 66.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.506 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.55 -18.09 46.17 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.332 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -82.63 -21.32 35.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.522 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -69.52 -15.96 63.34 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.825 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.03 -19.24 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.989 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.69 -46.17 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -113.0 125.3 54.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.739 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -132.01 110.45 10.75 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 55.98 27.29 11.01 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.029 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 18.4 p -83.49 -34.72 25.28 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.597 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.896 ' O ' ' N ' ' B' ' 102' ' ' LEU . 15.0 tp -89.61 -34.76 16.2 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.36 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -67.59 -29.18 68.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 43.0 mtt180 -69.21 -18.05 63.85 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.677 HD22 HD22 ' A' ' 41' ' ' LEU . 11.7 mt -112.02 -27.06 8.56 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.671 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.896 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.8 OUTLIER -88.56 -60.68 1.89 Allowed 'General case' 0 C--N 1.351 0.638 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 103' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' B' ' 107' ' ' LEU . 41.7 mt-30 -69.57 -22.18 63.56 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.641 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 8.8 mm-40 -83.72 -19.79 34.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.512 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.52 ' HB3' ' OE2' ' B' ' 106' ' ' GLU . 2.9 tmt_? -88.67 -11.9 43.97 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.517 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 106' ' ' GLU . . . . . 0.52 ' OE2' ' HB3' ' B' ' 105' ' ' ARG . 2.1 mp0 -115.97 -39.34 3.48 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' B' ' 103' ' ' GLN . 4.2 mm? -88.79 10.27 21.6 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 111.95 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.38 39.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.591 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' GLU . . . . . 0.405 ' OE2' ' HA ' ' B' ' 106' ' ' GLU . 42.5 mt-10 -100.24 143.77 27.14 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.934 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.52 160.68 48.68 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.686 2.257 . . . . 0.0 112.738 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 mp -142.64 87.46 2.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.184 0.516 . . . . 0.0 110.252 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 18.0 p -112.53 146.65 35.42 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.071 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.29 121.5 8.29 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.638 2.225 . . . . 0.0 112.703 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 53.0 m -126.13 -10.15 6.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.86 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -139.73 55.89 0.64 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.435 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -102.43 134.22 46.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.786 0.327 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -85.18 -41.89 15.23 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.331 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.17 -7.71 52.98 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.418 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 92.8 m95 62.35 121.79 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.559 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.822 179.999 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.8 mttp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.595 0.236 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.83 146.74 56.37 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.247 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.93 143.79 56.17 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.687 2.258 . . . . 0.0 112.809 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.0 m -80.57 -8.1 59.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.498 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp -82.87 -32.26 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.128 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.96 -27.02 28.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.557 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.0 -32.56 74.15 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.574 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.06 -41.36 9.53 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.208 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.522 ' O ' HD13 ' A' ' 13' ' ' LEU . 22.1 mt -62.26 -43.16 99.47 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 122.339 0.256 . . . . 0.0 111.27 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.675 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.1 m -60.79 -39.86 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 111.713 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.5 -48.74 49.06 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.754 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.8 -41.73 61.97 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -66.75 -39.63 87.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.421 0.153 . . . . 0.0 110.982 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.675 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.7 mp -71.38 -39.57 71.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.647 0.26 . . . . 0.0 110.83 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.515 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.37 -40.11 77.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.244 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.5 tp -69.85 -32.83 71.43 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.54 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.58 -43.26 73.18 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.059 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 14' ' ' LEU . 61.7 t -69.0 -43.9 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.087 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 15' ' ' LEU . 98.7 t -66.22 -43.04 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.014 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.58 82.04 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.4 tp -69.45 -36.04 76.24 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.534 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.19 -52.85 25.08 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.219 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.577 ' O ' HG12 ' A' ' 27' ' ' ILE . 12.1 mt -65.53 -36.33 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.689 0.28 . . . . 0.0 110.456 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.96 -46.24 89.92 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.37 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HG ' ' NH2' ' A' ' 28' ' ' ARG . 17.5 mt -74.12 -24.38 59.43 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.663 0.268 . . . . 0.0 111.221 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.8 t80 -76.89 -38.07 54.28 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.303 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 23' ' ' ILE . 46.7 mm -83.68 -33.43 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.236 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.494 ' NH2' ' HG ' ' A' ' 25' ' ' LEU . 68.6 mtm180 -64.19 -25.81 68.24 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.67 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -79.47 -18.2 52.55 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.2 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.07 -21.43 27.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.51 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 49.0 m80 -69.65 -15.73 63.24 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.9 -179.784 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.7 mt -82.58 -16.47 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.676 0.274 . . . . 0.0 111.042 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.45 -46.34 12.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.719 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -119.3 130.31 55.33 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.72 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -130.78 -45.27 1.06 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -138.47 31.55 2.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.185 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.3 p -83.32 -38.66 21.79 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.675 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.931 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.5 mm? -89.86 -36.61 14.97 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.515 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.4 -28.91 70.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.083 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 31.3 mtt180 -68.1 -20.21 64.91 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.515 HD22 HD22 ' B' ' 101' ' ' LEU . 6.9 mt -112.31 -25.76 9.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.828 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.931 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -87.84 -57.68 2.85 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 39.9 mt-30 -72.6 -21.84 61.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.583 -179.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 8.4 mm-40 -83.82 -19.63 34.63 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.449 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 41' ' ' LEU . 3.0 tmt_? -88.59 -11.87 44.29 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.436 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.08 -38.34 3.64 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.07 10.01 25.93 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.968 0.413 . . . . 0.0 111.857 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.51 48.0 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.537 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -97.21 146.18 30.9 Favored Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.34 145.23 58.91 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.651 2.234 . . . . 0.0 112.8 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mt -142.79 87.37 1.99 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.251 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.9 p -100.49 147.61 33.83 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.174 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.92 1.41 7.13 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.695 2.263 . . . . 0.0 113.225 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.2 p -86.33 3.18 44.57 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.186 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -129.93 54.93 0.78 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.54 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -107.77 149.72 27.85 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.708 0.289 . . . . 0.0 110.871 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.29 -42.61 14.47 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.207 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.406 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 9.6 mt -90.08 -9.21 49.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.469 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' TRP . . . . . 0.406 ' CE3' ' HB2' ' A' ' 58' ' ' LEU . 30.9 m-90 -131.38 145.35 51.79 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.8 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.872 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 mttp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.633 0.254 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.82 146.77 56.51 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.225 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.93 143.8 56.17 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.624 2.216 . . . . 0.0 112.797 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.0 m -80.59 -8.03 59.46 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.536 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.471 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.8 mp -82.91 -32.32 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.44 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.91 -26.91 28.97 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.612 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -32.62 74.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.484 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.86 -41.5 9.61 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.297 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.515 ' O ' HD13 ' B' ' 73' ' ' LEU . 22.1 mt -62.25 -43.07 99.67 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.684 -0.258 . . . . 0.0 111.344 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.668 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.1 m -60.88 -39.79 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.733 0.302 . . . . 0.0 111.735 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.56 -48.6 49.55 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.862 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.85 -41.7 61.87 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.515 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -66.8 -39.67 87.84 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.438 0.161 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.668 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -71.3 -39.66 71.32 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.77 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.516 ' O ' HG23 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.32 -40.03 77.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.415 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.5 tp -69.92 -32.81 71.29 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.6 -43.21 73.24 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.033 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.616 HG23 ' O ' ' B' ' 74' ' ' LEU . 61.6 t -69.04 -43.91 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.036 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.516 HG23 ' O ' ' B' ' 75' ' ' LEU . 99.0 t -66.24 -43.09 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.957 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.83 -37.57 82.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.4 tp -69.46 -36.05 76.21 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.599 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.2 -52.8 25.31 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.249 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.582 ' O ' HG12 ' B' ' 87' ' ' ILE . 12.0 mt -65.48 -36.28 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.665 0.269 . . . . 0.0 110.537 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.92 -46.25 89.95 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.339 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 85' ' ' LEU . . . . . 0.5 ' HG ' ' NH2' ' B' ' 88' ' ' ARG . 17.8 mt -74.14 -24.47 59.43 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.525 0.202 . . . . 0.0 111.071 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.8 t80 -76.89 -38.08 54.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.306 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.582 HG12 ' O ' ' B' ' 83' ' ' ILE . 46.6 mm -83.59 -33.46 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.258 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.5 ' NH2' ' HG ' ' B' ' 85' ' ' LEU . 69.0 mtm180 -64.16 -25.88 68.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.638 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -79.37 -18.32 52.62 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.244 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.02 -21.44 27.78 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.527 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 49.5 m80 -69.63 -15.73 63.25 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.926 -179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.7 mt -82.61 -16.34 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.067 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.55 -46.31 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.715 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -119.35 130.18 55.22 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.811 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -130.73 -45.1 1.06 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -138.44 31.54 2.34 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.159 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 18.2 p -83.37 -38.69 21.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.599 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.911 ' O ' ' N ' ' B' ' 102' ' ' LEU . 1.5 mm? -89.83 -36.52 15.04 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.567 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.35 -29.05 70.13 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 123.565 0.746 . . . . 0.0 109.126 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 31.6 mtt180 -67.97 -20.21 65.02 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' B' ' 105' ' ' ARG . 6.8 mt -112.23 -25.83 9.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.868 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.911 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.3 OUTLIER -87.89 -57.72 2.83 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 -72.47 -21.95 61.14 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.685 -179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 8.5 mm-40 -83.68 -19.71 34.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.449 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' B' ' 101' ' ' LEU . 2.9 tmt_? -88.68 -11.74 44.39 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.381 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.14 -38.36 3.62 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.13 10.1 25.74 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.025 0.44 . . . . 0.0 111.882 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.59 48.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.501 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -97.18 146.23 30.99 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.908 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.39 145.2 58.5 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.738 2.292 . . . . 0.0 112.711 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 9.9 mt -142.82 87.43 1.99 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.233 0.539 . . . . 0.0 110.303 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 17.7 p -100.47 147.62 33.84 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.1 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.95 1.39 7.17 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.634 2.223 . . . . 0.0 113.186 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 44.4 p -86.29 3.08 44.85 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.208 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -129.8 54.99 0.77 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.531 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -107.83 149.6 28.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.692 0.282 . . . . 0.0 110.934 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.09 -42.66 14.6 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.336 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 118' ' ' LEU . . . . . 0.403 ' HB2' ' CE3' ' B' ' 119' ' ' TRP . 9.6 mt -90.08 -9.17 49.45 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.418 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 119' ' ' TRP . . . . . 0.403 ' CE3' ' HB2' ' B' ' 118' ' ' LEU . 31.0 m-90 -131.45 145.27 51.71 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 53.0 m . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.867 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 30.7 tttm . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.613 0.244 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.81 146.78 56.57 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.19 139.52 42.42 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.642 2.228 . . . . 0.0 112.834 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.4 m -80.53 -7.19 59.11 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.544 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.5 mp -82.97 -32.87 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.083 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.95 -27.12 28.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.553 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.09 -32.54 74.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.593 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.98 -41.41 9.57 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.233 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 13' ' ' LEU . 23.4 mt -62.31 -43.32 99.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.694 -0.253 . . . . 0.0 111.285 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.66 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.0 m -60.66 -39.56 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.737 0.303 . . . . 0.0 111.717 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.5 -49.19 46.11 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.82 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.5 -41.77 62.65 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.91 -41.39 91.5 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.818 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.66 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.6 mp -70.35 -39.53 74.6 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.902 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.31 -37.88 77.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.414 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.03 -35.01 73.99 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.646 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 14.8 mt -69.48 -42.15 75.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 14' ' ' LEU . 58.0 t -68.71 -44.97 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.058 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 15' ' ' LEU . 93.0 t -65.91 -43.19 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.82 84.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.078 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.93 -36.31 77.82 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.614 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.36 -49.98 41.58 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.286 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 mt -64.17 -41.23 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 110.495 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -64.44 -44.39 95.35 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.366 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.6 mt -72.78 -24.66 60.97 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.724 0.297 . . . . 0.0 111.038 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.91 -40.67 62.98 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.11 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 12.4 mt -83.65 -27.27 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.999 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.3 ttt180 -63.58 -25.79 68.4 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.488 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -81.66 -35.0 30.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.329 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.25 -21.27 27.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.47 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 27' ' ' ILE . 4.3 t60 -69.89 -15.81 63.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.804 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt -81.51 -10.89 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.102 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.18 -45.94 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.72 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -127.4 128.14 45.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.725 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -129.73 -43.29 1.24 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.159 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.39 17.61 5.94 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.271 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.19 -32.03 26.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.308 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.916 ' O ' ' N ' ' A' ' 42' ' ' LEU . 15.8 tp -89.42 -35.73 15.86 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.3 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 43' ' ' GLN . 27.4 mmt180 -67.52 -28.92 68.23 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 27.6 mtp180 -69.96 -18.79 63.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.709 HD22 HD22 ' B' ' 101' ' ' LEU . 13.5 mt -111.33 -27.37 8.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.718 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.916 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -79.19 -46.48 17.83 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-O 120.746 0.308 . . . . 0.0 111.05 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLN . . . . . 0.473 ' O ' HD12 ' A' ' 47' ' ' LEU . 13.2 mm-40 -83.32 -3.19 57.24 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.616 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 10.3 tt0 -83.01 -40.28 20.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.497 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -88.41 -11.74 45.21 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.532 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -82.18 -22.99 35.74 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.341 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 43' ' ' GLN . 9.6 mt -100.97 2.03 40.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.196 0.522 . . . . 0.0 111.193 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 44' ' ' GLU . 3.5 t -128.08 57.24 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.459 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -101.01 148.29 34.88 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.801 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.1 134.77 30.25 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.638 2.226 . . . . 0.0 112.782 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 tp -142.83 87.41 1.99 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.233 0.54 . . . . 0.0 110.171 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -99.69 146.03 31.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.108 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.22 118.38 5.64 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.639 2.226 . . . . 0.0 112.743 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.1 m -103.05 -11.28 18.24 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.965 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.27 -55.67 0.25 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.458 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -126.71 139.18 53.34 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.622 0.248 . . . . 0.0 110.976 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.24 -40.36 16.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.306 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.4 tp -89.98 -8.21 52.2 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.295 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -130.47 144.17 51.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.858 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.805 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 30.9 tttm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.61 0.243 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.93 146.65 55.82 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.235 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.13 139.46 42.47 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.723 2.282 . . . . 0.0 112.78 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.0 m -80.53 -7.13 59.1 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.543 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.467 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.5 mp -83.04 -32.86 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.055 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.437 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -27.21 28.77 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.629 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -32.68 74.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.498 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.89 -41.33 9.71 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.264 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.524 ' O ' HD13 ' B' ' 73' ' ' LEU . 22.9 mt -62.18 -43.57 98.53 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 122.377 0.271 . . . . 0.0 111.308 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.653 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.0 m -60.46 -39.61 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.746 0.308 . . . . 0.0 111.723 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.48 -49.27 45.71 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.718 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.462 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.59 -41.73 62.49 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.524 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.92 -41.28 91.61 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.005 0.191 . . . . 0.0 110.823 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.653 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -70.42 -39.56 74.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.833 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.28 -37.83 78.05 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.413 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.1 -35.06 73.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.6 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 14.8 mt -69.49 -42.07 75.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.158 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.613 HG23 ' O ' ' B' ' 74' ' ' LEU . 57.9 t -68.85 -44.84 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.085 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.497 HG23 ' O ' ' B' ' 75' ' ' LEU . 93.6 t -65.84 -43.28 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.964 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.25 -37.64 83.85 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.1 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.3 tp -68.95 -36.38 77.85 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.608 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.33 -50.04 41.41 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.311 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 mt -64.2 -41.1 91.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.634 0.254 . . . . 0.0 110.546 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 84' ' ' GLY . . . . . 0.563 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -64.39 -44.52 95.22 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.395 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 20.7 mt -72.69 -24.77 61.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.643 0.259 . . . . 0.0 110.971 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.84 -40.71 63.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' B' ' 91' ' ' HIS . 12.3 mt -83.53 -27.41 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.996 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.563 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.3 ttt180 -63.56 -25.63 68.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.476 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -81.8 -34.91 30.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.364 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.26 -21.38 27.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.481 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 91' ' ' HIS . . . . . 0.427 ' HB2' ' O ' ' B' ' 87' ' ' ILE . 4.2 t60 -69.81 -15.73 63.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.883 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 mt -81.55 -11.0 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.101 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.6 t -94.04 -45.94 13.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.778 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -127.34 128.14 45.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.775 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -129.83 -43.17 1.24 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.162 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.32 17.56 5.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.309 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.15 -32.04 26.86 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.381 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.917 ' O ' ' N ' ' B' ' 102' ' ' LEU . 15.8 tp -89.37 -35.75 15.89 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.353 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 99' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' B' ' 103' ' ' GLN . 27.4 mmt180 -67.46 -28.92 68.27 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.474 -0.785 . . . . 0.0 108.922 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.561 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 27.5 mtp180 -69.99 -18.83 63.35 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 176.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.709 HD22 HD22 ' A' ' 41' ' ' LEU . 13.3 mt -111.31 -27.3 8.72 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.777 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.917 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.7 OUTLIER -79.38 -46.38 17.7 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-O 120.601 0.238 . . . . 0.0 110.991 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 103' ' ' GLN . . . . . 0.461 ' O ' HD12 ' B' ' 107' ' ' LEU . 13.2 mm-40 -83.27 -3.25 57.26 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.62 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 10.3 tt0 -83.06 -40.17 20.23 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.545 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -88.46 -11.78 44.93 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.558 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -82.06 -23.13 36.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.353 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 107' ' ' LEU . . . . . 0.461 HD12 ' O ' ' B' ' 103' ' ' GLN . 9.6 mt -100.97 2.09 40.34 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.13 0.49 . . . . 0.0 111.136 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' VAL . . . . . 0.469 HG23 ' O ' ' B' ' 104' ' ' GLU . 3.5 t -128.1 57.28 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.453 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -101.03 148.21 34.78 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.863 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.19 134.8 30.14 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.641 2.227 . . . . 0.0 112.756 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 tp -142.78 87.36 1.99 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.204 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 18.0 p -99.62 146.08 31.21 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.107 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.25 118.34 5.61 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.721 2.281 . . . . 0.0 112.8 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 52.6 m -103.13 -11.23 18.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.897 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.35 -55.73 0.24 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.546 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -126.79 139.22 53.27 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.683 0.277 . . . . 0.0 110.837 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.14 -40.48 16.68 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.351 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 tp -90.01 -8.09 52.41 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.356 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -130.5 144.27 51.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.765 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.823 -179.993 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.63 0.252 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.0 146.63 55.6 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.222 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.83 140.53 46.58 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.713 2.275 . . . . 0.0 112.78 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 t -80.57 -7.74 59.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.496 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.472 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.5 mp -82.89 -32.57 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.143 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.447 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.96 -26.2 29.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.572 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -63.84 -33.21 75.17 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.562 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.13 9.82 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.268 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.521 ' O ' HD13 ' A' ' 13' ' ' LEU . 22.0 mt -62.22 -43.36 99.0 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 122.286 0.235 . . . . 0.0 111.291 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.679 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.0 m -60.9 -39.99 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.769 0.319 . . . . 0.0 111.73 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.26 -48.5 52.01 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.828 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.454 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.93 -42.43 60.6 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -66.25 -39.54 89.57 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.846 -0.161 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.679 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.8 mp -71.86 -39.59 69.58 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.68 0.276 . . . . 0.0 110.846 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.75 -39.4 76.75 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.394 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.2 tp -70.22 -33.71 72.0 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.49 -43.29 73.44 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.12 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 14' ' ' LEU . 58.2 t -69.43 -43.58 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.129 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 15' ' ' LEU . 89.3 t -66.7 -43.27 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.114 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.38 -39.27 85.61 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.158 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.1 tp -69.37 -35.2 75.6 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.598 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.02 -52.4 28.41 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.305 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.597 ' O ' HG12 ' A' ' 27' ' ' ILE . 12.1 mt -65.58 -37.18 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.648 0.261 . . . . 0.0 110.566 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -64.48 -46.16 91.14 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.382 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.9 mt -74.21 -24.98 59.41 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.497 0.189 . . . . 0.0 111.208 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.1 t80 -75.82 -39.26 57.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.278 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 23' ' ' ILE . 41.6 mm -83.66 -30.51 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.116 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.569 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.6 ttt180 -64.91 -26.1 68.17 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.693 0.283 . . . . 0.0 111.337 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.9 -18.19 44.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.414 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.54 -21.5 35.35 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.597 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -68.48 -21.56 64.61 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.687 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mt -83.25 -10.96 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 t -96.03 -22.05 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ARG . . . . . 0.544 ' NH2' ' HB3' ' A' ' 38' ' ' LEU . 45.1 mtp180 -92.15 145.17 24.72 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.062 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -108.73 26.4 10.6 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.943 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 58.62 30.79 20.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.713 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.432 ' O ' HD12 ' A' ' 41' ' ' LEU . 18.4 p -83.25 -13.87 54.38 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.622 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.968 ' O ' ' N ' ' A' ' 42' ' ' LEU . 13.4 tp -89.02 -40.41 13.0 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.265 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.405 ' HA ' ' CB ' ' A' ' 42' ' ' LEU . 74.6 mtp180 -66.45 -31.66 72.54 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.674 0.79 . . . . 0.0 108.959 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.631 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 26.0 mmt180 -69.48 -19.42 63.75 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 37' ' ' THR . 27.6 mt -111.53 -25.67 9.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.008 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.968 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.3 tt -70.93 -43.91 67.22 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-O 120.623 0.249 . . . . 0.0 110.996 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -87.52 -13.62 42.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.475 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.631 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 9.1 tt0 -84.16 -39.69 19.1 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.669 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.406 ' HG3' ' CD1' ' B' ' 101' ' ' LEU . 21.3 mmt180 -88.19 -12.24 44.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.843 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -100.09 12.87 35.89 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.782 0.325 . . . . 0.0 111.094 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.7 tp 58.87 34.37 23.62 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.416 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t 54.12 52.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.347 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -101.1 141.08 21.91 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.89 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.68 135.19 27.69 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.671 2.247 . . . . 0.0 112.787 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 tt -142.84 87.28 1.98 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.14 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.9 t -139.41 139.78 23.69 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.07 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.86 0.63 8.03 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.564 2.176 . . . . 0.0 113.133 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.8 m -87.15 3.85 44.69 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.242 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.26 -108.8 3.5 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.539 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -126.73 141.95 51.69 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.733 0.302 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -85.23 -41.37 15.66 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.394 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.02 -8.76 50.79 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.475 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -130.45 141.27 50.53 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.829 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 53.4 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.886 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.683 0.278 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.97 146.85 56.6 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.095 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.1 140.61 45.6 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.628 2.219 . . . . 0.0 112.743 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.1 t -80.6 -7.7 59.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.472 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.465 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.5 mp -83.01 -32.6 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.051 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.444 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.85 -26.22 29.65 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.688 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -63.95 -33.13 75.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.551 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.15 9.82 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.333 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.518 ' O ' HD13 ' B' ' 73' ' ' LEU . 21.9 mt -62.24 -43.14 99.5 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.648 -0.276 . . . . 0.0 111.393 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.674 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.2 m -60.97 -40.13 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.699 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.22 -48.48 52.42 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.9 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.95 -42.5 60.43 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.518 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -66.2 -39.65 89.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.867 -0.151 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.674 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -71.85 -39.42 69.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.591 0.234 . . . . 0.0 110.861 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.95 -39.38 76.1 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.385 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 76' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.2 tp -70.09 -33.84 72.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.593 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 77' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.37 -43.36 73.71 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.074 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 74' ' ' LEU . 58.2 t -69.41 -43.48 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.165 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.486 HG23 ' O ' ' B' ' 75' ' ' LEU . 88.8 t -66.71 -43.38 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.029 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.25 85.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.151 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 81' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.1 tp -69.21 -35.28 76.05 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.669 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.98 -52.43 28.44 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.241 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.592 ' O ' HG12 ' B' ' 87' ' ' ILE . 12.0 mt -65.6 -37.21 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.667 0.27 . . . . 0.0 110.564 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 84' ' ' GLY . . . . . 0.568 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -64.41 -46.18 91.22 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.485 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 18.0 mt -74.18 -24.86 59.43 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.547 0.213 . . . . 0.0 111.252 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.2 t80 -76.02 -39.25 56.1 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.592 HG12 ' O ' ' B' ' 83' ' ' ILE . 41.5 mm -83.56 -30.53 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.186 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 88' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.7 ttt180 -64.97 -26.07 68.14 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.254 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.99 -18.22 44.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.272 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.52 -21.53 35.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.54 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -68.5 -21.55 64.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.741 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt -83.16 -11.03 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.097 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.97 -22.06 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.944 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 94' ' ' ARG . . . . . 0.549 ' NH2' ' HB3' ' B' ' 98' ' ' LEU . 45.5 mtp180 -92.15 145.12 24.76 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.053 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -108.8 26.68 10.28 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.971 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 58.61 30.67 20.17 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.681 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.432 ' O ' HD12 ' B' ' 101' ' ' LEU . 18.5 p -83.25 -13.87 54.38 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.659 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.944 ' O ' ' N ' ' B' ' 102' ' ' LEU . 13.3 tp -88.96 -40.41 13.06 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.317 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 99' ' ' ARG . . . . . 0.407 ' HA ' ' CB ' ' B' ' 102' ' ' LEU . 74.8 mtp180 -66.5 -31.59 72.41 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.646 0.778 . . . . 0.0 109.015 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.63 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 26.1 mmt180 -69.42 -19.46 63.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.432 HD12 ' O ' ' B' ' 97' ' ' THR . 27.8 mt -111.47 -25.68 9.48 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.048 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.944 ' N ' ' O ' ' B' ' 98' ' ' LEU . 1.3 tt -70.94 -43.85 67.32 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-O 120.666 0.269 . . . . 0.0 110.984 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -87.46 -13.71 42.46 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.508 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 9.1 tt0 -84.05 -39.84 19.1 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.628 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.411 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 21.3 mmt180 -88.14 -12.18 44.78 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.765 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -100.17 12.81 36.13 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.816 0.341 . . . . 0.0 111.038 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 tp 59.01 34.26 23.47 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.392 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 t 54.13 52.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.301 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -101.02 141.13 22.02 Favored Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.905 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.8 135.23 27.51 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.592 2.195 . . . . 0.0 112.778 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 tt -142.92 87.33 1.98 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.224 0.535 . . . . 0.0 110.07 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.9 t -139.53 139.69 23.14 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.016 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.62 0.55 8.0 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.653 2.236 . . . . 0.0 113.269 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 53.0 m -87.25 3.9 44.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.173 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.18 -108.74 3.49 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.481 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -126.73 141.98 51.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.693 0.282 . . . . 0.0 110.841 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.35 -41.33 15.59 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.3 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.06 -8.62 51.02 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.504 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -130.51 141.3 50.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.735 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 53.1 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.951 179.94 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.669 0.271 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.13 146.48 54.65 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.166 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.05 141.43 48.09 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.636 2.224 . . . . 0.0 112.666 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.8 m -80.72 -7.43 59.35 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.513 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.6 mp -82.96 -32.73 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.134 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ALA . . . . . 0.444 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.99 -26.23 29.36 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.62 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.04 -33.08 74.94 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.539 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.79 -41.13 9.95 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.382 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.524 ' O ' HD13 ' A' ' 13' ' ' LEU . 21.9 mt -62.3 -43.55 98.56 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.7 -0.25 . . . . 0.0 111.37 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.662 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 23.5 m -60.71 -40.48 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 111.761 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.0 -48.88 51.45 Favored Glycine 0 C--O 1.235 0.201 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.808 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ALA . . . . . 0.452 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.57 -42.82 61.11 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.25 -41.16 94.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.442 0.163 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.9 mp -70.54 -40.01 73.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.626 0.251 . . . . 0.0 110.953 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -69.46 -36.84 76.97 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.603 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 tp -69.93 -36.8 75.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.573 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.7 mt -68.48 -44.22 75.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.274 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 14' ' ' LEU . 61.9 t -67.35 -44.88 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.229 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 15' ' ' LEU . 83.8 t -67.03 -39.11 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.2 83.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.054 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.6 mt -69.36 -34.33 74.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.657 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.35 -54.3 20.78 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.277 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.538 ' O ' HG12 ' A' ' 27' ' ' ILE . 15.1 mt -66.3 -35.72 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.592 0.234 . . . . 0.0 110.634 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.06 -45.98 90.24 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.473 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.56 -24.69 56.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.53 0.205 . . . . 0.0 111.299 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.9 t80 -77.78 -36.87 50.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.333 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 23' ' ' ILE . 52.1 mm -83.69 -36.62 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.309 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -67.65 -29.2 68.45 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.619 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -82.1 -18.24 43.69 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.469 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -85.32 -21.77 28.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.529 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -81.97 -15.93 52.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.489 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.8 mm -83.32 -11.76 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.965 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.71 -18.74 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.02 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -92.65 151.72 19.95 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.161 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -99.04 173.63 6.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.614 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.85 28.5 0.68 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.461 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.435 HG21 ' CZ ' ' B' ' 105' ' ' ARG . 9.1 t -83.23 -15.32 50.81 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.673 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LEU . . . . . 0.956 ' O ' ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -89.31 -38.83 13.89 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.415 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -66.98 -29.4 69.24 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.025 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 98.8 mtt180 -70.06 -18.41 63.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' LEU . . . . . 0.973 HD22 HD22 ' B' ' 101' ' ' LEU . 38.7 mt -112.09 -26.69 8.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.115 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.956 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.2 tt -90.12 -53.09 4.63 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.89 -24.25 55.64 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.492 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 28.8 mt-10 -83.92 -19.84 34.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.748 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 41' ' ' LEU . 2.4 tmt_? -88.06 -31.71 19.13 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.959 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -92.32 0.73 57.47 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.5 mp 56.81 35.36 26.17 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.637 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 t 54.49 51.59 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.232 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -111.0 143.21 27.85 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.951 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.68 163.89 37.39 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.623 2.215 . . . . 0.0 112.66 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.78 87.39 1.99 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.244 0.545 . . . . 0.0 110.221 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 p -139.27 146.77 50.28 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.067 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.92 118.53 5.73 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.763 2.309 . . . . 0.0 112.789 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.6 p -109.41 -10.44 14.9 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.957 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.61 101.23 2.27 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.477 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 63.37 127.66 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.008 0.523 . . . . 0.0 111.608 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -85.13 -38.23 19.29 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.407 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.6 mp -90.13 -9.03 49.83 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.445 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -131.66 145.49 51.69 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.754 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.2 m . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.915 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.718 0.294 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.04 146.5 54.96 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.224 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.06 141.41 48.02 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.623 2.215 . . . . 0.0 112.771 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.6 m -80.6 -7.55 59.3 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.493 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 65' ' ' ILE . . . . . 0.474 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.6 mp -82.88 -32.9 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.094 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 66' ' ' ALA . . . . . 0.45 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.98 -26.14 29.44 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.544 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.03 -33.16 75.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.47 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.88 -41.05 9.92 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.329 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 69' ' ' LEU . . . . . 0.533 ' O ' HD13 ' B' ' 73' ' ' LEU . 22.1 mt -62.42 -43.6 98.43 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 115.691 -0.254 . . . . 0.0 111.324 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 70' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.4 m -60.45 -40.64 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.873 0.368 . . . . 0.0 111.825 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 71' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.97 -48.91 51.43 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.819 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 72' ' ' ALA . . . . . 0.46 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.62 -42.74 61.09 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 73' ' ' LEU . . . . . 0.533 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.27 -41.24 94.43 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.882 -0.144 . . . . 0.0 110.862 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 74' ' ' LEU . . . . . 0.658 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -70.61 -39.94 73.48 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.895 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 75' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.52 -36.85 76.82 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.485 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tp -69.96 -36.61 75.39 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.64 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.67 -44.01 74.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.274 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 78' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 74' ' ' LEU . 61.6 t -67.48 -44.98 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.134 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 79' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 75' ' ' LEU . 84.7 t -66.78 -39.23 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.096 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.19 83.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.042 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 20.7 mt -69.36 -34.39 74.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.636 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 82' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.27 -54.19 21.68 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.398 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 83' ' ' ILE . . . . . 0.533 ' O ' HG12 ' B' ' 87' ' ' ILE . 14.9 mt -66.4 -35.73 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.553 0.216 . . . . 0.0 110.599 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.06 -46.12 89.8 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.435 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.34 -24.77 57.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.569 0.223 . . . . 0.0 111.351 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 86' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.9 t80 -77.88 -36.82 49.28 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.282 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 87' ' ' ILE . . . . . 0.533 HG12 ' O ' ' B' ' 83' ' ' ILE . 52.2 mm -83.63 -36.61 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.344 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -67.7 -29.17 68.36 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.571 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -82.21 -18.18 43.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.416 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -85.3 -21.83 28.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.521 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -81.96 -16.07 51.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.483 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 6.7 mm -83.18 -11.7 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.046 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.75 -18.66 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.102 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -92.77 151.71 19.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.048 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -98.92 173.68 6.73 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.687 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.9 28.51 0.69 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.391 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 97' ' ' THR . . . . . 0.432 HG21 ' CZ ' ' A' ' 45' ' ' ARG . 8.9 t -83.32 -15.32 50.5 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.623 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 98' ' ' LEU . . . . . 0.931 ' O ' ' N ' ' B' ' 102' ' ' LEU . 0.2 OUTLIER -89.28 -38.75 13.97 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.427 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.08 -29.35 69.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 100' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 98.8 mtt180 -70.17 -18.31 63.2 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 101' ' ' LEU . . . . . 0.973 HD22 HD22 ' A' ' 41' ' ' LEU . 38.3 mt -112.12 -26.65 8.73 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.074 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 102' ' ' LEU . . . . . 0.931 ' N ' ' O ' ' B' ' 98' ' ' LEU . 1.2 tt -90.17 -53.11 4.61 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.73 -24.51 56.16 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.528 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 104' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 29.0 mt-10 -83.72 -19.9 34.39 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.806 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' B' ' 101' ' ' LEU . 2.4 tmt_? -88.09 -31.61 19.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.003 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -92.31 0.72 57.47 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 5.5 mp 56.84 35.34 26.16 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.679 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t 54.56 51.55 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.205 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -111.07 143.18 27.81 Favored Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.71 163.87 37.5 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.591 2.194 . . . . 0.0 112.67 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.69 87.19 1.98 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.131 0.491 . . . . 0.0 110.259 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 17.6 p -139.22 146.81 50.61 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.048 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.02 118.52 5.73 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.639 2.226 . . . . 0.0 112.786 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 39.8 p -109.34 -10.48 14.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.025 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.59 101.18 2.26 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.473 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 63.51 127.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.965 0.506 . . . . 0.0 111.588 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -85.14 -38.22 19.29 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.346 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.02 -9.19 49.52 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.427 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -131.57 145.58 51.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.805 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 52.5 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.923 179.969 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.531 0.23 0 CA-C-O 120.362 0.125 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.27 139.02 40.84 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.626 2.217 . . . . 0.0 112.729 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.8 m -80.58 -7.14 59.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.503 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.4 mp -82.94 -32.6 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.131 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.91 -28.33 27.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.587 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.15 -31.9 73.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.545 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.96 -41.94 9.21 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.229 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 13' ' ' LEU . 23.9 mt -61.98 -43.21 99.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.749 -0.225 . . . . 0.0 111.194 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.697 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 25.2 m -61.0 -39.05 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.832 0.349 . . . . 0.0 111.656 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.21 -48.4 52.99 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.742 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -74.28 -43.16 58.02 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.33 -40.0 93.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.455 0.169 . . . . 0.0 110.954 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.697 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.1 mp -72.41 -39.77 67.66 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.082 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.2 OUTLIER -70.16 -39.25 75.43 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.567 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -70.08 -34.7 73.49 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.591 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.44 -42.29 75.14 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 14' ' ' LEU . 99.3 t -69.1 -42.85 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.128 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 15' ' ' LEU . 94.8 t -68.89 -39.69 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.024 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.59 -36.46 73.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.352 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 1.7 tp -70.27 -44.97 67.34 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.71 -56.22 8.66 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.529 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.1 mm -64.25 -37.64 80.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.745 0.307 . . . . 0.0 110.621 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.16 -46.58 87.45 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.329 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.7 mt -73.05 -24.0 60.65 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.677 0.275 . . . . 0.0 110.986 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.51 -39.91 64.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.194 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.402 ' O ' ' HD2' ' A' ' 31' ' ' HIS . 18.9 mt -83.34 -33.68 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.248 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.76 -26.0 66.76 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.645 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -81.88 -18.16 44.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.401 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.51 -21.61 38.52 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.617 -179.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.402 ' HD2' ' O ' ' A' ' 27' ' ' ILE . 58.0 m-70 -70.74 -28.63 64.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.692 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt . . . . . 0 N--CA 1.466 0.347 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.106 179.938 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.013 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 6.1 tp . . . . . 0 N--CA 1.462 0.137 0 CA-C-O 121.058 0.456 . . . . 0.0 110.312 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -97.87 -33.87 11.07 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 114.706 -1.133 . . . . 0.0 107.966 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -75.68 -21.84 57.24 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.157 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 22.7 mt -104.84 -19.72 13.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.405 177.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.013 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 4.1 tt . . . . . 0 N--CA 1.469 0.522 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.676 179.405 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.263 0 N-CA-C 111.184 0.068 . . . . 0.0 111.184 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.14 138.95 41.1 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.726 2.284 . . . . 0.0 112.719 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 52.8 m -80.52 -7.24 59.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.49 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.468 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.4 mp -82.9 -32.76 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.072 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.444 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -28.22 28.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.605 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.13 -31.97 73.37 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.538 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.99 -41.86 9.25 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.228 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.531 ' O ' HD13 ' B' ' 73' ' ' LEU . 23.8 mt -62.02 -43.2 99.34 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.625 0.25 . . . . 0.0 111.215 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.69 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 25.5 m -61.02 -39.09 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 111.619 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.18 -48.47 52.66 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.714 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' B' ' 76' ' ' LEU . . . -74.2 -43.17 58.27 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.531 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.31 -40.0 93.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.029 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.69 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.1 mp -72.3 -39.85 67.97 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.095 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.2 OUTLIER -70.21 -39.22 75.28 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.553 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 0.7 OUTLIER -70.04 -34.65 73.51 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.67 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.45 -42.43 74.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.976 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.601 HG23 ' O ' ' B' ' 74' ' ' LEU . 99.9 t -68.99 -42.88 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.128 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.5 HG23 ' O ' ' B' ' 75' ' ' LEU . 95.5 t -68.91 -39.73 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.031 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.46 -36.53 73.97 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.371 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 1.7 tp -70.37 -44.89 67.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.035 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.76 -56.22 8.6 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.489 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 47.2 mm -64.22 -37.71 80.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.683 0.277 . . . . 0.0 110.554 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.05 -46.64 88.17 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.406 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 25.8 mt -73.1 -23.94 60.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.577 0.227 . . . . 0.0 110.962 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -39.83 64.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.25 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 18.8 mt -83.34 -33.76 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.2 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.76 -25.97 66.75 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.682 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -81.96 -18.03 44.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.416 179.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.55 -21.58 38.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.575 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -70.77 -28.6 64.8 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.683 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mt . . . . . 0 N--CA 1.465 0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.065 179.949 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 1.028 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 6.1 tp . . . . . 0 N--CA 1.462 0.148 0 CA-C-O 121.105 0.479 . . . . 0.0 110.342 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -97.81 -33.88 11.09 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.025 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 70.1 mtp180 -75.61 -21.83 57.41 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.224 177.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 22.8 mt -104.78 -19.72 13.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.42 177.725 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 1.028 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 4.2 tt . . . . . 0 N--CA 1.47 0.564 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 179.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 CA--C 1.532 0.27 0 CA-C-O 120.331 0.11 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.38 143.72 59.07 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.629 2.219 . . . . 0.0 112.803 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 t -80.58 -8.35 59.57 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.465 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.7 mp -83.01 -32.0 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.089 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.93 -26.62 29.17 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.585 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.0 -32.87 74.56 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.524 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.94 -41.36 9.64 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.245 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 13' ' ' LEU . 22.3 mt -62.14 -42.99 99.79 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.736 -0.232 . . . . 0.0 111.36 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.683 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 23.9 m -60.93 -39.47 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.777 0.322 . . . . 0.0 111.688 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.68 -48.98 46.31 Favored Glycine 0 C--O 1.236 0.222 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.703 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.46 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.75 -41.3 62.68 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -67.09 -39.69 86.81 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.683 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.6 mp -71.25 -39.38 71.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.625 0.25 . . . . 0.0 110.771 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.33 -40.48 77.57 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.303 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 tp -69.64 -32.25 70.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 3.5 tp -69.96 -42.55 73.04 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.91 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 14' ' ' LEU . 59.1 t -69.18 -43.42 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.015 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 15' ' ' LEU . 91.0 t -66.46 -43.46 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.852 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.79 83.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.101 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 3.2 tp -69.44 -36.35 76.54 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.522 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.41 ' O ' ' HD1' ' A' ' 26' ' ' PHE . . . -67.42 -53.38 25.35 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.222 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.578 ' O ' HG12 ' A' ' 27' ' ' ILE . 11.0 mt -64.47 -37.34 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.649 0.261 . . . . 0.0 110.536 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.66 -44.32 95.13 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.414 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 mt -73.45 -27.01 61.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.445 0.164 . . . . 0.0 111.141 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.41 ' HD1' ' O ' ' A' ' 22' ' ' GLY . 2.8 m-85 -76.43 -36.59 57.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.432 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 23' ' ' ILE . 47.5 mm -83.52 -32.84 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.237 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -67.73 -25.77 65.82 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.554 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.79 -33.79 30.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.164 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -86.32 -21.33 27.34 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.411 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 27' ' ' ILE . 3.2 t60 -70.03 -15.94 63.08 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.806 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt . . . . . 0 CA--C 1.533 0.298 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.133 179.91 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.95 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.3 mm? . . . . . 0 C--O 1.221 -0.405 0 CA-C-O 120.531 0.205 . . . . 0.0 110.489 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -63.28 -28.57 70.11 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.313 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 30.7 mtt180 -67.52 -21.84 65.46 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.537 HD22 HD22 ' B' ' 101' ' ' LEU . 5.4 mt -111.78 -26.31 9.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 113.537 -1.665 . . . . 0.0 109.941 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.95 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.353 0.721 0 CA-C-O 120.577 0.227 . . . . 0.0 111.448 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 C--O 1.234 0.245 0 CA-C-O 120.248 0.07 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.49 143.71 58.38 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.606 2.204 . . . . 0.0 112.797 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.1 t -80.53 -8.39 59.56 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.517 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.466 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.7 mp -82.9 -32.1 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.128 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.437 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.95 -26.5 29.22 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.659 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.03 -32.77 74.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.542 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.08 -41.24 9.6 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.243 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.2 mt -62.17 -43.08 99.64 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 122.331 0.253 . . . . 0.0 111.365 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.673 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 23.4 m -61.0 -39.31 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.878 0.371 . . . . 0.0 111.782 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.78 -48.79 46.91 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.809 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.459 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.86 -41.22 62.52 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -67.19 -39.54 86.4 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.434 0.159 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.673 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.5 mp -71.35 -39.37 71.35 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.641 0.258 . . . . 0.0 110.712 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.535 ' O ' HG23 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.33 -40.48 77.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.266 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 2.4 tp -69.74 -32.29 70.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.42 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' B' ' 73' ' ' LEU . 3.5 tp -69.88 -42.6 73.24 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.016 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.616 HG23 ' O ' ' B' ' 74' ' ' LEU . 59.1 t -69.13 -43.44 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.983 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.535 HG23 ' O ' ' B' ' 75' ' ' LEU . 91.0 t -66.44 -43.42 91.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.899 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.86 83.62 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.08 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 3.1 tp -69.31 -36.41 76.96 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.53 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.414 ' O ' ' HD1' ' B' ' 86' ' ' PHE . . . -67.51 -53.23 25.81 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.196 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.59 ' O ' HG12 ' B' ' 87' ' ' ILE . 11.0 mt -64.59 -37.33 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.704 0.287 . . . . 0.0 110.495 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.3 95.04 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.396 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 19.0 mt -73.43 -27.05 61.22 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.557 0.218 . . . . 0.0 111.287 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.414 ' HD1' ' O ' ' B' ' 82' ' ' GLY . 2.7 m-85 -76.51 -36.42 57.77 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.458 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.59 HG12 ' O ' ' B' ' 83' ' ' ILE . 47.6 mm -83.58 -32.77 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.212 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -67.77 -25.82 65.8 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.459 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.81 -33.74 30.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.201 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -86.21 -21.43 27.46 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.501 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 91' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' B' ' 87' ' ' ILE . 3.2 t60 -69.98 -15.89 63.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.726 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mt . . . . . 0 N--CA 1.465 0.318 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.044 179.957 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.947 ' O ' ' N ' ' B' ' 102' ' ' LEU . 1.3 mm? . . . . . 0 C--O 1.222 -0.37 0 CA-C-O 120.607 0.241 . . . . 0.0 110.588 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -63.29 -28.74 70.22 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.577 0.751 . . . . 0.0 109.272 178.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 31.1 mtt180 -67.42 -21.85 65.55 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.653 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.537 HD22 HD22 ' A' ' 41' ' ' LEU . 5.4 mt -111.8 -26.2 9.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.979 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.947 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.352 0.691 0 CA-C-O 120.61 0.243 . . . . 0.0 111.464 -179.262 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.534 0.359 0 N-CA-C 111.178 0.066 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.57 147.06 81.43 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.556 2.171 . . . . 0.0 112.6 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.1 m -80.66 -21.74 41.12 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.494 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.475 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.3 mp -83.0 -22.12 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.481 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.92 -33.89 24.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.601 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -27.81 69.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.465 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.87 -44.67 7.59 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.238 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.508 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 18.6 mt -62.36 -42.47 99.43 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.586 0.231 . . . . 0.0 111.227 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.71 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 22.4 m -61.37 -41.85 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.761 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -67.1 -48.23 60.74 Favored Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.974 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.443 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -74.11 -44.14 55.01 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.73 -38.84 90.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.432 0.158 . . . . 0.0 111.092 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.1 mp -72.76 -39.44 66.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.586 0.232 . . . . 0.0 110.958 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -70.29 -38.22 74.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.363 179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.9 tp -71.02 -35.19 71.91 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.688 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tt -68.99 -44.38 72.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.257 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 14' ' ' LEU . 58.6 t -69.45 -44.48 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.365 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 15' ' ' LEU . 74.4 t -66.77 -42.33 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.171 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.37 83.63 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.977 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.68 -35.64 77.47 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.614 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.97 -52.69 26.95 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.36 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.545 ' O ' HG12 ' A' ' 27' ' ' ILE . 13.7 mt -65.96 -35.23 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.558 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -65.75 -45.78 86.91 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.117 -0.564 . . . . 0.0 112.402 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.0 mt -75.24 -24.82 57.72 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.55 0.214 . . . . 0.0 111.309 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.8 t80 -77.56 -37.86 49.79 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.253 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 23' ' ' ILE . 50.6 mm -83.65 -33.44 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.194 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 15.0 ttm180 -66.22 -26.96 67.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.654 0.264 . . . . 0.0 111.312 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -82.23 -18.21 43.34 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.347 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -83.9 -21.77 31.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.521 -179.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.09 -20.43 34.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.473 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 28' ' ' ARG . 11.0 mm . . . . . 0 N--CA 1.464 0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.995 179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.061 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 3.3 mm? . . . . . 0 C--O 1.226 -0.181 0 CA-C-O 120.948 0.404 . . . . 0.0 110.614 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -98.03 -35.44 10.44 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.367 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -73.85 -19.07 60.84 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.441 178.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 41' ' ' LEU . 3.0 mm? -108.57 -20.7 13.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.508 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.061 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 3.9 tt . . . . . 0 N--CA 1.469 0.503 0 CA-C-O 120.824 0.345 . . . . 0.0 110.754 179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.534 0.341 0 N-CA-C 111.128 0.047 . . . . 0.0 111.128 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.79 147.05 80.4 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.628 2.219 . . . . 0.0 112.487 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -80.47 -21.94 41.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.505 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.478 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.3 mp -82.81 -22.14 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.247 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.478 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.91 -33.95 24.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.56 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.61 -27.84 69.51 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.539 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.82 -44.7 7.6 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.266 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 18.4 mt -62.19 -42.71 99.54 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-O 120.627 0.251 . . . . 0.0 111.25 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 22.5 m -61.31 -41.79 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.766 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.08 -48.33 60.34 Favored Glycine 0 CA--C 1.517 0.177 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.008 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.436 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -74.12 -44.17 54.84 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.71 -38.71 89.96 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.403 0.144 . . . . 0.0 111.126 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.1 mp -72.79 -39.56 66.6 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.92 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -70.17 -38.27 75.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.442 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.9 tp -71.02 -35.18 71.93 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.697 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 2.1 tt -68.88 -44.44 73.26 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.296 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 74' ' ' LEU . 58.4 t -69.47 -44.46 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.312 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.436 HG23 ' O ' ' B' ' 75' ' ' LEU . 75.0 t -66.81 -42.39 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.154 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.27 83.76 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.098 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.2 tp -68.74 -35.58 77.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.94 -52.7 27.01 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.404 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.54 ' O ' HG12 ' B' ' 87' ' ' ILE . 13.7 mt -65.94 -35.38 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.616 0.246 . . . . 0.0 110.514 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -65.58 -45.9 87.29 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.451 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 16.0 mt -75.1 -24.87 58.15 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.558 0.218 . . . . 0.0 111.281 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.8 t80 -77.58 -37.89 49.5 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.225 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.54 HG12 ' O ' ' B' ' 83' ' ' ILE . 50.7 mm -83.55 -33.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.202 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 15.1 ttm180 -66.05 -27.08 67.83 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.657 0.265 . . . . 0.0 111.327 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -82.16 -18.25 43.45 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.412 179.815 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -83.72 -21.84 32.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.621 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.09 -20.47 34.84 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.426 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . 0.437 HG12 ' O ' ' B' ' 88' ' ' ARG . 11.1 mm . . . . . 0 N--CA 1.464 0.258 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.983 179.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 1.073 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 3.3 mm? . . . . . 0 N--CA 1.463 0.176 0 CA-C-O 121.1 0.476 . . . . 0.0 110.58 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -98.15 -35.41 10.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.38 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 -73.85 -19.05 60.84 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.48 178.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.431 HD13 ' HA ' ' B' ' 101' ' ' LEU . 3.0 mm? -108.52 -20.81 12.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.536 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 1.073 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 3.8 tt . . . . . 0 N--CA 1.472 0.625 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.772 179.488 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.531 0.239 0 N-CA-C 111.205 0.076 . . . . 0.0 111.205 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.99 141.77 49.34 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.711 2.274 . . . . 0.0 112.765 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 m -80.57 -7.67 59.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.534 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.7 mp -82.93 -32.38 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.075 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.436 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -84.01 -27.64 28.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.552 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.42 -31.98 73.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.456 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.04 -41.69 9.32 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.217 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.546 ' O ' HD13 ' A' ' 13' ' ' LEU . 23.2 mt -62.01 -43.65 98.39 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 122.309 0.244 . . . . 0.0 111.187 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.686 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 25.2 m -60.48 -38.18 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 111.663 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -69.0 -49.32 42.03 Favored Glycine 0 CA--C 1.518 0.24 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.756 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.449 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.58 -41.48 62.84 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.9 mp -66.21 -41.79 89.65 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.79 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.8 mp -70.5 -38.83 74.38 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.916 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -69.7 -37.16 76.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.442 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tp -69.81 -36.93 76.06 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.6 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.58 -40.85 76.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.288 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 14' ' ' LEU . 93.1 t -69.57 -42.37 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.2 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 15' ' ' LEU . 97.7 t -70.62 -38.38 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.176 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.67 -39.17 73.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.295 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.7 tp -70.86 -43.4 68.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.945 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.82 -57.84 7.5 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.5 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.564 ' O ' HG12 ' A' ' 27' ' ' ILE . 41.4 mm -65.86 -33.64 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.643 0.259 . . . . 0.0 110.589 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -65.6 -47.65 75.32 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.322 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt -74.8 -24.1 58.59 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.55 0.214 . . . . 0.0 111.147 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.2 t80 -75.43 -39.69 58.56 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.242 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 23' ' ' ILE . 45.5 mm -83.59 -32.33 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.192 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.558 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.2 ttt180 -65.4 -26.1 67.84 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.351 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -81.74 -18.04 45.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.406 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -81.53 -21.48 38.52 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.616 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.416 ' HD2' ' O ' ' A' ' 27' ' ' ILE . 54.8 m-70 -70.57 -27.86 64.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.642 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 mt . . . . . 0 N--CA 1.466 0.342 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.136 179.888 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.008 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 23.3 mt . . . . . 0 N--CA 1.462 0.167 0 CA-C-O 121.239 0.542 . . . . 0.0 110.138 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.85 -33.29 11.3 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -77.24 -24.24 51.2 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.013 177.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 14.5 mt -100.37 -20.29 15.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.238 177.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.008 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 2.6 tp . . . . . 0 N--CA 1.469 0.511 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.585 179.344 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.253 0 N-CA-C 111.221 0.082 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.14 141.9 49.09 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.635 2.223 . . . . 0.0 112.698 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.6 m -80.67 -7.66 59.38 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.497 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.471 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.6 mp -82.81 -32.38 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.116 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.435 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.96 -27.7 28.31 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.552 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.44 -31.99 73.44 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.521 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.01 -41.67 9.36 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.207 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.549 ' O ' HD13 ' B' ' 73' ' ' LEU . 23.1 mt -61.95 -43.59 98.53 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.598 0.237 . . . . 0.0 111.32 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.672 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 25.4 m -60.44 -38.23 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 111.605 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -69.13 -49.29 41.28 Favored Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.671 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.455 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.51 -41.5 62.99 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.549 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.9 mp -66.2 -41.76 89.72 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.806 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.672 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -70.62 -38.7 73.97 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.875 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.0 OUTLIER -69.62 -37.3 76.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.481 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tp -69.73 -36.89 76.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.61 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 18.1 mt -69.62 -40.74 76.39 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.32 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 74' ' ' LEU . 93.1 t -69.63 -42.46 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.188 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.485 HG23 ' O ' ' B' ' 75' ' ' LEU . 98.1 t -70.51 -38.45 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.089 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.68 -39.24 73.66 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.22 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 1.7 tp -70.9 -43.31 68.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.937 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.84 -57.87 7.44 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.49 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.556 ' O ' HG12 ' B' ' 87' ' ' ILE . 41.2 mm -65.78 -33.64 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.581 0.229 . . . . 0.0 110.625 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -65.64 -47.61 75.4 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.361 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 20.7 mt -74.84 -24.03 58.54 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.563 0.22 . . . . 0.0 111.179 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.3 t80 -75.51 -39.73 58.04 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.159 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.556 HG12 ' O ' ' B' ' 83' ' ' ILE . 45.6 mm -83.59 -32.38 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.135 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.1 ttt180 -65.36 -26.01 67.83 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.438 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -81.72 -18.01 45.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.46 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -81.61 -21.38 38.35 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.59 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 91' ' ' HIS . . . . . 0.414 ' HD2' ' O ' ' B' ' 87' ' ' ILE . 54.9 m-70 -70.65 -27.8 64.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.644 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 1.8 mt . . . . . 0 N--CA 1.465 0.324 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.102 179.899 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 1.01 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 23.8 mt . . . . . 0 N--CA 1.464 0.254 0 CA-C-O 121.204 0.526 . . . . 0.0 110.121 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.83 -33.17 11.35 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 75.5 mtp180 -77.45 -24.17 50.33 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 114.281 -1.327 . . . . 0.0 107.896 177.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 14.6 mt -100.39 -20.35 15.85 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.29 177.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 1.01 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 2.6 tp . . . . . 0 N--CA 1.468 0.471 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.686 179.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.234 0.255 0 N-CA-C 111.234 0.087 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.9 141.21 48.12 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.78 2.32 . . . . 0.0 112.696 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 t -80.69 -7.6 59.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.44 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.6 mp -82.99 -32.66 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.09 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.455 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.95 -25.86 29.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.656 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -63.78 -33.49 75.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.59 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.0 -40.91 9.95 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.289 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.514 ' O ' HD13 ' A' ' 13' ' ' LEU . 22.0 mt -62.24 -43.38 98.96 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 122.283 0.233 . . . . 0.0 111.393 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.1 m -60.91 -41.09 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 111.779 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -67.51 -48.34 57.64 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.877 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.447 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.99 -43.5 57.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.4 -39.47 92.25 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 122.911 0.132 . . . . 0.0 110.971 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.68 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.0 mp -72.22 -39.83 68.23 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.605 0.241 . . . . 0.0 110.924 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -70.2 -38.43 75.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.583 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.3 tp -70.69 -34.52 72.05 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.657 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.34 -44.14 72.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.162 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 14' ' ' LEU . 59.8 t -69.25 -44.04 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.226 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 15' ' ' LEU . 71.8 t -66.55 -43.27 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.151 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.26 86.49 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.124 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.36 -36.32 79.04 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.635 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.93 -50.14 43.14 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.299 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 mt -64.39 -41.22 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.669 0.271 . . . . 0.0 110.603 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.42 -44.65 96.45 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.404 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.501 ' HG ' ' NH2' ' A' ' 28' ' ' ARG . 20.1 mt -73.95 -23.83 59.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.595 0.236 . . . . 0.0 110.931 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 6.6 t80 -74.43 -39.13 62.79 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.35 -35.0 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.255 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.501 ' NH2' ' HG ' ' A' ' 25' ' ' LEU . 74.0 mtm180 -64.14 -26.29 68.47 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.656 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -82.14 -18.13 43.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.358 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.46 ' NH2' ' HE2' ' A' ' 26' ' ' PHE . 97.6 mtt180 -86.12 -21.58 27.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.622 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -70.39 -29.32 65.93 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.713 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt . . . . . 0 N--CA 1.466 0.327 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.097 179.923 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 1.044 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.462 0.147 0 CA-C-O 121.132 0.491 . . . . 0.0 110.475 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -97.66 -34.46 10.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -74.73 -20.24 59.91 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.097 177.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 6.8 mt -104.82 -22.47 13.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.315 177.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 1.044 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 2.9 tt . . . . . 0 N--CA 1.469 0.482 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.555 179.4 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.259 0 CA-C-O 120.312 0.101 . . . . 0.0 111.19 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.04 141.3 47.74 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.6 2.2 . . . . 0.0 112.708 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.4 t -80.61 -7.7 59.36 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.413 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.468 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.6 mp -82.88 -32.65 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.133 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.451 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.99 -25.9 29.62 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.639 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -63.76 -33.62 76.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.465 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.86 -40.96 10.02 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.289 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.515 ' O ' HD13 ' B' ' 73' ' ' LEU . 21.9 mt -62.26 -43.37 98.98 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.346 0.258 . . . . 0.0 111.381 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 23.7 m -60.99 -40.96 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.765 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.58 -48.43 56.7 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.806 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.453 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.86 -43.63 58.03 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.515 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.27 -39.42 92.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.45 0.167 . . . . 0.0 111.056 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.0 mp -72.39 -39.68 67.8 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.646 0.26 . . . . 0.0 110.947 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -70.13 -38.52 75.57 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.584 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.3 tp -70.76 -34.53 71.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.566 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.21 -44.23 72.5 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.168 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 74' ' ' LEU . 59.9 t -69.31 -43.88 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.286 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 75' ' ' LEU . 71.7 t -66.51 -43.5 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.029 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.15 86.52 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.159 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.3 tp -68.39 -36.33 78.99 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.683 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.88 -50.1 43.73 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.427 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 19.1 mt -64.44 -41.23 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.652 0.263 . . . . 0.0 110.562 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.55 -44.63 96.29 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.317 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.497 ' HG ' ' NH2' ' B' ' 88' ' ' ARG . 20.0 mt -73.86 -23.85 59.67 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.704 0.288 . . . . 0.0 111.015 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 6.5 t80 -74.37 -39.22 62.88 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.127 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.29 -35.08 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.258 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.497 ' NH2' ' HG ' ' B' ' 85' ' ' LEU . 74.2 mtm180 -64.11 -26.3 68.48 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.632 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 98.5 mtt180 -82.11 -18.3 43.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . 0.464 ' NH2' ' HE2' ' B' ' 86' ' ' PHE . 97.6 mtt180 -86.01 -21.71 27.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.607 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -70.31 -29.44 66.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.69 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.465 0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 179.917 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 1.029 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 4.2 mm? . . . . . 0 N--CA 1.463 0.193 0 CA-C-O 121.042 0.449 . . . . 0.0 110.414 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -97.59 -34.46 10.95 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 68.8 mtp180 -74.63 -20.26 59.97 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.127 177.744 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 6.8 mt -104.78 -22.56 13.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.239 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 1.029 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 2.8 tt . . . . . 0 N--CA 1.469 0.489 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.637 179.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.25 0 CA-C-O 120.286 0.089 . . . . 0.0 111.186 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.93 150.59 73.34 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.597 2.198 . . . . 0.0 112.691 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.7 m -80.59 -10.12 59.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.595 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 5' ' ' ILE . 3.1 mp -82.88 -30.89 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.076 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.444 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.92 -27.1 28.82 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.637 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -63.86 -32.68 74.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.543 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.52 9.55 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.346 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.52 ' O ' HD13 ' A' ' 13' ' ' LEU . 21.8 mt -62.15 -43.02 99.76 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 115.725 -0.237 . . . . 0.0 111.431 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.5 m -60.83 -39.61 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.726 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.69 -48.81 47.39 Favored Glycine 0 C--O 1.235 0.217 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.836 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.82 -41.41 62.37 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -67.03 -39.65 87.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.438 0.161 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.68 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.5 mp -71.37 -39.35 71.28 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.766 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.37 -40.44 77.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.323 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tp -69.55 -32.68 71.63 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.528 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 3.5 tp -69.68 -43.0 73.38 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.99 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 14' ' ' LEU . 60.0 t -68.99 -43.65 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.061 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 15' ' ' LEU . 93.3 t -66.34 -43.31 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.69 -37.5 82.39 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.094 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -69.78 -35.85 75.22 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.592 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.14 -52.75 25.88 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.279 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.599 ' O ' HG12 ' A' ' 27' ' ' ILE . 11.2 mt -65.13 -37.76 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.633 0.254 . . . . 0.0 110.577 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.94 -46.53 91.28 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.31 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.56 -24.47 60.11 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.587 0.232 . . . . 0.0 111.126 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 8.1 t80 -75.81 -38.74 57.89 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.274 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 23' ' ' ILE . 39.3 mm -83.7 -31.91 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.196 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -66.62 -25.8 66.77 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.691 0.281 . . . . 0.0 111.578 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.7 -18.09 45.64 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.304 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -82.68 -21.29 34.96 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.529 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -69.57 -15.8 63.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.883 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.9 mt . . . . . 0 N--CA 1.466 0.354 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.01 179.922 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.906 ' O ' ' N ' ' A' ' 42' ' ' LEU . 15.1 tp . . . . . 0 C--O 1.223 -0.331 0 CA-C-O 120.683 0.278 . . . . 0.0 110.378 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -67.71 -29.09 68.25 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 42.8 mtt180 -69.28 -17.99 63.8 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.395 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.677 HD22 HD22 ' B' ' 101' ' ' LEU . 11.7 mt -112.0 -27.11 8.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.633 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.906 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.351 0.672 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.239 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.531 0.247 0 CA-C-O 120.296 0.093 . . . . 0.0 111.189 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.68 150.49 74.46 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.668 2.246 . . . . 0.0 112.755 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.4 m -80.63 -10.14 59.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.473 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.465 HD12 ' H ' ' B' ' 65' ' ' ILE . 3.1 mp -82.95 -30.83 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.082 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.438 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -26.97 28.94 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.628 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -63.89 -32.68 74.28 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.528 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.89 -41.6 9.51 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.289 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.1 mt -62.21 -43.11 99.57 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.657 -0.272 . . . . 0.0 111.31 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.67 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.2 m -60.81 -39.5 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.744 0.306 . . . . 0.0 111.767 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.73 -48.87 46.73 Favored Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.775 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.462 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.76 -41.33 62.6 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -67.11 -39.73 86.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.876 -0.147 . . . . 0.0 110.85 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -71.27 -39.36 71.62 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.67 0.271 . . . . 0.0 110.824 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.529 ' O ' HG23 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.31 -40.48 77.64 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.389 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.3 tp -69.6 -32.54 71.34 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.556 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.83 -42.87 73.05 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.997 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.618 HG23 ' O ' ' B' ' 74' ' ' LEU . 59.7 t -69.06 -43.67 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.066 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.529 HG23 ' O ' ' B' ' 75' ' ' LEU . 94.3 t -66.3 -43.41 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.61 -37.44 82.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.146 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.2 tp -69.82 -35.73 75.04 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.63 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.2 -52.71 25.85 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.215 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.607 ' O ' HG12 ' B' ' 87' ' ' ILE . 11.2 mt -65.23 -37.77 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 110.471 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.98 -46.44 91.42 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.377 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.53 -24.54 60.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.595 0.236 . . . . 0.0 111.179 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 8.3 t80 -75.85 -38.64 57.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.269 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.607 HG12 ' O ' ' B' ' 83' ' ' ILE . 39.1 mm -83.72 -31.91 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.178 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -66.65 -25.95 66.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.506 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.55 -18.09 46.17 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.332 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -82.63 -21.32 35.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.522 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -69.52 -15.96 63.34 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.825 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.9 mt . . . . . 0 CA--C 1.533 0.325 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.989 179.989 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.896 ' O ' ' N ' ' B' ' 102' ' ' LEU . 15.0 tp . . . . . 0 C--O 1.222 -0.366 0 CA-C-O 120.655 0.264 . . . . 0.0 110.36 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 98.9 mtt180 -67.59 -29.18 68.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 43.0 mtt180 -69.21 -18.05 63.85 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.677 HD22 HD22 ' A' ' 41' ' ' LEU . 11.7 mt -112.02 -27.06 8.56 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.671 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.896 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.351 0.638 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.233 0.236 0 CA-C-O 120.374 0.13 . . . . 0.0 111.247 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.93 143.79 56.17 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.687 2.258 . . . . 0.0 112.809 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.0 m -80.57 -8.1 59.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.498 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp -82.87 -32.26 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.128 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.96 -27.02 28.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.557 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.0 -32.56 74.15 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.574 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.06 -41.36 9.53 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.208 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.522 ' O ' HD13 ' A' ' 13' ' ' LEU . 22.1 mt -62.26 -43.16 99.47 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 122.339 0.256 . . . . 0.0 111.27 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.675 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.1 m -60.79 -39.86 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 111.713 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.5 -48.74 49.06 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.754 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.8 -41.73 61.97 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -66.75 -39.63 87.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.421 0.153 . . . . 0.0 110.982 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.675 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.7 mp -71.38 -39.57 71.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.647 0.26 . . . . 0.0 110.83 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.515 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.37 -40.11 77.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.244 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.5 tp -69.85 -32.83 71.43 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.54 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.58 -43.26 73.18 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.059 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 14' ' ' LEU . 61.7 t -69.0 -43.9 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.087 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 15' ' ' LEU . 98.7 t -66.22 -43.04 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.014 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.58 82.04 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.4 tp -69.45 -36.04 76.24 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.534 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.19 -52.85 25.08 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.219 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.577 ' O ' HG12 ' A' ' 27' ' ' ILE . 12.1 mt -65.53 -36.33 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.689 0.28 . . . . 0.0 110.456 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.96 -46.24 89.92 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.37 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HG ' ' NH2' ' A' ' 28' ' ' ARG . 17.5 mt -74.12 -24.38 59.43 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.663 0.268 . . . . 0.0 111.221 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.8 t80 -76.89 -38.07 54.28 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.303 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 23' ' ' ILE . 46.7 mm -83.68 -33.43 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.236 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.494 ' NH2' ' HG ' ' A' ' 25' ' ' LEU . 68.6 mtm180 -64.19 -25.81 68.24 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.67 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -79.47 -18.2 52.55 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.2 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.07 -21.43 27.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.51 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.426 ' HD2' ' O ' ' A' ' 27' ' ' ILE . 42.8 m-70 -69.65 -15.73 63.24 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.9 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 CA--C 1.533 0.305 0 CA-C-O 120.676 0.274 . . . . 0.0 111.042 179.902 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.931 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.5 mm? . . . . . 0 C--O 1.223 -0.336 0 CA-C-O 120.548 0.214 . . . . 0.0 110.515 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.4 -28.91 70.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.083 178.589 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 31.3 mtt180 -68.1 -20.21 64.91 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.515 HD22 HD22 ' B' ' 101' ' ' LEU . 6.9 mt -112.31 -25.76 9.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.828 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.931 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.352 0.696 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.279 0 CA-C-O 120.28 0.086 . . . . 0.0 111.225 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.93 143.8 56.17 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.624 2.216 . . . . 0.0 112.797 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.0 m -80.59 -8.03 59.46 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.536 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.471 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.8 mp -82.91 -32.32 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.44 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.91 -26.91 28.97 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.612 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -32.62 74.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.484 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.86 -41.5 9.61 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.297 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.515 ' O ' HD13 ' B' ' 73' ' ' LEU . 22.1 mt -62.25 -43.07 99.67 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.684 -0.258 . . . . 0.0 111.344 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.668 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.1 m -60.88 -39.79 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.733 0.302 . . . . 0.0 111.735 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.56 -48.6 49.55 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.862 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.85 -41.7 61.87 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.515 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -66.8 -39.67 87.84 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.438 0.161 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.668 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -71.3 -39.66 71.32 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.77 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.516 ' O ' HG23 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.32 -40.03 77.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.415 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.5 tp -69.92 -32.81 71.29 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.6 -43.21 73.24 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.033 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.616 HG23 ' O ' ' B' ' 74' ' ' LEU . 61.6 t -69.04 -43.91 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.036 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.516 HG23 ' O ' ' B' ' 75' ' ' LEU . 99.0 t -66.24 -43.09 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.957 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.83 -37.57 82.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.4 tp -69.46 -36.05 76.21 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.599 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.2 -52.8 25.31 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.249 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.582 ' O ' HG12 ' B' ' 87' ' ' ILE . 12.0 mt -65.48 -36.28 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.665 0.269 . . . . 0.0 110.537 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.92 -46.25 89.95 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.339 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . 0.5 ' HG ' ' NH2' ' B' ' 88' ' ' ARG . 17.8 mt -74.14 -24.47 59.43 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.525 0.202 . . . . 0.0 111.071 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.8 t80 -76.89 -38.08 54.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.306 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.582 HG12 ' O ' ' B' ' 83' ' ' ILE . 46.6 mm -83.59 -33.46 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.258 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.5 ' NH2' ' HG ' ' B' ' 85' ' ' LEU . 69.0 mtm180 -64.16 -25.88 68.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.638 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -79.37 -18.32 52.62 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.244 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.02 -21.44 27.78 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.527 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 91' ' ' HIS . . . . . 0.417 ' HD2' ' O ' ' B' ' 87' ' ' ILE . 43.0 m-70 -69.63 -15.73 63.25 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.926 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.7 mt . . . . . 0 N--CA 1.466 0.338 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.067 179.83 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.911 ' O ' ' N ' ' B' ' 102' ' ' LEU . 1.5 mm? . . . . . 0 C--O 1.221 -0.41 0 CA-C-O 120.544 0.211 . . . . 0.0 110.567 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -64.35 -29.05 70.13 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 123.565 0.746 . . . . 0.0 109.126 178.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 31.6 mtt180 -67.97 -20.21 65.02 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 176.584 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.515 HD22 HD22 ' A' ' 41' ' ' LEU . 6.8 mt -112.23 -25.83 9.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.868 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.911 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.352 0.713 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.199 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.53 0.186 0 CA-C-O 120.323 0.106 . . . . 0.0 111.197 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.19 139.52 42.42 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.642 2.228 . . . . 0.0 112.834 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.4 m -80.53 -7.19 59.11 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.544 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.5 mp -82.97 -32.87 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.083 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.95 -27.12 28.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.553 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.09 -32.54 74.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.593 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.98 -41.41 9.57 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.233 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 13' ' ' LEU . 23.4 mt -62.31 -43.32 99.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.694 -0.253 . . . . 0.0 111.285 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.66 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.0 m -60.66 -39.56 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.737 0.303 . . . . 0.0 111.717 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.5 -49.19 46.11 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.82 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.5 -41.77 62.65 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.91 -41.39 91.5 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.818 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.66 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.6 mp -70.35 -39.53 74.6 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.902 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.31 -37.88 77.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.414 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.03 -35.01 73.99 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.646 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 14.8 mt -69.48 -42.15 75.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 14' ' ' LEU . 58.0 t -68.71 -44.97 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.058 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 15' ' ' LEU . 93.0 t -65.91 -43.19 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.82 84.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.078 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.93 -36.31 77.82 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.614 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.36 -49.98 41.58 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.286 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 mt -64.17 -41.23 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 110.495 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -64.44 -44.39 95.35 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.366 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.6 mt -72.78 -24.66 60.97 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.724 0.297 . . . . 0.0 111.038 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.91 -40.67 62.98 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.11 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 12.4 mt -83.65 -27.27 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.999 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.3 ttt180 -63.58 -25.79 68.4 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.488 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -81.66 -35.0 30.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.329 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.25 -21.27 27.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.47 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 27' ' ' ILE . 4.3 t60 -69.89 -15.81 63.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.804 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.102 179.939 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.916 ' O ' ' N ' ' A' ' 42' ' ' LEU . 15.8 tp . . . . . 0 C--O 1.222 -0.361 0 N-CA-C 110.3 -0.259 . . . . 0.0 110.3 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -67.52 -28.92 68.23 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.6 mtp180 -69.96 -18.79 63.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.709 HD22 HD22 ' B' ' 101' ' ' LEU . 13.5 mt -111.33 -27.37 8.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.718 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.916 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.351 0.659 0 CA-C-O 120.746 0.308 . . . . 0.0 111.05 -179.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 C--O 1.234 0.248 0 N-CA-C 111.235 0.087 . . . . 0.0 111.235 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.13 139.46 42.47 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.723 2.282 . . . . 0.0 112.78 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.0 m -80.53 -7.13 59.1 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.543 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.467 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.5 mp -83.04 -32.86 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.055 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.437 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -27.21 28.77 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.629 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -32.68 74.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.498 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.89 -41.33 9.71 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.264 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.524 ' O ' HD13 ' B' ' 73' ' ' LEU . 22.9 mt -62.18 -43.57 98.53 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 122.377 0.271 . . . . 0.0 111.308 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.653 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.0 m -60.46 -39.61 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.746 0.308 . . . . 0.0 111.723 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.48 -49.27 45.71 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.718 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.462 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.59 -41.73 62.49 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.524 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.92 -41.28 91.61 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.005 0.191 . . . . 0.0 110.823 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.653 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -70.42 -39.56 74.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.833 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.28 -37.83 78.05 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.413 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.1 -35.06 73.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.6 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 14.8 mt -69.49 -42.07 75.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.158 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.613 HG23 ' O ' ' B' ' 74' ' ' LEU . 57.9 t -68.85 -44.84 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.085 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.497 HG23 ' O ' ' B' ' 75' ' ' LEU . 93.6 t -65.84 -43.28 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.964 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.25 -37.64 83.85 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.1 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.3 tp -68.95 -36.38 77.85 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.608 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.33 -50.04 41.41 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.311 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 mt -64.2 -41.1 91.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.634 0.254 . . . . 0.0 110.546 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . 0.563 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -64.39 -44.52 95.22 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.395 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 20.7 mt -72.69 -24.77 61.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.643 0.259 . . . . 0.0 110.971 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.84 -40.71 63.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' B' ' 91' ' ' HIS . 12.3 mt -83.53 -27.41 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.996 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.563 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.3 ttt180 -63.56 -25.63 68.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.476 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -81.8 -34.91 30.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.364 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.26 -21.38 27.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.481 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 91' ' ' HIS . . . . . 0.427 ' HB2' ' O ' ' B' ' 87' ' ' ILE . 4.2 t60 -69.81 -15.73 63.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.883 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 mt . . . . . 0 N--CA 1.466 0.326 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.101 179.909 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.917 ' O ' ' N ' ' B' ' 102' ' ' LEU . 15.8 tp . . . . . 0 C--O 1.222 -0.343 0 CA-C-O 120.64 0.257 . . . . 0.0 110.353 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 27.4 mmt180 -67.46 -28.92 68.27 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.474 -0.785 . . . . 0.0 108.922 178.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 27.5 mtp180 -69.99 -18.83 63.35 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 176.522 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.709 HD22 HD22 ' A' ' 41' ' ' LEU . 13.3 mt -111.31 -27.3 8.72 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.777 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.917 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.7 OUTLIER . . . . . 0 C--N 1.351 0.654 0 CA-C-O 120.601 0.238 . . . . 0.0 110.991 -179.661 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 CA--C 1.532 0.258 0 N-CA-C 111.222 0.082 . . . . 0.0 111.222 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.83 140.53 46.58 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.713 2.275 . . . . 0.0 112.78 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 t -80.57 -7.74 59.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.496 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.472 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.5 mp -82.89 -32.57 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.143 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.447 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.96 -26.2 29.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.572 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -63.84 -33.21 75.17 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.562 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.13 9.82 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.268 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.521 ' O ' HD13 ' A' ' 13' ' ' LEU . 22.0 mt -62.22 -43.36 99.0 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 122.286 0.235 . . . . 0.0 111.291 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.679 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.0 m -60.9 -39.99 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.769 0.319 . . . . 0.0 111.73 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.26 -48.5 52.01 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.828 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.454 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.93 -42.43 60.6 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -66.25 -39.54 89.57 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.846 -0.161 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.679 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.8 mp -71.86 -39.59 69.58 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.68 0.276 . . . . 0.0 110.846 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.75 -39.4 76.75 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.394 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.2 tp -70.22 -33.71 72.0 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.49 -43.29 73.44 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.12 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 14' ' ' LEU . 58.2 t -69.43 -43.58 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.129 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 15' ' ' LEU . 89.3 t -66.7 -43.27 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.114 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.38 -39.27 85.61 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.158 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.1 tp -69.37 -35.2 75.6 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.598 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.02 -52.4 28.41 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.305 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.597 ' O ' HG12 ' A' ' 27' ' ' ILE . 12.1 mt -65.58 -37.18 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.648 0.261 . . . . 0.0 110.566 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -64.48 -46.16 91.14 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.382 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.9 mt -74.21 -24.98 59.41 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.497 0.189 . . . . 0.0 111.208 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.1 t80 -75.82 -39.26 57.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.278 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 23' ' ' ILE . 41.6 mm -83.66 -30.51 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.116 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.569 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.6 ttt180 -64.91 -26.1 68.17 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.693 0.283 . . . . 0.0 111.337 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.9 -18.19 44.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.414 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.54 -21.5 35.35 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.597 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -68.48 -21.56 64.61 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.687 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mt . . . . . 0 N--CA 1.465 0.295 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.102 179.879 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.968 ' O ' ' N ' ' A' ' 42' ' ' LEU . 13.4 tp . . . . . 0 C--O 1.222 -0.353 0 N-CA-C 110.265 -0.272 . . . . 0.0 110.265 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.405 ' HA ' ' CB ' ' A' ' 42' ' ' LEU . 74.6 mtp180 -66.45 -31.66 72.54 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.674 0.79 . . . . 0.0 108.959 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 26.0 mmt180 -69.48 -19.42 63.75 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.038 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . . . . . . . . . 27.6 mt -111.53 -25.67 9.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.008 177.899 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.968 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.351 0.65 0 CA-C-O 120.623 0.249 . . . . 0.0 110.996 -179.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt . . . . . 0 CA--C 1.532 0.286 0 CA-C-O 120.322 0.106 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.1 140.61 45.6 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.628 2.219 . . . . 0.0 112.743 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.1 t -80.6 -7.7 59.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.472 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.465 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.5 mp -83.01 -32.6 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.051 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.444 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.85 -26.22 29.65 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.688 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -63.95 -33.13 75.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.551 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.15 9.82 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.333 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.518 ' O ' HD13 ' B' ' 73' ' ' LEU . 21.9 mt -62.24 -43.14 99.5 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.648 -0.276 . . . . 0.0 111.393 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.674 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.2 m -60.97 -40.13 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.699 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.22 -48.48 52.42 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.9 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.95 -42.5 60.43 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.518 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -66.2 -39.65 89.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.867 -0.151 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.674 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -71.85 -39.42 69.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.591 0.234 . . . . 0.0 110.861 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.95 -39.38 76.1 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.385 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.2 tp -70.09 -33.84 72.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.593 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.37 -43.36 73.71 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.074 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 74' ' ' LEU . 58.2 t -69.41 -43.48 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.165 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.486 HG23 ' O ' ' B' ' 75' ' ' LEU . 88.8 t -66.71 -43.38 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.029 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.25 85.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.151 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.1 tp -69.21 -35.28 76.05 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.669 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.98 -52.43 28.44 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.241 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.592 ' O ' HG12 ' B' ' 87' ' ' ILE . 12.0 mt -65.6 -37.21 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.667 0.27 . . . . 0.0 110.564 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . 0.568 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -64.41 -46.18 91.22 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.485 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 18.0 mt -74.18 -24.86 59.43 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.547 0.213 . . . . 0.0 111.252 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.2 t80 -76.02 -39.25 56.1 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.592 HG12 ' O ' ' B' ' 83' ' ' ILE . 41.5 mm -83.56 -30.53 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.186 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.7 ttt180 -64.97 -26.07 68.14 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.254 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.99 -18.22 44.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.272 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.52 -21.53 35.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.54 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -68.5 -21.55 64.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.741 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt . . . . . 0 N--CA 1.466 0.35 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.097 179.828 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.944 ' O ' ' N ' ' B' ' 102' ' ' LEU . 13.3 tp . . . . . 0 C--O 1.222 -0.387 0 N-CA-C 110.317 -0.253 . . . . 0.0 110.317 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . 0.407 ' HA ' ' CB ' ' B' ' 102' ' ' LEU . 74.8 mtp180 -66.5 -31.59 72.41 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.646 0.778 . . . . 0.0 109.015 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 26.1 mmt180 -69.42 -19.46 63.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . . . . . . . . . 27.8 mt -111.47 -25.68 9.48 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.048 177.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.944 ' N ' ' O ' ' B' ' 98' ' ' LEU . 1.3 tt . . . . . 0 C--N 1.352 0.679 0 CA-C-O 120.666 0.269 . . . . 0.0 110.984 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.532 0.273 0 CA-C-O 120.333 0.111 . . . . 0.0 111.166 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.05 141.43 48.09 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.636 2.224 . . . . 0.0 112.666 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.8 m -80.72 -7.43 59.35 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.513 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.6 mp -82.96 -32.73 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.134 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ALA . . . . . 0.444 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.99 -26.23 29.36 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.62 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.04 -33.08 74.94 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.539 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.79 -41.13 9.95 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.382 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.524 ' O ' HD13 ' A' ' 13' ' ' LEU . 21.9 mt -62.3 -43.55 98.56 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.7 -0.25 . . . . 0.0 111.37 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.662 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 23.5 m -60.71 -40.48 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 111.761 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.0 -48.88 51.45 Favored Glycine 0 C--O 1.235 0.201 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.808 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ALA . . . . . 0.452 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.57 -42.82 61.11 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.25 -41.16 94.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.442 0.163 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.9 mp -70.54 -40.01 73.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.626 0.251 . . . . 0.0 110.953 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -69.46 -36.84 76.97 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.603 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 tp -69.93 -36.8 75.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.573 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.7 mt -68.48 -44.22 75.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.274 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 14' ' ' LEU . 61.9 t -67.35 -44.88 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.229 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 15' ' ' LEU . 83.8 t -67.03 -39.11 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.2 83.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.054 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.6 mt -69.36 -34.33 74.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.657 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.35 -54.3 20.78 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.277 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.538 ' O ' HG12 ' A' ' 27' ' ' ILE . 15.1 mt -66.3 -35.72 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.592 0.234 . . . . 0.0 110.634 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.06 -45.98 90.24 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.473 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.56 -24.69 56.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.53 0.205 . . . . 0.0 111.299 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.9 t80 -77.78 -36.87 50.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.333 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 23' ' ' ILE . 52.1 mm -83.69 -36.62 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.309 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -67.65 -29.2 68.45 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.619 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -82.1 -18.24 43.69 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.469 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -85.32 -21.77 28.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.529 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -81.97 -15.93 52.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.489 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.8 mm . . . . . 0 CA--C 1.533 0.304 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.965 179.902 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' LEU . . . . . 0.956 ' O ' ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.221 -0.403 0 N-CA-C 110.415 -0.217 . . . . 0.0 110.415 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -66.98 -29.4 69.24 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.025 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -70.06 -18.41 63.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' LEU . . . . . 0.973 HD22 HD22 ' B' ' 101' ' ' LEU . 38.7 mt -112.09 -26.69 8.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.115 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.956 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.2 tt . . . . . 0 C--N 1.351 0.647 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp . . . . . 0 CA--C 1.531 0.23 0 N-CA-C 111.224 0.083 . . . . 0.0 111.224 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.06 141.41 48.02 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.623 2.215 . . . . 0.0 112.771 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.6 m -80.6 -7.55 59.3 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.493 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 65' ' ' ILE . . . . . 0.474 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.6 mp -82.88 -32.9 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.094 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 66' ' ' ALA . . . . . 0.45 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.98 -26.14 29.44 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.544 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.03 -33.16 75.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.47 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.88 -41.05 9.92 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.329 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 69' ' ' LEU . . . . . 0.533 ' O ' HD13 ' B' ' 73' ' ' LEU . 22.1 mt -62.42 -43.6 98.43 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 115.691 -0.254 . . . . 0.0 111.324 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 70' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.4 m -60.45 -40.64 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.873 0.368 . . . . 0.0 111.825 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 71' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.97 -48.91 51.43 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.819 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 72' ' ' ALA . . . . . 0.46 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.62 -42.74 61.09 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 73' ' ' LEU . . . . . 0.533 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.27 -41.24 94.43 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.882 -0.144 . . . . 0.0 110.862 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 74' ' ' LEU . . . . . 0.658 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -70.61 -39.94 73.48 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.895 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 75' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.52 -36.85 76.82 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.485 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tp -69.96 -36.61 75.39 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.64 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.67 -44.01 74.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.274 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 78' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 74' ' ' LEU . 61.6 t -67.48 -44.98 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.134 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 79' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 75' ' ' LEU . 84.7 t -66.78 -39.23 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.096 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.19 83.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.042 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 20.7 mt -69.36 -34.39 74.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.636 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 82' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.27 -54.19 21.68 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.398 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 83' ' ' ILE . . . . . 0.533 ' O ' HG12 ' B' ' 87' ' ' ILE . 14.9 mt -66.4 -35.73 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.553 0.216 . . . . 0.0 110.599 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.06 -46.12 89.8 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.435 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.34 -24.77 57.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.569 0.223 . . . . 0.0 111.351 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 86' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.9 t80 -77.88 -36.82 49.28 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.282 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 87' ' ' ILE . . . . . 0.533 HG12 ' O ' ' B' ' 83' ' ' ILE . 52.2 mm -83.63 -36.61 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.344 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -67.7 -29.17 68.36 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.571 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -82.21 -18.18 43.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.416 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -85.3 -21.83 28.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.521 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -81.96 -16.07 51.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.483 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 6.7 mm . . . . . 0 N--CA 1.466 0.367 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.046 179.847 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 98' ' ' LEU . . . . . 0.931 ' O ' ' N ' ' B' ' 102' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.22 -0.462 0 N-CA-C 110.427 -0.212 . . . . 0.0 110.427 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.08 -29.35 69.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 100' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -70.17 -18.31 63.2 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 101' ' ' LEU . . . . . 0.973 HD22 HD22 ' A' ' 41' ' ' LEU . 38.3 mt -112.12 -26.65 8.73 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.074 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 102' ' ' LEU . . . . . 0.931 ' N ' ' O ' ' B' ' 98' ' ' LEU . 1.2 tt . . . . . 0 C--N 1.351 0.636 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.8 mttp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.582 0.229 . . . . 0.0 111.091 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.97 146.7 55.95 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.163 179.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.27 139.02 40.84 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.626 2.217 . . . . 0.0 112.729 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.8 m -80.58 -7.14 59.14 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.503 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.4 mp -82.94 -32.6 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.301 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.131 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.441 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.91 -28.33 27.97 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.587 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.15 -31.9 73.26 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.545 -179.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.96 -41.94 9.21 Favored Glycine 0 C--N 1.336 0.552 0 C-N-CA 121.146 -0.55 . . . . 0.0 112.229 179.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.539 ' O ' HD13 ' A' ' 13' ' ' LEU . 23.9 mt -61.98 -43.21 99.33 Favored 'General case' 0 N--CA 1.462 0.152 0 CA-C-N 115.749 -0.225 . . . . 0.0 111.194 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.697 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 25.2 m -61.0 -39.05 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-O 120.832 0.349 . . . . 0.0 111.656 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.21 -48.4 52.99 Favored Glycine 0 CA--C 1.518 0.231 0 CA-C-N 115.87 -0.605 . . . . 0.0 112.742 179.875 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.488 ' O ' ' HB2' ' A' ' 16' ' ' LEU . . . -74.28 -43.16 58.02 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -179.092 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.539 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.33 -40.0 93.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.455 0.169 . . . . 0.0 110.954 -179.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.697 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.1 mp -72.41 -39.77 67.66 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.606 -0.27 . . . . 0.0 111.082 179.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.2 OUTLIER -70.16 -39.25 75.43 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.567 179.619 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.488 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 0.7 OUTLIER -70.08 -34.7 73.49 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.591 179.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.44 -42.29 75.14 Favored 'General case' 0 C--O 1.234 0.241 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.086 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 14' ' ' LEU . 99.3 t -69.1 -42.85 82.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 CA-C-N 116.45 -0.341 . . . . 0.0 111.128 179.799 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.517 HG23 ' O ' ' A' ' 15' ' ' LEU . 94.8 t -68.89 -39.69 80.22 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.56 -0.291 . . . . 0.0 111.024 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.59 -36.46 73.57 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.352 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 1.7 tp -70.27 -44.97 67.34 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.009 179.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -69.71 -56.22 8.66 Favored Glycine 0 C--N 1.337 0.621 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.529 179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 47.1 mm -64.25 -37.64 80.45 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 CA-C-O 120.745 0.307 . . . . 0.0 110.621 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.16 -46.58 87.45 Favored Glycine 0 C--N 1.338 0.676 0 CA-C-N 116.074 -0.512 . . . . 0.0 112.329 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 25.7 mt -73.05 -24.0 60.65 Favored 'General case' 0 C--O 1.233 0.189 0 CA-C-O 120.677 0.275 . . . . 0.0 110.986 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.51 -39.91 64.45 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.194 179.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.402 ' O ' ' HD2' ' A' ' 31' ' ' HIS . 18.9 mt -83.34 -33.68 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.296 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.248 179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.76 -26.0 66.76 Favored 'General case' 0 N--CA 1.468 0.433 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.645 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.488 ' O ' HG23 ' A' ' 33' ' ' VAL . 96.5 mtt180 -81.88 -18.16 44.76 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.351 -0.386 . . . . 0.0 111.401 179.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 99.2 mtt180 -81.51 -21.61 38.52 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.617 -179.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.402 ' HD2' ' O ' ' A' ' 27' ' ' ILE . 58.0 m-70 -70.74 -28.63 64.86 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.418 -0.356 . . . . 0.0 111.692 -179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 3.0 mt -83.17 -24.39 8.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.106 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 29' ' ' ARG . 2.6 t -95.55 -7.39 9.78 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.941 179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' A' ' 30' ' ' ARG . 28.4 ttt180 -92.49 159.95 15.29 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.9 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.73 153.09 20.97 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.037 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.51 17.76 6.02 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.365 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.451 ' O ' HD12 ' A' ' 41' ' ' LEU . 18.2 p -83.0 -16.73 46.02 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.715 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.013 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 6.1 tp -89.71 -13.91 35.86 Favored 'General case' 0 N--CA 1.462 0.137 0 CA-C-O 121.058 0.456 . . . . 0.0 110.312 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 33.6 mtm180 -97.87 -33.87 11.07 Favored 'General case' 0 CA--C 1.514 -0.415 0 CA-C-N 114.706 -1.133 . . . . 0.0 107.966 179.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.672 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 70.1 mtp180 -75.68 -21.84 57.24 Favored 'General case' 0 CA--C 1.52 -0.2 0 CA-C-N 114.512 -1.222 . . . . 0.0 108.157 177.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.451 HD12 ' O ' ' A' ' 37' ' ' THR . 22.7 mt -104.84 -19.72 13.81 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 114.442 -1.254 . . . . 0.0 109.405 177.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.013 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 4.1 tt -62.54 -45.36 93.31 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.676 179.405 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -92.04 -12.76 32.29 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.62 179.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.672 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 1.9 tp10 -83.79 -43.68 15.16 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.56 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -88.24 -10.98 47.94 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.686 -179.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.528 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 5.2 tt0 -63.33 -59.7 4.36 Favored 'General case' 0 CA--C 1.534 0.327 0 CA-C-N 116.509 -0.314 . . . . 0.0 111.621 -179.748 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 mp -146.5 27.38 1.12 Allowed 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.966 0.412 . . . . 0.0 111.26 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.473 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 3.1 t -127.28 58.12 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.331 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.429 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -95.44 141.43 23.19 Favored Pre-proline 0 CA--C 1.53 0.209 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.884 179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_endo -70.54 132.98 23.13 Favored 'Trans proline' 0 C--N 1.354 0.842 0 C-N-CA 122.575 2.184 . . . . 0.0 112.832 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mt -142.83 87.23 1.97 Allowed 'General case' 0 C--O 1.234 0.27 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.308 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 p -138.33 146.72 52.59 Favored Pre-proline 0 C--N 1.328 -0.366 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.158 179.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.5 119.16 6.16 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.614 2.209 . . . . 0.0 112.731 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 15.2 t -100.56 -10.51 20.94 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 115.838 -0.619 . . . . 0.0 110.857 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -179.79 75.58 0.06 OUTLIER Glycine 0 C--N 1.334 0.448 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.449 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -127.62 -42.18 1.64 Allowed 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.671 0.272 . . . . 0.0 111.063 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -85.16 -42.89 14.32 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.28 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 9.7 mt -90.09 -8.29 51.74 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.446 179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 82.7 m95 -129.31 143.61 50.91 Favored 'General case' 0 C--O 1.232 0.146 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.248 1.002 0 CA-C-O 118.174 -0.917 . . . . 0.0 110.786 -179.975 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 mttp . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.596 0.236 . . . . 0.0 111.044 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.88 146.6 55.68 Favored Pre-proline 0 CA--C 1.532 0.263 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.184 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -69.14 138.95 41.1 Favored 'Trans proline' 0 C--N 1.354 0.822 0 C-N-CA 122.726 2.284 . . . . 0.0 112.719 179.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 52.8 m -80.52 -7.24 59.13 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.024 -0.534 . . . . 0.0 111.49 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.468 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.4 mp -82.9 -32.76 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.072 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.444 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -28.22 28.06 Favored 'General case' 0 C--O 1.234 0.237 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.605 -179.945 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.13 -31.97 73.37 Favored 'General case' 0 N--CA 1.465 0.291 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.538 -179.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.99 -41.86 9.25 Favored Glycine 0 C--N 1.335 0.518 0 C-N-CA 121.154 -0.546 . . . . 0.0 112.228 179.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.531 ' O ' HD13 ' B' ' 73' ' ' LEU . 23.8 mt -62.02 -43.2 99.34 Favored 'General case' 0 N--CA 1.462 0.135 0 CA-C-O 120.625 0.25 . . . . 0.0 111.215 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.69 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 25.5 m -61.02 -39.09 81.05 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.183 0 CA-C-O 120.852 0.358 . . . . 0.0 111.619 -179.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.534 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.18 -48.47 52.66 Favored Glycine 0 C--N 1.33 0.223 0 CA-C-N 115.889 -0.596 . . . . 0.0 112.714 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.492 ' O ' ' HB2' ' B' ' 76' ' ' LEU . . . -74.2 -43.17 58.27 Favored 'General case' 0 N--CA 1.464 0.242 0 N-CA-C 112.62 0.6 . . . . 0.0 112.62 -179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.531 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.31 -40.0 93.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.803 -0.18 . . . . 0.0 111.029 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.69 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.1 mp -72.3 -39.85 67.97 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.62 -0.264 . . . . 0.0 111.095 178.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.534 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.2 OUTLIER -70.21 -39.22 75.28 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.553 179.699 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 0.7 OUTLIER -70.04 -34.65 73.51 Favored 'General case' 0 N--CA 1.462 0.17 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.67 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.441 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.45 -42.43 74.94 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.976 179.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.601 HG23 ' O ' ' B' ' 74' ' ' LEU . 99.9 t -68.99 -42.88 82.33 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.492 -0.322 . . . . 0.0 111.128 179.806 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.5 HG23 ' O ' ' B' ' 75' ' ' LEU . 95.5 t -68.91 -39.73 80.23 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.624 -0.262 . . . . 0.0 111.031 179.838 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.46 -36.53 73.97 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.371 179.748 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 1.7 tp -70.37 -44.89 67.14 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.035 179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -69.76 -56.22 8.6 Favored Glycine 0 C--N 1.337 0.62 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.489 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 47.2 mm -64.22 -37.71 80.61 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 CA-C-O 120.683 0.277 . . . . 0.0 110.554 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.05 -46.64 88.17 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.406 179.471 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 25.8 mt -73.1 -23.94 60.57 Favored 'General case' 0 N--CA 1.463 0.213 0 CA-C-O 120.577 0.227 . . . . 0.0 110.962 179.454 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.52 -39.83 64.47 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.25 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 18.8 mt -83.34 -33.76 10.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.2 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 94.1 mtt180 -66.76 -25.97 66.75 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.682 -179.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.491 ' O ' HG23 ' B' ' 93' ' ' VAL . 96.5 mtt180 -81.96 -18.03 44.92 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.416 179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . 0.509 ' O ' ' HB2' ' B' ' 94' ' ' ARG . 99.2 mtt180 -81.55 -21.58 38.41 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.575 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 57.7 m-70 -70.77 -28.6 64.8 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.512 -0.313 . . . . 0.0 111.683 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 3.0 mt -83.25 -24.38 8.12 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.293 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.065 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.491 HG23 ' O ' ' B' ' 89' ' ' ARG . 2.6 t -95.54 -7.34 9.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.256 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.99 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.509 ' HB2' ' O ' ' B' ' 90' ' ' ARG . 28.3 ttt180 -92.4 159.91 15.34 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.353 -0.385 . . . . 0.0 110.94 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -89.76 153.11 20.94 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.065 -179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.5 17.75 6.01 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 115.924 -0.58 . . . . 0.0 111.377 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.455 ' O ' HD12 ' B' ' 101' ' ' LEU . 18.5 p -82.99 -16.71 46.13 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.791 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 1.028 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 6.1 tp -89.72 -13.94 35.74 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-O 121.105 0.479 . . . . 0.0 110.342 -179.847 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 33.8 mtm180 -97.81 -33.88 11.09 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-N 114.665 -1.152 . . . . 0.0 108.025 179.149 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.688 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 70.1 mtp180 -75.61 -21.83 57.41 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 114.58 -1.191 . . . . 0.0 108.224 177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.455 HD12 ' O ' ' B' ' 97' ' ' THR . 22.8 mt -104.78 -19.72 13.83 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.346 -1.297 . . . . 0.0 109.42 177.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 1.028 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 4.2 tt -62.6 -45.26 93.68 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.662 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 10.9 tt0 -92.01 -12.82 32.18 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.647 179.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.688 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 1.9 tp10 -83.8 -43.73 15.1 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.521 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 25.0 mmt180 -88.17 -11.07 47.88 Favored 'General case' 0 N--CA 1.464 0.241 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.651 -179.617 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' B' ' 102' ' ' LEU . 5.2 tt0 -63.4 -59.74 4.29 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 116.502 -0.317 . . . . 0.0 111.498 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 3.3 mp -146.43 27.34 1.13 Allowed 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 120.929 0.395 . . . . 0.0 111.225 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.458 ' HB ' ' O ' ' B' ' 104' ' ' GLU . 3.1 t -127.19 58.13 0.31 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.341 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.463 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -95.57 141.43 23.18 Favored Pre-proline 0 CA--C 1.531 0.214 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.873 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 49.1 Cg_endo -70.53 132.96 23.1 Favored 'Trans proline' 0 C--N 1.355 0.896 0 C-N-CA 122.646 2.231 . . . . 0.0 112.831 -179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 9.9 mt -142.84 87.25 1.98 Allowed 'General case' 0 C--O 1.235 0.316 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.282 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 17.9 p -138.36 146.76 52.7 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 115.548 -0.751 . . . . 0.0 111.121 179.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_endo -69.47 119.07 6.09 Favored 'Trans proline' 0 C--N 1.354 0.819 0 C-N-CA 122.662 2.241 . . . . 0.0 112.806 179.897 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 14.9 t -100.5 -10.6 20.91 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.84 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -179.78 75.63 0.06 OUTLIER Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.069 -0.586 . . . . 0.0 112.509 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -127.68 -42.14 1.63 Allowed 'General case' 0 N--CA 1.463 0.185 0 CA-C-O 120.542 0.211 . . . . 0.0 110.994 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 58.4 mttp -85.12 -42.94 14.31 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.282 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 9.6 mt -90.04 -8.3 51.85 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.465 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 82.9 m95 -129.28 143.63 50.92 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 -179.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.136 -0.935 . . . . 0.0 110.829 179.949 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 N--CA 1.485 1.297 0 CA-C-O 120.613 0.244 . . . . 0.0 110.926 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.5 146.77 57.11 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.183 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_endo -68.38 143.72 59.07 Favored 'Trans proline' 0 C--N 1.355 0.892 0 C-N-CA 122.629 2.219 . . . . 0.0 112.803 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 13.9 t -80.58 -8.35 59.57 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.465 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.467 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.7 mp -83.01 -32.0 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.28 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.089 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.442 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.93 -26.62 29.17 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.585 -179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.0 -32.87 74.56 Favored 'General case' 0 N--CA 1.466 0.358 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.524 -179.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.94 -41.36 9.64 Favored Glycine 0 C--N 1.336 0.54 0 C-N-CA 121.127 -0.558 . . . . 0.0 112.245 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.525 ' O ' HD13 ' A' ' 13' ' ' LEU . 22.3 mt -62.14 -42.99 99.79 Favored 'General case' 0 N--CA 1.462 0.148 0 CA-C-N 115.736 -0.232 . . . . 0.0 111.36 -179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.683 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 23.9 m -60.93 -39.47 82.15 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-O 120.777 0.322 . . . . 0.0 111.688 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.469 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.68 -48.98 46.31 Favored Glycine 0 C--O 1.236 0.222 0 CA-C-N 115.935 -0.575 . . . . 0.0 112.703 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.46 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.75 -41.3 62.68 Favored 'General case' 0 N--CA 1.462 0.16 0 N-CA-C 112.641 0.608 . . . . 0.0 112.641 -179.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.525 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -67.09 -39.69 86.81 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.848 -0.16 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.683 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.6 mp -71.25 -39.38 71.65 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.625 0.25 . . . . 0.0 110.771 178.748 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.516 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.33 -40.48 77.57 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.303 179.348 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.4 tp -69.64 -32.25 70.82 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.502 179.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.44 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 3.5 tp -69.96 -42.55 73.04 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.91 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 14' ' ' LEU . 59.1 t -69.18 -43.42 81.53 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.383 0 CA-C-N 116.435 -0.348 . . . . 0.0 111.015 179.734 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 15' ' ' LEU . 91.0 t -66.46 -43.46 90.99 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.852 179.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.47 -37.79 83.44 Favored 'General case' 0 C--O 1.235 0.306 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.101 179.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.41 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 3.2 tp -69.44 -36.35 76.54 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.522 179.379 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.41 ' O ' ' HD1' ' A' ' 26' ' ' PHE . . . -67.42 -53.38 25.35 Favored Glycine 0 C--N 1.337 0.593 0 CA-C-N 116.034 -0.53 . . . . 0.0 112.222 179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.578 ' O ' HG12 ' A' ' 27' ' ' ILE . 11.0 mt -64.47 -37.34 79.78 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.29 0 CA-C-O 120.649 0.261 . . . . 0.0 110.536 179.458 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.66 -44.32 95.13 Favored Glycine 0 C--N 1.337 0.589 0 C-N-CA 121.084 -0.579 . . . . 0.0 112.414 179.568 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 19.1 mt -73.45 -27.01 61.19 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.445 0.164 . . . . 0.0 111.141 179.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.41 ' HD1' ' O ' ' A' ' 22' ' ' GLY . 2.8 m-85 -76.43 -36.59 57.9 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.432 179.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.578 HG12 ' O ' ' A' ' 23' ' ' ILE . 47.5 mm -83.52 -32.84 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.237 179.921 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 72.0 mtm180 -67.73 -25.77 65.82 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.472 -0.331 . . . . 0.0 111.554 179.849 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.79 -33.79 30.66 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.164 179.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -86.32 -21.33 27.34 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.061 -0.518 . . . . 0.0 111.411 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.472 ' HB2' ' O ' ' A' ' 27' ' ' ILE . 3.2 t60 -70.03 -15.94 63.08 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.806 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt -81.96 -10.88 12.25 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 CA-C-N 116.558 -0.292 . . . . 0.0 111.133 179.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.23 -45.22 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.238 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.745 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -120.6 128.6 53.19 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.748 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -132.05 -43.85 0.96 Allowed 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.205 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.93 25.4 4.29 Favored 'General case' 0 CA--C 1.531 0.227 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.283 -179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 19.1 p -83.29 -37.39 23.52 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.621 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.95 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.3 mm? -89.71 -38.32 13.94 Favored 'General case' 0 C--O 1.221 -0.405 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.489 -179.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.43 ' HD3' ' OE1' ' A' ' 43' ' ' GLN . 99.3 mtt180 -63.28 -28.57 70.11 Favored 'General case' 0 CA--C 1.515 -0.367 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.313 178.489 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.498 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 30.7 mtt180 -67.52 -21.84 65.46 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.047 -1.464 . . . . 0.0 107.047 176.671 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.537 HD22 HD22 ' B' ' 101' ' ' LEU . 5.4 mt -111.78 -26.31 9.03 Favored 'General case' 0 N--CA 1.446 -0.63 0 CA-C-N 113.537 -1.665 . . . . 0.0 109.941 177.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.95 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -83.67 -51.08 7.57 Favored 'General case' 0 C--N 1.353 0.721 0 CA-C-O 120.577 0.227 . . . . 0.0 111.448 -179.278 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.43 ' OE1' ' HD3' ' A' ' 39' ' ' ARG . 54.3 mt-30 -77.44 -9.97 59.19 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.03 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.498 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 9.7 tt0 -83.27 -45.52 13.72 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.255 179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -88.37 -11.71 45.43 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.336 -179.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.546 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 10.9 tt0 -62.76 -29.72 70.9 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.265 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -106.31 9.27 32.0 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-O 121.087 0.47 . . . . 0.0 111.06 179.746 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 44' ' ' GLU . 3.3 t -127.73 53.53 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-N 115.515 -0.766 . . . . 0.0 110.4 179.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -111.03 135.75 20.84 Favored Pre-proline 0 C--N 1.331 -0.223 0 CA-C-N 115.906 -0.588 . . . . 0.0 110.89 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.54 131.99 18.28 Favored 'Trans proline' 0 C--N 1.355 0.907 0 C-N-CA 122.594 2.196 . . . . 0.0 112.65 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.8 mt -142.95 87.31 1.97 Allowed 'General case' 0 C--O 1.234 0.249 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.314 179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.8 p -140.21 132.74 14.73 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.522 -0.763 . . . . 0.0 111.03 179.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.61 154.07 49.49 Favored 'Trans proline' 0 C--N 1.355 0.891 0 C-N-CA 122.547 2.165 . . . . 0.0 112.735 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 53.4 m 60.43 20.77 10.42 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.795 -179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.49 -157.98 18.78 Favored Glycine 0 C--N 1.334 0.421 0 C-N-CA 121.075 -0.583 . . . . 0.0 112.528 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.523 ' HB2' ' NE1' ' A' ' 59' ' ' TRP . 41.8 mt-10 -107.56 152.91 23.63 Favored 'General case' 0 C--O 1.233 0.188 0 CA-C-O 120.819 0.342 . . . . 0.0 110.95 -179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -85.06 -20.07 30.97 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.671 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.66 -10.59 19.79 Favored 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 112.306 0.484 . . . . 0.0 112.306 -179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.523 ' NE1' ' HB2' ' A' ' 56' ' ' GLU . 68.9 p-90 -134.67 -16.95 1.99 Allowed 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.355 179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 50.3 m . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.115 -0.945 . . . . 0.0 110.906 179.975 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 97.0 mttt . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.739 0.304 . . . . 0.0 110.853 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.59 146.76 56.9 Favored Pre-proline 0 C--O 1.234 0.245 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.181 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -68.49 143.71 58.38 Favored 'Trans proline' 0 C--N 1.353 0.781 0 C-N-CA 122.606 2.204 . . . . 0.0 112.797 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.1 t -80.53 -8.39 59.56 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.517 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.466 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.7 mp -82.9 -32.1 9.53 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.358 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.128 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.437 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.95 -26.5 29.22 Favored 'General case' 0 N--CA 1.464 0.267 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.659 -179.934 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.03 -32.77 74.44 Favored 'General case' 0 N--CA 1.466 0.333 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.542 -179.73 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.08 -41.24 9.6 Favored Glycine 0 C--N 1.335 0.503 0 C-N-CA 121.151 -0.547 . . . . 0.0 112.243 179.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.513 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.2 mt -62.17 -43.08 99.64 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 122.331 0.253 . . . . 0.0 111.365 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.673 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 23.4 m -61.0 -39.31 81.77 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.24 0 CA-C-O 120.878 0.371 . . . . 0.0 111.782 -179.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.78 -48.79 46.91 Favored Glycine 0 C--N 1.331 0.275 0 CA-C-N 115.857 -0.611 . . . . 0.0 112.809 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.459 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.86 -41.22 62.52 Favored 'General case' 0 N--CA 1.463 0.211 0 N-CA-C 112.614 0.598 . . . . 0.0 112.614 -179.091 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.513 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -67.19 -39.54 86.4 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 120.434 0.159 . . . . 0.0 110.838 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.673 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.5 mp -71.35 -39.37 71.35 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-O 120.641 0.258 . . . . 0.0 110.712 178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.535 ' O ' HG23 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.33 -40.48 77.57 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.266 179.397 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 2.4 tp -69.74 -32.29 70.75 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.42 179.284 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.448 ' HB2' ' O ' ' B' ' 73' ' ' LEU . 3.5 tp -69.88 -42.6 73.24 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.016 179.407 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.616 HG23 ' O ' ' B' ' 74' ' ' LEU . 59.1 t -69.13 -43.44 81.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.983 179.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.535 HG23 ' O ' ' B' ' 75' ' ' LEU . 91.0 t -66.44 -43.42 91.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.424 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.899 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.45 -37.86 83.62 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.08 179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 3.1 tp -69.31 -36.41 76.96 Favored 'General case' 0 C--O 1.233 0.212 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.53 179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.414 ' O ' ' HD1' ' B' ' 86' ' ' PHE . . . -67.51 -53.23 25.81 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.196 179.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.59 ' O ' HG12 ' B' ' 87' ' ' ILE . 11.0 mt -64.59 -37.33 79.79 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.704 0.287 . . . . 0.0 110.495 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.74 -44.3 95.04 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.232 -0.509 . . . . 0.0 112.396 179.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 19.0 mt -73.43 -27.05 61.22 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-O 120.557 0.218 . . . . 0.0 111.287 179.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.414 ' HD1' ' O ' ' B' ' 82' ' ' GLY . 2.7 m-85 -76.51 -36.42 57.77 Favored 'General case' 0 N--CA 1.464 0.264 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.458 179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.59 HG12 ' O ' ' B' ' 83' ' ' ILE . 47.6 mm -83.58 -32.77 9.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.212 179.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -67.77 -25.82 65.8 Favored 'General case' 0 N--CA 1.466 0.347 0 CA-C-N 116.576 -0.284 . . . . 0.0 111.459 179.944 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 84.0 mtm180 -81.81 -33.74 30.62 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.201 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -86.21 -21.43 27.46 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.501 179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 91' ' ' HIS . . . . . 0.46 ' HB2' ' O ' ' B' ' 87' ' ' ILE . 3.2 t60 -69.98 -15.89 63.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.726 -179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.2 mt -81.98 -10.96 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.318 0 CA-C-N 116.683 -0.235 . . . . 0.0 111.044 179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.4 t -92.29 -45.14 14.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.24 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.704 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 97.9 mtt180 -120.6 128.58 53.16 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.688 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -132.01 -43.9 0.96 Allowed 'General case' 0 C--O 1.233 0.191 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.177 -179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -132.87 25.44 4.31 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.318 -179.804 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 18.9 p -83.31 -37.42 23.44 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.618 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.947 ' O ' ' N ' ' B' ' 102' ' ' LEU . 1.3 mm? -89.62 -38.18 14.11 Favored 'General case' 0 C--O 1.222 -0.37 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.588 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . 0.428 ' HD3' ' OE1' ' B' ' 103' ' ' GLN . 99.3 mtt180 -63.29 -28.74 70.22 Favored 'General case' 0 CA--C 1.515 -0.396 0 C-N-CA 123.577 0.751 . . . . 0.0 109.272 178.445 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.503 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 31.1 mtt180 -67.42 -21.85 65.55 Favored 'General case' 0 CA--C 1.521 -0.161 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 176.653 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.537 HD22 HD22 ' A' ' 41' ' ' LEU . 5.4 mt -111.8 -26.2 9.08 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 113.438 -1.71 . . . . 0.0 109.979 177.762 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.947 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.3 OUTLIER -83.77 -51.12 7.49 Favored 'General case' 0 C--N 1.352 0.691 0 CA-C-O 120.61 0.243 . . . . 0.0 111.464 -179.262 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . 0.428 ' OE1' ' HD3' ' B' ' 99' ' ' ARG . 54.3 mt-30 -77.36 -10.0 59.19 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.043 179.851 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.503 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 9.7 tt0 -83.44 -45.32 13.79 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.152 -0.477 . . . . 0.0 111.228 179.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 25.9 mmt180 -88.42 -11.75 45.16 Favored 'General case' 0 N--CA 1.464 0.236 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.289 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' B' ' 102' ' ' LEU . 10.9 tt0 -62.76 -29.75 70.93 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.303 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -106.25 9.16 32.14 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.032 0.444 . . . . 0.0 111.063 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.409 HG23 ' O ' ' B' ' 104' ' ' GLU . 3.3 t -127.68 53.56 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.442 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.447 179.615 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -111.17 135.86 20.9 Favored Pre-proline 0 CA--C 1.53 0.192 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.75 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -72.51 131.95 18.26 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.571 2.181 . . . . 0.0 112.732 179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 9.8 mt -142.92 87.24 1.97 Allowed 'General case' 0 C--O 1.234 0.272 0 CA-C-O 121.239 0.542 . . . . 0.0 110.303 179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 16.8 p -140.13 132.77 14.84 Favored Pre-proline 0 C--N 1.328 -0.327 0 CA-C-N 115.54 -0.754 . . . . 0.0 110.989 179.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -73.63 154.17 49.42 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 122.524 2.149 . . . . 0.0 112.77 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 52.5 m 60.36 20.75 10.31 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.835 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.56 -157.99 18.73 Favored Glycine 0 C--N 1.334 0.461 0 C-N-CA 121.055 -0.593 . . . . 0.0 112.573 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . 0.523 ' HB2' ' NE1' ' B' ' 119' ' ' TRP . 41.8 mt-10 -107.62 152.93 23.63 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 120.806 0.336 . . . . 0.0 110.972 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 97.4 mttt -85.15 -20.0 30.93 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 115.845 -0.616 . . . . 0.0 111.657 -179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.6 mp -63.7 -10.53 19.8 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 112.327 0.492 . . . . 0.0 112.327 -179.405 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 119' ' ' TRP . . . . . 0.523 ' NE1' ' HB2' ' B' ' 116' ' ' GLU . 68.8 p-90 -134.7 -17.03 1.98 Allowed 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.556 -0.293 . . . . 0.0 111.374 179.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 50.6 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.164 -0.922 . . . . 0.0 110.963 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.67 0.271 . . . . 0.0 110.884 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.8 155.01 76.76 Favored Pre-proline 0 CA--C 1.534 0.359 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.178 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_exo -66.57 147.06 81.43 Favored 'Trans proline' 0 C--N 1.358 1.075 0 C-N-CA 122.556 2.171 . . . . 0.0 112.6 179.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.1 m -80.66 -21.74 41.12 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.494 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.475 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.3 mp -83.0 -22.12 8.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.167 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.481 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.92 -33.89 24.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.601 -179.905 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.65 -27.81 69.48 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.465 -179.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.87 -44.67 7.59 Favored Glycine 0 C--N 1.334 0.462 0 C-N-CA 121.274 -0.489 . . . . 0.0 112.238 179.536 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.508 ' O ' ' HB2' ' A' ' 13' ' ' LEU . 18.6 mt -62.36 -42.47 99.43 Favored 'General case' 0 N--CA 1.461 0.113 0 CA-C-O 120.586 0.231 . . . . 0.0 111.227 179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.71 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 22.4 m -61.37 -41.85 91.45 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.761 -179.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -67.1 -48.23 60.74 Favored Glycine 0 C--N 1.33 0.242 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.974 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.443 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -74.11 -44.14 55.01 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.508 ' HB2' ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.73 -38.84 90.26 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 120.432 0.158 . . . . 0.0 111.092 -179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.71 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.1 mp -72.76 -39.44 66.82 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 120.586 0.232 . . . . 0.0 110.958 178.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -70.29 -38.22 74.97 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.363 179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.9 tp -71.02 -35.19 71.91 Favored 'General case' 0 N--CA 1.462 0.141 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.688 179.461 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 2.1 tt -68.99 -44.38 72.98 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.257 179.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.564 HG23 ' O ' ' A' ' 14' ' ' LEU . 58.6 t -69.45 -44.48 79.97 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.409 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.365 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.442 HG23 ' O ' ' A' ' 15' ' ' LEU . 74.4 t -66.77 -42.33 89.19 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.347 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.171 -179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.9 -39.37 83.63 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.504 -0.317 . . . . 0.0 110.977 179.597 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.68 -35.64 77.47 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.614 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.97 -52.69 26.95 Favored Glycine 0 C--N 1.337 0.638 0 CA-C-N 115.925 -0.579 . . . . 0.0 112.36 179.472 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.545 ' O ' HG12 ' A' ' 27' ' ' ILE . 13.7 mt -65.96 -35.23 74.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-O 120.642 0.258 . . . . 0.0 110.558 179.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.537 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -65.75 -45.78 86.91 Favored Glycine 0 C--N 1.336 0.549 0 C-N-CA 121.117 -0.564 . . . . 0.0 112.402 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.0 mt -75.24 -24.82 57.72 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 120.55 0.214 . . . . 0.0 111.309 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.8 t80 -77.56 -37.86 49.79 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-N 116.358 -0.383 . . . . 0.0 111.253 179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.545 HG12 ' O ' ' A' ' 23' ' ' ILE . 50.6 mm -83.65 -33.44 9.65 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.194 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.537 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 15.0 ttm180 -66.22 -26.96 67.63 Favored 'General case' 0 N--CA 1.466 0.373 0 CA-C-O 120.654 0.264 . . . . 0.0 111.312 179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.493 ' O ' HG23 ' A' ' 33' ' ' VAL . 99.1 mtt180 -82.23 -18.21 43.34 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.347 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.55 ' O ' ' HB2' ' A' ' 34' ' ' ARG . 74.6 mtp180 -83.9 -21.77 31.8 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.521 -179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.09 -20.43 34.89 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.473 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . 0.426 HG12 ' O ' ' A' ' 28' ' ' ARG . 11.0 mm -83.23 -29.56 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.263 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.995 179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 29' ' ' ARG . 2.3 t -95.94 -3.6 10.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.291 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.015 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.55 ' HB2' ' O ' ' A' ' 30' ' ' ARG . 28.8 ttt180 -90.8 157.11 17.57 Favored 'General case' 0 C--O 1.234 0.284 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.931 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -93.0 157.36 16.35 Favored 'General case' 0 C--O 1.232 0.172 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.987 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -88.9 28.04 1.24 Allowed 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.064 -0.517 . . . . 0.0 111.284 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.665 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 18.1 p -82.98 -13.97 54.95 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.729 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.061 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 3.3 mm? -90.43 -18.2 25.84 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.948 0.404 . . . . 0.0 110.614 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 45.1 mtm180 -98.03 -35.44 10.44 Favored 'General case' 0 CA--C 1.516 -0.331 0 CA-C-N 114.878 -1.055 . . . . 0.0 108.367 179.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.66 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 94.9 mtt180 -73.85 -19.07 60.84 Favored 'General case' 0 CA--C 1.521 -0.163 0 CA-C-N 114.874 -1.057 . . . . 0.0 108.441 178.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' A' ' 37' ' ' THR . 3.0 mm? -108.57 -20.7 13.01 Favored 'General case' 0 N--CA 1.449 -0.504 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.508 177.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.061 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 3.9 tt -62.81 -44.61 95.7 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.824 0.345 . . . . 0.0 110.754 179.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.1 tt0 -92.85 -11.39 33.73 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.681 179.525 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.66 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 6.6 tt0 -83.79 -45.14 13.64 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.563 -179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 24.3 mmt180 -88.08 -11.03 48.27 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.395 -0.366 . . . . 0.0 111.748 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.582 ' HB2' ' O ' ' A' ' 42' ' ' LEU . 9.6 tt0 -62.44 -57.13 12.35 Favored 'General case' 0 N--CA 1.465 0.295 0 CA-C-N 116.396 -0.365 . . . . 0.0 111.611 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tp -150.13 27.17 0.78 Allowed 'General case' 0 C--O 1.233 0.235 0 CA-C-O 121.017 0.437 . . . . 0.0 111.242 -179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.462 ' HB ' ' O ' ' A' ' 44' ' ' GLU . 3.4 t -126.69 60.02 0.3 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.325 0 CA-C-N 115.864 -0.607 . . . . 0.0 110.46 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -94.91 148.07 34.13 Favored Pre-proline 0 C--O 1.233 0.224 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.974 179.877 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -68.85 133.13 26.46 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.625 2.217 . . . . 0.0 112.801 -179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 tp -142.99 87.3 1.97 Allowed 'General case' 0 N--CA 1.454 -0.268 0 CA-C-O 121.233 0.539 . . . . 0.0 110.194 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.2 p -99.34 155.05 36.95 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.53 -0.759 . . . . 0.0 111.112 179.72 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.81 119.54 6.58 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 122.67 2.246 . . . . 0.0 112.539 179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.6 p -100.27 -10.3 21.46 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.793 -0.639 . . . . 0.0 110.938 179.667 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -111.28 -98.62 2.46 Favored Glycine 0 C--N 1.333 0.397 0 C-N-CA 121.057 -0.592 . . . . 0.0 112.476 179.967 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -102.35 149.33 24.45 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.734 0.302 . . . . 0.0 110.865 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.23 -42.15 14.94 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.367 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.23 -9.1 49.28 Favored 'General case' 0 C--O 1.233 0.202 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.409 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -131.27 144.7 51.48 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.926 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 41.4 p . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.151 -0.928 . . . . 0.0 110.92 179.992 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.488 1.442 0 CA-C-O 120.713 0.292 . . . . 0.0 110.783 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.86 155.02 76.67 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.128 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_exo -66.79 147.05 80.4 Favored 'Trans proline' 0 C--N 1.357 1.018 0 C-N-CA 122.628 2.219 . . . . 0.0 112.487 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 52.4 m -80.47 -21.94 41.54 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 115.912 -0.586 . . . . 0.0 111.505 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.478 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.3 mp -82.81 -22.14 9.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.247 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.478 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.91 -33.95 24.63 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.56 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -63.61 -27.84 69.51 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.539 -179.784 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.82 -44.7 7.6 Favored Glycine 0 C--N 1.335 0.482 0 C-N-CA 121.164 -0.541 . . . . 0.0 112.266 179.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.512 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 18.4 mt -62.19 -42.71 99.54 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-O 120.627 0.251 . . . . 0.0 111.25 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.703 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 22.5 m -61.31 -41.79 91.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.766 -179.572 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.546 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.08 -48.33 60.34 Favored Glycine 0 CA--C 1.517 0.177 0 CA-C-N 115.94 -0.573 . . . . 0.0 113.008 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.436 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -74.12 -44.17 54.84 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.809 0.67 . . . . 0.0 112.809 -178.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.512 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.71 -38.71 89.96 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-O 120.403 0.144 . . . . 0.0 111.126 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.703 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.1 mp -72.79 -39.56 66.6 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.688 -0.233 . . . . 0.0 110.92 178.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.546 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -70.17 -38.27 75.38 Favored 'General case' 0 N--CA 1.463 0.216 0 CA-C-N 116.339 -0.391 . . . . 0.0 110.442 179.594 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.9 tp -71.02 -35.18 71.93 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-N 115.989 -0.55 . . . . 0.0 110.697 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.435 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 2.1 tt -68.88 -44.44 73.26 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.296 179.601 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.562 HG23 ' O ' ' B' ' 74' ' ' LEU . 58.4 t -69.47 -44.46 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.387 0 CA-C-N 116.473 -0.33 . . . . 0.0 111.312 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.436 HG23 ' O ' ' B' ' 75' ' ' LEU . 75.0 t -66.81 -42.39 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.363 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.154 -179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.87 -39.27 83.76 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.098 179.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.2 tp -68.74 -35.58 77.3 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.596 179.307 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.94 -52.7 27.01 Favored Glycine 0 C--N 1.338 0.646 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.404 179.426 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.54 ' O ' HG12 ' B' ' 87' ' ' ILE . 13.7 mt -65.94 -35.38 74.95 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.616 0.246 . . . . 0.0 110.514 179.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . 0.533 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -65.58 -45.9 87.29 Favored Glycine 0 C--N 1.336 0.539 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.451 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 16.0 mt -75.1 -24.87 58.15 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-O 120.558 0.218 . . . . 0.0 111.281 179.696 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.8 t80 -77.58 -37.89 49.5 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.225 179.793 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.54 HG12 ' O ' ' B' ' 83' ' ' ILE . 50.7 mm -83.55 -33.62 9.92 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.411 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.202 -179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.533 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 15.1 ttm180 -66.05 -27.08 67.83 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 120.657 0.265 . . . . 0.0 111.327 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.498 ' O ' HG23 ' B' ' 93' ' ' VAL . 99.1 mtt180 -82.16 -18.25 43.45 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.412 179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . 0.548 ' O ' ' HB2' ' B' ' 94' ' ' ARG . 74.7 mtp180 -83.72 -21.84 32.19 Favored 'General case' 0 N--CA 1.464 0.226 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.621 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 27.8 m80 -83.09 -20.47 34.84 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.426 -179.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . 0.437 HG12 ' O ' ' B' ' 88' ' ' ARG . 11.1 mm -83.33 -29.49 7.91 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.258 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.983 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 89' ' ' ARG . 2.4 t -95.96 -3.51 10.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.009 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.548 ' HB2' ' O ' ' B' ' 90' ' ' ARG . 28.8 ttt180 -90.78 157.15 17.55 Favored 'General case' 0 C--O 1.233 0.201 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.949 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -93.07 157.34 16.34 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.005 -179.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -88.86 28.1 1.22 Allowed 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.268 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.662 ' O ' ' HB2' ' B' ' 101' ' ' LEU . 17.8 p -83.09 -13.81 54.95 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.701 -179.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 1.073 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 3.3 mm? -90.51 -18.14 25.83 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-O 121.1 0.476 . . . . 0.0 110.58 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 45.2 mtm180 -98.15 -35.41 10.4 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 114.878 -1.056 . . . . 0.0 108.38 179.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.654 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 94.9 mtt180 -73.85 -19.05 60.84 Favored 'General case' 0 CA--C 1.521 -0.147 0 CA-C-N 114.917 -1.038 . . . . 0.0 108.48 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' B' ' 97' ' ' THR . 3.0 mm? -108.52 -20.81 12.98 Favored 'General case' 0 N--CA 1.45 -0.436 0 CA-C-N 114.428 -1.26 . . . . 0.0 109.536 177.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 1.073 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 3.8 tt -62.75 -44.56 95.89 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.772 179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -92.87 -11.42 33.58 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.643 179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.654 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 6.6 tt0 -83.7 -45.16 13.72 Favored 'General case' 0 N--CA 1.466 0.369 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.581 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 24.4 mmt180 -88.08 -11.08 48.16 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.671 -179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.572 ' HB2' ' O ' ' B' ' 102' ' ' LEU . 9.6 tt0 -62.43 -57.12 12.38 Favored 'General case' 0 N--CA 1.466 0.337 0 CA-C-N 116.49 -0.323 . . . . 0.0 111.645 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 tp -150.06 27.22 0.78 Allowed 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 121.007 0.432 . . . . 0.0 111.173 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.471 ' HB ' ' O ' ' B' ' 104' ' ' GLU . 3.4 t -126.78 60.08 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.469 179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -95.03 148.06 34.06 Favored Pre-proline 0 CA--C 1.529 0.167 0 CA-C-N 115.816 -0.629 . . . . 0.0 111.004 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -68.85 133.0 26.09 Favored 'Trans proline' 0 C--N 1.354 0.841 0 C-N-CA 122.7 2.267 . . . . 0.0 112.803 -179.894 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 tp -142.85 87.3 1.98 Allowed 'General case' 0 C--O 1.235 0.304 0 CA-C-O 121.146 0.498 . . . . 0.0 110.137 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 18.2 p -99.4 155.03 36.97 Favored Pre-proline 0 C--N 1.327 -0.383 0 CA-C-N 115.503 -0.771 . . . . 0.0 111.148 179.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_exo -66.82 119.58 6.61 Favored 'Trans proline' 0 C--N 1.358 1.032 0 C-N-CA 122.572 2.181 . . . . 0.0 112.62 179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 39.9 p -100.23 -10.39 21.42 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.934 179.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -111.3 -98.53 2.45 Favored Glycine 0 C--N 1.334 0.455 0 C-N-CA 121.039 -0.601 . . . . 0.0 112.466 -179.976 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -102.31 149.31 24.46 Favored 'General case' 0 C--O 1.233 0.214 0 CA-C-O 120.694 0.283 . . . . 0.0 110.906 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.28 -42.18 14.87 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.307 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -90.16 -9.23 49.02 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.416 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 31.0 m-90 -131.21 144.77 51.59 Favored 'General case' 0 C--O 1.232 0.141 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.865 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 40.5 p . . . . . 0 C--O 1.249 1.069 0 CA-C-O 118.182 -0.913 . . . . 0.0 110.901 179.988 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.698 0.285 . . . . 0.0 110.922 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.01 146.3 54.17 Favored Pre-proline 0 CA--C 1.531 0.239 0 CA-C-N 116.042 -0.526 . . . . 0.0 111.205 -179.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.99 141.77 49.34 Favored 'Trans proline' 0 C--N 1.355 0.876 0 C-N-CA 122.711 2.274 . . . . 0.0 112.765 179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.9 m -80.57 -7.67 59.32 Favored 'General case' 0 C--O 1.235 0.301 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.534 179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.465 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.7 mp -82.93 -32.38 9.69 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.075 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.436 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -84.01 -27.64 28.25 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.552 -179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -64.42 -31.98 73.42 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.456 -179.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.04 -41.69 9.32 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.147 -0.549 . . . . 0.0 112.217 179.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.546 ' O ' HD13 ' A' ' 13' ' ' LEU . 23.2 mt -62.01 -43.65 98.39 Favored 'General case' 0 C--O 1.227 -0.13 0 C-N-CA 122.309 0.244 . . . . 0.0 111.187 179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.686 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 25.2 m -60.48 -38.18 77.17 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 CA-C-O 120.862 0.363 . . . . 0.0 111.663 -179.688 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.527 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -69.0 -49.32 42.03 Favored Glycine 0 CA--C 1.518 0.24 0 CA-C-N 115.923 -0.581 . . . . 0.0 112.756 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.449 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.58 -41.48 62.84 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.562 0.578 . . . . 0.0 112.562 -179.152 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.546 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.9 mp -66.21 -41.79 89.65 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.79 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.686 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.8 mp -70.5 -38.83 74.38 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.6 -0.273 . . . . 0.0 110.916 178.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.527 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.0 OUTLIER -69.7 -37.16 76.5 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.442 179.592 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tp -69.81 -36.93 76.06 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.6 179.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 18.1 mt -69.58 -40.85 76.49 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.288 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.6 HG23 ' O ' ' A' ' 14' ' ' LEU . 93.1 t -69.57 -42.37 80.62 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.395 0 CA-C-N 116.464 -0.335 . . . . 0.0 111.2 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 15' ' ' LEU . 97.7 t -70.62 -38.38 73.09 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 CA-C-N 116.523 -0.308 . . . . 0.0 111.176 179.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -70.67 -39.17 73.7 Favored 'General case' 0 C--O 1.234 0.257 0 CA-C-N 116.495 -0.32 . . . . 0.0 111.295 179.806 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.7 tp -70.86 -43.4 68.54 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.945 179.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.459 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.82 -57.84 7.5 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 121.231 -0.509 . . . . 0.0 112.5 179.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.564 ' O ' HG12 ' A' ' 27' ' ' ILE . 41.4 mm -65.86 -33.64 64.93 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.273 0 CA-C-O 120.643 0.259 . . . . 0.0 110.589 179.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.558 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -65.6 -47.65 75.32 Favored Glycine 0 C--N 1.337 0.617 0 C-N-CA 121.082 -0.58 . . . . 0.0 112.322 179.399 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.9 mt -74.8 -24.1 58.59 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-O 120.55 0.214 . . . . 0.0 111.147 179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.459 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.2 t80 -75.43 -39.69 58.56 Favored 'General case' 0 CA--C 1.532 0.279 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.242 179.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.564 HG12 ' O ' ' A' ' 23' ' ' ILE . 45.5 mm -83.59 -32.33 8.9 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.192 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.558 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.2 ttt180 -65.4 -26.1 67.84 Favored 'General case' 0 N--CA 1.466 0.364 0 CA-C-N 116.595 -0.275 . . . . 0.0 111.351 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -81.74 -18.04 45.63 Favored 'General case' 0 N--CA 1.464 0.247 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.406 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -81.53 -21.48 38.52 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.616 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.416 ' HD2' ' O ' ' A' ' 27' ' ' ILE . 54.8 m-70 -70.57 -27.86 64.45 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.642 -179.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.8 mt -83.19 -13.23 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.342 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.136 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 t -95.8 -9.2 9.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.279 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.004 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.424 ' NH2' HD13 ' A' ' 38' ' ' LEU . 31.0 ttt180 -92.38 157.83 16.4 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.867 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.5 tttt -91.51 154.32 19.19 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.003 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.44 20.34 3.94 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.36 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.427 ' O ' HD12 ' A' ' 41' ' ' LEU . 18.5 p -83.19 -16.62 45.86 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.657 -179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.008 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 23.3 mt -89.41 -10.67 45.64 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 121.239 0.542 . . . . 0.0 110.138 179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.85 -33.29 11.3 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.682 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 75.5 mtp180 -77.24 -24.24 51.2 Favored 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 114.254 -1.339 . . . . 0.0 108.013 177.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.427 HD12 ' O ' ' A' ' 37' ' ' THR . 14.5 mt -100.37 -20.29 15.89 Favored 'General case' 0 N--CA 1.451 -0.42 0 CA-C-N 114.285 -1.325 . . . . 0.0 109.238 177.644 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.008 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 2.6 tp -62.83 -48.49 78.86 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.585 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 46.3 mt-30 -88.06 -10.24 50.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.747 179.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.682 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 2.2 tp10 -83.68 -40.98 18.24 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.536 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -88.66 -12.05 43.54 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.458 -179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.469 ' OE2' ' HG ' ' A' ' 42' ' ' LEU . 32.3 mt-10 -96.37 -24.3 16.22 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.606 -179.771 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.3 tp -94.97 0.33 54.56 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 121.113 0.482 . . . . 0.0 111.384 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 44' ' ' GLU . 3.3 t -129.94 55.85 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.53 179.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -111.05 145.27 32.11 Favored Pre-proline 0 C--O 1.233 0.213 0 CA-C-N 115.857 -0.611 . . . . 0.0 110.869 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -69.56 132.04 22.81 Favored 'Trans proline' 0 C--N 1.355 0.898 0 C-N-CA 122.616 2.211 . . . . 0.0 112.767 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 tt -142.82 87.3 1.98 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.135 0.493 . . . . 0.0 110.204 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.1 p -137.18 131.61 17.75 Favored Pre-proline 0 C--N 1.327 -0.373 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.067 179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -74.0 155.89 47.73 Favored 'Trans proline' 0 C--N 1.355 0.916 0 C-N-CA 122.519 2.146 . . . . 0.0 112.742 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.6 m 60.42 20.97 10.61 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.029 -0.532 . . . . 0.0 111.892 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.16 -147.23 18.38 Favored Glycine 0 C--N 1.334 0.465 0 C-N-CA 120.99 -0.624 . . . . 0.0 112.489 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.5 148.5 25.13 Favored 'General case' 0 C--O 1.232 0.145 0 CA-C-O 120.626 0.25 . . . . 0.0 110.889 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -85.15 -41.73 15.41 Favored 'General case' 0 C--O 1.232 0.148 0 CA-C-N 116.07 -0.514 . . . . 0.0 111.404 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.16 -8.97 49.93 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.156 -0.475 . . . . 0.0 111.467 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -131.33 142.55 50.11 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.835 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.8 p . . . . . 0 C--O 1.25 1.084 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.883 -179.966 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.487 1.382 0 CA-C-O 120.646 0.26 . . . . 0.0 110.943 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.9 146.33 54.52 Favored Pre-proline 0 CA--C 1.532 0.253 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.221 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.5 Cg_endo -69.14 141.9 49.09 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.635 2.223 . . . . 0.0 112.698 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.6 m -80.67 -7.66 59.38 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.497 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.471 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.6 mp -82.81 -32.38 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.116 -179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.435 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.96 -27.7 28.31 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.552 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -64.44 -31.99 73.44 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.521 -179.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -82.01 -41.67 9.36 Favored Glycine 0 C--N 1.337 0.584 0 C-N-CA 121.12 -0.562 . . . . 0.0 112.207 179.338 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.549 ' O ' HD13 ' B' ' 73' ' ' LEU . 23.1 mt -61.95 -43.59 98.53 Favored 'General case' 0 N--CA 1.462 0.132 0 CA-C-O 120.598 0.237 . . . . 0.0 111.32 179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.672 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 25.4 m -60.44 -38.23 77.22 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.232 0 CA-C-O 120.811 0.339 . . . . 0.0 111.605 -179.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -69.13 -49.29 41.28 Favored Glycine 0 CA--C 1.518 0.249 0 CA-C-N 115.891 -0.595 . . . . 0.0 112.671 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.455 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.51 -41.5 62.99 Favored 'General case' 0 N--CA 1.463 0.213 0 N-CA-C 112.592 0.59 . . . . 0.0 112.592 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.549 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.9 mp -66.2 -41.76 89.72 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-N 116.735 -0.211 . . . . 0.0 110.806 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.672 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -70.62 -38.7 73.97 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-N 116.599 -0.273 . . . . 0.0 110.875 179.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.0 OUTLIER -69.62 -37.3 76.77 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.481 179.546 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 3.5 tp -69.73 -36.89 76.27 Favored 'General case' 0 CA--C 1.53 0.185 0 CA-C-N 115.998 -0.546 . . . . 0.0 110.61 179.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.401 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 18.1 mt -69.62 -40.74 76.39 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.32 179.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 74' ' ' LEU . 93.1 t -69.63 -42.46 80.49 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.361 0 CA-C-N 116.473 -0.331 . . . . 0.0 111.188 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.485 HG23 ' O ' ' B' ' 75' ' ' LEU . 98.1 t -70.51 -38.45 73.72 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 CA-C-N 116.63 -0.259 . . . . 0.0 111.089 179.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -70.68 -39.24 73.66 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.22 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.401 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 1.7 tp -70.9 -43.31 68.59 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.937 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.84 -57.87 7.44 Favored Glycine 0 C--N 1.337 0.61 0 C-N-CA 121.178 -0.534 . . . . 0.0 112.49 179.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.556 ' O ' HG12 ' B' ' 87' ' ' ILE . 41.2 mm -65.78 -33.64 64.98 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 CA-C-O 120.581 0.229 . . . . 0.0 110.625 179.631 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . 0.565 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -65.64 -47.61 75.4 Favored Glycine 0 C--N 1.337 0.585 0 C-N-CA 121.068 -0.587 . . . . 0.0 112.361 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 20.7 mt -74.84 -24.03 58.54 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-O 120.563 0.22 . . . . 0.0 111.179 179.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.454 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.3 t80 -75.51 -39.73 58.04 Favored 'General case' 0 N--CA 1.464 0.259 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.159 179.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.556 HG12 ' O ' ' B' ' 83' ' ' ILE . 45.6 mm -83.59 -32.38 8.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.322 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.135 179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.565 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.1 ttt180 -65.36 -26.01 67.83 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.608 -0.269 . . . . 0.0 111.438 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -81.72 -18.01 45.82 Favored 'General case' 0 N--CA 1.464 0.244 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.46 179.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -81.61 -21.38 38.35 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 116.253 -0.431 . . . . 0.0 111.59 -179.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 91' ' ' HIS . . . . . 0.414 ' HD2' ' O ' ' B' ' 87' ' ' ILE . 54.9 m-70 -70.65 -27.8 64.32 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.644 -179.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 1.8 mt -83.22 -13.27 11.98 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.324 0 CA-C-N 116.442 -0.344 . . . . 0.0 111.102 179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 2.7 t -95.69 -9.31 9.29 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.287 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.997 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.432 ' NH2' HD13 ' B' ' 98' ' ' LEU . 31.1 ttt180 -92.32 157.89 16.39 Favored 'General case' 0 C--O 1.232 0.164 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.859 -179.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -91.57 154.36 19.12 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.87 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -89.5 20.44 3.92 Favored 'General case' 0 CA--C 1.532 0.265 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.343 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.428 ' O ' HD12 ' B' ' 101' ' ' LEU . 18.6 p -83.18 -16.68 45.65 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.266 -0.424 . . . . 0.0 111.627 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 1.01 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 23.8 mt -89.46 -10.67 45.54 Favored 'General case' 0 N--CA 1.464 0.254 0 CA-C-O 121.204 0.526 . . . . 0.0 110.121 -179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -97.83 -33.17 11.35 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 107.436 -1.32 . . . . 0.0 107.436 178.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.676 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 75.5 mtp180 -77.45 -24.17 50.33 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 114.281 -1.327 . . . . 0.0 107.896 177.666 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.428 HD12 ' O ' ' B' ' 97' ' ' THR . 14.6 mt -100.39 -20.35 15.85 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-N 114.328 -1.306 . . . . 0.0 109.29 177.619 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 1.01 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 2.6 tp -62.75 -48.51 78.89 Favored 'General case' 0 N--CA 1.468 0.471 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.686 179.245 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -87.99 -10.26 50.93 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.776 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.676 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 2.2 tp10 -83.7 -41.03 18.15 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 116.187 -0.461 . . . . 0.0 111.494 -179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 7.6 tpt180 -88.65 -11.98 43.79 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.475 -0.33 . . . . 0.0 111.53 -179.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.465 ' OE2' ' HG ' ' B' ' 102' ' ' LEU . 32.3 mt-10 -96.33 -24.31 16.24 Favored 'General case' 0 N--CA 1.464 0.253 0 CA-C-N 116.378 -0.373 . . . . 0.0 111.594 -179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 3.4 tp -95.0 0.29 54.49 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-O 121.166 0.508 . . . . 0.0 111.332 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.429 HG23 ' O ' ' B' ' 104' ' ' GLU . 3.3 t -129.96 55.94 0.34 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-N 115.412 -0.813 . . . . 0.0 110.437 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -111.11 145.26 32.1 Favored Pre-proline 0 C--N 1.332 -0.178 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.879 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 43.5 Cg_endo -69.64 132.1 22.8 Favored 'Trans proline' 0 C--N 1.354 0.858 0 C-N-CA 122.64 2.227 . . . . 0.0 112.683 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 tt -142.93 87.34 1.98 Allowed 'General case' 0 C--O 1.233 0.209 0 CA-C-O 121.208 0.528 . . . . 0.0 110.166 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 17.3 p -137.23 131.41 17.63 Favored Pre-proline 0 C--N 1.328 -0.354 0 CA-C-N 115.487 -0.779 . . . . 0.0 111.083 179.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -73.8 155.81 48.71 Favored 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.543 2.162 . . . . 0.0 112.832 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 53.1 m 60.51 20.93 10.68 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.827 179.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 99.12 -147.12 18.35 Favored Glycine 0 C--N 1.333 0.414 0 C-N-CA 121.072 -0.585 . . . . 0.0 112.509 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.59 148.48 25.18 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.648 0.261 . . . . 0.0 110.961 179.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -85.23 -41.58 15.47 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.396 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.05 -9.24 49.27 Favored 'General case' 0 C--O 1.234 0.249 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.455 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -131.23 142.51 50.17 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 41.1 p . . . . . 0 C--O 1.25 1.123 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.967 179.965 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 50.6 tttt . . . . . 0 N--CA 1.487 1.408 0 CA-C-O 120.607 0.241 . . . . 0.0 110.902 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.77 146.3 56.69 Favored Pre-proline 0 C--O 1.234 0.255 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.234 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_endo -68.9 141.21 48.12 Favored 'Trans proline' 0 C--N 1.352 0.761 0 C-N-CA 122.78 2.32 . . . . 0.0 112.696 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.2 t -80.69 -7.6 59.38 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.059 -0.519 . . . . 0.0 111.44 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.6 mp -82.99 -32.66 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.09 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.455 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.95 -25.86 29.73 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.364 -0.38 . . . . 0.0 111.656 -179.933 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -63.78 -33.49 75.78 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.59 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.0 -40.91 9.95 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.106 -0.569 . . . . 0.0 112.289 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.514 ' O ' HD13 ' A' ' 13' ' ' LEU . 22.0 mt -62.24 -43.38 98.96 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 122.283 0.233 . . . . 0.0 111.393 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.1 m -60.91 -41.09 87.54 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-O 120.826 0.346 . . . . 0.0 111.779 -179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -67.51 -48.34 57.64 Favored Glycine 0 C--N 1.33 0.211 0 CA-C-N 115.97 -0.559 . . . . 0.0 112.877 -179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.447 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.99 -43.5 57.84 Favored 'General case' 0 N--CA 1.463 0.224 0 N-CA-C 112.667 0.617 . . . . 0.0 112.667 -178.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.514 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.4 -39.47 92.25 Favored 'General case' 0 C--O 1.236 0.368 0 O-C-N 122.911 0.132 . . . . 0.0 110.971 -179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.68 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 4.0 mp -72.22 -39.83 68.23 Favored 'General case' 0 C--O 1.233 0.233 0 CA-C-O 120.605 0.241 . . . . 0.0 110.924 178.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.52 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -70.2 -38.43 75.32 Favored 'General case' 0 N--CA 1.463 0.176 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.583 179.574 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.3 tp -70.69 -34.52 72.05 Favored 'General case' 0 C--O 1.231 0.126 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.657 179.264 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.437 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.34 -44.14 72.22 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 116.097 -0.501 . . . . 0.0 111.162 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.57 HG23 ' O ' ' A' ' 14' ' ' LEU . 59.8 t -69.25 -44.04 80.88 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.464 0 CA-C-N 116.515 -0.311 . . . . 0.0 111.226 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 15' ' ' LEU . 71.8 t -66.55 -43.27 90.75 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.151 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.15 -39.26 86.49 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 116.445 -0.343 . . . . 0.0 111.124 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.36 -36.32 79.04 Favored 'General case' 0 C--O 1.234 0.256 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.635 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.93 -50.14 43.14 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 116.101 -0.5 . . . . 0.0 112.299 179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 18.9 mt -64.39 -41.22 91.7 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 CA-C-O 120.669 0.271 . . . . 0.0 110.603 179.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.42 -44.65 96.45 Favored Glycine 0 C--N 1.337 0.635 0 C-N-CA 121.184 -0.532 . . . . 0.0 112.404 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.501 ' HG ' ' NH2' ' A' ' 28' ' ' ARG . 20.1 mt -73.95 -23.83 59.55 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-O 120.595 0.236 . . . . 0.0 110.931 179.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 6.6 t80 -74.43 -39.13 62.79 Favored 'General case' 0 CA--C 1.531 0.246 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.144 179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.35 -35.0 11.41 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.376 -0.374 . . . . 0.0 111.255 179.695 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.501 ' NH2' ' HG ' ' A' ' 25' ' ' LEU . 74.0 mtm180 -64.14 -26.29 68.47 Favored 'General case' 0 N--CA 1.467 0.42 0 CA-C-N 116.451 -0.341 . . . . 0.0 111.656 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.449 ' O ' HG23 ' A' ' 33' ' ' VAL . 98.6 mtt180 -82.14 -18.13 43.94 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.358 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.46 ' NH2' ' HE2' ' A' ' 26' ' ' PHE . 97.6 mtt180 -86.12 -21.58 27.53 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.622 -179.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 54.3 m-70 -70.39 -29.32 65.93 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.463 -0.335 . . . . 0.0 111.713 -179.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.8 mt -83.32 -19.01 10.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.097 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 29' ' ' ARG . 4.1 t -97.94 -28.29 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.986 179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -92.36 156.24 17.36 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.007 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -94.0 158.34 15.67 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.923 179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -88.55 34.89 0.76 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.351 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' A' ' 41' ' ' LEU . 19.2 p -82.99 -16.43 47.26 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.716 179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 1.044 ' O ' ' HB2' ' A' ' 42' ' ' LEU . 4.2 mm? -89.81 -14.8 33.67 Favored 'General case' 0 N--CA 1.462 0.147 0 CA-C-O 121.132 0.491 . . . . 0.0 110.475 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 38.9 ttt180 -97.66 -34.46 10.93 Favored 'General case' 0 CA--C 1.516 -0.352 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.657 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 68.8 mtp180 -74.73 -20.24 59.91 Favored 'General case' 0 CA--C 1.52 -0.192 0 CA-C-N 114.678 -1.147 . . . . 0.0 108.097 177.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' A' ' 37' ' ' THR . 6.8 mt -104.82 -22.47 13.17 Favored 'General case' 0 N--CA 1.448 -0.534 0 CA-C-N 114.193 -1.367 . . . . 0.0 109.315 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 1.044 ' HB2' ' O ' ' A' ' 38' ' ' LEU . 2.9 tt -66.98 -48.81 67.37 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.555 179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -84.51 -8.94 58.76 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.068 -0.514 . . . . 0.0 110.51 179.442 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.657 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 0.8 OUTLIER -83.44 -35.85 24.66 Favored 'General case' 0 N--CA 1.464 0.255 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.4 179.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -88.12 -11.68 46.28 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.248 -179.644 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.454 ' OE1' HD23 ' A' ' 42' ' ' LEU . 32.4 mt-10 -75.26 -13.64 60.45 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.379 -0.373 . . . . 0.0 111.48 179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.5 tp -117.18 4.83 12.66 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 121.085 0.469 . . . . 0.0 110.991 179.737 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 44' ' ' GLU . 4.5 t -126.34 62.34 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.478 -0.783 . . . . 0.0 110.506 179.495 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -99.13 130.59 26.98 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 115.786 -0.643 . . . . 0.0 110.759 179.891 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.7 133.51 20.43 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.474 2.116 . . . . 0.0 112.717 -179.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.9 87.4 1.98 Allowed 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.117 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -123.48 145.92 48.29 Favored Pre-proline 0 C--N 1.327 -0.398 0 CA-C-N 115.528 -0.76 . . . . 0.0 111.102 179.61 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -69.42 120.62 7.43 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 122.533 2.155 . . . . 0.0 112.743 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 39.0 p -120.67 -10.09 9.25 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.908 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 160.39 57.13 0.01 OUTLIER Glycine 0 C--N 1.335 0.48 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.531 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -101.76 148.29 25.46 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 120.74 0.305 . . . . 0.0 111.004 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -85.19 -41.32 15.74 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.347 -179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.11 -8.99 49.99 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.543 -179.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -131.37 135.06 46.9 Favored 'General case' 0 C--O 1.232 0.181 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.851 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 40.4 p . . . . . 0 C--O 1.251 1.183 0 CA-C-O 118.407 -0.806 . . . . 0.0 110.903 -179.99 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 50.5 tttt . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.623 0.249 . . . . 0.0 110.934 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -126.83 146.35 56.99 Favored Pre-proline 0 CA--C 1.532 0.259 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.19 -179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -69.04 141.3 47.74 Favored 'Trans proline' 0 C--N 1.354 0.845 0 C-N-CA 122.6 2.2 . . . . 0.0 112.708 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.4 t -80.61 -7.7 59.36 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.413 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.468 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.6 mp -82.88 -32.65 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.286 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.133 -179.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.451 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.99 -25.9 29.62 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.639 -179.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -63.76 -33.62 76.06 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.465 -179.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.86 -40.96 10.02 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.289 179.551 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.515 ' O ' HD13 ' B' ' 73' ' ' LEU . 21.9 mt -62.26 -43.37 98.98 Favored 'General case' 0 CA--C 1.528 0.111 0 C-N-CA 122.346 0.258 . . . . 0.0 111.381 -179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.665 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 23.7 m -60.99 -40.96 87.3 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-N 116.437 -0.347 . . . . 0.0 111.765 -179.558 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.53 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.58 -48.43 56.7 Favored Glycine 0 CA--C 1.518 0.28 0 CA-C-N 116.007 -0.542 . . . . 0.0 112.806 -179.937 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.453 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.86 -43.63 58.03 Favored 'General case' 0 N--CA 1.463 0.21 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -178.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.515 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.27 -39.42 92.6 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-O 120.45 0.167 . . . . 0.0 111.056 -179.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.665 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 4.0 mp -72.39 -39.68 67.8 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 120.646 0.26 . . . . 0.0 110.947 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.53 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -70.13 -38.52 75.57 Favored 'General case' 0 N--CA 1.463 0.198 0 CA-C-N 116.345 -0.388 . . . . 0.0 110.584 179.451 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.445 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.3 tp -70.76 -34.53 71.94 Favored 'General case' 0 N--CA 1.462 0.169 0 CA-C-N 116.002 -0.544 . . . . 0.0 110.566 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.432 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.21 -44.23 72.5 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.168 179.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.577 HG23 ' O ' ' B' ' 74' ' ' LEU . 59.9 t -69.31 -43.88 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.426 -0.352 . . . . 0.0 111.286 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.445 HG23 ' O ' ' B' ' 75' ' ' LEU . 71.7 t -66.51 -43.5 90.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.424 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.029 179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.14 -39.15 86.52 Favored 'General case' 0 N--CA 1.464 0.26 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.159 179.656 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.432 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.3 tp -68.39 -36.33 78.99 Favored 'General case' 0 CA--C 1.53 0.201 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.683 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.486 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.88 -50.1 43.73 Favored Glycine 0 C--N 1.337 0.596 0 CA-C-N 115.968 -0.56 . . . . 0.0 112.427 179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 19.1 mt -64.44 -41.23 91.69 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 CA-C-O 120.652 0.263 . . . . 0.0 110.562 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.55 -44.63 96.29 Favored Glycine 0 C--N 1.336 0.56 0 C-N-CA 121.169 -0.539 . . . . 0.0 112.317 179.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.497 ' HG ' ' NH2' ' B' ' 88' ' ' ARG . 20.0 mt -73.86 -23.85 59.67 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-O 120.704 0.288 . . . . 0.0 111.015 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.486 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 6.5 t80 -74.37 -39.22 62.88 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.13 -0.487 . . . . 0.0 111.127 179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . . . . . . . . . 16.0 mt -83.29 -35.08 11.55 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.282 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.258 179.766 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.497 ' NH2' ' HG ' ' B' ' 85' ' ' LEU . 74.2 mtm180 -64.11 -26.3 68.48 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.483 -0.326 . . . . 0.0 111.632 -179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . 0.449 ' O ' HG23 ' B' ' 93' ' ' VAL . 98.5 mtt180 -82.11 -18.3 43.43 Favored 'General case' 0 N--CA 1.466 0.341 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.279 179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . 0.464 ' NH2' ' HE2' ' B' ' 86' ' ' PHE . 97.6 mtt180 -86.01 -21.71 27.66 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.607 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 53.9 m-70 -70.31 -29.44 66.17 Favored 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.69 -179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.7 mt -83.21 -18.94 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.3 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.15 179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . 0.449 HG23 ' O ' ' B' ' 89' ' ' ARG . 4.2 t -98.04 -28.21 3.66 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.935 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 19.1 ttt180 -92.34 156.33 17.32 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.016 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 96.5 mttt -94.19 158.36 15.63 Favored 'General case' 0 C--O 1.232 0.143 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.913 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -88.58 35.05 0.76 Allowed 'General case' 0 CA--C 1.532 0.28 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.368 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.532 ' O ' ' HB2' ' B' ' 101' ' ' LEU . 18.9 p -83.15 -16.54 46.33 Favored 'General case' 0 N--CA 1.465 0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.511 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 1.029 ' O ' ' HB2' ' B' ' 102' ' ' LEU . 4.2 mm? -89.74 -14.83 33.8 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-O 121.042 0.449 . . . . 0.0 110.414 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 39.0 ttt180 -97.59 -34.46 10.95 Favored 'General case' 0 CA--C 1.515 -0.367 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 179.349 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.675 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 68.8 mtp180 -74.63 -20.26 59.97 Favored 'General case' 0 CA--C 1.52 -0.187 0 CA-C-N 114.61 -1.177 . . . . 0.0 108.127 177.744 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.532 ' HB2' ' O ' ' B' ' 97' ' ' THR . 6.8 mt -104.78 -22.56 13.17 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-N 114.228 -1.351 . . . . 0.0 109.239 177.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 1.029 ' HB2' ' O ' ' B' ' 98' ' ' LEU . 2.8 tt -66.77 -48.93 67.53 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.637 179.342 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -84.47 -8.95 58.78 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.513 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.675 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 0.8 OUTLIER -83.38 -35.85 24.78 Favored 'General case' 0 N--CA 1.464 0.272 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.494 179.897 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 8.0 tpt180 -88.14 -11.72 46.09 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.257 -179.642 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.452 ' OE1' HD23 ' B' ' 102' ' ' LEU . 32.3 mt-10 -75.36 -13.5 60.41 Favored 'General case' 0 N--CA 1.464 0.237 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.432 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 3.5 tp -117.26 4.78 12.61 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 121.171 0.51 . . . . 0.0 111.027 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.498 HG23 ' O ' ' B' ' 104' ' ' GLU . 4.5 t -126.37 62.36 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.415 -0.812 . . . . 0.0 110.417 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 12.1 tt0 -99.17 130.51 27.11 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.709 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -72.78 133.45 20.2 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.541 2.161 . . . . 0.0 112.724 -179.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.88 87.36 1.98 Allowed 'General case' 0 C--O 1.234 0.26 0 CA-C-O 121.197 0.523 . . . . 0.0 110.173 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 17.9 p -123.44 145.93 48.22 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.537 -0.756 . . . . 0.0 111.095 179.635 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.43 120.57 7.39 Favored 'Trans proline' 0 C--N 1.355 0.888 0 C-N-CA 122.705 2.27 . . . . 0.0 112.692 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 39.4 p -120.66 -10.04 9.26 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.913 179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 160.33 57.16 0.01 OUTLIER Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.093 -0.575 . . . . 0.0 112.498 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -101.77 148.29 25.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 120.681 0.277 . . . . 0.0 110.972 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 65.7 mttm -85.31 -41.2 15.73 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.325 -179.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.11 -9.07 49.75 Favored 'General case' 0 C--O 1.233 0.205 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.574 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 91.4 m95 -131.37 134.95 46.8 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.861 -179.97 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 39.4 p . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.306 -0.854 . . . . 0.0 110.873 179.998 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 65.9 mttm . . . . . 0 N--CA 1.487 1.388 0 CA-C-O 120.721 0.296 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.08 146.87 56.38 Favored Pre-proline 0 CA--C 1.532 0.25 0 CA-C-N 116.075 -0.512 . . . . 0.0 111.186 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_endo -68.93 150.59 73.34 Favored 'Trans proline' 0 C--N 1.354 0.829 0 C-N-CA 122.597 2.198 . . . . 0.0 112.691 -179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.7 m -80.59 -10.12 59.75 Favored 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.595 -179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.464 ' H ' HD12 ' A' ' 5' ' ' ILE . 3.1 mp -82.88 -30.89 8.77 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.376 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.076 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.444 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.92 -27.1 28.82 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 116.334 -0.394 . . . . 0.0 111.637 -179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -63.86 -32.68 74.28 Favored 'General case' 0 N--CA 1.466 0.35 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.543 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.52 9.55 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 121.115 -0.564 . . . . 0.0 112.346 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.52 ' O ' HD13 ' A' ' 13' ' ' LEU . 21.8 mt -62.15 -43.02 99.76 Favored 'General case' 0 C--O 1.227 -0.102 0 CA-C-N 115.725 -0.237 . . . . 0.0 111.431 179.933 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.68 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.5 m -60.83 -39.61 82.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.275 0 CA-C-O 120.78 0.324 . . . . 0.0 111.726 -179.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.69 -48.81 47.39 Favored Glycine 0 C--O 1.235 0.217 0 CA-C-N 115.871 -0.604 . . . . 0.0 112.836 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.82 -41.41 62.37 Favored 'General case' 0 N--CA 1.464 0.245 0 N-CA-C 112.607 0.595 . . . . 0.0 112.607 -179.092 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.52 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -67.03 -39.65 87.05 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.438 0.161 . . . . 0.0 110.915 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.68 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.5 mp -71.37 -39.35 71.28 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 116.63 -0.259 . . . . 0.0 110.766 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.52 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.37 -40.44 77.46 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.323 179.426 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.3 tp -69.55 -32.68 71.63 Favored 'General case' 0 N--CA 1.462 0.128 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.528 179.218 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.439 ' HB2' ' O ' ' A' ' 13' ' ' LEU . 3.5 tp -69.68 -43.0 73.38 Favored 'General case' 0 CA--C 1.53 0.205 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.99 179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.613 HG23 ' O ' ' A' ' 14' ' ' LEU . 60.0 t -68.99 -43.65 81.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.384 0 CA-C-N 116.393 -0.367 . . . . 0.0 111.061 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.52 HG23 ' O ' ' A' ' 15' ' ' LEU . 93.3 t -66.34 -43.31 91.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 179.758 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.69 -37.5 82.39 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.094 179.606 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -69.78 -35.85 75.22 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.592 179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.431 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.14 -52.75 25.88 Favored Glycine 0 C--N 1.337 0.594 0 CA-C-N 115.948 -0.569 . . . . 0.0 112.279 179.371 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.599 ' O ' HG12 ' A' ' 27' ' ' ILE . 11.2 mt -65.13 -37.76 81.02 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.308 0 CA-C-O 120.633 0.254 . . . . 0.0 110.577 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -63.94 -46.53 91.28 Favored Glycine 0 C--N 1.335 0.519 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.31 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.56 -24.47 60.11 Favored 'General case' 0 N--CA 1.465 0.29 0 CA-C-O 120.587 0.232 . . . . 0.0 111.126 179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.431 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 8.1 t80 -75.81 -38.74 57.89 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.274 179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.599 HG12 ' O ' ' A' ' 23' ' ' ILE . 39.3 mm -83.7 -31.91 8.53 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.299 0 CA-C-N 116.455 -0.339 . . . . 0.0 111.196 179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -66.62 -25.8 66.77 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 120.691 0.281 . . . . 0.0 111.578 179.797 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.7 -18.09 45.64 Favored 'General case' 0 C--O 1.234 0.263 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.304 179.89 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 74.7 mtp180 -82.68 -21.29 34.96 Favored 'General case' 0 N--CA 1.466 0.34 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.529 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 35.1 m80 -69.57 -15.8 63.29 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.883 -179.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.05 -19.19 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.01 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 t -96.78 -46.09 12.86 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.214 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.706 179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -113.04 125.31 54.25 Favored 'General case' 0 C--O 1.232 0.183 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.736 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -132.05 110.5 10.76 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.046 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 55.99 27.32 11.05 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.1 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.2 p -83.5 -34.78 25.26 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.555 179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.906 ' O ' ' N ' ' A' ' 42' ' ' LEU . 15.1 tp -89.54 -34.71 16.27 Favored 'General case' 0 C--O 1.223 -0.331 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.378 -179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.448 ' HD3' ' NE2' ' A' ' 43' ' ' GLN . 98.9 mtt180 -67.71 -29.09 68.25 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.461 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 42.8 mtt180 -69.28 -17.99 63.8 Favored 'General case' 0 CA--C 1.52 -0.179 0 N-CA-C 106.893 -1.521 . . . . 0.0 106.893 176.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.677 HD22 HD22 ' B' ' 101' ' ' LEU . 11.7 mt -112.0 -27.11 8.55 Favored 'General case' 0 N--CA 1.445 -0.677 0 CA-C-N 113.415 -1.72 . . . . 0.0 109.633 177.715 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.906 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.8 OUTLIER -88.69 -60.54 1.93 Allowed 'General case' 0 C--N 1.351 0.672 0 N-CA-C 111.735 0.272 . . . . 0.0 111.735 -179.239 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.489 ' O ' ' HB2' ' A' ' 47' ' ' LEU . 37.7 mt-30 -69.66 -22.08 63.47 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.697 -179.633 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.461 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 8.8 mm-40 -83.8 -19.69 34.59 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.423 -0.353 . . . . 0.0 111.569 179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.516 ' HB3' ' OE2' ' A' ' 46' ' ' GLU . 2.9 tmt_? -88.71 -11.85 43.98 Favored 'General case' 0 CA--C 1.533 0.317 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.432 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.516 ' OE2' ' HB3' ' A' ' 45' ' ' ARG . 2.1 mp0 -116.12 -39.25 3.45 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 112.157 0.429 . . . . 0.0 112.157 -179.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.489 ' HB2' ' O ' ' A' ' 43' ' ' GLN . 4.2 mm? -88.83 10.33 21.5 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.969 0.414 . . . . 0.0 112.031 -179.223 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.4 39.73 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.643 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.406 ' OE2' ' HA ' ' A' ' 46' ' ' GLU . 42.5 mt-10 -100.25 143.83 27.26 Favored Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.882 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_endo -70.64 160.61 48.88 Favored 'Trans proline' 0 C--N 1.355 0.903 0 C-N-CA 122.639 2.226 . . . . 0.0 112.745 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 4.7 mp -142.59 87.41 2.0 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.253 0.549 . . . . 0.0 110.229 179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.1 p -112.45 146.76 35.61 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.122 179.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -69.37 121.43 8.2 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 122.647 2.232 . . . . 0.0 112.739 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.4 m -126.04 -10.12 6.54 Favored 'General case' 0 C--O 1.234 0.26 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.905 179.809 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -139.86 55.91 0.63 Allowed Glycine 0 C--N 1.335 0.494 0 C-N-CA 120.988 -0.625 . . . . 0.0 112.391 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -102.31 134.32 45.8 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-O 120.721 0.296 . . . . 0.0 110.832 179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.22 -41.99 15.1 Favored 'General case' 0 CA--C 1.53 0.191 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.237 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.21 -7.67 52.99 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.342 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 92.8 m95 62.23 121.89 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.677 0 C-N-CA 122.975 0.51 . . . . 0.0 111.537 -179.921 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.248 1.018 0 CA-C-O 118.213 -0.898 . . . . 0.0 110.897 179.947 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 65.9 mttm . . . . . 0 N--CA 1.485 1.323 0 CA-C-O 120.715 0.293 . . . . 0.0 110.97 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.1 146.71 55.68 Favored Pre-proline 0 CA--C 1.531 0.247 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.189 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -68.68 150.49 74.46 Favored 'Trans proline' 0 C--N 1.355 0.877 0 C-N-CA 122.668 2.246 . . . . 0.0 112.755 179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.4 m -80.63 -10.14 59.75 Favored 'General case' 0 N--CA 1.465 0.317 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.473 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.465 HD12 ' H ' ' B' ' 65' ' ' ILE . 3.1 mp -82.95 -30.83 8.64 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.082 -179.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.438 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -26.97 28.94 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.305 -0.407 . . . . 0.0 111.628 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -63.89 -32.68 74.28 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-N 116.257 -0.429 . . . . 0.0 111.528 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.89 -41.6 9.51 Favored Glycine 0 C--N 1.335 0.487 0 C-N-CA 121.105 -0.569 . . . . 0.0 112.289 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.514 ' O ' ' HB2' ' B' ' 73' ' ' LEU . 22.1 mt -62.21 -43.11 99.57 Favored 'General case' 0 N--CA 1.461 0.081 0 CA-C-N 115.657 -0.272 . . . . 0.0 111.31 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.67 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.2 m -60.81 -39.5 82.03 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.341 0 CA-C-O 120.744 0.306 . . . . 0.0 111.767 -179.618 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.485 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.73 -48.87 46.73 Favored Glycine 0 CA--C 1.518 0.246 0 CA-C-N 115.989 -0.55 . . . . 0.0 112.775 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.462 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.76 -41.33 62.6 Favored 'General case' 0 N--CA 1.464 0.258 0 N-CA-C 112.576 0.584 . . . . 0.0 112.576 -179.064 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.514 ' HB2' ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -67.11 -39.73 86.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.876 -0.147 . . . . 0.0 110.85 -179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.67 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -71.27 -39.36 71.62 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 120.67 0.271 . . . . 0.0 110.824 178.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.529 ' O ' HG23 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.31 -40.48 77.64 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.389 179.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.4 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.3 tp -69.6 -32.54 71.34 Favored 'General case' 0 CA--C 1.529 0.15 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.556 179.201 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.451 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.83 -42.87 73.05 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 115.997 -0.547 . . . . 0.0 110.997 179.506 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.618 HG23 ' O ' ' B' ' 74' ' ' LEU . 59.7 t -69.06 -43.67 81.67 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 CA-C-N 116.432 -0.349 . . . . 0.0 111.066 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.529 HG23 ' O ' ' B' ' 75' ' ' LEU . 94.3 t -66.3 -43.41 91.58 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.365 -0.38 . . . . 0.0 110.988 179.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.61 -37.44 82.52 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.146 179.596 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.451 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.2 tp -69.82 -35.73 75.04 Favored 'General case' 0 C--O 1.233 0.185 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.63 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.2 -52.71 25.85 Favored Glycine 0 C--N 1.337 0.632 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.215 179.391 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.607 ' O ' HG12 ' B' ' 87' ' ' ILE . 11.2 mt -65.23 -37.77 80.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.332 0 CA-C-O 120.585 0.231 . . . . 0.0 110.471 179.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -63.98 -46.44 91.42 Favored Glycine 0 C--N 1.336 0.568 0 C-N-CA 121.136 -0.554 . . . . 0.0 112.377 179.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 18.7 mt -73.53 -24.54 60.15 Favored 'General case' 0 N--CA 1.464 0.235 0 CA-C-O 120.595 0.236 . . . . 0.0 111.179 179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.438 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 8.3 t80 -75.85 -38.64 57.81 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.269 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.607 HG12 ' O ' ' B' ' 83' ' ' ILE . 39.1 mm -83.72 -31.91 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 CA-C-N 116.39 -0.368 . . . . 0.0 111.178 179.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 91.7 mtt180 -66.65 -25.95 66.82 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.604 -0.271 . . . . 0.0 111.506 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -81.55 -18.09 46.17 Favored 'General case' 0 N--CA 1.464 0.268 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.332 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -82.63 -21.32 35.1 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.522 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 35.3 m80 -69.52 -15.96 63.34 Favored 'General case' 0 N--CA 1.466 0.362 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.825 -179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.9 mt -83.03 -19.24 10.1 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 CA-C-N 116.578 -0.283 . . . . 0.0 110.989 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.69 -46.17 12.88 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.223 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.711 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 99.1 mtt180 -113.0 125.3 54.25 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.739 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -132.01 110.45 10.75 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.026 -179.998 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 95.8 mtt180 55.98 27.29 11.01 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.989 -0.551 . . . . 0.0 112.029 179.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 18.4 p -83.49 -34.72 25.28 Favored 'General case' 0 N--CA 1.463 0.218 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.597 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.896 ' O ' ' N ' ' B' ' 102' ' ' LEU . 15.0 tp -89.61 -34.76 16.2 Favored 'General case' 0 C--O 1.222 -0.366 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.36 -179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . 0.439 ' HD3' ' NE2' ' B' ' 103' ' ' GLN . 98.9 mtt180 -67.59 -29.18 68.47 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.454 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 43.0 mtt180 -69.21 -18.05 63.85 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.946 -1.502 . . . . 0.0 106.946 176.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.677 HD22 HD22 ' A' ' 41' ' ' LEU . 11.7 mt -112.02 -27.06 8.56 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 113.367 -1.742 . . . . 0.0 109.671 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.896 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.8 OUTLIER -88.56 -60.68 1.89 Allowed 'General case' 0 C--N 1.351 0.638 0 N-CA-C 111.797 0.295 . . . . 0.0 111.797 -179.384 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . 0.484 ' O ' ' HB2' ' B' ' 107' ' ' LEU . 37.5 mt-30 -69.57 -22.18 63.56 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.559 -0.291 . . . . 0.0 111.641 -179.594 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.454 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 8.8 mm-40 -83.72 -19.79 34.59 Favored 'General case' 0 N--CA 1.464 0.269 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.512 179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.52 ' HB3' ' OE2' ' B' ' 106' ' ' GLU . 2.9 tmt_? -88.67 -11.9 43.97 Favored 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.517 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . 0.52 ' OE2' ' HB3' ' B' ' 105' ' ' ARG . 2.1 mp0 -115.97 -39.34 3.48 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 112.191 0.441 . . . . 0.0 112.191 -179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.484 ' HB2' ' O ' ' B' ' 103' ' ' GLN . 4.2 mm? -88.79 10.27 21.6 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-O 120.927 0.394 . . . . 0.0 111.95 -179.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 t -137.38 39.81 0.5 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.591 179.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . 0.405 ' OE2' ' HA ' ' B' ' 106' ' ' GLU . 42.5 mt-10 -100.24 143.77 27.14 Favored Pre-proline 0 C--O 1.233 0.215 0 CA-C-N 116.009 -0.542 . . . . 0.0 110.934 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -70.52 160.68 48.68 Favored 'Trans proline' 0 C--N 1.354 0.852 0 C-N-CA 122.686 2.257 . . . . 0.0 112.738 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 4.7 mp -142.64 87.46 2.0 Favored 'General case' 0 C--O 1.233 0.22 0 CA-C-O 121.184 0.516 . . . . 0.0 110.252 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 18.0 p -112.53 146.65 35.42 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 115.485 -0.78 . . . . 0.0 111.071 179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.29 121.5 8.29 Favored 'Trans proline' 0 C--N 1.354 0.826 0 C-N-CA 122.638 2.225 . . . . 0.0 112.703 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 53.0 m -126.13 -10.15 6.49 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.86 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -139.73 55.89 0.64 Allowed Glycine 0 C--N 1.333 0.384 0 C-N-CA 121.083 -0.579 . . . . 0.0 112.435 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -102.43 134.22 46.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.786 0.327 . . . . 0.0 110.824 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -85.18 -41.89 15.23 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.331 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.17 -7.71 52.98 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.418 179.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 92.8 m95 62.35 121.79 0.01 OUTLIER 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.559 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 15.1 t . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.207 -0.902 . . . . 0.0 110.822 179.999 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 58.8 mttp . . . . . 0 N--CA 1.488 1.457 0 CA-C-O 120.595 0.236 . . . . 0.0 111.005 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.83 146.74 56.37 Favored Pre-proline 0 C--O 1.233 0.236 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.247 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -68.93 143.79 56.17 Favored 'Trans proline' 0 C--N 1.354 0.846 0 C-N-CA 122.687 2.258 . . . . 0.0 112.809 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.0 m -80.57 -8.1 59.47 Favored 'General case' 0 C--O 1.234 0.274 0 CA-C-N 116.041 -0.527 . . . . 0.0 111.498 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.462 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.8 mp -82.87 -32.26 9.69 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.128 -179.911 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.96 -27.02 28.79 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.557 -179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.0 -32.56 74.15 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.574 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -82.06 -41.36 9.53 Favored Glycine 0 C--N 1.336 0.543 0 C-N-CA 121.109 -0.567 . . . . 0.0 112.208 179.5 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.522 ' O ' HD13 ' A' ' 13' ' ' LEU . 22.1 mt -62.26 -43.16 99.47 Favored 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 122.339 0.256 . . . . 0.0 111.27 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.675 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.1 m -60.79 -39.86 83.16 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.782 0.325 . . . . 0.0 111.713 -179.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.474 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.5 -48.74 49.06 Favored Glycine 0 CA--C 1.518 0.259 0 CA-C-N 116.0 -0.546 . . . . 0.0 112.754 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.8 -41.73 61.97 Favored 'General case' 0 N--CA 1.463 0.222 0 N-CA-C 112.612 0.597 . . . . 0.0 112.612 -179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.522 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -66.75 -39.63 87.97 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-O 120.421 0.153 . . . . 0.0 110.982 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.675 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.7 mp -71.38 -39.57 71.13 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.647 0.26 . . . . 0.0 110.83 178.724 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.515 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.37 -40.11 77.63 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.244 179.502 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.408 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.5 tp -69.85 -32.83 71.43 Favored 'General case' 0 N--CA 1.462 0.151 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.54 179.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.434 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.58 -43.26 73.18 Favored 'General case' 0 CA--C 1.531 0.222 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.059 179.513 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 14' ' ' LEU . 61.7 t -69.0 -43.9 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.471 0 CA-C-N 116.391 -0.368 . . . . 0.0 111.087 179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.515 HG23 ' O ' ' A' ' 15' ' ' LEU . 98.7 t -66.22 -43.04 92.02 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.359 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.014 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.85 -37.58 82.04 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.06 179.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.434 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.4 tp -69.45 -36.04 76.24 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.534 179.368 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.427 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.19 -52.85 25.08 Favored Glycine 0 C--N 1.338 0.64 0 CA-C-N 116.042 -0.526 . . . . 0.0 112.219 179.414 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.577 ' O ' HG12 ' A' ' 27' ' ' ILE . 12.1 mt -65.53 -36.33 77.38 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-O 120.689 0.28 . . . . 0.0 110.456 179.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -64.96 -46.24 89.92 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.183 -0.532 . . . . 0.0 112.37 179.51 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.494 ' HG ' ' NH2' ' A' ' 28' ' ' ARG . 17.5 mt -74.12 -24.38 59.43 Favored 'General case' 0 N--CA 1.462 0.175 0 CA-C-O 120.663 0.268 . . . . 0.0 111.221 179.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.427 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.8 t80 -76.89 -38.07 54.28 Favored 'General case' 0 CA--C 1.531 0.231 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.303 179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.577 HG12 ' O ' ' A' ' 23' ' ' ILE . 46.7 mm -83.68 -33.43 9.6 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.292 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.236 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.494 ' NH2' ' HG ' ' A' ' 25' ' ' LEU . 68.6 mtm180 -64.19 -25.81 68.24 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.67 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 20.2 ttp180 -79.47 -18.2 52.55 Favored 'General case' 0 CA--C 1.533 0.308 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.2 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.07 -21.43 27.69 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.51 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.426 ' HD2' ' O ' ' A' ' 27' ' ' ILE . 42.8 m-70 -69.65 -15.73 63.24 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-N 116.398 -0.364 . . . . 0.0 111.9 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.7 mt -82.58 -16.47 11.6 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.305 0 CA-C-O 120.676 0.274 . . . . 0.0 111.042 179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.45 -46.34 12.95 Favored 'Isoleucine or valine' 0 C--O 1.233 0.191 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.719 179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -119.3 130.31 55.33 Favored 'General case' 0 C--O 1.231 0.132 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.72 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -130.78 -45.27 1.06 Allowed 'General case' 0 C--O 1.233 0.22 0 CA-C-N 116.143 -0.48 . . . . 0.0 111.136 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -138.47 31.55 2.33 Favored 'General case' 0 CA--C 1.531 0.245 0 CA-C-N 116.306 -0.406 . . . . 0.0 111.185 -179.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 18.3 p -83.32 -38.66 21.79 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.675 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.931 ' O ' ' N ' ' A' ' 42' ' ' LEU . 1.5 mm? -89.86 -36.61 14.97 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.515 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.446 ' HD3' ' NE2' ' A' ' 43' ' ' GLN . 98.8 mtt180 -64.4 -28.91 70.01 Favored 'General case' 0 CA--C 1.517 -0.32 0 CA-C-N 115.584 -0.735 . . . . 0.0 109.083 178.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.444 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 31.3 mtt180 -68.1 -20.21 64.91 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 106.985 -1.487 . . . . 0.0 106.985 176.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.515 HD22 HD22 ' B' ' 101' ' ' LEU . 6.9 mt -112.31 -25.76 9.1 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.828 177.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.931 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.3 OUTLIER -87.84 -57.68 2.85 Favored 'General case' 0 C--N 1.352 0.696 0 N-CA-C 111.884 0.327 . . . . 0.0 111.884 -179.228 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.446 ' NE2' ' HD3' ' A' ' 39' ' ' ARG . 36.5 mt-30 -72.6 -21.84 61.06 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.583 -179.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.444 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 8.4 mm-40 -83.82 -19.63 34.63 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.449 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.502 ' HB2' ' O ' ' A' ' 41' ' ' LEU . 3.0 tmt_? -88.59 -11.87 44.29 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.436 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.08 -38.34 3.64 Favored 'General case' 0 N--CA 1.464 0.246 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -179.205 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.07 10.01 25.93 Favored 'General case' 0 N--CA 1.467 0.389 0 CA-C-O 120.968 0.413 . . . . 0.0 111.857 -179.12 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.51 48.0 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.537 179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -97.21 146.18 30.9 Favored Pre-proline 0 CA--C 1.53 0.177 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.927 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.34 145.23 58.91 Favored 'Trans proline' 0 C--N 1.355 0.908 0 C-N-CA 122.651 2.234 . . . . 0.0 112.8 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 9.9 mt -142.79 87.37 1.99 Allowed 'General case' 0 C--O 1.236 0.386 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.251 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.9 p -100.49 147.61 33.83 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-N 115.648 -0.705 . . . . 0.0 111.174 179.618 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.92 1.41 7.13 Favored 'Trans proline' 0 C--N 1.356 0.929 0 C-N-CA 122.695 2.263 . . . . 0.0 113.225 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 45.2 p -86.33 3.18 44.57 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.186 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -129.93 54.93 0.78 Allowed Glycine 0 C--N 1.334 0.417 0 C-N-CA 121.107 -0.568 . . . . 0.0 112.54 -179.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -107.77 149.72 27.85 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 120.708 0.289 . . . . 0.0 110.871 -179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.29 -42.61 14.47 Favored 'General case' 0 CA--C 1.53 0.198 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.207 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.406 ' HB2' ' CE3' ' A' ' 59' ' ' TRP . 9.6 mt -90.08 -9.21 49.3 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.469 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . 0.406 ' CE3' ' HB2' ' A' ' 58' ' ' LEU . 30.9 m-90 -131.38 145.35 51.79 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.878 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.8 m . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.872 -179.986 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 58.9 mttp . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.633 0.254 . . . . 0.0 111.083 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.82 146.77 56.51 Favored Pre-proline 0 CA--C 1.532 0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.225 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -68.93 143.8 56.17 Favored 'Trans proline' 0 C--N 1.354 0.86 0 C-N-CA 122.624 2.216 . . . . 0.0 112.797 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.0 m -80.59 -8.03 59.46 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.536 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.471 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.8 mp -82.91 -32.32 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.063 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.44 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.91 -26.91 28.97 Favored 'General case' 0 N--CA 1.464 0.249 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.612 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -32.62 74.25 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.484 -179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.86 -41.5 9.61 Favored Glycine 0 C--N 1.336 0.533 0 C-N-CA 121.126 -0.559 . . . . 0.0 112.297 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.515 ' O ' HD13 ' B' ' 73' ' ' LEU . 22.1 mt -62.25 -43.07 99.67 Favored 'General case' 0 N--CA 1.461 0.085 0 CA-C-N 115.684 -0.258 . . . . 0.0 111.344 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.668 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.1 m -60.88 -39.79 83.15 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.302 0 CA-C-O 120.733 0.302 . . . . 0.0 111.735 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.491 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.56 -48.6 49.55 Favored Glycine 0 C--N 1.33 0.226 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.862 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.85 -41.7 61.87 Favored 'General case' 0 N--CA 1.462 0.172 0 N-CA-C 112.651 0.612 . . . . 0.0 112.651 -179.105 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.515 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -66.8 -39.67 87.84 Favored 'General case' 0 C--O 1.234 0.253 0 CA-C-O 120.438 0.161 . . . . 0.0 110.944 179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.668 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -71.3 -39.66 71.32 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-N 116.593 -0.276 . . . . 0.0 110.77 178.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.516 ' O ' HG23 ' B' ' 79' ' ' VAL . 0.1 OUTLIER -69.32 -40.03 77.86 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.415 179.397 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.407 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.5 tp -69.92 -32.81 71.29 Favored 'General case' 0 C--O 1.231 0.13 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.5 179.317 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.442 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.6 -43.21 73.24 Favored 'General case' 0 CA--C 1.531 0.238 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.033 179.522 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.616 HG23 ' O ' ' B' ' 74' ' ' LEU . 61.6 t -69.04 -43.91 81.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.448 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.036 179.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.516 HG23 ' O ' ' B' ' 75' ' ' LEU . 99.0 t -66.24 -43.09 91.94 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 CA-C-N 116.512 -0.313 . . . . 0.0 110.957 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.83 -37.57 82.1 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.094 179.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.4 tp -69.46 -36.05 76.21 Favored 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.599 179.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.434 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -68.2 -52.8 25.31 Favored Glycine 0 C--N 1.338 0.639 0 CA-C-N 115.915 -0.584 . . . . 0.0 112.249 179.393 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.582 ' O ' HG12 ' B' ' 87' ' ' ILE . 12.0 mt -65.48 -36.28 77.29 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-O 120.665 0.269 . . . . 0.0 110.537 179.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -64.92 -46.25 89.95 Favored Glycine 0 C--N 1.336 0.581 0 C-N-CA 121.144 -0.55 . . . . 0.0 112.339 179.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . 0.5 ' HG ' ' NH2' ' B' ' 88' ' ' ARG . 17.8 mt -74.14 -24.47 59.43 Favored 'General case' 0 N--CA 1.463 0.214 0 CA-C-O 120.525 0.202 . . . . 0.0 111.071 179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.434 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.8 t80 -76.89 -38.08 54.26 Favored 'General case' 0 CA--C 1.531 0.235 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.306 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.582 HG12 ' O ' ' B' ' 83' ' ' ILE . 46.6 mm -83.59 -33.46 9.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.34 0 CA-C-N 116.382 -0.372 . . . . 0.0 111.258 179.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.5 ' NH2' ' HG ' ' B' ' 85' ' ' LEU . 69.0 mtm180 -64.16 -25.88 68.28 Favored 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 116.619 -0.264 . . . . 0.0 111.638 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 20.1 ttp180 -79.37 -18.32 52.62 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.244 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.02 -21.44 27.78 Favored 'General case' 0 N--CA 1.464 0.225 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.527 -179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 91' ' ' HIS . . . . . 0.417 ' HD2' ' O ' ' B' ' 87' ' ' ILE . 43.0 m-70 -69.63 -15.73 63.25 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 116.365 -0.379 . . . . 0.0 111.926 -179.797 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.7 mt -82.61 -16.34 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.338 0 CA-C-N 116.577 -0.283 . . . . 0.0 111.067 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.6 t -96.55 -46.31 12.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.715 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -119.35 130.18 55.22 Favored 'General case' 0 C--O 1.232 0.176 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.811 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 17.9 mtpp -130.73 -45.1 1.06 Allowed 'General case' 0 N--CA 1.462 0.175 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.098 179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -138.44 31.54 2.34 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.159 -179.887 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 18.2 p -83.37 -38.69 21.67 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.599 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.911 ' O ' ' N ' ' B' ' 102' ' ' LEU . 1.5 mm? -89.83 -36.52 15.04 Favored 'General case' 0 C--O 1.221 -0.41 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.567 -179.823 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . 0.447 ' HD3' ' NE2' ' B' ' 103' ' ' GLN . 98.8 mtt180 -64.35 -29.05 70.13 Favored 'General case' 0 CA--C 1.515 -0.398 0 C-N-CA 123.565 0.746 . . . . 0.0 109.126 178.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.451 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 31.6 mtt180 -67.97 -20.21 65.02 Favored 'General case' 0 CA--C 1.519 -0.243 0 N-CA-C 107.1 -1.444 . . . . 0.0 107.1 176.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.516 ' O ' ' HB2' ' B' ' 105' ' ' ARG . 6.8 mt -112.23 -25.83 9.09 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-N 113.429 -1.714 . . . . 0.0 109.868 177.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.911 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.3 OUTLIER -87.89 -57.72 2.83 Favored 'General case' 0 C--N 1.352 0.713 0 N-CA-C 111.887 0.329 . . . . 0.0 111.887 -179.199 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . 0.447 ' NE2' ' HD3' ' B' ' 99' ' ' ARG . 36.6 mt-30 -72.47 -21.95 61.14 Favored 'General case' 0 N--CA 1.463 0.225 0 CA-C-N 116.478 -0.328 . . . . 0.0 111.685 -179.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.451 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 8.5 mm-40 -83.68 -19.71 34.83 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-N 116.347 -0.388 . . . . 0.0 111.449 179.92 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' B' ' 101' ' ' LEU . 2.9 tmt_? -88.68 -11.74 44.39 Favored 'General case' 0 CA--C 1.532 0.287 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.381 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -116.14 -38.36 3.62 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -179.25 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.13 10.1 25.74 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-O 121.025 0.44 . . . . 0.0 111.882 -179.067 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 t -136.59 48.02 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.763 -0.653 . . . . 0.0 110.501 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -97.18 146.23 30.99 Favored Pre-proline 0 C--O 1.234 0.258 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.908 180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 42.1 Cg_endo -69.39 145.2 58.5 Favored 'Trans proline' 0 C--N 1.354 0.837 0 C-N-CA 122.738 2.292 . . . . 0.0 112.711 179.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 9.9 mt -142.82 87.43 1.99 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.233 0.539 . . . . 0.0 110.303 179.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 17.7 p -100.47 147.62 33.84 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.502 -0.772 . . . . 0.0 111.1 179.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -73.95 1.39 7.17 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 122.634 2.223 . . . . 0.0 113.186 179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 44.4 p -86.29 3.08 44.85 Favored 'General case' 0 C--O 1.235 0.313 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.208 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -129.8 54.99 0.77 Allowed Glycine 0 C--N 1.333 0.387 0 C-N-CA 121.134 -0.555 . . . . 0.0 112.531 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 9.0 mm-40 -107.83 149.6 28.05 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-O 120.692 0.282 . . . . 0.0 110.934 -179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.09 -42.66 14.6 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-N 116.086 -0.506 . . . . 0.0 111.336 -179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . 0.403 ' HB2' ' CE3' ' B' ' 119' ' ' TRP . 9.6 mt -90.08 -9.17 49.45 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.418 -179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 119' ' ' TRP . . . . . 0.403 ' CE3' ' HB2' ' B' ' 118' ' ' LEU . 31.0 m-90 -131.45 145.27 51.71 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.861 -179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 53.0 m . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.867 179.994 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 30.7 tttm . . . . . 0 N--CA 1.486 1.34 0 CA-C-O 120.613 0.244 . . . . 0.0 110.978 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.81 146.78 56.57 Favored Pre-proline 0 CA--C 1.53 0.186 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.197 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 42.0 Cg_endo -69.19 139.52 42.42 Favored 'Trans proline' 0 C--N 1.355 0.918 0 C-N-CA 122.642 2.228 . . . . 0.0 112.834 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.4 m -80.53 -7.19 59.11 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.039 -0.528 . . . . 0.0 111.544 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.473 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.5 mp -82.97 -32.87 9.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 CA-C-N 116.297 -0.411 . . . . 0.0 111.083 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.445 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.95 -27.12 28.74 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.553 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.09 -32.54 74.14 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.593 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.98 -41.41 9.57 Favored Glycine 0 C--N 1.335 0.504 0 C-N-CA 121.157 -0.544 . . . . 0.0 112.233 179.459 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.528 ' O ' HD13 ' A' ' 13' ' ' LEU . 23.4 mt -62.31 -43.32 99.1 Favored 'General case' 0 N--CA 1.462 0.14 0 CA-C-N 115.694 -0.253 . . . . 0.0 111.285 -179.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.66 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.0 m -60.66 -39.56 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.285 0 CA-C-O 120.737 0.303 . . . . 0.0 111.717 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.487 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.5 -49.19 46.11 Favored Glycine 0 CA--C 1.518 0.279 0 CA-C-N 115.928 -0.578 . . . . 0.0 112.82 179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.458 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.5 -41.77 62.65 Favored 'General case' 0 N--CA 1.463 0.183 0 N-CA-C 112.63 0.604 . . . . 0.0 112.63 -179.07 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.528 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.91 -41.39 91.5 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-N 116.767 -0.197 . . . . 0.0 110.818 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.66 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.6 mp -70.35 -39.53 74.6 Favored 'General case' 0 C--O 1.234 0.275 0 CA-C-N 116.567 -0.288 . . . . 0.0 110.902 178.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.31 -37.88 77.99 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.414 179.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.03 -35.01 73.99 Favored 'General case' 0 C--O 1.232 0.138 0 CA-C-N 115.976 -0.557 . . . . 0.0 110.646 179.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.446 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 14.8 mt -69.48 -42.15 75.2 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.174 179.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.601 HG23 ' O ' ' A' ' 14' ' ' LEU . 58.0 t -68.71 -44.97 81.95 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 CA-C-N 116.416 -0.356 . . . . 0.0 111.058 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 15' ' ' LEU . 93.0 t -65.91 -43.19 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.394 0 CA-C-N 116.391 -0.368 . . . . 0.0 110.889 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.15 -37.82 84.43 Favored 'General case' 0 C--O 1.234 0.245 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.078 179.539 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.446 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.2 tp -68.93 -36.31 77.82 Favored 'General case' 0 N--CA 1.463 0.221 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.614 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -68.36 -49.98 41.58 Favored Glycine 0 C--N 1.337 0.616 0 C-N-CA 121.158 -0.544 . . . . 0.0 112.286 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 17.1 mt -64.17 -41.23 91.76 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-O 120.775 0.321 . . . . 0.0 110.495 179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.567 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -64.44 -44.39 95.35 Favored Glycine 0 C--N 1.338 0.69 0 C-N-CA 121.162 -0.542 . . . . 0.0 112.366 179.541 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 20.6 mt -72.78 -24.66 60.97 Favored 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.724 0.297 . . . . 0.0 111.038 179.463 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.91 -40.67 62.98 Favored 'General case' 0 C--O 1.234 0.242 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.11 179.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.418 ' O ' ' HB2' ' A' ' 31' ' ' HIS . 12.4 mt -83.65 -27.27 7.5 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.999 179.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.567 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.3 ttt180 -63.58 -25.79 68.4 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.488 179.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 74.6 mtp180 -81.66 -35.0 30.44 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.329 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.25 -21.27 27.49 Favored 'General case' 0 N--CA 1.466 0.334 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.47 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . 0.418 ' HB2' ' O ' ' A' ' 27' ' ' ILE . 4.3 t60 -69.89 -15.81 63.14 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.804 -179.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 mt -81.51 -10.89 12.36 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.614 -0.266 . . . . 0.0 111.102 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 t -94.18 -45.94 13.61 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.226 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.72 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -127.4 128.14 45.32 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.725 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -129.73 -43.29 1.24 Allowed 'General case' 0 C--O 1.234 0.238 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.159 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.39 17.61 5.94 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 116.332 -0.395 . . . . 0.0 111.271 -179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.19 -32.03 26.79 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.371 -0.377 . . . . 0.0 111.308 -179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.916 ' O ' ' N ' ' A' ' 42' ' ' LEU . 15.8 tp -89.42 -35.73 15.86 Favored 'General case' 0 C--O 1.222 -0.361 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.3 -179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.403 ' O ' ' HB2' ' A' ' 43' ' ' GLN . 27.4 mmt180 -67.52 -28.92 68.23 Favored 'General case' 0 CA--C 1.515 -0.371 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.56 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 27.6 mtp180 -69.96 -18.79 63.37 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 176.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.709 HD22 HD22 ' B' ' 101' ' ' LEU . 13.5 mt -111.33 -27.37 8.68 Favored 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 113.433 -1.712 . . . . 0.0 109.718 177.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.916 ' N ' ' O ' ' A' ' 38' ' ' LEU . 0.7 OUTLIER -79.19 -46.48 17.83 Favored 'General case' 0 C--N 1.351 0.659 0 CA-C-O 120.746 0.308 . . . . 0.0 111.05 -179.69 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . 0.473 ' O ' HD12 ' A' ' 47' ' ' LEU . 13.2 mm-40 -83.32 -3.19 57.24 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.616 179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 10.3 tt0 -83.01 -40.28 20.17 Favored 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.497 179.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -88.41 -11.74 45.21 Favored 'General case' 0 C--O 1.235 0.317 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.532 -179.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 -82.18 -22.99 35.74 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.429 -0.35 . . . . 0.0 111.341 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.473 HD12 ' O ' ' A' ' 43' ' ' GLN . 9.6 mt -100.97 2.03 40.27 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-O 121.196 0.522 . . . . 0.0 111.193 179.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 44' ' ' GLU . 3.5 t -128.08 57.24 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.364 -0.835 . . . . 0.0 110.459 179.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -101.01 148.29 34.88 Favored Pre-proline 0 C--O 1.233 0.201 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.801 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.1 134.77 30.25 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.638 2.226 . . . . 0.0 112.782 179.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 3.9 tp -142.83 87.41 1.99 Allowed 'General case' 0 C--O 1.234 0.281 0 CA-C-O 121.233 0.54 . . . . 0.0 110.171 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 18.0 p -99.69 146.03 31.14 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 115.506 -0.77 . . . . 0.0 111.108 179.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.22 118.38 5.64 Favored 'Trans proline' 0 C--N 1.356 0.935 0 C-N-CA 122.639 2.226 . . . . 0.0 112.743 -179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.1 m -103.05 -11.28 18.24 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.965 179.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 166.27 -55.67 0.25 Allowed Glycine 0 C--N 1.334 0.431 0 C-N-CA 120.969 -0.634 . . . . 0.0 112.458 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -126.71 139.18 53.34 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.622 0.248 . . . . 0.0 110.976 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.24 -40.36 16.71 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.306 -179.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.4 tp -89.98 -8.21 52.2 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.295 -179.873 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -130.47 144.17 51.23 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.858 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.25 1.09 0 CA-C-O 118.257 -0.878 . . . . 0.0 110.805 -179.96 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 30.9 tttm . . . . . 0 N--CA 1.486 1.371 0 CA-C-O 120.61 0.243 . . . . 0.0 110.957 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -136.93 146.65 55.82 Favored Pre-proline 0 C--O 1.234 0.248 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.235 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_endo -69.13 139.46 42.47 Favored 'Trans proline' 0 C--N 1.353 0.806 0 C-N-CA 122.723 2.282 . . . . 0.0 112.78 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.0 m -80.53 -7.13 59.1 Favored 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.543 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.467 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.5 mp -83.04 -32.86 9.88 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-N 116.29 -0.413 . . . . 0.0 111.055 -179.877 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.437 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.9 -27.21 28.77 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.629 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.06 -32.68 74.32 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.498 -179.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.89 -41.33 9.71 Favored Glycine 0 C--N 1.334 0.468 0 C-N-CA 121.104 -0.57 . . . . 0.0 112.264 179.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.524 ' O ' HD13 ' B' ' 73' ' ' LEU . 22.9 mt -62.18 -43.57 98.53 Favored 'General case' 0 C--N 1.334 -0.105 0 C-N-CA 122.377 0.271 . . . . 0.0 111.308 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.653 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.0 m -60.46 -39.61 81.68 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.328 0 CA-C-O 120.746 0.308 . . . . 0.0 111.723 -179.603 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.501 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.48 -49.27 45.71 Favored Glycine 0 CA--C 1.519 0.303 0 CA-C-N 115.902 -0.59 . . . . 0.0 112.718 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.462 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.59 -41.73 62.49 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 112.566 0.58 . . . . 0.0 112.566 -178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.524 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.92 -41.28 91.61 Favored 'General case' 0 C--N 1.33 -0.272 0 O-C-N 123.005 0.191 . . . . 0.0 110.823 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.653 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.6 mp -70.42 -39.56 74.34 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.609 -0.269 . . . . 0.0 110.833 178.939 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.501 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.28 -37.83 78.05 Favored 'General case' 0 N--CA 1.463 0.179 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.413 179.529 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 3.3 tp -70.1 -35.06 73.87 Favored 'General case' 0 CA--C 1.53 0.187 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.6 179.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.447 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 14.8 mt -69.49 -42.07 75.27 Favored 'General case' 0 CA--C 1.53 0.196 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.158 179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.613 HG23 ' O ' ' B' ' 74' ' ' LEU . 57.9 t -68.85 -44.84 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.368 0 CA-C-N 116.59 -0.277 . . . . 0.0 111.085 179.735 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.497 HG23 ' O ' ' B' ' 75' ' ' LEU . 93.6 t -65.84 -43.28 93.22 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.356 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.964 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.25 -37.64 83.85 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-N 116.251 -0.432 . . . . 0.0 111.1 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.447 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.3 tp -68.95 -36.38 77.85 Favored 'General case' 0 CA--C 1.53 0.179 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.608 179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . . . . . . . . . . . -68.33 -50.04 41.41 Favored Glycine 0 C--N 1.337 0.616 0 CA-C-N 115.986 -0.552 . . . . 0.0 112.311 179.391 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . . . . . . . . . 17.0 mt -64.2 -41.1 91.36 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 CA-C-O 120.634 0.254 . . . . 0.0 110.546 179.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . 0.563 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -64.39 -44.52 95.22 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 121.225 -0.512 . . . . 0.0 112.395 179.432 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 20.7 mt -72.69 -24.77 61.05 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-O 120.643 0.259 . . . . 0.0 110.971 179.493 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -73.84 -40.71 63.11 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.114 179.393 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.427 ' O ' ' HB2' ' B' ' 91' ' ' HIS . 12.3 mt -83.53 -27.41 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.996 179.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.563 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.3 ttt180 -63.56 -25.63 68.33 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.476 179.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 74.5 mtp180 -81.8 -34.91 30.03 Favored 'General case' 0 N--CA 1.464 0.245 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.364 -179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -86.26 -21.38 27.4 Favored 'General case' 0 N--CA 1.463 0.208 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.481 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 91' ' ' HIS . . . . . 0.427 ' HB2' ' O ' ' B' ' 87' ' ' ILE . 4.2 t60 -69.81 -15.73 63.16 Favored 'General case' 0 N--CA 1.465 0.312 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.883 -179.652 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 mt -81.55 -11.0 12.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.326 0 CA-C-N 116.591 -0.277 . . . . 0.0 111.101 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.6 t -94.04 -45.94 13.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.778 179.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 85.3 mtm180 -127.34 128.14 45.41 Favored 'General case' 0 C--O 1.233 0.199 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.775 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -129.83 -43.17 1.24 Allowed 'General case' 0 C--O 1.233 0.188 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.162 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -129.32 17.56 5.98 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.329 -0.396 . . . . 0.0 111.309 -179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.15 -32.04 26.86 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.381 -179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.917 ' O ' ' N ' ' B' ' 102' ' ' LEU . 15.8 tp -89.37 -35.75 15.89 Favored 'General case' 0 C--O 1.222 -0.343 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.353 -179.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . 0.402 ' O ' ' HB2' ' B' ' 103' ' ' GLN . 27.4 mmt180 -67.46 -28.92 68.27 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.474 -0.785 . . . . 0.0 108.922 178.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.561 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 27.5 mtp180 -69.99 -18.83 63.35 Favored 'General case' 0 CA--C 1.52 -0.186 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 176.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.709 HD22 HD22 ' A' ' 41' ' ' LEU . 13.3 mt -111.31 -27.3 8.72 Favored 'General case' 0 N--CA 1.447 -0.611 0 CA-C-N 113.506 -1.679 . . . . 0.0 109.777 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.917 ' N ' ' O ' ' B' ' 98' ' ' LEU . 0.7 OUTLIER -79.38 -46.38 17.7 Favored 'General case' 0 C--N 1.351 0.654 0 CA-C-O 120.601 0.238 . . . . 0.0 110.991 -179.661 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . 0.461 ' O ' HD12 ' B' ' 107' ' ' LEU . 13.2 mm-40 -83.27 -3.25 57.26 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.62 179.401 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.561 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 10.3 tt0 -83.06 -40.17 20.23 Favored 'General case' 0 N--CA 1.464 0.246 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.545 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . . . . . . . . . 11.9 mmt180 -88.46 -11.78 44.93 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.558 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -82.06 -23.13 36.0 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.353 179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . 0.461 HD12 ' O ' ' B' ' 103' ' ' GLN . 9.6 mt -100.97 2.09 40.34 Favored 'General case' 0 C--O 1.232 0.177 0 CA-C-O 121.13 0.49 . . . . 0.0 111.136 179.823 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . 0.469 HG23 ' O ' ' B' ' 104' ' ' GLU . 3.5 t -128.1 57.28 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-N 115.391 -0.822 . . . . 0.0 110.453 179.511 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -101.03 148.21 34.78 Favored Pre-proline 0 C--O 1.233 0.221 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.863 179.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -69.19 134.8 30.14 Favored 'Trans proline' 0 C--N 1.355 0.887 0 C-N-CA 122.641 2.227 . . . . 0.0 112.756 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 3.9 tp -142.78 87.36 1.99 Allowed 'General case' 0 C--O 1.234 0.273 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.204 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 18.0 p -99.62 146.08 31.21 Favored Pre-proline 0 C--N 1.327 -0.37 0 CA-C-N 115.572 -0.74 . . . . 0.0 111.107 179.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -69.25 118.34 5.61 Favored 'Trans proline' 0 C--N 1.353 0.8 0 C-N-CA 122.721 2.281 . . . . 0.0 112.8 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 52.6 m -103.13 -11.23 18.21 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.897 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 166.35 -55.73 0.24 Allowed Glycine 0 C--N 1.334 0.442 0 C-N-CA 121.083 -0.58 . . . . 0.0 112.546 -179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -126.79 139.22 53.27 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 120.683 0.277 . . . . 0.0 110.837 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -85.14 -40.48 16.68 Favored 'General case' 0 N--CA 1.463 0.199 0 CA-C-N 116.057 -0.52 . . . . 0.0 111.351 -179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 3.4 tp -90.01 -8.09 52.41 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.356 -179.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -130.5 144.27 51.3 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.765 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 15.4 t . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.135 -0.936 . . . . 0.0 110.823 -179.993 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.486 1.369 0 CA-C-O 120.63 0.252 . . . . 0.0 111.017 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.3 pt -137.0 146.63 55.6 Favored Pre-proline 0 CA--C 1.532 0.258 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.222 -179.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -68.83 140.53 46.58 Favored 'Trans proline' 0 C--N 1.353 0.802 0 C-N-CA 122.713 2.275 . . . . 0.0 112.78 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 14.0 t -80.57 -7.74 59.35 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.496 179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.472 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.5 mp -82.89 -32.57 9.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.334 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.143 -179.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.447 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.96 -26.2 29.45 Favored 'General case' 0 N--CA 1.465 0.28 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.572 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.1 m -63.84 -33.21 75.17 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.343 -0.39 . . . . 0.0 111.562 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.13 9.82 Favored Glycine 0 C--N 1.334 0.423 0 C-N-CA 121.155 -0.545 . . . . 0.0 112.268 179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.521 ' O ' HD13 ' A' ' 13' ' ' LEU . 22.0 mt -62.22 -43.36 99.0 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 122.286 0.235 . . . . 0.0 111.291 179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.679 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 24.0 m -60.9 -39.99 83.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.31 0 CA-C-O 120.769 0.319 . . . . 0.0 111.73 -179.542 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.497 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.26 -48.5 52.01 Favored Glycine 0 CA--C 1.518 0.23 0 CA-C-N 116.043 -0.526 . . . . 0.0 112.828 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.454 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.93 -42.43 60.6 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 112.655 0.613 . . . . 0.0 112.655 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.521 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -66.25 -39.54 89.57 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 116.846 -0.161 . . . . 0.0 110.982 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.679 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.8 mp -71.86 -39.59 69.58 Favored 'General case' 0 C--O 1.233 0.21 0 CA-C-O 120.68 0.276 . . . . 0.0 110.846 178.886 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.504 ' O ' HG23 ' A' ' 19' ' ' VAL . 0.1 OUTLIER -69.75 -39.4 76.75 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.394 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.423 ' HB2' ' O ' ' A' ' 12' ' ' ALA . 2.2 tp -70.22 -33.71 72.0 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.587 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.43 ' O ' ' HB2' ' A' ' 21' ' ' LEU . 3.5 tp -69.49 -43.29 73.44 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-N 116.047 -0.524 . . . . 0.0 111.12 179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.593 HG23 ' O ' ' A' ' 14' ' ' LEU . 58.2 t -69.43 -43.58 80.74 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 CA-C-N 116.442 -0.345 . . . . 0.0 111.129 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.504 HG23 ' O ' ' A' ' 15' ' ' LEU . 89.3 t -66.7 -43.27 90.25 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.369 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.114 179.882 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.38 -39.27 85.61 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 116.282 -0.417 . . . . 0.0 111.158 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.43 ' HB2' ' O ' ' A' ' 17' ' ' LEU . 2.1 tp -69.37 -35.2 75.6 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.598 179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.446 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -68.02 -52.4 28.41 Favored Glycine 0 C--N 1.337 0.611 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.305 179.444 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.597 ' O ' HG12 ' A' ' 27' ' ' ILE . 12.1 mt -65.58 -37.18 79.4 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.339 0 CA-C-O 120.648 0.261 . . . . 0.0 110.566 179.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.569 ' O ' ' HB2' ' A' ' 28' ' ' ARG . . . -64.48 -46.16 91.14 Favored Glycine 0 C--N 1.336 0.566 0 C-N-CA 121.011 -0.614 . . . . 0.0 112.382 179.58 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 17.9 mt -74.21 -24.98 59.41 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 120.497 0.189 . . . . 0.0 111.208 179.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.446 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.1 t80 -75.82 -39.26 57.11 Favored 'General case' 0 CA--C 1.532 0.263 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.278 179.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.597 HG12 ' O ' ' A' ' 23' ' ' ILE . 41.6 mm -83.66 -30.51 7.9 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.116 179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.569 ' HB2' ' O ' ' A' ' 24' ' ' GLY . 31.6 ttt180 -64.91 -26.1 68.17 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 120.693 0.283 . . . . 0.0 111.337 179.814 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.9 -18.19 44.59 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.414 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.54 -21.5 35.35 Favored 'General case' 0 N--CA 1.464 0.24 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.597 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 39.8 m80 -68.48 -21.56 64.61 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.476 -0.329 . . . . 0.0 111.687 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 1.4 mt -83.25 -10.96 11.96 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 116.424 -0.353 . . . . 0.0 111.102 179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 t -96.03 -22.05 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.267 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.918 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . 0.544 ' NH2' ' HB3' ' A' ' 38' ' ' LEU . 45.1 mtp180 -92.15 145.17 24.72 Favored 'General case' 0 C--O 1.234 0.252 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.062 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -108.73 26.4 10.6 Favored 'General case' 0 C--O 1.234 0.286 0 CA-C-N 115.945 -0.571 . . . . 0.0 110.943 179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 58.62 30.79 20.34 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.713 -179.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.432 ' O ' HD12 ' A' ' 41' ' ' LEU . 18.4 p -83.25 -13.87 54.38 Favored 'General case' 0 N--CA 1.465 0.307 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.622 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.968 ' O ' ' N ' ' A' ' 42' ' ' LEU . 13.4 tp -89.02 -40.41 13.0 Favored 'General case' 0 C--O 1.222 -0.353 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.265 -179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.405 ' HA ' ' CB ' ' A' ' 42' ' ' LEU . 74.6 mtp180 -66.45 -31.66 72.54 Favored 'General case' 0 CA--C 1.515 -0.382 0 C-N-CA 123.674 0.79 . . . . 0.0 108.959 178.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.631 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 26.0 mmt180 -69.48 -19.42 63.75 Favored 'General case' 0 CA--C 1.521 -0.142 0 N-CA-C 107.3 -1.37 . . . . 0.0 107.3 177.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.432 HD12 ' O ' ' A' ' 37' ' ' THR . 27.6 mt -111.53 -25.67 9.46 Favored 'General case' 0 N--CA 1.448 -0.558 0 CA-C-N 113.787 -1.551 . . . . 0.0 110.008 177.899 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.968 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.3 tt -70.93 -43.91 67.22 Favored 'General case' 0 C--N 1.351 0.65 0 CA-C-O 120.623 0.249 . . . . 0.0 110.996 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 54.2 mt-30 -87.52 -13.62 42.53 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.475 179.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.631 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 9.1 tt0 -84.16 -39.69 19.1 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.055 -0.52 . . . . 0.0 111.669 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.406 ' HG3' ' CD1' ' B' ' 101' ' ' LEU . 21.3 mmt180 -88.19 -12.24 44.44 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.843 -179.28 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -100.09 12.87 35.89 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-O 120.782 0.325 . . . . 0.0 111.094 179.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.7 tp 58.87 34.37 23.62 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.416 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.1 t 54.12 52.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.471 0.625 0 CA-C-N 115.841 -0.618 . . . . 0.0 111.347 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -101.1 141.08 21.91 Favored Pre-proline 0 C--O 1.233 0.219 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.89 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_endo -70.68 135.19 27.69 Favored 'Trans proline' 0 C--N 1.354 0.867 0 C-N-CA 122.671 2.247 . . . . 0.0 112.787 179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 2.6 tt -142.84 87.28 1.98 Allowed 'General case' 0 C--O 1.234 0.247 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.14 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.9 t -139.41 139.78 23.69 Favored Pre-proline 0 CA--C 1.535 0.368 0 CA-C-N 115.532 -0.758 . . . . 0.0 111.07 179.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -73.86 0.63 8.03 Favored 'Trans proline' 0 C--N 1.354 0.825 0 C-N-CA 122.564 2.176 . . . . 0.0 113.133 179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 52.8 m -87.15 3.85 44.69 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.242 179.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 101.26 -108.8 3.5 Favored Glycine 0 C--N 1.335 0.509 0 C-N-CA 120.984 -0.627 . . . . 0.0 112.539 -179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -126.73 141.95 51.69 Favored 'General case' 0 C--O 1.232 0.154 0 CA-C-O 120.733 0.302 . . . . 0.0 110.862 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -85.23 -41.37 15.66 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-N 116.065 -0.516 . . . . 0.0 111.394 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.02 -8.76 50.79 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 116.275 -0.421 . . . . 0.0 111.475 -179.883 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -130.45 141.27 50.53 Favored 'General case' 0 C--O 1.233 0.211 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.829 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 53.4 m . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.169 -0.919 . . . . 0.0 110.886 179.983 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 120.683 0.278 . . . . 0.0 110.882 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.3 pt -136.97 146.85 56.6 Favored Pre-proline 0 CA--C 1.532 0.286 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.095 -179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -69.1 140.61 45.6 Favored 'Trans proline' 0 C--N 1.354 0.861 0 C-N-CA 122.628 2.219 . . . . 0.0 112.743 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 14.1 t -80.6 -7.7 59.35 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.472 -179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.465 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.5 mp -83.01 -32.6 9.73 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.33 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.051 -179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.444 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.85 -26.22 29.65 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.688 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.1 m -63.95 -33.13 75.02 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.551 -179.737 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.92 -41.15 9.82 Favored Glycine 0 C--N 1.335 0.494 0 C-N-CA 121.19 -0.528 . . . . 0.0 112.333 179.464 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.518 ' O ' HD13 ' B' ' 73' ' ' LEU . 21.9 mt -62.24 -43.14 99.5 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-N 115.648 -0.276 . . . . 0.0 111.393 179.94 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.674 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.2 m -60.97 -40.13 84.45 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.307 0 CA-C-O 120.883 0.373 . . . . 0.0 111.699 -179.586 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.515 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -68.22 -48.48 52.42 Favored Glycine 0 C--N 1.33 0.217 0 CA-C-N 115.955 -0.566 . . . . 0.0 112.9 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.457 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.95 -42.5 60.43 Favored 'General case' 0 N--CA 1.462 0.138 0 N-CA-C 112.605 0.595 . . . . 0.0 112.605 -179.037 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.518 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -66.2 -39.65 89.82 Favored 'General case' 0 C--O 1.235 0.324 0 CA-C-N 116.867 -0.151 . . . . 0.0 110.874 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.674 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -71.85 -39.42 69.71 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-O 120.591 0.234 . . . . 0.0 110.861 178.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.515 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.95 -39.38 76.1 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.385 179.536 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . 0.427 ' HB2' ' O ' ' B' ' 72' ' ' ALA . 2.2 tp -70.09 -33.84 72.4 Favored 'General case' 0 N--CA 1.462 0.134 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.593 179.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . 0.428 ' O ' ' HB2' ' B' ' 81' ' ' LEU . 3.5 tp -69.37 -43.36 73.71 Favored 'General case' 0 CA--C 1.533 0.307 0 CA-C-N 116.031 -0.531 . . . . 0.0 111.074 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.606 HG23 ' O ' ' B' ' 74' ' ' LEU . 58.2 t -69.41 -43.48 80.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.457 0 CA-C-N 116.373 -0.376 . . . . 0.0 111.165 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.486 HG23 ' O ' ' B' ' 75' ' ' LEU . 88.8 t -66.71 -43.38 90.14 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.317 0 CA-C-N 116.497 -0.32 . . . . 0.0 111.029 179.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.43 -39.25 85.43 Favored 'General case' 0 C--O 1.234 0.25 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.151 179.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' B' ' 77' ' ' LEU . 2.1 tp -69.21 -35.28 76.05 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.669 179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.453 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.98 -52.43 28.44 Favored Glycine 0 C--N 1.339 0.709 0 CA-C-N 115.998 -0.546 . . . . 0.0 112.241 179.431 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.592 ' O ' HG12 ' B' ' 87' ' ' ILE . 12.0 mt -65.6 -37.21 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 CA-C-O 120.667 0.27 . . . . 0.0 110.564 179.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . 0.568 ' O ' ' HB2' ' B' ' 88' ' ' ARG . . . -64.41 -46.18 91.22 Favored Glycine 0 C--N 1.337 0.612 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.485 179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 18.0 mt -74.18 -24.86 59.43 Favored 'General case' 0 N--CA 1.465 0.294 0 CA-C-O 120.547 0.213 . . . . 0.0 111.252 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.453 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.2 t80 -76.02 -39.25 56.1 Favored 'General case' 0 CA--C 1.532 0.271 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.107 179.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.592 HG12 ' O ' ' B' ' 83' ' ' ILE . 41.5 mm -83.56 -30.53 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.186 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . 0.568 ' HB2' ' O ' ' B' ' 84' ' ' GLY . 31.7 ttt180 -64.97 -26.07 68.14 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 116.511 -0.313 . . . . 0.0 111.254 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -81.99 -18.22 44.16 Favored 'General case' 0 N--CA 1.465 0.322 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.272 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -82.52 -21.53 35.38 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.54 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -68.5 -21.55 64.59 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.741 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 1.3 mt -83.16 -11.03 11.99 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.097 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.97 -22.06 5.32 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.944 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . 0.549 ' NH2' ' HB3' ' B' ' 98' ' ' LEU . 45.5 mtp180 -92.15 145.12 24.76 Favored 'General case' 0 N--CA 1.462 0.145 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.053 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -108.8 26.68 10.28 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.971 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 95.0 mtt180 58.61 30.67 20.17 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.681 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.432 ' O ' HD12 ' B' ' 101' ' ' LEU . 18.5 p -83.25 -13.87 54.38 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.659 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.944 ' O ' ' N ' ' B' ' 102' ' ' LEU . 13.3 tp -88.96 -40.41 13.06 Favored 'General case' 0 C--O 1.222 -0.387 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.317 -179.992 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . 0.407 ' HA ' ' CB ' ' B' ' 102' ' ' LEU . 74.8 mtp180 -66.5 -31.59 72.41 Favored 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.646 0.778 . . . . 0.0 109.015 178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.63 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 26.1 mmt180 -69.42 -19.46 63.8 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 107.366 -1.346 . . . . 0.0 107.366 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.432 HD12 ' O ' ' B' ' 97' ' ' THR . 27.8 mt -111.47 -25.68 9.48 Favored 'General case' 0 N--CA 1.448 -0.551 0 CA-C-N 113.832 -1.531 . . . . 0.0 110.048 177.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.944 ' N ' ' O ' ' B' ' 98' ' ' LEU . 1.3 tt -70.94 -43.85 67.32 Favored 'General case' 0 C--N 1.352 0.679 0 CA-C-O 120.666 0.269 . . . . 0.0 110.984 -179.564 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -87.46 -13.71 42.46 Favored 'General case' 0 C--O 1.233 0.203 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.508 179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.63 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 9.1 tt0 -84.05 -39.84 19.1 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.628 -179.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.411 ' HG3' ' CD1' ' A' ' 41' ' ' LEU . 21.3 mmt180 -88.14 -12.18 44.78 Favored 'General case' 0 N--CA 1.465 0.282 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.765 -179.255 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -100.17 12.81 36.13 Favored 'General case' 0 C--O 1.234 0.258 0 CA-C-O 120.816 0.341 . . . . 0.0 111.038 179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 3.6 tp 59.01 34.26 23.47 Favored 'General case' 0 N--CA 1.471 0.579 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.392 179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 t 54.13 52.71 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 CA-C-N 115.806 -0.634 . . . . 0.0 111.301 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -101.02 141.13 22.02 Favored Pre-proline 0 CA--C 1.529 0.17 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.905 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 49.2 Cg_endo -70.8 135.23 27.51 Favored 'Trans proline' 0 C--N 1.355 0.885 0 C-N-CA 122.592 2.195 . . . . 0.0 112.778 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 2.6 tt -142.92 87.33 1.98 Allowed 'General case' 0 C--O 1.232 0.183 0 CA-C-O 121.224 0.535 . . . . 0.0 110.07 -179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 6.9 t -139.53 139.69 23.14 Favored Pre-proline 0 CA--C 1.534 0.362 0 CA-C-N 115.454 -0.794 . . . . 0.0 111.016 179.598 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 59.2 Cg_endo -73.62 0.55 8.0 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.653 2.236 . . . . 0.0 113.269 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 53.0 m -87.25 3.9 44.8 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.173 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . 101.18 -108.74 3.49 Favored Glycine 0 C--N 1.335 0.475 0 C-N-CA 121.05 -0.595 . . . . 0.0 112.481 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -126.73 141.98 51.68 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.693 0.282 . . . . 0.0 110.841 -179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -85.35 -41.33 15.59 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.3 -179.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.06 -8.62 51.02 Favored 'General case' 0 C--O 1.234 0.262 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.504 -179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 10.6 t-105 -130.51 141.3 50.49 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.735 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 53.1 m . . . . . 0 C--O 1.249 1.059 0 CA-C-O 118.168 -0.92 . . . . 0.0 110.951 179.94 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' LYS . . . . . . . . . . . . . 97.1 mttt . . . . . 0 N--CA 1.487 1.386 0 CA-C-O 120.669 0.271 . . . . 0.0 110.919 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.13 146.48 54.65 Favored Pre-proline 0 CA--C 1.532 0.273 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.166 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' PRO . . . . . . . . . . . . . 40.3 Cg_endo -69.05 141.43 48.09 Favored 'Trans proline' 0 C--N 1.354 0.834 0 C-N-CA 122.636 2.224 . . . . 0.0 112.666 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 53.8 m -80.72 -7.43 59.35 Favored 'General case' 0 CA--C 1.531 0.242 0 CA-C-N 116.01 -0.541 . . . . 0.0 111.513 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.463 ' H ' HD12 ' A' ' 5' ' ' ILE . 2.6 mp -82.96 -32.73 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.287 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.134 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ALA . . . . . 0.444 ' O ' HG22 ' A' ' 10' ' ' VAL . . . -83.99 -26.23 29.36 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.62 -179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -64.04 -33.08 74.94 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.539 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -81.79 -41.13 9.95 Favored Glycine 0 C--N 1.335 0.477 0 C-N-CA 121.21 -0.519 . . . . 0.0 112.382 179.378 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.524 ' O ' HD13 ' A' ' 13' ' ' LEU . 21.9 mt -62.3 -43.55 98.56 Favored 'General case' 0 N--CA 1.462 0.143 0 CA-C-N 115.7 -0.25 . . . . 0.0 111.37 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.662 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 23.5 m -60.71 -40.48 85.0 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 CA-C-O 120.808 0.337 . . . . 0.0 111.761 -179.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLY . . . . . 0.511 ' O ' ' HB2' ' A' ' 15' ' ' LEU . . . -68.0 -48.88 51.45 Favored Glycine 0 C--O 1.235 0.201 0 CA-C-N 115.957 -0.565 . . . . 0.0 112.808 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ALA . . . . . 0.452 ' HB2' ' C ' ' B' ' 71' ' ' GLY . . . -73.57 -42.82 61.11 Favored 'General case' 0 N--CA 1.464 0.262 0 N-CA-C 112.686 0.624 . . . . 0.0 112.686 -179.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.524 HD13 ' O ' ' A' ' 9' ' ' LEU . 10.8 mp -65.25 -41.16 94.56 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 120.442 0.163 . . . . 0.0 110.927 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.662 ' HB2' ' O ' ' A' ' 10' ' ' VAL . 3.9 mp -70.54 -40.01 73.67 Favored 'General case' 0 C--O 1.234 0.27 0 CA-C-O 120.626 0.251 . . . . 0.0 110.953 178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.511 ' HB2' ' O ' ' A' ' 11' ' ' GLY . 0.1 OUTLIER -69.46 -36.84 76.97 Favored 'General case' 0 N--CA 1.462 0.162 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.603 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.3 tp -69.93 -36.8 75.61 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.573 179.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 16.7 mt -68.48 -44.22 75.25 Favored 'General case' 0 N--CA 1.463 0.217 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.274 179.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.587 HG23 ' O ' ' A' ' 14' ' ' LEU . 61.9 t -67.35 -44.88 86.89 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.416 0 CA-C-N 116.537 -0.301 . . . . 0.0 111.229 179.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' VAL . . . . . 0.476 HG23 ' O ' ' A' ' 15' ' ' LEU . 83.8 t -67.03 -39.11 82.64 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.048 179.932 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -67.72 -41.2 83.88 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.407 -0.36 . . . . 0.0 111.054 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 20.6 mt -69.36 -34.33 74.41 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.657 179.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.447 ' O ' ' HB2' ' A' ' 26' ' ' PHE . . . -67.35 -54.3 20.78 Favored Glycine 0 C--N 1.338 0.667 0 CA-C-N 116.017 -0.538 . . . . 0.0 112.277 179.476 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.538 ' O ' HG12 ' A' ' 27' ' ' ILE . 15.1 mt -66.3 -35.72 75.65 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.354 0 CA-C-O 120.592 0.234 . . . . 0.0 110.634 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -65.06 -45.98 90.24 Favored Glycine 0 C--N 1.336 0.582 0 C-N-CA 121.108 -0.568 . . . . 0.0 112.473 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.56 -24.69 56.69 Favored 'General case' 0 N--CA 1.464 0.274 0 CA-C-O 120.53 0.205 . . . . 0.0 111.299 179.789 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' PHE . . . . . 0.447 ' HB2' ' O ' ' A' ' 22' ' ' GLY . 7.9 t80 -77.78 -36.87 50.0 Favored 'General case' 0 CA--C 1.533 0.295 0 CA-C-N 116.477 -0.328 . . . . 0.0 111.333 179.696 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.538 HG12 ' O ' ' A' ' 23' ' ' ILE . 52.1 mm -83.69 -36.62 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.327 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.309 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 22.5 mmt180 -67.65 -29.2 68.45 Favored 'General case' 0 N--CA 1.467 0.403 0 CA-C-N 116.637 -0.256 . . . . 0.0 111.619 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -82.1 -18.24 43.69 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.469 179.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . . . . . . . . . 73.5 mtp180 -85.32 -21.77 28.8 Favored 'General case' 0 N--CA 1.465 0.297 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.529 -179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' HIS . . . . . . . . . . . . . 23.7 m80 -81.97 -15.93 52.13 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.489 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ILE . . . . . . . . . . . . . 6.8 mm -83.32 -11.76 11.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 CA-C-N 116.411 -0.358 . . . . 0.0 110.965 179.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.71 -18.74 6.52 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.271 0 CA-C-N 116.283 -0.417 . . . . 0.0 111.02 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ARG . . . . . . . . . . . . . 87.9 mtt180 -92.65 151.72 19.95 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 116.367 -0.379 . . . . 0.0 111.161 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 48.6 tttt -99.04 173.63 6.73 Favored 'General case' 0 CA--C 1.531 0.237 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.614 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.85 28.5 0.68 Allowed 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.461 -179.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.435 HG21 ' CZ ' ' B' ' 105' ' ' ARG . 9.1 t -83.23 -15.32 50.81 Favored 'General case' 0 CA--C 1.533 0.31 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.673 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LEU . . . . . 0.956 ' O ' ' N ' ' A' ' 42' ' ' LEU . 0.2 OUTLIER -89.31 -38.83 13.89 Favored 'General case' 0 C--O 1.221 -0.403 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.415 -179.964 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -66.98 -29.4 69.24 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.025 178.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 44' ' ' GLU . 98.8 mtt180 -70.06 -18.41 63.28 Favored 'General case' 0 CA--C 1.52 -0.183 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' LEU . . . . . 0.973 HD22 HD22 ' B' ' 101' ' ' LEU . 38.7 mt -112.09 -26.69 8.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-N 113.435 -1.711 . . . . 0.0 110.115 177.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.956 ' N ' ' O ' ' A' ' 38' ' ' LEU . 1.2 tt -90.12 -53.09 4.63 Favored 'General case' 0 C--N 1.351 0.647 0 N-CA-C 111.767 0.284 . . . . 0.0 111.767 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.89 -24.25 55.64 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.492 -179.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' A' ' 40' ' ' ARG . 28.8 mt-10 -83.92 -19.84 34.02 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 116.527 -0.306 . . . . 0.0 111.748 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ARG . . . . . 0.542 ' HB2' ' O ' ' A' ' 41' ' ' LEU . 2.4 tmt_? -88.06 -31.71 19.13 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.546 -0.297 . . . . 0.0 110.959 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -92.32 0.73 57.47 Favored 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.103 179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 5.5 mp 56.81 35.36 26.17 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.637 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.0 t 54.49 51.59 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.635 0 CA-C-N 115.844 -0.617 . . . . 0.0 111.232 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -111.0 143.21 27.85 Favored Pre-proline 0 C--O 1.232 0.151 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.951 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -70.68 163.89 37.39 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 122.623 2.215 . . . . 0.0 112.66 179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.78 87.39 1.99 Allowed 'General case' 0 C--O 1.235 0.3 0 CA-C-O 121.244 0.545 . . . . 0.0 110.221 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.7 p -139.27 146.77 50.28 Favored Pre-proline 0 C--N 1.328 -0.361 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.067 179.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -68.92 118.53 5.73 Favored 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.763 2.309 . . . . 0.0 112.789 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 40.6 p -109.41 -10.44 14.9 Favored 'General case' 0 C--O 1.233 0.216 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.957 179.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -100.61 101.23 2.27 Favored Glycine 0 C--N 1.334 0.431 0 C-N-CA 121.017 -0.611 . . . . 0.0 112.477 -179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 63.37 127.66 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.008 0.523 . . . . 0.0 111.608 -179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -85.13 -38.23 19.29 Favored 'General case' 0 C--O 1.233 0.219 0 CA-C-N 115.913 -0.585 . . . . 0.0 111.407 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 5.6 mp -90.13 -9.03 49.83 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.445 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' TRP . . . . . . . . . . . . . 8.2 t-105 -131.66 145.49 51.69 Favored 'General case' 0 C--O 1.232 0.184 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.754 -179.963 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.2 m . . . . . 0 C--O 1.251 1.17 0 CA-C-O 118.248 -0.882 . . . . 0.0 110.915 179.975 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 61' ' ' LYS . . . . . . . . . . . . . 97.2 mttt . . . . . 0 N--CA 1.486 1.355 0 CA-C-O 120.718 0.294 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 62' ' ' ILE . . . . . . . . . . . . . 1.7 pp -137.04 146.5 54.96 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.224 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 63' ' ' PRO . . . . . . . . . . . . . 40.8 Cg_endo -69.06 141.41 48.02 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.623 2.215 . . . . 0.0 112.771 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 64' ' ' SER . . . . . . . . . . . . . 53.6 m -80.6 -7.55 59.3 Favored 'General case' 0 N--CA 1.464 0.273 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.493 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 65' ' ' ILE . . . . . 0.474 HD12 ' H ' ' B' ' 65' ' ' ILE . 2.6 mp -82.88 -32.9 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.343 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.094 -179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 66' ' ' ALA . . . . . 0.45 ' O ' HG22 ' B' ' 70' ' ' VAL . . . -83.98 -26.14 29.44 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.544 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 67' ' ' THR . . . . . . . . . . . . . 1.3 m -64.03 -33.16 75.12 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.47 -179.798 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 68' ' ' GLY . . . . . . . . . . . . . . . -81.88 -41.05 9.92 Favored Glycine 0 C--N 1.334 0.43 0 C-N-CA 121.139 -0.553 . . . . 0.0 112.329 179.5 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 69' ' ' LEU . . . . . 0.533 ' O ' HD13 ' B' ' 73' ' ' LEU . 22.1 mt -62.42 -43.6 98.43 Favored 'General case' 0 CA--C 1.527 0.069 0 CA-C-N 115.691 -0.254 . . . . 0.0 111.324 -179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 70' ' ' VAL . . . . . 0.658 ' O ' ' HB2' ' B' ' 74' ' ' LEU . 24.4 m -60.45 -40.64 84.81 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.873 0.368 . . . . 0.0 111.825 -179.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 71' ' ' GLY . . . . . 0.523 ' O ' ' HB2' ' B' ' 75' ' ' LEU . . . -67.97 -48.91 51.43 Favored Glycine 0 CA--C 1.518 0.236 0 CA-C-N 115.942 -0.572 . . . . 0.0 112.819 -179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 72' ' ' ALA . . . . . 0.46 ' HB2' ' C ' ' A' ' 11' ' ' GLY . . . -73.62 -42.74 61.09 Favored 'General case' 0 N--CA 1.463 0.179 0 N-CA-C 112.68 0.622 . . . . 0.0 112.68 -178.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 73' ' ' LEU . . . . . 0.533 HD13 ' O ' ' B' ' 69' ' ' LEU . 10.8 mp -65.27 -41.24 94.43 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 116.882 -0.144 . . . . 0.0 110.862 -179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 74' ' ' LEU . . . . . 0.658 ' HB2' ' O ' ' B' ' 70' ' ' VAL . 3.8 mp -70.61 -39.94 73.48 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-N 116.58 -0.282 . . . . 0.0 110.895 179.03 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 75' ' ' LEU . . . . . 0.523 ' HB2' ' O ' ' B' ' 71' ' ' GLY . 0.1 OUTLIER -69.52 -36.85 76.82 Favored 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.485 179.611 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 76' ' ' LEU . . . . . . . . . . . . . 4.3 tp -69.96 -36.61 75.39 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.64 179.402 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 77' ' ' LEU . . . . . . . . . . . . . 16.6 mt -68.67 -44.01 74.95 Favored 'General case' 0 C--O 1.233 0.227 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.274 179.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 78' ' ' VAL . . . . . 0.595 HG23 ' O ' ' B' ' 74' ' ' LEU . 61.6 t -67.48 -44.98 86.33 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.472 0 CA-C-N 116.535 -0.302 . . . . 0.0 111.134 179.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 79' ' ' VAL . . . . . 0.463 HG23 ' O ' ' B' ' 75' ' ' LEU . 84.7 t -66.78 -39.23 83.18 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.438 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.096 179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 80' ' ' ALA . . . . . . . . . . . . . . . -67.77 -41.19 83.68 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.345 -0.389 . . . . 0.0 111.042 179.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 81' ' ' LEU . . . . . . . . . . . . . 20.7 mt -69.36 -34.39 74.51 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.636 179.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 82' ' ' GLY . . . . . 0.437 ' O ' ' HB2' ' B' ' 86' ' ' PHE . . . -67.27 -54.19 21.68 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 121.144 -0.551 . . . . 0.0 112.398 179.437 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 83' ' ' ILE . . . . . 0.533 ' O ' HG12 ' B' ' 87' ' ' ILE . 14.9 mt -66.4 -35.73 75.63 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.335 0 CA-C-O 120.553 0.216 . . . . 0.0 110.599 179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 84' ' ' GLY . . . . . . . . . . . . . . . -65.06 -46.12 89.8 Favored Glycine 0 C--N 1.336 0.555 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.435 179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 85' ' ' LEU . . . . . . . . . . . . . 16.4 mt -75.34 -24.77 57.4 Favored 'General case' 0 N--CA 1.463 0.219 0 CA-C-O 120.569 0.223 . . . . 0.0 111.351 179.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 86' ' ' PHE . . . . . 0.437 ' HB2' ' O ' ' B' ' 82' ' ' GLY . 7.9 t80 -77.88 -36.82 49.28 Favored 'General case' 0 CA--C 1.533 0.32 0 CA-C-N 116.446 -0.343 . . . . 0.0 111.282 179.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 87' ' ' ILE . . . . . 0.533 HG12 ' O ' ' B' ' 83' ' ' ILE . 52.2 mm -83.63 -36.61 12.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.349 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.344 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 88' ' ' ARG . . . . . . . . . . . . . 22.6 mmt180 -67.7 -29.17 68.36 Favored 'General case' 0 N--CA 1.467 0.402 0 CA-C-N 116.621 -0.263 . . . . 0.0 111.571 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 89' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -82.21 -18.18 43.52 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.416 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 90' ' ' ARG . . . . . . . . . . . . . 73.6 mtp180 -85.3 -21.83 28.8 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 116.35 -0.386 . . . . 0.0 111.521 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 91' ' ' HIS . . . . . . . . . . . . . 23.6 m80 -81.96 -16.07 51.68 Favored 'General case' 0 N--CA 1.464 0.252 0 CA-C-N 116.452 -0.34 . . . . 0.0 111.483 -179.906 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 92' ' ' ILE . . . . . . . . . . . . . 6.7 mm -83.18 -11.7 12.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 CA-C-N 116.356 -0.383 . . . . 0.0 111.046 179.847 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 93' ' ' VAL . . . . . . . . . . . . . 3.5 t -95.75 -18.66 6.54 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.273 -0.422 . . . . 0.0 111.102 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 94' ' ' ARG . . . . . . . . . . . . . 87.8 mtt180 -92.77 151.71 19.88 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.048 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 95' ' ' LYS . . . . . . . . . . . . . 48.4 tttt -98.92 173.68 6.73 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.687 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 96' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -84.9 28.51 0.69 Allowed 'General case' 0 CA--C 1.536 0.432 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.391 -179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 97' ' ' THR . . . . . 0.432 HG21 ' CZ ' ' A' ' 45' ' ' ARG . 8.9 t -83.32 -15.32 50.5 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.623 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 98' ' ' LEU . . . . . 0.931 ' O ' ' N ' ' B' ' 102' ' ' LEU . 0.2 OUTLIER -89.28 -38.75 13.97 Favored 'General case' 0 C--O 1.22 -0.462 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.427 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 99' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -67.08 -29.35 69.1 Favored 'General case' 0 CA--C 1.515 -0.375 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 178.474 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 100' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' B' ' 104' ' ' GLU . 98.8 mtt180 -70.17 -18.31 63.2 Favored 'General case' 0 CA--C 1.52 -0.18 0 N-CA-C 106.904 -1.517 . . . . 0.0 106.904 176.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' LEU . . . . . 0.973 HD22 HD22 ' A' ' 41' ' ' LEU . 38.3 mt -112.12 -26.65 8.73 Favored 'General case' 0 N--CA 1.447 -0.621 0 CA-C-N 113.428 -1.715 . . . . 0.0 110.074 177.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' LEU . . . . . 0.931 ' N ' ' O ' ' B' ' 98' ' ' LEU . 1.2 tt -90.17 -53.11 4.61 Favored 'General case' 0 C--N 1.351 0.636 0 N-CA-C 111.727 0.269 . . . . 0.0 111.727 -179.141 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -75.73 -24.51 56.16 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.528 -179.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' GLU . . . . . 0.536 ' HB2' ' O ' ' B' ' 100' ' ' ARG . 29.0 mt-10 -83.72 -19.9 34.39 Favored 'General case' 0 N--CA 1.465 0.281 0 CA-C-N 116.493 -0.321 . . . . 0.0 111.806 -179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' ARG . . . . . 0.543 ' HB2' ' O ' ' B' ' 101' ' ' LEU . 2.4 tmt_? -88.09 -31.61 19.15 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 116.484 -0.326 . . . . 0.0 111.003 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -92.31 0.72 57.47 Favored 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.125 179.848 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' LEU . . . . . . . . . . . . . 5.5 mp 56.84 35.34 26.16 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.679 -179.88 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' VAL . . . . . . . . . . . . . 3.0 t 54.56 51.55 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.649 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.205 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -111.07 143.18 27.81 Favored Pre-proline 0 N--CA 1.463 0.191 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.92 -179.936 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.71 163.87 37.5 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.591 2.194 . . . . 0.0 112.67 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -142.69 87.19 1.98 Allowed 'General case' 0 C--O 1.235 0.317 0 CA-C-O 121.131 0.491 . . . . 0.0 110.259 -179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' THR . . . . . . . . . . . . . 17.6 p -139.22 146.81 50.61 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.048 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -69.02 118.52 5.73 Favored 'Trans proline' 0 C--N 1.354 0.827 0 C-N-CA 122.639 2.226 . . . . 0.0 112.786 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' SER . . . . . . . . . . . . . 39.8 p -109.34 -10.48 14.92 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.804 -0.635 . . . . 0.0 111.025 179.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' GLY . . . . . . . . . . . . . . . -100.59 101.18 2.26 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.473 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' GLU . . . . . . . . . . . . . 9.2 mm-40 63.51 127.57 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 122.965 0.506 . . . . 0.0 111.588 -179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 117' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -85.14 -38.22 19.29 Favored 'General case' 0 C--O 1.233 0.186 0 CA-C-N 115.991 -0.549 . . . . 0.0 111.346 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 118' ' ' LEU . . . . . . . . . . . . . 5.7 mp -90.02 -9.19 49.52 Favored 'General case' 0 C--O 1.233 0.195 0 CA-C-N 116.341 -0.391 . . . . 0.0 111.427 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 119' ' ' TRP . . . . . . . . . . . . . 8.3 t-105 -131.57 145.58 51.79 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.805 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 120' ' ' SER . . . . . . . . . . . . . 52.5 m . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.303 -0.856 . . . . 0.0 110.923 179.969 . . . . . . . . 0 0 . 1 stop_ save_